DrugA,DrugB,Interaction,Mechanism,risk_level
Cilostazol,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Cilostazol.,increase,risk
Cilostazol,Vilazodone,The metabolism of Cilostazol can be decreased when combined with Vilazodone.,decrease,no risk
Cilostazol,Viloxazine,The metabolism of Cilostazol can be decreased when combined with Viloxazine.,decrease,no risk
Cilostazol,Vinblastine,The metabolism of Cilostazol can be decreased when combined with Vinblastine.,decrease,no risk
Cilostazol,Vincristine,The metabolism of Vincristine can be decreased when combined with Cilostazol.,decrease,no risk
Cilostazol,Vindesine,The risk or severity of bleeding can be increased when Cilostazol is combined with Vindesine.,increase,risk
Cilostazol,Vinorelbine,The risk or severity of bleeding can be increased when Cilostazol is combined with Vinorelbine.,increase,risk
Cilostazol,Vitamin E,Vitamin E may increase the antiplatelet activities of Cilostazol.,increase,no risk
Cilostazol,Vonoprazan,The risk or severity of adverse effects can be increased when Vonoprazan is combined with Cilostazol.,increase,risk
Cilostazol,Vorapaxar,The risk or severity of bleeding can be increased when Cilostazol is combined with Vorapaxar.,increase,risk
Cilostazol,Voriconazole,The serum concentration of Cilostazol can be increased when it is combined with Voriconazole.,increase,no risk
Cilostazol,Vorinostat,The risk or severity of bleeding can be increased when Cilostazol is combined with Vorinostat.,increase,risk
Cilostazol,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Cilostazol.,increase,risk
Cilostazol,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Cilostazol.,decrease,no risk
Cilostazol,Warfarin,The serum concentration of Cilostazol can be increased when it is combined with Warfarin.,increase,no risk
Cilostazol,Xamoterol,The risk or severity of Tachycardia can be increased when Cilostazol is combined with Xamoterol.,increase,risk
Cilostazol,Ximelagatran,The risk or severity of bleeding can be increased when Cilostazol is combined with Ximelagatran.,increase,risk
Cilostazol,Xylometazoline,The risk or severity of Tachycardia can be increased when Cilostazol is combined with Xylometazoline.,increase,risk
Cilostazol,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Cilostazol.,decrease,no risk
Cilostazol,Zafirlukast,The serum concentration of Cilostazol can be increased when it is combined with Zafirlukast.,increase,no risk
Cilostazol,Zaleplon,Zaleplon may decrease the excretion rate of Cilostazol which could result in a higher serum level.,decrease,no risk
Cilostazol,Zanamivir,Zanamivir may decrease the excretion rate of Cilostazol which could result in a higher serum level.,decrease,no risk
Cilostazol,Zidovudine,The risk or severity of bleeding can be increased when Cilostazol is combined with Zidovudine.,increase,risk
Cilostazol,Zileuton,The metabolism of Cilostazol can be decreased when combined with Zileuton.,decrease,no risk
Cilostazol,Zimelidine,The metabolism of Cilostazol can be decreased when combined with Zimelidine.,decrease,no risk
Cilostazol,Ziprasidone,The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Ziprasidone.,increase,risk
Cilostazol,Zolmitriptan,The metabolism of Cilostazol can be decreased when combined with Zolmitriptan.,decrease,no risk
Cilostazol,Zolpidem,The metabolism of Cilostazol can be decreased when combined with Zolpidem.,decrease,no risk
Cilostazol,Zonisamide,The serum concentration of Cilostazol can be increased when it is combined with Zonisamide.,increase,no risk
Cilostazol,Zotepine,The metabolism of Zotepine can be decreased when combined with Cilostazol.,decrease,no risk
Cilostazol,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Zuclopenthixol.,increase,risk
Itraconazole,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Bepridil,The metabolism of Bepridil can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Betamethasone,The metabolism of Betamethasone can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Betaxolol,The risk or severity of hyperkalemia can be increased when Betaxolol is combined with Itraconazole.,increase,risk
Itraconazole,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Bilastine,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Bilastine.,increase,risk
Itraconazole,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Itraconazole,Bisoprolol,The metabolism of Bisoprolol can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Boceprevir,The serum concentration of Boceprevir can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Bosentan,The metabolism of Bosentan can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Itraconazole.,increase,risk
Itraconazole,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Brompheniramine,The metabolism of Brompheniramine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Itraconazole.,increase,risk
Itraconazole,Budesonide,The metabolism of Budesonide can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Bumadizone,The risk or severity of hyperkalemia can be increased when Itraconazole is combined with Bumadizone.,increase,risk
Itraconazole,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Bupropion,The serum concentration of Bupropion can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Buserelin,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Buserelin.,increase,risk
Itraconazole,Buspirone,The serum concentration of Buspirone can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Busulfan,The metabolism of Busulfan can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Butriptyline,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Butriptyline.,increase,risk
Itraconazole,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Gadobenic acid.,increase,risk
Itraconazole,Galantamine,The metabolism of Galantamine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Itraconazole.,increase,risk
Itraconazole,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Gemifloxacin.,increase,risk
Itraconazole,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Glecaprevir,Itraconazole may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Itraconazole,Glofitamab,The serum concentration of Itraconazole can be increased when it is combined with Glofitamab.,increase,no risk
Itraconazole,Glyburide,The metabolism of Glyburide can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Goserelin,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Goserelin.,increase,risk
Itraconazole,Granisetron,The metabolism of Granisetron can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Haloperidol,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Haloperidol.,increase,risk
Itraconazole,Halothane,The metabolism of Halothane can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Itraconazole.,increase,risk
Itraconazole,Histrelin,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Histrelin.,increase,risk
Itraconazole,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Itraconazole.,increase,risk
Itraconazole,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Itraconazole,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Hydroxyzine.,increase,risk
Itraconazole,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Itraconazole.,increase,risk
Itraconazole,Ketamine,The metabolism of Ketamine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Ketoconazole,The metabolism of Itraconazole can be decreased when combined with Ketoconazole.,decrease,no risk
Itraconazole,Ketoprofen,The risk or severity of hyperkalemia can be increased when Ketoprofen is combined with Itraconazole.,increase,risk
Itraconazole,Ketorolac,The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Itraconazole.,increase,risk
Itraconazole,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Itraconazole.,increase,risk
Itraconazole,Ofloxacin,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Ofloxacin.,increase,risk
Itraconazole,Olanzapine,Olanzapine can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Itraconazole,Olaparib,The metabolism of Olaparib can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Itraconazole.,increase,risk
Itraconazole,Olodaterol,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Olodaterol.,increase,risk
Itraconazole,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Ombitasvir,Itraconazole may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Itraconazole,Omeprazole,Omeprazole can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Itraconazole,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Opium,The metabolism of Opium can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Itraconazole.,increase,risk
Itraconazole,Oxaprozin,The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Itraconazole.,increase,risk
Itraconazole,Oxatomide,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Oxatomide.,increase,risk
Itraconazole,Oxprenolol,The risk or severity of hyperkalemia can be increased when Itraconazole is combined with Oxprenolol.,increase,risk
Itraconazole,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Itraconazole is combined with Oxyphenbutazone.,increase,risk
Itraconazole,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Itraconazole.,increase,risk
Itraconazole,Ozanimod,Itraconazole may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Itraconazole,Quazepam,The metabolism of Quazepam can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Itraconazole.,increase,risk
Itraconazole,Quinidine,The metabolism of Quinidine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Quinine,The metabolism of Quinine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Udenafil,The metabolism of Udenafil can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Vadadustat,The serum concentration of Itraconazole can be increased when it is combined with Vadadustat.,increase,no risk
Itraconazole,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Valsartan,The risk or severity of hyperkalemia can be increased when Valsartan is combined with Itraconazole.,increase,risk
Itraconazole,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Itraconazole.,increase,risk
Itraconazole,Venetoclax,The risk or severity of tumor lysis syndrome can be increased when Itraconazole is combined with Venetoclax.,increase,risk
Itraconazole,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Verapamil,The metabolism of Verapamil can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Vernakalant,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Vernakalant.,increase,risk
Itraconazole,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Viloxazine,The metabolism of Itraconazole can be decreased when combined with Viloxazine.,decrease,no risk
Itraconazole,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Vincristine,The metabolism of Vincristine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Vindesine,The metabolism of Vindesine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Itraconazole,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Voriconazole,The metabolism of Itraconazole can be decreased when combined with Voriconazole.,decrease,no risk
Itraconazole,Vorinostat,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Vorinostat.,increase,risk
Itraconazole,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Itraconazole.,increase,no risk
Itraconazole,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Warfarin,The metabolism of Warfarin can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Xylometazoline,The therapeutic efficacy of Itraconazole can be increased when used in combination with Xylometazoline.,increase,no risk
Itraconazole,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Ziconotide,The therapeutic efficacy of Itraconazole can be increased when used in combination with Ziconotide.,increase,no risk
Itraconazole,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Zileuton,The metabolism of Zileuton can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Zimelidine,The metabolism of Itraconazole can be decreased when combined with Zimelidine.,decrease,no risk
Itraconazole,Ziprasidone,The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Ziprasidone.,increase,risk
Itraconazole,Zofenopril,The risk or severity of hyperkalemia can be increased when Itraconazole is combined with Zofenopril.,increase,risk
Itraconazole,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Zotepine,The metabolism of Zotepine can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Itraconazole.,decrease,no risk
Itraconazole,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Itraconazole.,increase,no risk
Procarbazine,Bendroflumethiazide,Procarbazine may increase the hypotensive activities of Bendroflumethiazide.,increase,no risk
Procarbazine,Benperidol,The risk or severity of adverse effects can be increased when Procarbazine is combined with Benperidol.,increase,risk
Procarbazine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Procarbazine is combined with Benzocaine.,increase,risk
Procarbazine,Benzphetamine,Procarbazine may increase the hypertensive activities of Benzphetamine.,increase,no risk
Procarbazine,Benzthiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Procarbazine.,increase,risk
Procarbazine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Procarbazine is combined with Benzyl alcohol.,increase,risk
Procarbazine,Bepridil,Procarbazine may increase the hypotensive activities of Bepridil.,increase,no risk
Procarbazine,Betahistine,The metabolism of Betahistine can be decreased when combined with Procarbazine.,decrease,no risk
Procarbazine,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Procarbazine.,increase,risk
Procarbazine,Betaxolol,Procarbazine may increase the hypotensive activities of Betaxolol.,increase,no risk
Procarbazine,Bethanidine,Procarbazine may increase the hypotensive activities of Bethanidine.,increase,no risk
Procarbazine,Betrixaban,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Betrixaban.,increase,risk
Procarbazine,Bexagliflozin,Procarbazine may increase the hypoglycemic activities of Bexagliflozin.,increase,no risk
Procarbazine,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Procarbazine.,increase,risk
Procarbazine,Bezafibrate,Procarbazine may increase the hepatotoxic activities of Bezafibrate.,increase,no risk
Procarbazine,Bimekizumab,The risk or severity of adverse effects can be increased when Procarbazine is combined with Bimekizumab.,increase,risk
Procarbazine,Bisoprolol,Procarbazine may increase the hypotensive activities of Bisoprolol.,increase,no risk
Procarbazine,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Bivalirudin.,increase,risk
Procarbazine,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Procarbazine.,increase,risk
Procarbazine,Blinatumomab,The risk or severity of adverse effects can be increased when Procarbazine is combined with Blinatumomab.,increase,risk
Procarbazine,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Procarbazine.",decrease,no risk
Procarbazine,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Procarbazine.,increase,risk
Procarbazine,Bosentan,Procarbazine may increase the hypotensive activities of Bosentan.,increase,no risk
Procarbazine,Bosutinib,The risk or severity of adverse effects can be increased when Procarbazine is combined with Bosutinib.,increase,risk
Procarbazine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Procarbazine.,increase,risk
Procarbazine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Procarbazine.,increase,risk
Procarbazine,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Procarbazine is combined with Brentuximab vedotin.,increase,risk
Procarbazine,Bretylium,Procarbazine may increase the hypotensive activities of Bretylium.,increase,no risk
Procarbazine,Brexanolone,The risk or severity of CNS depression can be increased when Procarbazine is combined with Brexanolone.,increase,risk
Procarbazine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Procarbazine.,decrease,no risk
Procarbazine,Brimonidine,The metabolism of Brimonidine can be decreased when combined with Procarbazine.,decrease,no risk
Procarbazine,Brivaracetam,The risk or severity of CNS depression can be increased when Procarbazine is combined with Brivaracetam.,increase,risk
Procarbazine,Brodalumab,The risk or severity of adverse effects can be increased when Procarbazine is combined with Brodalumab.,increase,risk
Procarbazine,Bromazepam,The risk or severity of CNS depression can be increased when Procarbazine is combined with Bromazepam.,increase,risk
Procarbazine,Bromocriptine,Procarbazine may increase the hypertensive activities of Bromocriptine.,increase,no risk
Procarbazine,Bromperidol,The risk or severity of adverse effects can be increased when Procarbazine is combined with Bromperidol.,increase,risk
Procarbazine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Procarbazine.,increase,risk
Procarbazine,Budesonide,The risk or severity of adverse effects can be increased when Procarbazine is combined with Budesonide.,increase,risk
Procarbazine,Bumetanide,Procarbazine may increase the orthostatic hypotensive activities of Bumetanide.,increase,no risk
Procarbazine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Procarbazine is combined with Bupivacaine.,increase,risk
Procarbazine,Buprenorphine,Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Procarbazine,Bupropion,The risk or severity of adverse effects can be increased when Procarbazine is combined with Bupropion.,increase,risk
Procarbazine,Buspirone,The risk or severity of hypertension can be increased when Procarbazine is combined with Buspirone.,increase,risk
Procarbazine,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Procarbazine.,increase,risk
Procarbazine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Procarbazine.,increase,risk
Procarbazine,Butacaine,The risk or severity of methemoglobinemia can be increased when Procarbazine is combined with Butacaine.,increase,risk
Procarbazine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Procarbazine.,increase,risk
Procarbazine,Butamben,The risk or severity of methemoglobinemia can be increased when Procarbazine is combined with Butamben.,increase,risk
Procarbazine,Butaperazine,The risk or severity of extrapyramidal symptoms can be increased when Procarbazine is combined with Butaperazine.,increase,risk
Procarbazine,Butobarbital,The risk or severity of CNS depression can be increased when Procarbazine is combined with Butobarbital.,increase,risk
Procarbazine,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Procarbazine.,increase,risk
Procarbazine,Butriptyline,Procarbazine may increase the serotonergic activities of Butriptyline.,increase,no risk
Procarbazine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Procarbazine.,increase,risk
Procarbazine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Procarbazine is combined with Gabapentin enacarbil.,increase,risk
Procarbazine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Procarbazine.,increase,risk
Procarbazine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Procarbazine is combined with Ganaxolone.",increase,risk
Procarbazine,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Procarbazine.",increase,risk
Procarbazine,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Procarbazine.,increase,risk
Procarbazine,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Procarbazine is combined with Gemfibrozil.",increase,risk
Procarbazine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Procarbazine.,increase,risk
Procarbazine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Procarbazine.,increase,risk
Procarbazine,Gilteritinib,The therapeutic efficacy of Procarbazine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Procarbazine,Glatiramer,The risk or severity of adverse effects can be increased when Procarbazine is combined with Glatiramer.,increase,risk
Procarbazine,Gliclazide,Procarbazine may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Procarbazine,Glimepiride,Procarbazine may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Procarbazine,Glipizide,Procarbazine may increase the hypoglycemic activities of Glipizide.,increase,no risk
Procarbazine,Gliquidone,Procarbazine may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Procarbazine,Glutethimide,The risk or severity of CNS depression can be increased when Procarbazine is combined with Glutethimide.,increase,risk
Procarbazine,Glyburide,Procarbazine may increase the hypoglycemic activities of Glyburide.,increase,no risk
Procarbazine,Glymidine,Procarbazine may increase the hypoglycemic activities of Glymidine.,increase,no risk
Procarbazine,Golimumab,The risk or severity of adverse effects can be increased when Procarbazine is combined with Golimumab.,increase,risk
Procarbazine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Procarbazine.,increase,risk
Procarbazine,Guanabenz,Procarbazine may increase the hypotensive activities of Guanabenz.,increase,no risk
Procarbazine,Guanadrel,Procarbazine may increase the hypotensive activities of Guanadrel.,increase,no risk
Procarbazine,Guanethidine,Procarbazine may increase the hypotensive activities of Guanethidine.,increase,no risk
Procarbazine,Guanfacine,Procarbazine may increase the hypotensive activities of Guanfacine.,increase,no risk
Procarbazine,Guanoxan,Procarbazine may increase the hypotensive activities of Guanoxan.,increase,no risk
Procarbazine,Guselkumab,The risk or severity of adverse effects can be increased when Procarbazine is combined with Guselkumab.,increase,risk
Procarbazine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Procarbazine.,decrease,no risk
Procarbazine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Procarbazine.,increase,risk
Procarbazine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Procarbazine.,increase,risk
Procarbazine,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Procarbazine.,increase,risk
Procarbazine,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Heparin.,increase,risk
Procarbazine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Procarbazine.,decrease,no risk
Procarbazine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Procarbazine.,decrease,no risk
Procarbazine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Procarbazine.,increase,risk
Procarbazine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Procarbazine.,increase,risk
Procarbazine,Hydralazine,Procarbazine may increase the hypotensive activities of Hydralazine.,increase,no risk
Procarbazine,Hydrochlorothiazide,Procarbazine may increase the hypotensive activities of Hydrochlorothiazide.,increase,no risk
Procarbazine,Hydrocodone,Procarbazine may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Procarbazine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Procarbazine is combined with Hydrocortisone acetate.,increase,risk
Procarbazine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Procarbazine is combined with Hydrocortisone butyrate.,increase,risk
Procarbazine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Procarbazine is combined with Hydrocortisone succinate.,increase,risk
Procarbazine,Hydroflumethiazide,Procarbazine may increase the hypotensive activities of Hydroflumethiazide.,increase,no risk
Procarbazine,Hydromorphone,Procarbazine may increase the serotonergic activities of Hydromorphone.,increase,no risk
Procarbazine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Procarbazine is combined with Hydroxychloroquine.,increase,risk
Procarbazine,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Procarbazine.,increase,risk
Procarbazine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Procarbazine.,increase,no risk
Procarbazine,Hyoscyamine,Procarbazine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Procarbazine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Procarbazine.,decrease,no risk
Procarbazine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Procarbazine.,decrease,no risk
Procarbazine,Ketamine,The risk or severity of CNS depression can be increased when Procarbazine is combined with Ketamine.,increase,risk
Procarbazine,Ketazolam,The risk or severity of CNS depression can be increased when Procarbazine is combined with Ketazolam.,increase,risk
Procarbazine,Obinutuzumab,The risk or severity of adverse effects can be increased when Procarbazine is combined with Obinutuzumab.,increase,risk
Procarbazine,Ocrelizumab,The risk or severity of adverse effects can be increased when Procarbazine is combined with Ocrelizumab.,increase,risk
Procarbazine,Ofatumumab,The risk or severity of adverse effects can be increased when Procarbazine is combined with Ofatumumab.,increase,risk
Procarbazine,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ofloxacin is combined with Procarbazine.",increase,risk
Procarbazine,Olanzapine,Procarbazine may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Procarbazine,Olaparib,The risk or severity of adverse effects can be increased when Procarbazine is combined with Olaparib.,increase,risk
Procarbazine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Procarbazine is combined with Oliceridine.",increase,risk
Procarbazine,Olmesartan,Procarbazine may increase the hypotensive activities of Olmesartan.,increase,no risk
Procarbazine,Olodaterol,The risk or severity of adverse effects can be increased when Procarbazine is combined with Olodaterol.,increase,risk
Procarbazine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Procarbazine.,increase,risk
Procarbazine,Opicapone,Procarbazine may increase the orthostatic hypotensive activities of Opicapone.,increase,no risk
Procarbazine,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Procarbazine.,increase,risk
Procarbazine,Orciprenaline,The risk or severity of adverse effects can be increased when Procarbazine is combined with Orciprenaline.,increase,risk
Procarbazine,Orphenadrine,Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Procarbazine,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Procarbazine.,increase,risk
Procarbazine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Procarbazine.,increase,risk
Procarbazine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Procarbazine.,increase,risk
Procarbazine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Procarbazine is combined with Oxetacaine.,increase,risk
Procarbazine,Oxitriptan,The risk or severity of CNS depression can be increased when Procarbazine is combined with Oxitriptan.,increase,risk
Procarbazine,Oxprenolol,Procarbazine may increase the hypotensive activities of Oxprenolol.,increase,no risk
Procarbazine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Procarbazine is combined with Oxybuprocaine.,increase,risk
Procarbazine,Oxycodone,Procarbazine may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Oxycodone.,increase,no risk
Procarbazine,Oxymetazoline,The serum concentration of Oxymetazoline can be increased when it is combined with Procarbazine.,increase,no risk
Procarbazine,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Procarbazine.,increase,risk
Procarbazine,Ozanimod,The risk or severity of adverse effects can be increased when Procarbazine is combined with Ozanimod.,increase,risk
Procarbazine,Quazepam,The risk or severity of CNS depression can be increased when Procarbazine is combined with Quazepam.,increase,risk
Procarbazine,Quetiapine,Procarbazine may increase the orthostatic hypotensive activities of Quetiapine.,increase,no risk
Procarbazine,Quinapril,Procarbazine may increase the hypotensive activities of Quinapril.,increase,no risk
Procarbazine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Procarbazine.,increase,risk
Procarbazine,Quinupramine,Procarbazine may increase the serotonergic activities of Quinupramine.,increase,no risk
Procarbazine,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Procarbazine is combined with Ubidecarenone.",increase,risk
Procarbazine,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Procarbazine.,increase,risk
Procarbazine,Upadacitinib,The risk or severity of adverse effects can be increased when Procarbazine is combined with Upadacitinib.,increase,risk
Procarbazine,Urethane,The risk or severity of CNS depression can be increased when Procarbazine is combined with Urethane.,increase,risk
Procarbazine,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Urokinase.,increase,risk
Procarbazine,Valbenazine,The risk or severity of adverse effects can be increased when Procarbazine is combined with Valbenazine.,increase,risk
Procarbazine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Procarbazine is combined with Valproate bismuth.,increase,risk
Procarbazine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Procarbazine.,increase,risk
Procarbazine,Valsartan,Procarbazine may increase the hypotensive activities of Valsartan.,increase,no risk
Procarbazine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Procarbazine.,increase,risk
Procarbazine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Procarbazine.,decrease,no risk
Procarbazine,Vecuronium,The risk or severity of CNS depression can be increased when Procarbazine is combined with Vecuronium.,increase,risk
Procarbazine,Vedolizumab,The risk or severity of adverse effects can be increased when Procarbazine is combined with Vedolizumab.,increase,risk
Procarbazine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Procarbazine is combined with Venlafaxine.,increase,risk
Procarbazine,Verapamil,Procarbazine may increase the orthostatic hypotensive activities of Verapamil.,increase,no risk
Procarbazine,Vericiguat,Procarbazine may increase the orthostatic hypotensive activities of Vericiguat.,increase,no risk
Procarbazine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Procarbazine.,decrease,no risk
Procarbazine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Procarbazine.,increase,risk
Procarbazine,Vilanterol,The risk or severity of hypertension and cardiovascular complications can be increased when Procarbazine is combined with Vilanterol.,increase,risk
Procarbazine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Procarbazine.,decrease,no risk
Procarbazine,Vildagliptin,Procarbazine may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Procarbazine,Viloxazine,The risk or severity of hypertension can be increased when Viloxazine is combined with Procarbazine.,increase,risk
Procarbazine,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Procarbazine.,increase,risk
Procarbazine,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Procarbazine.,increase,risk
Procarbazine,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Procarbazine.,increase,risk
Procarbazine,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Procarbazine.,increase,risk
Procarbazine,Voclosporin,The risk or severity of adverse effects can be increased when Procarbazine is combined with Voclosporin.,increase,risk
Procarbazine,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Vorapaxar.,increase,risk
Procarbazine,Vorinostat,The risk or severity of adverse effects can be increased when Procarbazine is combined with Vorinostat.,increase,risk
Procarbazine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Procarbazine.,decrease,no risk
Procarbazine,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Warfarin.,increase,risk
Procarbazine,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Ximelagatran.,increase,risk
Procarbazine,Xylometazoline,Procarbazine may increase the hypertensive activities of Xylometazoline.,increase,no risk
Procarbazine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Procarbazine.,increase,risk
Procarbazine,Yohimbine,The risk or severity of CNS depression can be increased when Procarbazine is combined with Yohimbine.,increase,risk
Procarbazine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Procarbazine.,increase,risk
Procarbazine,Ziconotide,The risk or severity of CNS depression can be increased when Procarbazine is combined with Ziconotide.,increase,risk
Procarbazine,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Procarbazine.,increase,risk
Procarbazine,Zimelidine,Procarbazine may increase the serotonergic activities of Zimelidine.,increase,no risk
Procarbazine,Ziprasidone,The risk or severity of adverse effects can be increased when Procarbazine is combined with Ziprasidone.,increase,risk
Procarbazine,Zofenopril,Procarbazine may increase the hypotensive activities of Zofenopril.,increase,no risk
Procarbazine,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Procarbazine is combined with Zolmitriptan.,increase,risk
Procarbazine,Zolpidem,Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Procarbazine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Procarbazine.,increase,risk
Procarbazine,Zopiclone,The risk or severity of adverse effects can be increased when Procarbazine is combined with Zopiclone.,increase,risk
Procarbazine,Zotepine,The risk or severity of adverse effects can be increased when Procarbazine is combined with Zotepine.,increase,risk
Procarbazine,Zuclopenthixol,The risk or severity of adverse effects can be increased when Procarbazine is combined with Zuclopenthixol.,increase,risk
Procarbazine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Procarbazine.,increase,risk
Arsenic trioxide,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Arsenic trioxide.,decrease,no risk
Arsenic trioxide,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Bacitracin,Bacitracin may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Baclofen,Baclofen may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Balsalazide,Balsalazide may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Baricitinib,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Baricitinib.,increase,risk
Arsenic trioxide,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Beclomethasone dipropionate,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Bedaquiline,The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Bedaquiline.,increase,risk
Arsenic trioxide,Belantamab mafodotin,The serum concentration of Belantamab mafodotin can be increased when it is combined with Arsenic trioxide.,increase,no risk
Arsenic trioxide,Belatacept,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Belatacept.,increase,risk
Arsenic trioxide,Belimumab,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Belimumab.,increase,risk
Arsenic trioxide,Belinostat,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Belinostat.,increase,risk
Arsenic trioxide,Belumosudil,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Belumosudil.,increase,risk
Arsenic trioxide,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Benazepril,The risk or severity of adverse effects can be increased when Benazepril is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Arsenic trioxide.,increase,no risk
Arsenic trioxide,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Arsenic trioxide,Benorilate,Benorilate may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Benserazide,Arsenic trioxide may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Benznidazole,Arsenic trioxide may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Benzocaine,The risk or severity of methemoglobinemia can be increased when Arsenic trioxide is combined with Benzocaine.,increase,risk
Arsenic trioxide,Benzthiazide,Benzthiazide may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Arsenic trioxide,Benzydamine,Benzydamine may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Arsenic trioxide is combined with Benzyl alcohol.,increase,risk
Arsenic trioxide,Bepotastine,Arsenic trioxide may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Bepridil,The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Bepridil.,increase,risk
Arsenic trioxide,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Arsenic trioxide.,increase,no risk
Arsenic trioxide,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Betaxolol,The risk or severity of adverse effects can be increased when Betaxolol is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Bethanidine,Arsenic trioxide may increase the hypotensive activities of Bethanidine.,increase,no risk
Arsenic trioxide,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Arsenic trioxide.,increase,no risk
Arsenic trioxide,Bevacizumab,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Arsenic trioxide.,decrease,no risk
Arsenic trioxide,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Bicisate,Arsenic trioxide may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Bimekizumab,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Bimekizumab.,increase,risk
Arsenic trioxide,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Arsenic trioxide.,increase,no risk
Arsenic trioxide,Bismuth subgallate,Arsenic trioxide may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Arsenic trioxide.,increase,no risk
Arsenic trioxide,Bisoxatin,Arsenic trioxide may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Blinatumomab,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Blinatumomab.,increase,risk
Arsenic trioxide,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Arsenic trioxide.",decrease,no risk
Arsenic trioxide,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Arsenic trioxide.,increase,no risk
Arsenic trioxide,Bosentan,Arsenic trioxide may increase the hypotensive activities of Bosentan.,increase,no risk
Arsenic trioxide,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Arsenic trioxide.,increase,no risk
Arsenic trioxide,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Arsenic trioxide.,increase,no risk
Arsenic trioxide,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Brivaracetam,Arsenic trioxide may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Brodalumab,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Brodalumab.,increase,risk
Arsenic trioxide,Bromazepam,Arsenic trioxide may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Arsenic trioxide.,decrease,no risk
Arsenic trioxide,Bromotheophylline,Bromotheophylline may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Arsenic trioxide,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Budesonide,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Budesonide.,increase,risk
Arsenic trioxide,Bumadizone,Bumadizone may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Bumetanide,Bumetanide may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Arsenic trioxide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Arsenic trioxide is combined with Bupivacaine.,increase,risk
Arsenic trioxide,Bupropion,Bupropion may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Buspirone,Buspirone may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Butabarbital,Butabarbital may increase the hypotensive activities of Arsenic trioxide.,increase,no risk
Arsenic trioxide,Butacaine,The risk or severity of methemoglobinemia can be increased when Arsenic trioxide is combined with Butacaine.,increase,risk
Arsenic trioxide,Butalbital,Butalbital may increase the hypotensive activities of Arsenic trioxide.,increase,no risk
Arsenic trioxide,Butamben,The risk or severity of methemoglobinemia can be increased when Arsenic trioxide is combined with Butamben.,increase,risk
Arsenic trioxide,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Gabapentin enacarbil,Arsenic trioxide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Gadodiamide,Gadodiamide may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Gadofosveset trisodium,Arsenic trioxide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Gadoteric acid,Arsenic trioxide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Gadoteridol,Gadoteridol may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Ganciclovir,Ganciclovir may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Arsenic trioxide.,increase,no risk
Arsenic trioxide,Gemfibrozil,Arsenic trioxide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Gentamicin,Arsenic trioxide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Gimeracil,Arsenic trioxide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Givosiran,Givosiran may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Glasdegib,The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Glasdegib.,increase,risk
Arsenic trioxide,Glatiramer,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Glatiramer.,increase,risk
Arsenic trioxide,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Arsenic trioxide.,increase,no risk
Arsenic trioxide,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Arsenic trioxide.,decrease,no risk
Arsenic trioxide,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Arsenic trioxide.,decrease,no risk
Arsenic trioxide,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Arsenic trioxide.,decrease,no risk
Arsenic trioxide,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Arsenic trioxide.,decrease,no risk
Arsenic trioxide,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Arsenic trioxide.,decrease,no risk
Arsenic trioxide,Glycerol phenylbutyrate,Arsenic trioxide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Arsenic trioxide.,decrease,no risk
Arsenic trioxide,Golimumab,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Golimumab.,increase,risk
Arsenic trioxide,Golodirsen,Arsenic trioxide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Arsenic trioxide.,increase,no risk
Arsenic trioxide,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Guanabenz,Arsenic trioxide may increase the hypotensive activities of Guanabenz.,increase,no risk
Arsenic trioxide,Guanadrel,Arsenic trioxide may increase the hypotensive activities of Guanadrel.,increase,no risk
Arsenic trioxide,Guanethidine,Arsenic trioxide may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Guanoxan,Arsenic trioxide may increase the hypotensive activities of Guanoxan.,increase,no risk
Arsenic trioxide,Guselkumab,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Guselkumab.,increase,risk
Arsenic trioxide,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Arsenic trioxide.,decrease,no risk
Arsenic trioxide,Halofantrine,The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Halofantrine.,increase,risk
Arsenic trioxide,Haloperidol,The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Haloperidol.,increase,risk
Arsenic trioxide,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Arsenic trioxide.,decrease,no risk
Arsenic trioxide,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Arsenic trioxide.,decrease,no risk
Arsenic trioxide,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Hydralazine,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Hydralazine.,increase,risk
Arsenic trioxide,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Hydrocortisone acetate.,increase,risk
Arsenic trioxide,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Hydrocortisone butyrate.,increase,risk
Arsenic trioxide,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Hydrocortisone succinate.,increase,risk
Arsenic trioxide,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Arsenic trioxide,Hydromorphone,Hydromorphone may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Hydroxychloroquine.,increase,risk
Arsenic trioxide,Hydroxyethyl Starch,Arsenic trioxide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Hydroxyzine.,increase,risk
Arsenic trioxide,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Arsenic trioxide.,decrease,no risk
Arsenic trioxide,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Arsenic trioxide.,decrease,no risk
Arsenic trioxide,Kanamycin,Arsenic trioxide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Ketamine,Arsenic trioxide may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Ketazolam,Arsenic trioxide may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Ketoprofen,Ketoprofen may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Ketorolac,Ketorolac may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Obinutuzumab,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Obinutuzumab.,increase,risk
Arsenic trioxide,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Arsenic trioxide.,increase,no risk
Arsenic trioxide,Octinoxate,Arsenic trioxide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Arsenic trioxide,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Arsenic trioxide.,increase,risk
Arsenic trioxide,Ofatumumab,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Ofatumumab.,increase,risk
Guanethidine,Bumadizone,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Bumadizone.,decrease,no risk
Guanethidine,Bumetanide,Bumetanide may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Guanethidine,Bupivacaine,Bupivacaine may increase the hypotensive activities of Guanethidine.,increase,no risk
Guanethidine,Bupropion,Bupropion may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Buspirone,Buspirone may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Guanethidine,Butabarbital,Butabarbital may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Butriptyline,Butriptyline may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Guanethidine,Gabapentin enacarbil,Guanethidine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Guanethidine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Gadodiamide,Gadodiamide may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Gadofosveset trisodium,Guanethidine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Guanethidine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Gadoteric acid,Guanethidine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Guanethidine,Gadoteridol,Gadoteridol may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Ganciclovir,Ganciclovir may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Gemcitabine,Gemcitabine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Gemfibrozil,Guanethidine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Guanethidine,Gentamicin,Guanethidine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Guanethidine,Gimeracil,Guanethidine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Guanethidine,Givosiran,Givosiran may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Glipizide,Glipizide may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Glycerol phenylbutyrate,Guanethidine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Guanethidine,Glycol salicylate,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Guanethidine,Golodirsen,Guanethidine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Guanethidine,Goserelin,Goserelin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Guanabenz,Guanabenz may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Guanethidine,Guanadrel,Guanadrel may increase the hypotensive activities of Guanethidine.,increase,no risk
Guanethidine,Guanfacine,Guanfacine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Guanethidine,Guanoxan,Guanethidine may increase the hypotensive activities of Guanoxan.,increase,no risk
Guanethidine,Haloperidol,Haloperidol may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Halothane,Halothane may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Guanethidine,Hydralazine,Guanethidine may increase the hypotensive activities of Hydralazine.,increase,no risk
Guanethidine,Hydrochlorothiazide,The therapeutic efficacy of Guanethidine can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Guanethidine,Hydroflumethiazide,The therapeutic efficacy of Guanethidine can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Guanethidine,Hydromorphone,Hydromorphone may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Hydroxyethyl Starch,Guanethidine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Guanethidine,Kanamycin,Guanethidine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Guanethidine,Ketamine,Guanethidine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Guanethidine,Ketazolam,Guanethidine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Guanethidine,Ketoprofen,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Ketoprofen.,decrease,no risk
Guanethidine,Ketorolac,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Ketorolac.,decrease,no risk
Guanethidine,Obinutuzumab,Guanethidine may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Guanethidine,Octinoxate,Guanethidine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Guanethidine,Olanzapine,Olanzapine may increase the hypotensive activities of Guanethidine.,increase,no risk
Guanethidine,Olmesartan,Olmesartan may increase the hypotensive activities of Guanethidine.,increase,no risk
Guanethidine,Olodaterol,Olodaterol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Guanethidine,Olsalazine,Olsalazine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Opicapone,Opicapone may increase the hypotensive activities of Guanethidine.,increase,no risk
Guanethidine,Opium,Guanethidine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Guanethidine,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Guanethidine,Oseltamivir,Oseltamivir may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Oxacillin,Oxacillin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Oxaprozin,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Oxaprozin.,decrease,no risk
Guanethidine,Oxazepam,Oxazepam may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Oxprenolol,Guanethidine may increase the hypotensive activities of Oxprenolol.,increase,no risk
Guanethidine,Oxybenzone,Guanethidine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Guanethidine,Oxymetazoline,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Guanethidine,Oxyphenbutazone,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Guanethidine,Oxyquinoline,Guanethidine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Guanethidine,Quetiapine,Quetiapine may increase the hypotensive activities of Guanethidine.,increase,no risk
Guanethidine,Quinapril,Quinapril may increase the hypotensive activities of Guanethidine.,increase,no risk
Guanethidine,Quinethazone,Quinethazone may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Guanethidine,Quinidine,Guanethidine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Quinine,Quinine may increase the hypotensive activities of Guanethidine.,increase,no risk
Guanethidine,Quinupramine,Quinupramine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Guanethidine,Udenafil,Udenafil may increase the antihypertensive activities of Guanethidine.,increase,no risk
Guanethidine,Unoprostone,Guanethidine may increase the hypotensive activities of Unoprostone.,increase,no risk
Guanethidine,Vaborbactam,Guanethidine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Guanethidine,Valaciclovir,Valaciclovir may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Valbenazine,Guanethidine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Guanethidine,Valdecoxib,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Valdecoxib.,decrease,no risk
Guanethidine,Valganciclovir,Guanethidine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Guanethidine,Valsartan,Valsartan may increase the hypotensive activities of Guanethidine.,increase,no risk
Guanethidine,Vancomycin,Guanethidine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Guanethidine,Vardenafil,Vardenafil may increase the antihypertensive activities of Guanethidine.,increase,no risk
Guanethidine,Varenicline,Guanethidine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Guanethidine,Venlafaxine,Venlafaxine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Verapamil,Verapamil may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Vericiguat,Vericiguat may increase the hypotensive activities of Guanethidine.,increase,no risk
Guanethidine,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Guanethidine.,decrease,no risk
Guanethidine,Vilanterol,Vilanterol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Guanethidine,Vilazodone,Vilazodone may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Guanethidine,Viloxazine,Guanethidine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Guanethidine,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Guanethidine,Warfarin,Guanethidine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Guanethidine,Xamoterol,Xamoterol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Guanethidine,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Guanethidine,Yohimbine,Yohimbine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Guanethidine,Zaleplon,Zaleplon may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Zanamivir,Zanamivir may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Guanethidine,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Guanethidine.,increase,no risk
Guanethidine,Zofenopril,Guanethidine may increase the hypotensive activities of Zofenopril.,increase,no risk
Guanethidine,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Guanethidine,Zonisamide,Zonisamide may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Guanethidine,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Moclobemide,Benzydamine,The risk or severity of hypertension can be increased when Moclobemide is combined with Benzydamine.,increase,risk
Moclobemide,Benzyl alcohol,The risk or severity of CNS depression can be increased when Moclobemide is combined with Benzyl alcohol.,increase,risk
Moclobemide,Bepridil,Moclobemide may increase the hypotensive activities of Bepridil.,increase,no risk
Moclobemide,Berotralstat,The metabolism of Moclobemide can be decreased when combined with Berotralstat.,decrease,no risk
Moclobemide,Betahistine,The metabolism of Betahistine can be decreased when combined with Moclobemide.,decrease,no risk
Moclobemide,Betaxolol,Moclobemide may increase the hypotensive activities of Betaxolol.,increase,no risk
Moclobemide,Bethanidine,Moclobemide may increase the hypotensive activities of Bethanidine.,increase,no risk
Moclobemide,Betrixaban,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Betrixaban.,increase,risk
Moclobemide,Bexagliflozin,Moclobemide may increase the hypoglycemic activities of Bexagliflozin.,increase,no risk
Moclobemide,Bezafibrate,Moclobemide may increase the hepatotoxic activities of Bezafibrate.,increase,no risk
Moclobemide,Bimekizumab,The metabolism of Moclobemide can be increased when combined with Bimekizumab.,increase,no risk
Moclobemide,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Moclobemide.,decrease,no risk
Moclobemide,Biperiden,The metabolism of Moclobemide can be decreased when combined with Biperiden.,decrease,no risk
Moclobemide,Bisoprolol,Moclobemide may increase the hypotensive activities of Bisoprolol.,increase,no risk
Moclobemide,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Bivalirudin.,increase,risk
Moclobemide,Bortezomib,The metabolism of Moclobemide can be decreased when combined with Bortezomib.,decrease,no risk
Moclobemide,Bosentan,Moclobemide may increase the hypotensive activities of Bosentan.,increase,no risk
Moclobemide,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Moclobemide.,increase,risk
Moclobemide,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Moclobemide.,increase,risk
Moclobemide,Bretylium,Moclobemide may increase the hypotensive activities of Bretylium.,increase,no risk
Moclobemide,Brexanolone,The risk or severity of CNS depression can be increased when Moclobemide is combined with Brexanolone.,increase,risk
Moclobemide,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Moclobemide.,decrease,no risk
Moclobemide,Brimonidine,The metabolism of Brimonidine can be decreased when combined with Moclobemide.,decrease,no risk
Moclobemide,Brivaracetam,The risk or severity of CNS depression can be increased when Moclobemide is combined with Brivaracetam.,increase,risk
Moclobemide,Bromazepam,The risk or severity of CNS depression can be increased when Moclobemide is combined with Bromazepam.,increase,risk
Moclobemide,Bromocriptine,Moclobemide may increase the hypertensive activities of Bromocriptine.,increase,no risk
Moclobemide,Bromperidol,The risk or severity of adverse effects can be increased when Moclobemide is combined with Bromperidol.,increase,risk
Moclobemide,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Moclobemide.,increase,risk
Moclobemide,Bumadizone,The risk or severity of hypertension can be increased when Moclobemide is combined with Bumadizone.,increase,risk
Moclobemide,Bumetanide,Moclobemide may increase the orthostatic hypotensive activities of Bumetanide.,increase,no risk
Moclobemide,Bupivacaine,Moclobemide may increase the orthostatic hypotensive activities of Bupivacaine.,increase,no risk
Moclobemide,Buprenorphine,Moclobemide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Moclobemide,Bupropion,The risk or severity of adverse effects can be increased when Moclobemide is combined with Bupropion.,increase,risk
Moclobemide,Buspirone,The risk or severity of hypertension can be increased when Moclobemide is combined with Buspirone.,increase,risk
Moclobemide,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Moclobemide.,increase,risk
Moclobemide,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Moclobemide.,increase,risk
Moclobemide,Butaperazine,The risk or severity of extrapyramidal symptoms can be increased when Moclobemide is combined with Butaperazine.,increase,risk
Moclobemide,Butobarbital,The risk or severity of CNS depression can be increased when Moclobemide is combined with Butobarbital.,increase,risk
Moclobemide,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Moclobemide.,increase,risk
Moclobemide,Butriptyline,Moclobemide may increase the serotonergic activities of Butriptyline.,increase,no risk
Moclobemide,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Moclobemide.,increase,risk
Moclobemide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Moclobemide is combined with Gabapentin enacarbil.,increase,risk
Moclobemide,Galantamine,The metabolism of Galantamine can be decreased when combined with Moclobemide.,decrease,no risk
Moclobemide,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Moclobemide.,increase,risk
Moclobemide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Moclobemide is combined with Ganaxolone.",increase,risk
Moclobemide,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Moclobemide.,decrease,no risk
Moclobemide,Gemfibrozil,The metabolism of Moclobemide can be decreased when combined with Gemfibrozil.,decrease,no risk
Moclobemide,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Moclobemide.,increase,risk
Moclobemide,Gilteritinib,The therapeutic efficacy of Moclobemide can be decreased when used in combination with Gilteritinib.,decrease,no risk
Moclobemide,Givosiran,The serum concentration of Moclobemide can be increased when it is combined with Givosiran.,increase,no risk
Moclobemide,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Moclobemide.,decrease,no risk
Moclobemide,Glimepiride,Moclobemide may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Moclobemide,Glipizide,Moclobemide may increase the hypoglycemic activities of Glipizide.,increase,no risk
Moclobemide,Gliquidone,Moclobemide may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Moclobemide,Glofitamab,The serum concentration of Moclobemide can be increased when it is combined with Glofitamab.,increase,no risk
Moclobemide,Glutethimide,The risk or severity of CNS depression can be increased when Moclobemide is combined with Glutethimide.,increase,risk
Moclobemide,Glyburide,The metabolism of Glyburide can be decreased when combined with Moclobemide.,decrease,no risk
Moclobemide,Glycerol phenylbutyrate,The metabolism of Moclobemide can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Moclobemide,Glymidine,Moclobemide may increase the hypoglycemic activities of Glymidine.,increase,no risk
Moclobemide,Golimumab,The metabolism of Moclobemide can be increased when combined with Golimumab.,increase,no risk
Moclobemide,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Moclobemide.,increase,risk
Moclobemide,Guanabenz,Moclobemide may increase the hypotensive activities of Guanabenz.,increase,no risk
Moclobemide,Guanadrel,Moclobemide may increase the hypotensive activities of Guanadrel.,increase,no risk
Moclobemide,Guanethidine,Moclobemide may increase the hypotensive activities of Guanethidine.,increase,no risk
Moclobemide,Guanfacine,Moclobemide may increase the hypotensive activities of Guanfacine.,increase,no risk
Moclobemide,Guanoxan,Moclobemide may increase the hypotensive activities of Guanoxan.,increase,no risk
Moclobemide,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Moclobemide.,increase,risk
Moclobemide,Halofantrine,The metabolism of Moclobemide can be decreased when combined with Halofantrine.,decrease,no risk
Moclobemide,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Moclobemide.,increase,risk
Moclobemide,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Moclobemide.,increase,risk
Moclobemide,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Heparin.,increase,risk
Moclobemide,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Moclobemide.,increase,risk
Moclobemide,Hydralazine,Moclobemide may increase the hypotensive activities of Hydralazine.,increase,no risk
Moclobemide,Hydrochlorothiazide,Moclobemide may increase the hypotensive activities of Hydrochlorothiazide.,increase,no risk
Moclobemide,Hydrocodone,Moclobemide may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Moclobemide,Hydroflumethiazide,Moclobemide may increase the hypotensive activities of Hydroflumethiazide.,increase,no risk
Moclobemide,Hydromorphone,Moclobemide may increase the serotonergic activities of Hydromorphone.,increase,no risk
Moclobemide,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Moclobemide.,increase,risk
Moclobemide,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Moclobemide.,increase,no risk
Moclobemide,Hyoscyamine,Moclobemide may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Moclobemide,Ketamine,The risk or severity of CNS depression can be increased when Moclobemide is combined with Ketamine.,increase,risk
Moclobemide,Ketazolam,The risk or severity of CNS depression can be increased when Moclobemide is combined with Ketazolam.,increase,risk
Moclobemide,Ketoconazole,The metabolism of Moclobemide can be decreased when combined with Ketoconazole.,decrease,no risk
Moclobemide,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Moclobemide.,increase,risk
Moclobemide,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Moclobemide.,increase,risk
Moclobemide,Obinutuzumab,Moclobemide may increase the orthostatic hypotensive activities of Obinutuzumab.,increase,no risk
Moclobemide,Olanzapine,Moclobemide may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Moclobemide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Moclobemide is combined with Oliceridine.",increase,risk
Moclobemide,Olmesartan,Moclobemide may increase the hypotensive activities of Olmesartan.,increase,no risk
Moclobemide,Olodaterol,The risk or severity of hypertension can be increased when Moclobemide is combined with Olodaterol.,increase,risk
Moclobemide,Omeprazole,The metabolism of Moclobemide can be decreased when combined with Omeprazole.,decrease,no risk
Moclobemide,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Moclobemide.,increase,risk
Moclobemide,Opicapone,Moclobemide may increase the orthostatic hypotensive activities of Opicapone.,increase,no risk
Moclobemide,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Moclobemide.,increase,risk
Moclobemide,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Moclobemide.,increase,risk
Moclobemide,Oritavancin,The metabolism of Moclobemide can be decreased when combined with Oritavancin.,decrease,no risk
Moclobemide,Orphenadrine,Moclobemide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Moclobemide,Osilodrostat,The metabolism of Moclobemide can be decreased when combined with Osilodrostat.,decrease,no risk
Moclobemide,Ospemifene,The metabolism of Moclobemide can be decreased when combined with Ospemifene.,decrease,no risk
Moclobemide,Oxamniquine,The metabolism of Moclobemide can be decreased when combined with Oxamniquine.,decrease,no risk
Moclobemide,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Moclobemide.,increase,risk
Moclobemide,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Moclobemide.,increase,risk
Moclobemide,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Moclobemide.,increase,risk
Moclobemide,Oxitriptan,The risk or severity of CNS depression can be increased when Moclobemide is combined with Oxitriptan.,increase,risk
Moclobemide,Oxprenolol,Moclobemide may increase the hypotensive activities of Oxprenolol.,increase,no risk
Moclobemide,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Moclobemide.,increase,risk
Moclobemide,Oxybutynin,The metabolism of Moclobemide can be decreased when combined with Oxybutynin.,decrease,no risk
Moclobemide,Oxycodone,Moclobemide may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Oxycodone.,increase,no risk
Moclobemide,Oxymetazoline,The serum concentration of Oxymetazoline can be increased when it is combined with Moclobemide.,increase,no risk
Moclobemide,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Moclobemide.,increase,risk
Moclobemide,Oxyphenbutazone,The risk or severity of hypertension can be increased when Moclobemide is combined with Oxyphenbutazone.,increase,risk
Moclobemide,Quazepam,The risk or severity of CNS depression can be increased when Moclobemide is combined with Quazepam.,increase,risk
Moclobemide,Quetiapine,Moclobemide may increase the orthostatic hypotensive activities of Quetiapine.,increase,no risk
Moclobemide,Quinapril,Moclobemide may increase the hypotensive activities of Quinapril.,increase,no risk
Moclobemide,Quinidine,The metabolism of Moclobemide can be decreased when combined with Quinidine.,decrease,no risk
Moclobemide,Quinine,The metabolism of Moclobemide can be decreased when combined with Quinine.,decrease,no risk
Moclobemide,Quinupramine,Moclobemide may increase the serotonergic activities of Quinupramine.,increase,no risk
Moclobemide,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Moclobemide.,decrease,no risk
Moclobemide,Urethane,The risk or severity of CNS depression can be increased when Moclobemide is combined with Urethane.,increase,risk
Moclobemide,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Urokinase.,increase,risk
Moclobemide,Valbenazine,The risk or severity of adverse effects can be increased when Moclobemide is combined with Valbenazine.,increase,risk
Moclobemide,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Moclobemide.,increase,risk
Moclobemide,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Moclobemide is combined with Valproate bismuth.,increase,risk
Moclobemide,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Moclobemide.,increase,risk
Moclobemide,Valsartan,Moclobemide may increase the hypotensive activities of Valsartan.,increase,no risk
Moclobemide,Vecuronium,The risk or severity of CNS depression can be increased when Moclobemide is combined with Vecuronium.,increase,risk
Moclobemide,Vemurafenib,The metabolism of Moclobemide can be decreased when combined with Vemurafenib.,decrease,no risk
Moclobemide,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Moclobemide is combined with Venlafaxine.,increase,risk
Moclobemide,Verapamil,Moclobemide may increase the orthostatic hypotensive activities of Verapamil.,increase,no risk
Moclobemide,Vericiguat,Moclobemide may increase the orthostatic hypotensive activities of Vericiguat.,increase,no risk
Moclobemide,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Moclobemide.,decrease,no risk
Moclobemide,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Moclobemide.,increase,risk
Moclobemide,Vilanterol,The risk or severity of hypertension and cardiovascular complications can be increased when Moclobemide is combined with Vilanterol.,increase,risk
Moclobemide,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Moclobemide.,decrease,no risk
Moclobemide,Vildagliptin,Moclobemide may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Moclobemide,Viloxazine,The risk or severity of hypertension can be increased when Viloxazine is combined with Moclobemide.,increase,risk
Moclobemide,Vinblastine,The metabolism of Moclobemide can be decreased when combined with Vinblastine.,decrease,no risk
Moclobemide,Vinorelbine,The metabolism of Moclobemide can be decreased when combined with Vinorelbine.,decrease,no risk
Moclobemide,Vonoprazan,The metabolism of Moclobemide can be decreased when combined with Vonoprazan.,decrease,no risk
Moclobemide,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Vorapaxar.,increase,risk
Moclobemide,Voriconazole,The metabolism of Moclobemide can be decreased when combined with Voriconazole.,decrease,no risk
Moclobemide,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Moclobemide.,decrease,no risk
Moclobemide,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Moclobemide.,decrease,no risk
Moclobemide,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Warfarin.,increase,risk
Moclobemide,Xamoterol,The risk or severity of hypertension can be increased when Moclobemide is combined with Xamoterol.,increase,risk
Moclobemide,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Ximelagatran.,increase,risk
Moclobemide,Xylometazoline,Moclobemide may increase the hypertensive activities of Xylometazoline.,increase,no risk
Moclobemide,Yohimbine,The risk or severity of CNS depression can be increased when Moclobemide is combined with Yohimbine.,increase,risk
Moclobemide,Zafirlukast,The metabolism of Moclobemide can be decreased when combined with Zafirlukast.,decrease,no risk
Moclobemide,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Moclobemide.,increase,risk
Moclobemide,Ziconotide,The risk or severity of CNS depression can be increased when Moclobemide is combined with Ziconotide.,increase,risk
Moclobemide,Zimelidine,Moclobemide may increase the serotonergic activities of Zimelidine.,increase,no risk
Moclobemide,Ziprasidone,The risk or severity of adverse effects can be increased when Moclobemide is combined with Ziprasidone.,increase,risk
Moclobemide,Zofenopril,Moclobemide may increase the hypotensive activities of Zofenopril.,increase,no risk
Moclobemide,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Moclobemide is combined with Zolmitriptan.,increase,risk
Moclobemide,Zolpidem,Moclobemide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Moclobemide,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Moclobemide.,increase,risk
Moclobemide,Zopiclone,The risk or severity of adverse effects can be increased when Moclobemide is combined with Zopiclone.,increase,risk
Moclobemide,Zotepine,The risk or severity of adverse effects can be increased when Moclobemide is combined with Zotepine.,increase,risk
Moclobemide,Zuclopenthixol,The risk or severity of adverse effects can be increased when Moclobemide is combined with Zuclopenthixol.,increase,risk
Moclobemide,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Moclobemide.,increase,risk
Kanamycin,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Gadodiamide,Gadodiamide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Gadoteric acid,Gadoteric acid may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Gadoteridol,Gadoteridol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Kanamycin.,increase,no risk
Kanamycin,Ganciclovir,Ganciclovir may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Gemcitabine,Gemcitabine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Gentamicin,Gentamicin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Gimeracil,Gimeracil may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Givosiran,Givosiran may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Glipizide,Glipizide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Glycol salicylate,The risk or severity of nephrotoxicity can be increased when Glycol salicylate is combined with Kanamycin.,increase,risk
Kanamycin,Golodirsen,Golodirsen may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Goserelin,Goserelin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Guanethidine,Guanethidine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Guanfacine,Guanfacine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Haloperidol,Haloperidol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Heparin,The therapeutic efficacy of Kanamycin can be decreased when used in combination with Heparin.,decrease,no risk
Kanamycin,Hetacillin,The serum concentration of Kanamycin can be decreased when it is combined with Hetacillin.,decrease,no risk
Kanamycin,Hydralazine,Hydralazine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Hydrochlorothiazide,Hydrochlorothiazide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Hydromorphone,Hydromorphone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Hydroxyethyl Starch,Hydroxyethyl Starch may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Ketamine,Ketamine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Ketazolam,Ketazolam may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Ketoprofen,Ketoprofen may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Ketorolac,Ketorolac may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Octinoxate,Octinoxate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Kanamycin is combined with Olsalazine.,increase,risk
Kanamycin,Opium,Opium may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Oseltamivir,Oseltamivir may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Ouabain,The risk or severity of adverse effects can be increased when Kanamycin is combined with Ouabain.,increase,risk
Kanamycin,Oxacillin,Oxacillin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Kanamycin.,increase,risk
Kanamycin,Oxaprozin,Oxaprozin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Oxazepam,Oxazepam may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Oxetacaine.,increase,risk
Kanamycin,Oxybenzone,Oxybenzone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Oxybuprocaine.,increase,risk
Kanamycin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Oxyquinoline,Oxyquinoline may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Kanamycin.,increase,risk
Kanamycin,Quetiapine,Quetiapine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Quinidine,Kanamycin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Kanamycin,Quinine,The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Kanamycin.,increase,risk
Kanamycin,Vaborbactam,Vaborbactam may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Valaciclovir,Valaciclovir may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Valbenazine,Valbenazine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Valdecoxib,Valdecoxib may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Valganciclovir,Valganciclovir may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Vancomycin,Vancomycin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Varenicline,Varenicline may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Kanamycin.,increase,no risk
Kanamycin,Venlafaxine,Venlafaxine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Verapamil,Verapamil may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Kanamycin.,decrease,no risk
Kanamycin,Vilanterol,Vilanterol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Viloxazine,Viloxazine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Viomycin,The risk or severity of neuromuscular blockade can be increased when Kanamycin is combined with Viomycin.,increase,risk
Kanamycin,Vortioxetine,Vortioxetine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Warfarin,Kanamycin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Kanamycin,Zaleplon,Zaleplon may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Zanamivir,Zanamivir may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Kanamycin,Zinc ascorbate,The therapeutic efficacy of Kanamycin can be decreased when used in combination with Zinc ascorbate.,decrease,no risk
Kanamycin,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Kanamycin is combined with Zoledronic acid.,increase,risk
Kanamycin,Zonisamide,Zonisamide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Orphenadrine,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Botulinum toxin type A.,increase,risk
Orphenadrine,Botulinum toxin type B,Botulinum toxin type B may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Orphenadrine.,increase,risk
Orphenadrine,Brexanolone,Brexanolone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Brexpiprazole,Brexpiprazole may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Brivaracetam,Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Bromazepam,Bromazepam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Bromocriptine,Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Bromperidol,Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Brompheniramine,Brompheniramine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Orphenadrine.,increase,risk
Orphenadrine,Bupivacaine,Bupivacaine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Buprenorphine,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Orphenadrine,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Orphenadrine.,increase,risk
Orphenadrine,Buserelin,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Buserelin.,increase,risk
Orphenadrine,Buspirone,Buspirone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Busulfan,The metabolism of Busulfan can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Butabarbital,Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Butalbital,Butalbital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Butaperazine,Butaperazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Butobarbital,Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Butorphanol,Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Butriptyline,Butriptyline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Butylscopolamine,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Butylscopolamine.,increase,risk
Orphenadrine,Gabapentin,Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Gabapentin enacarbil,Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Gadobenic acid.,increase,risk
Orphenadrine,Galantamine,The metabolism of Galantamine can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Gallamine triethiodide,Gallamine triethiodide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Orphenadrine is combined with Ganaxolone.",increase,risk
Orphenadrine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Orphenadrine.,increase,risk
Orphenadrine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Gemifloxacin.,increase,risk
Orphenadrine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Orphenadrine.,increase,no risk
Orphenadrine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Gilteritinib.,increase,risk
Orphenadrine,Ginkgo biloba,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Orphenadrine,Glasdegib,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Glasdegib.,increase,risk
Orphenadrine,Glofitamab,The serum concentration of Orphenadrine can be increased when it is combined with Glofitamab.,increase,no risk
Orphenadrine,Glucagon,Orphenadrine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Orphenadrine,Glutethimide,Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Orphenadrine.,decrease,no risk
Orphenadrine,Glycopyrronium,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Glycopyrronium.,increase,risk
Orphenadrine,Goserelin,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Goserelin.,increase,risk
Orphenadrine,Granisetron,Granisetron may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Grepafloxacin.,increase,risk
Orphenadrine,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Guanfacine,Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Halazepam,Halazepam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Halofantrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Halofantrine.,increase,risk
Orphenadrine,Haloperidol,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Haloperidol.,increase,risk
Orphenadrine,Halothane,Halothane may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Hexafluronium,Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Hexocyclium,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Hexocyclium.,increase,risk
Orphenadrine,Histrelin,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Histrelin.,increase,risk
Orphenadrine,Homatropine,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Homatropine.,increase,risk
Orphenadrine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Orphenadrine.,increase,risk
Orphenadrine,Huperzine A,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Huperzine A.,decrease,no risk
Orphenadrine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Orphenadrine.,decrease,no risk
Orphenadrine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Orphenadrine.,decrease,no risk
Orphenadrine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Orphenadrine.,decrease,no risk
Orphenadrine,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Orphenadrine.,increase,no risk
Orphenadrine,Hydrocodone,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Orphenadrine,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Orphenadrine.,increase,no risk
Orphenadrine,Hydromorphone,Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Hydroxyzine.,increase,risk
Orphenadrine,Hyoscyamine,Orphenadrine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Orphenadrine,Ketamine,Ketamine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Ketazolam,Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Ketoconazole,The metabolism of Orphenadrine can be decreased when combined with Ketoconazole.,decrease,no risk
Orphenadrine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Orphenadrine.,increase,risk
Orphenadrine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Ofloxacin.,increase,risk
Orphenadrine,Olanzapine,Olanzapine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Olaparib,The metabolism of Olaparib can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Orphenadrine is combined with Oliceridine.",increase,risk
Orphenadrine,Olodaterol,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Olodaterol.,increase,risk
Orphenadrine,Omaveloxolone,The serum concentration of Orphenadrine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Orphenadrine,Ondansetron,Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Opium,Opium may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Orphenadrine.,increase,risk
Orphenadrine,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Orphenadrine.,increase,risk
Orphenadrine,Oxatomide,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Oxatomide.,increase,risk
Orphenadrine,Oxazepam,Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Oxcarbazepine,Oxcarbazepine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Oxitriptan,Oxitriptan may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Oxprenolol,Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Oxybuprocaine,Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Orphenadrine.,increase,risk
Orphenadrine,Oxycodone,Oxycodone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Orphenadrine.,increase,risk
Orphenadrine,Oxymorphone,Oxymorphone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Orphenadrine.,increase,risk
Orphenadrine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Orphenadrine.,decrease,no risk
Orphenadrine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Orphenadrine.,increase,risk
Orphenadrine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Orphenadrine.,increase,risk
Orphenadrine,Quazepam,Quazepam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Quetiapine,Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Orphenadrine.,increase,no risk
Orphenadrine,Quinidine,The metabolism of Quinidine can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Quinine,Quinine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Quinupramine,Quinupramine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Quizartinib,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Quizartinib.,increase,risk
Orphenadrine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Orphenadrine.,increase,no risk
Orphenadrine,Umeclidinium,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Umeclidinium.,increase,risk
Orphenadrine,Urethane,Urethane may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Vadadustat,The serum concentration of Orphenadrine can be increased when it is combined with Vadadustat.,increase,no risk
Orphenadrine,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Orphenadrine.,increase,no risk
Orphenadrine,Valproic acid,Valproic acid may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Vecuronium,Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Orphenadrine.,increase,risk
Orphenadrine,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Venlafaxine,Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Verapamil,The metabolism of Orphenadrine can be decreased when combined with Verapamil.,decrease,no risk
Orphenadrine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Vigabatrin,Vigabatrin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Orphenadrine.,increase,risk
Orphenadrine,Vilazodone,Vilazodone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Viloxazine,The metabolism of Orphenadrine can be decreased when combined with Viloxazine.,decrease,no risk
Orphenadrine,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Vincristine,The metabolism of Vincristine can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Vindesine,The metabolism of Vindesine can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Voriconazole,The metabolism of Orphenadrine can be decreased when combined with Voriconazole.,decrease,no risk
Orphenadrine,Vorinostat,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Vorinostat.,increase,risk
Orphenadrine,Vortioxetine,Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Orphenadrine.,increase,no risk
Orphenadrine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Orphenadrine.,increase,no risk
Orphenadrine,Xamoterol,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Xamoterol.,increase,risk
Orphenadrine,Xylometazoline,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Xylometazoline.,increase,risk
Orphenadrine,Yohimbine,Yohimbine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Zaleplon,Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Ziconotide,Ziconotide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Zileuton,The metabolism of Zileuton can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Zimelidine,Zimelidine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Ziprasidone.,increase,risk
Orphenadrine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Orphenadrine.,decrease,no risk
Orphenadrine,Zolpidem,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Orphenadrine,Zonisamide,Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Zopiclone,Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Zotepine,Zotepine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Zuclopenthixol,Zuclopenthixol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Orphenadrine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Orphenadrine.,increase,risk
Phenobarbital,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Phenobarbital.,increase,no risk
Phenobarbital,Baricitinib,The metabolism of Baricitinib can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Bazedoxifene,The metabolism of Bazedoxifene can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Beclomethasone dipropionate,The metabolism of Beclomethasone dipropionate can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Bedaquiline,The serum concentration of Bedaquiline can be decreased when it is combined with Phenobarbital.,decrease,no risk
Phenobarbital,Belantamab mafodotin,Phenobarbital may increase the excretion rate of Belantamab mafodotin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Phenobarbital,Belinostat,The metabolism of Belinostat can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Belumosudil,The serum concentration of Belumosudil can be decreased when it is combined with Phenobarbital.,decrease,no risk
Phenobarbital,Belzutifan,The metabolism of Belzutifan can be decreased when combined with Phenobarbital.,decrease,no risk
Phenobarbital,Bempedoic acid,The metabolism of Bempedoic acid can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Benazepril,Phenobarbital may increase the hypotensive activities of Benazepril.,increase,no risk
Phenobarbital,Bendroflumethiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Phenobarbital is combined with Bendroflumethiazide.,increase,risk
Phenobarbital,Benperidol,The risk or severity of CNS depression can be increased when Phenobarbital is combined with Benperidol.,increase,risk
Phenobarbital,Bentonite,Bentonite can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenobarbital,Bentoquatam,Bentoquatam can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenobarbital,Benzatropine,The risk or severity of adverse effects can be increased when Benzatropine is combined with Phenobarbital.,increase,risk
Phenobarbital,Benzhydrocodone,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Benzhydrocodone.,increase,risk
Phenobarbital,Benzocaine,The risk or severity of methemoglobinemia can be increased when Phenobarbital is combined with Benzocaine.,increase,risk
Phenobarbital,Benzphetamine,The serum concentration of Phenobarbital can be decreased when it is combined with Benzphetamine.,decrease,no risk
Phenobarbital,Benzthiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Phenobarbital is combined with Benzthiazide.,increase,risk
Phenobarbital,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Phenobarbital is combined with Benzyl alcohol.,increase,risk
Phenobarbital,Bepridil,The metabolism of Bepridil can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Betaine,The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Betaine.,decrease,no risk
Phenobarbital,Betamethasone,The metabolism of Phenobarbital can be increased when combined with Betamethasone.,increase,no risk
Phenobarbital,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Betaxolol,Phenobarbital may increase the hypotensive activities of Betaxolol.,increase,no risk
Phenobarbital,Bexagliflozin,The metabolism of Bexagliflozin can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Bexarotene,The metabolism of Bexarotene can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Bezafibrate,The metabolism of Bezafibrate can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Bictegravir,The metabolism of Bictegravir can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Bifonazole,The metabolism of Phenobarbital can be decreased when combined with Bifonazole.,decrease,no risk
Phenobarbital,Bimekizumab,The metabolism of Phenobarbital can be increased when combined with Bimekizumab.,increase,no risk
Phenobarbital,Binimetinib,The metabolism of Binimetinib can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Biperiden,The risk or severity of adverse effects can be increased when Biperiden is combined with Phenobarbital.,increase,risk
Phenobarbital,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Phenobarbital.,decrease,no risk
Phenobarbital,Bisoprolol,The metabolism of Bisoprolol can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Phenobarbital.,decrease,no risk
Phenobarbital,Boceprevir,The serum concentration of Boceprevir can be decreased when it is combined with Phenobarbital.,decrease,no risk
Phenobarbital,Borage oil,The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Borage oil.,decrease,no risk
Phenobarbital,Bortezomib,The metabolism of Bortezomib can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Bosentan,The metabolism of Phenobarbital can be increased when combined with Bosentan.,increase,no risk
Phenobarbital,Bosutinib,The serum concentration of Bosutinib can be decreased when it is combined with Phenobarbital.,decrease,no risk
Phenobarbital,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Botulinum toxin type A.,increase,risk
Phenobarbital,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Botulinum toxin type B.,increase,risk
Phenobarbital,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Bretylium,Phenobarbital may increase the hypotensive activities of Bretylium.,increase,no risk
Phenobarbital,Brexanolone,The risk or severity of CNS depression can be increased when Phenobarbital is combined with Brexanolone.,increase,risk
Phenobarbital,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Brigatinib,The metabolism of Brigatinib can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Phenobarbital.,increase,no risk
Phenobarbital,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Bromazepam,The metabolism of Phenobarbital can be decreased when combined with Bromazepam.,decrease,no risk
Phenobarbital,Bromocriptine,The metabolism of Bromocriptine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Bromotheophylline,The serum concentration of Bromotheophylline can be decreased when it is combined with Phenobarbital.,decrease,no risk
Phenobarbital,Bromperidol,The risk or severity of CNS depression can be increased when Phenobarbital is combined with Bromperidol.,increase,risk
Phenobarbital,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Phenobarbital.,increase,risk
Phenobarbital,Budesonide,The metabolism of Budesonide can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Bumetanide,Phenobarbital may increase the hypotensive activities of Bumetanide.,increase,no risk
Phenobarbital,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Phenobarbital is combined with Bupivacaine.,increase,risk
Phenobarbital,Buprenorphine,Phenobarbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Phenobarbital,Bupropion,The metabolism of Bupropion can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Buspirone,The metabolism of Buspirone can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Busulfan,The metabolism of Busulfan can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Butabarbital,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Butabarbital.,increase,risk
Phenobarbital,Butacaine,The risk or severity of methemoglobinemia can be increased when Phenobarbital is combined with Butacaine.,increase,risk
Phenobarbital,Butalbital,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Butalbital.,increase,risk
Phenobarbital,Butamben,The risk or severity of methemoglobinemia can be increased when Phenobarbital is combined with Butamben.,increase,risk
Phenobarbital,Butaperazine,The risk or severity of CNS depression can be increased when Phenobarbital is combined with Butaperazine.,increase,risk
Phenobarbital,Butobarbital,The risk or severity of CNS depression can be increased when Phenobarbital is combined with Butobarbital.,increase,risk
Phenobarbital,Butorphanol,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Butorphanol.,increase,risk
Phenobarbital,Butriptyline,The metabolism of Butriptyline can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Butylscopolamine,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Butylscopolamine.,increase,risk
Phenobarbital,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Phenobarbital.,increase,risk
Phenobarbital,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Phenobarbital is combined with Gabapentin enacarbil.,increase,risk
Phenobarbital,Galantamine,The metabolism of Galantamine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Phenobarbital.,increase,risk
Phenobarbital,Gamolenic acid,The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Phenobarbital,Ganaxolone,The metabolism of Ganaxolone can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Ganciclovir,The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Ganciclovir.,decrease,no risk
Phenobarbital,Gefitinib,The metabolism of Gefitinib can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Gemfibrozil,The metabolism of Phenobarbital can be decreased when combined with Gemfibrozil.,decrease,no risk
Phenobarbital,Gepirone,The serum concentration of Gepirone can be decreased when it is combined with Phenobarbital.,decrease,no risk
Phenobarbital,Gestrinone,The metabolism of Gestrinone can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Ginkgo biloba,The metabolism of Phenobarbital can be decreased when combined with Ginkgo biloba.,decrease,no risk
Phenobarbital,Glasdegib,The serum concentration of Glasdegib can be decreased when it is combined with Phenobarbital.,decrease,no risk
Phenobarbital,Gliclazide,The metabolism of Phenobarbital can be decreased when combined with Gliclazide.,decrease,no risk
Phenobarbital,Glimepiride,Phenobarbital may increase the excretion rate of Glimepiride which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Phenobarbital,Glipizide,The metabolism of Glipizide can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Phenobarbital.,decrease,no risk
Phenobarbital,Glofitamab,The serum concentration of Phenobarbital can be increased when it is combined with Glofitamab.,increase,no risk
Phenobarbital,Glutethimide,The risk or severity of CNS depression can be increased when Phenobarbital is combined with Glutethimide.,increase,risk
Phenobarbital,Glyburide,The metabolism of Phenobarbital can be decreased when combined with Glyburide.,decrease,no risk
Phenobarbital,Glycerin,The metabolism of Phenobarbital can be increased when combined with Glycerin.,increase,no risk
Phenobarbital,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Phenobarbital.,increase,risk
Phenobarbital,Glycyrrhizic acid,Phenobarbital may increase the excretion rate of Glycyrrhizic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Phenobarbital,Golimumab,The metabolism of Phenobarbital can be increased when combined with Golimumab.,increase,no risk
Phenobarbital,Granisetron,The metabolism of Granisetron can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Grazoprevir,The metabolism of Grazoprevir can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Griseofulvin,The serum concentration of Griseofulvin can be decreased when it is combined with Phenobarbital.,decrease,no risk
Phenobarbital,Guanfacine,The metabolism of Guanfacine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Phenobarbital.,increase,risk
Phenobarbital,Halofantrine,The metabolism of Halofantrine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Phenobarbital.,increase,risk
Phenobarbital,Halothane,The metabolism of Phenobarbital can be decreased when combined with Halothane.,decrease,no risk
Phenobarbital,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Phenobarbital.,increase,risk
Phenobarbital,Hexocyclium,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Hexocyclium.,increase,risk
Phenobarbital,Homatropine,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Homatropine.,increase,risk
Phenobarbital,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Phenobarbital.,increase,risk
Phenobarbital,Huperzine A,The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Huperzine A.,decrease,no risk
Phenobarbital,Hydralazine,Phenobarbital may increase the hypotensive activities of Hydralazine.,increase,no risk
Phenobarbital,Hydrochlorothiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Phenobarbital is combined with Hydrochlorothiazide.,increase,risk
Phenobarbital,Hydrocodone,Phenobarbital may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Phenobarbital,Hydrocortisone,The metabolism of Phenobarbital can be increased when combined with Hydrocortisone.,increase,no risk
Phenobarbital,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Hydroflumethiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Phenobarbital is combined with Hydroflumethiazide.,increase,risk
Phenobarbital,Hydromorphone,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Hydromorphone.,increase,risk
Phenobarbital,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenobarbital,Hydroxychloroquine,The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Phenobarbital,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Phenobarbital.,increase,risk
Phenobarbital,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Phenobarbital.,increase,no risk
Phenobarbital,Kaolin,Kaolin can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenobarbital,Ketamine,The metabolism of Ketamine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Ketazolam,The metabolism of Ketazolam can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Ketoconazole,The metabolism of Ketoconazole can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Ketoprofen,The metabolism of Ketoprofen can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Ketorolac,The metabolism of Ketorolac can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Obinutuzumab,Phenobarbital may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Phenobarbital,Ofloxacin,Phenobarbital may increase the excretion rate of Ofloxacin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Phenobarbital,Olanzapine,The metabolism of Phenobarbital can be decreased when combined with Olanzapine.,decrease,no risk
Phenobarbital,Olaparib,The metabolism of Olaparib can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Phenobarbital is combined with Oliceridine.",increase,risk
Phenobarbital,Olmesartan,Phenobarbital may increase the hypotensive activities of Olmesartan.,increase,no risk
Phenobarbital,Olodaterol,The metabolism of Olodaterol can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Olutasidenib,The therapeutic efficacy of Olutasidenib can be decreased when used in combination with Phenobarbital.,decrease,no risk
Phenobarbital,Omaveloxolone,The therapeutic efficacy of Omaveloxolone can be decreased when used in combination with Phenobarbital.,decrease,no risk
Phenobarbital,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Omeprazole,The metabolism of Phenobarbital can be decreased when combined with Omeprazole.,decrease,no risk
Phenobarbital,Ondansetron,The metabolism of Ondansetron can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Opicapone,Phenobarbital may increase the hypotensive activities of Opicapone.,increase,no risk
Phenobarbital,Opium,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Opium.,increase,risk
Phenobarbital,Oritavancin,The metabolism of Phenobarbital can be decreased when combined with Oritavancin.,decrease,no risk
Phenobarbital,Orlistat,Orlistat can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenobarbital,Orphenadrine,Phenobarbital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Phenobarbital,Osilodrostat,The serum concentration of Osilodrostat can be decreased when it is combined with Phenobarbital.,decrease,no risk
Phenobarbital,Osimertinib,The metabolism of Osimertinib can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Ospemifene,The metabolism of Ospemifene can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Oxandrolone,The metabolism of Phenobarbital can be decreased when combined with Oxandrolone.,decrease,no risk
Phenobarbital,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Phenobarbital.,increase,risk
Phenobarbital,Oxcarbazepine,The serum concentration of Phenobarbital can be increased when it is combined with Oxcarbazepine.,increase,no risk
Phenobarbital,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Phenobarbital is combined with Oxetacaine.,increase,risk
Phenobarbital,Oxitriptan,The risk or severity of CNS depression can be increased when Phenobarbital is combined with Oxitriptan.,increase,risk
Phenobarbital,Oxprenolol,Phenobarbital may increase the hypotensive activities of Oxprenolol.,increase,no risk
Phenobarbital,Oxtriphylline,The serum concentration of Oxtriphylline can be decreased when it is combined with Phenobarbital.,decrease,no risk
Phenobarbital,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Phenobarbital is combined with Oxybuprocaine.,increase,risk
Phenobarbital,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Oxycodone,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Oxycodone.,increase,risk
Phenobarbital,Oxymorphone,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Oxymorphone.,increase,risk
Phenobarbital,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Phenobarbital.,increase,risk
Phenobarbital,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Phenobarbital.,decrease,no risk
Phenobarbital,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Phenobarbital.,increase,risk
Phenobarbital,Ozanimod,The metabolism of Ozanimod can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Quazepam,The metabolism of Quazepam can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Quetiapine,The metabolism of Quetiapine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Quinapril,Phenobarbital may increase the hypotensive activities of Quinapril.,increase,no risk
Phenobarbital,Quinethazone,The risk or severity of hypotension and orthostatic hypotension can be increased when Phenobarbital is combined with Quinethazone.,increase,risk
Phenobarbital,Quinidine,The serum concentration of Phenobarbital can be increased when it is combined with Quinidine.,increase,no risk
Phenobarbital,Quinine,The serum concentration of Phenobarbital can be increased when it is combined with Quinine.,increase,no risk
Phenobarbital,Quinupramine,The metabolism of Quinupramine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Quizartinib,The serum concentration of Quizartinib can be decreased when it is combined with Phenobarbital.,decrease,no risk
Phenobarbital,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Phenobarbital.,decrease,no risk
Phenobarbital,Udenafil,The metabolism of Udenafil can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Phenobarbital.,decrease,no risk
Phenobarbital,Umeclidinium,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Umeclidinium.,increase,risk
Phenobarbital,Upadacitinib,The metabolism of Upadacitinib can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Urethane,The risk or severity of CNS depression can be increased when Phenobarbital is combined with Urethane.,increase,risk
Phenobarbital,Ursodeoxycholic acid,Phenobarbital may increase the excretion rate of Ursodeoxycholic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Phenobarbital,Vadadustat,The serum concentration of Phenobarbital can be increased when it is combined with Vadadustat.,increase,no risk
Phenobarbital,Valbenazine,The serum concentration of Valbenazine can be decreased when it is combined with Phenobarbital.,decrease,no risk
Phenobarbital,Valdecoxib,The metabolism of Phenobarbital can be decreased when combined with Valdecoxib.,decrease,no risk
Phenobarbital,Valganciclovir,The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Valganciclovir.,decrease,no risk
Phenobarbital,Valproic acid,"The serum concentration of Phenobarbital, an active metabolite of Phenobarbital, can be increased when used in combination with Valproic acid.",increase,no risk
Phenobarbital,Valsartan,The metabolism of Phenobarbital can be decreased when combined with Valsartan.,decrease,no risk
Phenobarbital,Vamorolone,The metabolism of Vamorolone can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Vandetanib,The metabolism of Vandetanib can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Vardenafil,The metabolism of Vardenafil can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Vayarin,The metabolism of Phenobarbital can be decreased when combined with Vayarin.,decrease,no risk
Phenobarbital,Vecuronium,The risk or severity of CNS depression can be increased when Phenobarbital is combined with Vecuronium.,increase,risk
Phenobarbital,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Venetoclax,The metabolism of Venetoclax can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Verapamil,The metabolism of Verapamil can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Vericiguat,Phenobarbital may increase the hypotensive activities of Vericiguat.,increase,no risk
Phenobarbital,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Phenobarbital.,increase,risk
Phenobarbital,Vilanterol,The metabolism of Vilanterol can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Vilazodone,The metabolism of Vilazodone can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Viloxazine,The risk or severity of CNS depression can be increased when Phenobarbital is combined with Viloxazine.,increase,risk
Phenobarbital,Vinblastine,The metabolism of Vinblastine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Vincristine,The metabolism of Vincristine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Vindesine,The metabolism of Vindesine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Vinflunine,The metabolism of Vinflunine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Vitamin D,The metabolism of Vitamin D can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Vitamin E,The metabolism of Vitamin E can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Voclosporin,The metabolism of Voclosporin can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Vonoprazan,The therapeutic efficacy of Vonoprazan can be decreased when used in combination with Phenobarbital.,decrease,no risk
Phenobarbital,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Voriconazole,The serum concentration of Voriconazole can be decreased when it is combined with Phenobarbital.,decrease,no risk
Phenobarbital,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Voxelotor,The serum concentration of Voxelotor can be decreased when it is combined with Phenobarbital.,decrease,no risk
Phenobarbital,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Warfarin,The metabolism of Warfarin can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Phenobarbital.,decrease,no risk
Phenobarbital,Xylometazoline,The metabolism of Xylometazoline can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Yohimbine,The metabolism of Yohimbine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Zafirlukast,The metabolism of Phenobarbital can be decreased when combined with Zafirlukast.,decrease,no risk
Phenobarbital,Zaleplon,The metabolism of Zaleplon can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Ziconotide,The risk or severity of CNS depression can be increased when Phenobarbital is combined with Ziconotide.,increase,risk
Phenobarbital,Zidovudine,The metabolism of Zidovudine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Zileuton,The metabolism of Zileuton can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Zimelidine,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Zimelidine.,increase,risk
Phenobarbital,Zinc,Zinc can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenobarbital,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenobarbital,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenobarbital,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenobarbital,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenobarbital,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenobarbital,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Phenobarbital,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Phenobarbital,Ziprasidone,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Ziprasidone.,increase,risk
Phenobarbital,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Phenobarbital.,increase,risk
Phenobarbital,Zolpidem,Phenobarbital may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Phenobarbital,Zonisamide,The metabolism of Zonisamide can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Zopiclone,The metabolism of Zopiclone can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Zotepine,The metabolism of Zotepine can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Phenobarbital.,increase,no risk
Phenobarbital,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Phenobarbital.,increase,risk
Escitalopram,Benorilate,The risk or severity of gastrointestinal bleeding can be increased when Escitalopram is combined with Benorilate.,increase,risk
Escitalopram,Benoxaprofen,The risk or severity of gastrointestinal bleeding can be increased when Escitalopram is combined with Benoxaprofen.,increase,risk
Escitalopram,Benperidol,The risk or severity of adverse effects can be increased when Benperidol is combined with Escitalopram.,increase,risk
Escitalopram,Benzatropine,The serum concentration of Benzatropine can be increased when it is combined with Escitalopram.,increase,no risk
Escitalopram,Benzhydrocodone,The risk or severity of serotonin syndrome can be increased when Benzhydrocodone is combined with Escitalopram.,increase,risk
Escitalopram,Benzocaine,The serum concentration of Benzocaine can be increased when it is combined with Escitalopram.,increase,no risk
Escitalopram,Benzphetamine,The risk or severity of serotonin syndrome can be increased when Benzphetamine is combined with Escitalopram.,increase,risk
Escitalopram,Benzthiazide,The risk or severity of hyponatremia can be increased when Escitalopram is combined with Benzthiazide.,increase,risk
Escitalopram,Benzydamine,The risk or severity of gastrointestinal bleeding can be increased when Escitalopram is combined with Benzydamine.,increase,risk
Escitalopram,Benzyl alcohol,The serum concentration of Benzyl alcohol can be increased when it is combined with Escitalopram.,increase,no risk
Escitalopram,Bepridil,The serum concentration of Bepridil can be increased when it is combined with Escitalopram.,increase,no risk
Escitalopram,Berotralstat,The metabolism of Escitalopram can be decreased when combined with Berotralstat.,decrease,no risk
Escitalopram,Betaine,The therapeutic efficacy of Escitalopram can be decreased when used in combination with Betaine.,decrease,no risk
Escitalopram,Betaxolol,The serum concentration of Betaxolol can be increased when it is combined with Escitalopram.,increase,no risk
Escitalopram,Betrixaban,The risk or severity of bleeding can be increased when Escitalopram is combined with Betrixaban.,increase,risk
Escitalopram,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Escitalopram is combined with Bexagliflozin.,increase,risk
Escitalopram,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Escitalopram.,increase,risk
Escitalopram,Bimekizumab,The metabolism of Escitalopram can be increased when combined with Bimekizumab.,increase,no risk
Escitalopram,Biperiden,The metabolism of Escitalopram can be decreased when combined with Biperiden.,decrease,no risk
Escitalopram,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Escitalopram.,decrease,no risk
Escitalopram,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Escitalopram.,decrease,no risk
Escitalopram,Bivalirudin,The risk or severity of bleeding can be increased when Escitalopram is combined with Bivalirudin.,increase,risk
Escitalopram,Boceprevir,The serum concentration of Escitalopram can be decreased when it is combined with Boceprevir.,decrease,no risk
Escitalopram,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Escitalopram.,increase,no risk
Escitalopram,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Escitalopram is combined with Botulinum toxin type A.,increase,risk
Escitalopram,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Escitalopram is combined with Botulinum toxin type B.,increase,risk
Escitalopram,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Escitalopram.,increase,risk
Escitalopram,Brexanolone,The risk or severity of adverse effects can be increased when Brexanolone is combined with Escitalopram.,increase,risk
Escitalopram,Brexpiprazole,The risk or severity of serotonin syndrome can be increased when Brexpiprazole is combined with Escitalopram.,increase,risk
Escitalopram,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Escitalopram.,increase,no risk
Escitalopram,Brivaracetam,The risk or severity of adverse effects can be increased when Brivaracetam is combined with Escitalopram.,increase,risk
Escitalopram,Bromazepam,The risk or severity of adverse effects can be increased when Bromazepam is combined with Escitalopram.,increase,risk
Escitalopram,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Escitalopram.,increase,risk
Escitalopram,Bromperidol,The risk or severity of adverse effects can be increased when Bromperidol is combined with Escitalopram.,increase,risk
Escitalopram,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Escitalopram.,increase,risk
Escitalopram,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Escitalopram.,increase,risk
Escitalopram,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Escitalopram is combined with Bumadizone.,increase,risk
Escitalopram,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Escitalopram.,increase,no risk
Escitalopram,Buprenorphine,Escitalopram may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Escitalopram,Bupropion,The metabolism of Escitalopram can be decreased when combined with Bupropion.,decrease,no risk
Escitalopram,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Escitalopram.,increase,risk
Escitalopram,Buspirone,The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Escitalopram.,increase,risk
Escitalopram,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Escitalopram.,increase,risk
Escitalopram,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Escitalopram.,increase,risk
Escitalopram,Butaperazine,The risk or severity of adverse effects can be increased when Butaperazine is combined with Escitalopram.,increase,risk
Escitalopram,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Escitalopram.,increase,risk
Escitalopram,Butorphanol,The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Escitalopram.,increase,risk
Escitalopram,Butriptyline,The risk or severity of serotonin syndrome can be increased when Butriptyline is combined with Escitalopram.,increase,risk
Escitalopram,Butylscopolamine,The risk or severity of adverse effects can be increased when Escitalopram is combined with Butylscopolamine.,increase,risk
Cyclizine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Cyclizine.,increase,risk
Cyclizine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Cyclizine is combined with Gabapentin enacarbil.,increase,risk
Cyclizine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Gadobenic acid.,increase,risk
Cyclizine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Cyclizine.,increase,risk
Cyclizine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Cyclizine.,increase,risk
Cyclizine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Cyclizine is combined with Ganaxolone.",increase,risk
Cyclizine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Cyclizine.,increase,risk
Cyclizine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Gemifloxacin.,increase,risk
Cyclizine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Cyclizine.,increase,risk
Cyclizine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Gilteritinib.,increase,risk
Cyclizine,Glasdegib,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Glasdegib.,increase,risk
Cyclizine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Glipizide,The metabolism of Glipizide can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Glutethimide,The risk or severity of CNS depression can be increased when Cyclizine is combined with Glutethimide.,increase,risk
Cyclizine,Glyburide,The metabolism of Glyburide can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Goserelin,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Goserelin.,increase,risk
Cyclizine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Cyclizine.,increase,risk
Cyclizine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Grepafloxacin.,increase,risk
Cyclizine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Cyclizine.,increase,risk
Cyclizine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Cyclizine.,increase,risk
Cyclizine,Halofantrine,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Halofantrine.,increase,risk
Cyclizine,Haloperidol,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Haloperidol.,increase,risk
Cyclizine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Cyclizine.,increase,risk
Cyclizine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Cyclizine.,increase,risk
Cyclizine,Histrelin,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Histrelin.,increase,risk
Cyclizine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Cyclizine.,decrease,no risk
Cyclizine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Cyclizine.,decrease,no risk
Cyclizine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Cyclizine.,decrease,no risk
Cyclizine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Cyclizine.,increase,risk
Cyclizine,Hydrocodone,Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Cyclizine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Cyclizine.,increase,risk
Cyclizine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Hydroxychloroquine.,increase,risk
Cyclizine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Hydroxyzine.,increase,risk
Cyclizine,Hyoscyamine,Cyclizine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Cyclizine,Ketamine,The risk or severity of CNS depression can be increased when Cyclizine is combined with Ketamine.,increase,risk
Cyclizine,Ketazolam,The risk or severity of CNS depression can be increased when Cyclizine is combined with Ketazolam.,increase,risk
Cyclizine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Cyclizine.,increase,risk
Cyclizine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Cyclizine.,increase,risk
Cyclizine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Ofloxacin.,increase,risk
Cyclizine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Cyclizine.,increase,risk
Cyclizine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Cyclizine is combined with Oliceridine.",increase,risk
Cyclizine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Cyclizine.,increase,risk
Cyclizine,Opium,The risk or severity of CNS depression can be increased when Cyclizine is combined with Opium.,increase,risk
Cyclizine,Orphenadrine,Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Cyclizine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Cyclizine.,increase,risk
Cyclizine,Oxatomide,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Oxatomide.,increase,risk
Cyclizine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Cyclizine.,increase,risk
Cyclizine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Cyclizine.,increase,risk
Cyclizine,Oxitriptan,The risk or severity of CNS depression can be increased when Cyclizine is combined with Oxitriptan.,increase,risk
Cyclizine,Oxprenolol,The risk or severity of CNS depression can be increased when Cyclizine is combined with Oxprenolol.,increase,risk
Cyclizine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Cyclizine.,increase,risk
Cyclizine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Cyclizine.,increase,risk
Cyclizine,Oxymorphone,The risk or severity of CNS depression can be increased when Cyclizine is combined with Oxymorphone.,increase,risk
Cyclizine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Cyclizine.,increase,risk
Cyclizine,Quazepam,The risk or severity of CNS depression can be increased when Cyclizine is combined with Quazepam.,increase,risk
Cyclizine,Quetiapine,The risk or severity of CNS depression can be increased when Cyclizine is combined with Quetiapine.,increase,risk
Cyclizine,Quinidine,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Quinidine.,increase,risk
Cyclizine,Quinine,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Quinine.,increase,risk
Cyclizine,Quinupramine,The risk or severity of CNS depression can be increased when Cyclizine is combined with Quinupramine.,increase,risk
Cyclizine,Quizartinib,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Quizartinib.,increase,risk
Cyclizine,Urethane,The risk or severity of CNS depression can be increased when Cyclizine is combined with Urethane.,increase,risk
Cyclizine,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Valproic acid,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Valproic acid.,increase,risk
Cyclizine,Valsartan,The metabolism of Valsartan can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Vandetanib,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Vandetanib.,increase,risk
Cyclizine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Vecuronium,The risk or severity of CNS depression can be increased when Cyclizine is combined with Vecuronium.,increase,risk
Cyclizine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Cyclizine.,increase,risk
Cyclizine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Cyclizine.,increase,risk
Cyclizine,Vernakalant,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Vernakalant.,increase,risk
Cyclizine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Cyclizine.,increase,risk
Cyclizine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Cyclizine.,increase,risk
Cyclizine,Vilazodone,The risk or severity of CNS depression can be increased when Cyclizine is combined with Vilazodone.,increase,risk
Cyclizine,Viloxazine,The risk or severity of CNS depression can be increased when Cyclizine is combined with Viloxazine.,increase,risk
Cyclizine,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Vorinostat,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Vorinostat.,increase,risk
Cyclizine,Vortioxetine,The risk or severity of CNS depression can be increased when Cyclizine is combined with Vortioxetine.,increase,risk
Cyclizine,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Warfarin,The metabolism of Warfarin can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Yohimbine,The risk or severity of CNS depression can be increased when Cyclizine is combined with Yohimbine.,increase,risk
Cyclizine,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Cyclizine.,increase,risk
Cyclizine,Ziconotide,The risk or severity of CNS depression can be increased when Cyclizine is combined with Ziconotide.,increase,risk
Cyclizine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Zileuton,The metabolism of Zileuton can be decreased when combined with Cyclizine.,decrease,no risk
Cyclizine,Zimelidine,The risk or severity of adverse effects can be increased when Cyclizine is combined with Zimelidine.,increase,risk
Cyclizine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Ziprasidone.,increase,risk
Cyclizine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Cyclizine.,increase,risk
Cyclizine,Zolpidem,Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Cyclizine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Cyclizine.,increase,risk
Cyclizine,Zopiclone,The risk or severity of adverse effects can be increased when Cyclizine is combined with Zopiclone.,increase,risk
Cyclizine,Zotepine,The risk or severity of CNS depression can be increased when Cyclizine is combined with Zotepine.,increase,risk
Cyclizine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Zuclopenthixol.,increase,risk
Cyclizine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Cyclizine.,increase,risk
Idarubicin,Bevacizumab,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Idarubicin.,increase,risk
Idarubicin,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Idarubicin.,increase,risk
Idarubicin,Bimekizumab,The metabolism of Idarubicin can be increased when combined with Bimekizumab.,increase,no risk
Idarubicin,Biperiden,The metabolism of Idarubicin can be decreased when combined with Biperiden.,decrease,no risk
Idarubicin,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Idarubicin.,increase,risk
Idarubicin,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Idarubicin.,increase,risk
Idarubicin,Blinatumomab,The risk or severity of adverse effects can be increased when Idarubicin is combined with Blinatumomab.,increase,risk
Idarubicin,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Idarubicin.",decrease,no risk
Idarubicin,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Idarubicin.,increase,risk
Idarubicin,Bosentan,The metabolism of Idarubicin can be increased when combined with Bosentan.,increase,no risk
Idarubicin,Bosutinib,The risk or severity of adverse effects can be increased when Idarubicin is combined with Bosutinib.,increase,risk
Idarubicin,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Idarubicin is combined with Brentuximab vedotin.,increase,risk
Idarubicin,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Idarubicin.,decrease,no risk
Idarubicin,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Idarubicin.,decrease,no risk
Idarubicin,Brodalumab,The risk or severity of adverse effects can be increased when Idarubicin is combined with Brodalumab.,increase,risk
Idarubicin,Budesonide,The risk or severity of adverse effects can be increased when Idarubicin is combined with Budesonide.,increase,risk
Idarubicin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Bupivacaine.,increase,risk
Idarubicin,Buprenorphine,The metabolism of Idarubicin can be decreased when combined with Buprenorphine.,decrease,no risk
Idarubicin,Bupropion,The metabolism of Idarubicin can be decreased when combined with Bupropion.,decrease,no risk
Idarubicin,Buspirone,The metabolism of Idarubicin can be decreased when combined with Buspirone.,decrease,no risk
Idarubicin,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Idarubicin.,increase,risk
Idarubicin,Butacaine,The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Butacaine.,increase,risk
Idarubicin,Butamben,The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Butamben.,increase,risk
Idarubicin,Galantamine,The metabolism of Idarubicin can be decreased when combined with Galantamine.,decrease,no risk
Idarubicin,Gefitinib,The metabolism of Idarubicin can be decreased when combined with Gefitinib.,decrease,no risk
Idarubicin,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Idarubicin.,increase,risk
Idarubicin,Gemfibrozil,The metabolism of Idarubicin can be decreased when combined with Gemfibrozil.,decrease,no risk
Idarubicin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Idarubicin.,increase,risk
Idarubicin,Ginkgo biloba,The metabolism of Idarubicin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Idarubicin,Givosiran,The serum concentration of Idarubicin can be increased when it is combined with Givosiran.,increase,no risk
Idarubicin,Glatiramer,The risk or severity of adverse effects can be increased when Idarubicin is combined with Glatiramer.,increase,risk
Idarubicin,Gliclazide,The metabolism of Idarubicin can be decreased when combined with Gliclazide.,decrease,no risk
Idarubicin,Glimepiride,The metabolism of Idarubicin can be decreased when combined with Glimepiride.,decrease,no risk
Idarubicin,Glipizide,The metabolism of Idarubicin can be decreased when combined with Glipizide.,decrease,no risk
Idarubicin,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Idarubicin.,decrease,no risk
Idarubicin,Glofitamab,The serum concentration of Idarubicin can be increased when it is combined with Glofitamab.,increase,no risk
Idarubicin,Glyburide,The metabolism of Idarubicin can be decreased when combined with Glyburide.,decrease,no risk
Idarubicin,Glycerol phenylbutyrate,The metabolism of Idarubicin can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Idarubicin,Golimumab,The metabolism of Idarubicin can be increased when combined with Golimumab.,increase,no risk
Idarubicin,Guselkumab,The risk or severity of adverse effects can be increased when Idarubicin is combined with Guselkumab.,increase,risk
Idarubicin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Idarubicin.,decrease,no risk
Idarubicin,Halofantrine,The metabolism of Idarubicin can be decreased when combined with Halofantrine.,decrease,no risk
Idarubicin,Haloperidol,The serum concentration of Idarubicin can be increased when it is combined with Haloperidol.,increase,no risk
Idarubicin,Halothane,The metabolism of Idarubicin can be decreased when combined with Halothane.,decrease,no risk
Idarubicin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Idarubicin.,increase,risk
Idarubicin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Idarubicin.,decrease,no risk
Idarubicin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Idarubicin.,decrease,no risk
Idarubicin,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Idarubicin.,increase,risk
Idarubicin,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Idarubicin.,increase,risk
Idarubicin,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Idarubicin is combined with Hydrocortisone acetate.,increase,risk
Idarubicin,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Idarubicin is combined with Hydrocortisone butyrate.,increase,risk
Idarubicin,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Idarubicin is combined with Hydrocortisone succinate.,increase,risk
Idarubicin,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Idarubicin.,increase,risk
Idarubicin,Hydromorphone,The metabolism of Idarubicin can be decreased when combined with Hydromorphone.,decrease,no risk
Idarubicin,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Idarubicin is combined with Hydroxychloroquine.,increase,risk
Idarubicin,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Idarubicin.,increase,risk
Idarubicin,Hydroxyzine,The metabolism of Idarubicin can be decreased when combined with Hydroxyzine.,decrease,no risk
Idarubicin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Idarubicin.,decrease,no risk
Idarubicin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Idarubicin.,decrease,no risk
Idarubicin,Ketamine,The metabolism of Ketamine can be decreased when combined with Idarubicin.,decrease,no risk
Idarubicin,Ketoconazole,The metabolism of Idarubicin can be decreased when combined with Ketoconazole.,decrease,no risk
Idarubicin,Ketorolac,The metabolism of Idarubicin can be decreased when combined with Ketorolac.,decrease,no risk
Idarubicin,Obinutuzumab,The risk or severity of adverse effects can be increased when Idarubicin is combined with Obinutuzumab.,increase,risk
Idarubicin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Idarubicin.,increase,no risk
Idarubicin,Ofatumumab,The risk or severity of adverse effects can be increased when Idarubicin is combined with Ofatumumab.,increase,risk
Idarubicin,Olanzapine,The metabolism of Idarubicin can be decreased when combined with Olanzapine.,decrease,no risk
Idarubicin,Olaparib,The risk or severity of adverse effects can be increased when Idarubicin is combined with Olaparib.,increase,risk
Idarubicin,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Idarubicin.,decrease,no risk
Idarubicin,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Idarubicin.,decrease,no risk
Idarubicin,Ondansetron,The metabolism of Idarubicin can be decreased when combined with Ondansetron.,decrease,no risk
Idarubicin,Opium,The metabolism of Opium can be decreased when combined with Idarubicin.,decrease,no risk
Idarubicin,Oritavancin,The metabolism of Idarubicin can be decreased when combined with Oritavancin.,decrease,no risk
Idarubicin,Orphenadrine,The metabolism of Idarubicin can be decreased when combined with Orphenadrine.,decrease,no risk
Idarubicin,Osilodrostat,The metabolism of Idarubicin can be decreased when combined with Osilodrostat.,decrease,no risk
Idarubicin,Ospemifene,The metabolism of Idarubicin can be decreased when combined with Ospemifene.,decrease,no risk
Idarubicin,Ouabain,Ouabain may decrease the cardiotoxic activities of Idarubicin.,decrease,no risk
Idarubicin,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Idarubicin.,increase,risk
Idarubicin,Oxamniquine,The metabolism of Idarubicin can be decreased when combined with Oxamniquine.,decrease,no risk
Idarubicin,Oxandrolone,The metabolism of Idarubicin can be decreased when combined with Oxandrolone.,decrease,no risk
Idarubicin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Oxetacaine.,increase,risk
Idarubicin,Oxprenolol,The metabolism of Idarubicin can be decreased when combined with Oxprenolol.,decrease,no risk
Idarubicin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Oxybuprocaine.,increase,risk
Idarubicin,Oxybutynin,The metabolism of Idarubicin can be decreased when combined with Oxybutynin.,decrease,no risk
Idarubicin,Oxycodone,The metabolism of Idarubicin can be decreased when combined with Oxycodone.,decrease,no risk
Idarubicin,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Idarubicin.,decrease,no risk
Idarubicin,Ozanimod,The risk or severity of adverse effects can be increased when Idarubicin is combined with Ozanimod.,increase,risk
Idarubicin,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Idarubicin.,decrease,no risk
Idarubicin,Quinidine,The metabolism of Idarubicin can be decreased when combined with Quinidine.,decrease,no risk
Idarubicin,Quinine,The metabolism of Idarubicin can be decreased when combined with Quinine.,decrease,no risk
Idarubicin,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Idarubicin.,increase,risk
Idarubicin,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Idarubicin.,decrease,no risk
Idarubicin,Upadacitinib,The risk or severity of adverse effects can be increased when Idarubicin is combined with Upadacitinib.,increase,risk
Idarubicin,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Idarubicin.,increase,risk
Idarubicin,Vadadustat,The metabolism of Idarubicin can be decreased when combined with Vadadustat.,decrease,no risk
Idarubicin,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Idarubicin.,decrease,no risk
Idarubicin,Valdecoxib,The metabolism of Idarubicin can be decreased when combined with Valdecoxib.,decrease,no risk
Idarubicin,Valproic acid,The metabolism of Idarubicin can be decreased when combined with Valproic acid.,decrease,no risk
Idarubicin,Valsartan,The metabolism of Idarubicin can be decreased when combined with Valsartan.,decrease,no risk
Idarubicin,Vardenafil,The metabolism of Idarubicin can be decreased when combined with Vardenafil.,decrease,no risk
Idarubicin,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Idarubicin.,increase,risk
Idarubicin,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Idarubicin.,decrease,no risk
Idarubicin,Vedolizumab,The risk or severity of adverse effects can be increased when Idarubicin is combined with Vedolizumab.,increase,risk
Idarubicin,Vemurafenib,The metabolism of Idarubicin can be decreased when combined with Vemurafenib.,decrease,no risk
Idarubicin,Venlafaxine,The metabolism of Idarubicin can be decreased when combined with Venlafaxine.,decrease,no risk
Idarubicin,Verapamil,The metabolism of Idarubicin can be decreased when combined with Verapamil.,decrease,no risk
Idarubicin,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Idarubicin.,decrease,no risk
Idarubicin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Idarubicin.,decrease,no risk
Idarubicin,Vilanterol,The risk or severity of adverse effects can be increased when Idarubicin is combined with Vilanterol.,increase,risk
Idarubicin,Vilazodone,The metabolism of Idarubicin can be decreased when combined with Vilazodone.,decrease,no risk
Idarubicin,Viloxazine,The metabolism of Idarubicin can be decreased when combined with Viloxazine.,decrease,no risk
Idarubicin,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Idarubicin.,increase,risk
Idarubicin,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Idarubicin.,increase,risk
Idarubicin,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Idarubicin.,increase,risk
Idarubicin,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Idarubicin.,increase,risk
Idarubicin,Voclosporin,The risk or severity of adverse effects can be increased when Idarubicin is combined with Voclosporin.,increase,risk
Idarubicin,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Idarubicin.,increase,risk
Idarubicin,Voriconazole,The metabolism of Idarubicin can be decreased when combined with Voriconazole.,decrease,no risk
Idarubicin,Vorinostat,The risk or severity of adverse effects can be increased when Idarubicin is combined with Vorinostat.,increase,risk
Idarubicin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Idarubicin.,decrease,no risk
Idarubicin,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Idarubicin.,decrease,no risk
Idarubicin,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Idarubicin.,increase,risk
Idarubicin,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Idarubicin.,increase,risk
Idarubicin,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Idarubicin.,increase,risk
Idarubicin,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Idarubicin.,decrease,no risk
Idarubicin,Zafirlukast,The metabolism of Idarubicin can be decreased when combined with Zafirlukast.,decrease,no risk
Idarubicin,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Idarubicin.,increase,risk
Idarubicin,Zileuton,The metabolism of Idarubicin can be decreased when combined with Zileuton.,decrease,no risk
Idarubicin,Zolpidem,The metabolism of Idarubicin can be decreased when combined with Zolpidem.,decrease,no risk
Idarubicin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Idarubicin.,decrease,no risk
Idarubicin,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Idarubicin.,decrease,no risk
Chlormezanone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Chlormezanone.,increase,risk
Chlormezanone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Gabapentin enacarbil.,increase,risk
Chlormezanone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Chlormezanone.,increase,risk
Chlormezanone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Chlormezanone is combined with Ganaxolone.",increase,risk
Chlormezanone,Gepirone,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Gepirone.,increase,risk
Chlormezanone,Glutethimide,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Glutethimide.,increase,risk
Chlormezanone,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Chlormezanone.,increase,risk
Chlormezanone,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Chlormezanone.,increase,risk
Chlormezanone,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Chlormezanone.,increase,risk
Chlormezanone,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Chlormezanone.,increase,risk
Chlormezanone,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Chlormezanone.,increase,risk
Chlormezanone,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Chlormezanone.,increase,risk
Chlormezanone,Hydrocodone,Chlormezanone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Chlormezanone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Chlormezanone.,increase,risk
Chlormezanone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Chlormezanone.,increase,no risk
Chlormezanone,Ketamine,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Ketamine.,increase,risk
Chlormezanone,Ketazolam,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Ketazolam.,increase,risk
Chlormezanone,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Chlormezanone.,increase,risk
Chlormezanone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Chlormezanone is combined with Oliceridine.",increase,risk
Chlormezanone,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Chlormezanone.,increase,risk
Chlormezanone,Opium,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Opium.,increase,risk
Chlormezanone,Orphenadrine,Chlormezanone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Chlormezanone,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Chlormezanone.,increase,risk
Chlormezanone,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Chlormezanone.,increase,risk
Chlormezanone,Oxitriptan,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Oxitriptan.,increase,risk
Chlormezanone,Oxprenolol,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Oxprenolol.,increase,risk
Chlormezanone,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Chlormezanone.,increase,risk
Chlormezanone,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Chlormezanone.,increase,risk
Chlormezanone,Oxymorphone,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Oxymorphone.,increase,risk
Chlormezanone,Quazepam,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Quazepam.,increase,risk
Chlormezanone,Quetiapine,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Quetiapine.,increase,risk
Chlormezanone,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Chlormezanone.,increase,risk
Chlormezanone,Quinupramine,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Quinupramine.,increase,risk
Chlormezanone,Urethane,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Urethane.,increase,risk
Chlormezanone,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Chlormezanone.,increase,risk
Chlormezanone,Vecuronium,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Vecuronium.,increase,risk
Chlormezanone,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Chlormezanone.,increase,risk
Chlormezanone,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Chlormezanone.,increase,risk
Chlormezanone,Vilazodone,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Vilazodone.,increase,risk
Chlormezanone,Viloxazine,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Viloxazine.,increase,risk
Chlormezanone,Vortioxetine,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Vortioxetine.,increase,risk
Chlormezanone,Yohimbine,The therapeutic efficacy of Chlormezanone can be increased when used in combination with Yohimbine.,increase,no risk
Chlormezanone,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Chlormezanone.,increase,risk
Chlormezanone,Ziconotide,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Ziconotide.,increase,risk
Chlormezanone,Zimelidine,The risk or severity of adverse effects can be increased when Chlormezanone is combined with Zimelidine.,increase,risk
Chlormezanone,Ziprasidone,The risk or severity of adverse effects can be increased when Chlormezanone is combined with Ziprasidone.,increase,risk
Chlormezanone,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Chlormezanone.,increase,risk
Chlormezanone,Zolpidem,Chlormezanone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Chlormezanone,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Chlormezanone.,increase,risk
Chlormezanone,Zopiclone,The risk or severity of adverse effects can be increased when Chlormezanone is combined with Zopiclone.,increase,risk
Chlormezanone,Zotepine,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Zotepine.,increase,risk
Chlormezanone,Zuclopenthixol,The risk or severity of CNS depression can be increased when Chlormezanone is combined with Zuclopenthixol.,increase,risk
Chlormezanone,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Chlormezanone.,increase,risk
Rescinnamine,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Glycol salicylate is combined with Rescinnamine.",increase,risk
Rescinnamine,Guanabenz,Guanabenz may decrease the antihypertensive activities of Rescinnamine.,decrease,no risk
Rescinnamine,Guanadrel,Rescinnamine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Rescinnamine,Guanethidine,Rescinnamine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Rescinnamine,Guanfacine,Guanfacine may decrease the antihypertensive activities of Rescinnamine.,decrease,no risk
Rescinnamine,Guanoxan,Rescinnamine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Rescinnamine,Halothane,Halothane may decrease the antihypertensive activities of Rescinnamine.,decrease,no risk
Rescinnamine,Heparin,The risk or severity of hyperkalemia can be increased when Rescinnamine is combined with Heparin.,increase,risk
Rescinnamine,Holcus lanatus pollen,The risk or severity of adverse effects can be increased when Rescinnamine is combined with Holcus lanatus pollen.,increase,risk
Rescinnamine,Hydralazine,Rescinnamine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Rescinnamine,Hydrochlorothiazide,The therapeutic efficacy of Rescinnamine can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Rescinnamine,Hydroflumethiazide,The therapeutic efficacy of Rescinnamine can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Rescinnamine,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Rescinnamine.,increase,risk
Rescinnamine,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketoprofen is combined with Rescinnamine.",increase,risk
Rescinnamine,Ketorolac,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketorolac is combined with Rescinnamine.",increase,risk
Rescinnamine,Koeleria macrantha pollen,The risk or severity of adverse effects can be increased when Rescinnamine is combined with Koeleria macrantha pollen.,increase,risk
Rescinnamine,Obinutuzumab,Rescinnamine may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Rescinnamine,Olanzapine,Olanzapine may increase the hypotensive activities of Rescinnamine.,increase,no risk
Rescinnamine,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Rescinnamine is combined with Olmesartan.",increase,risk
Rescinnamine,Olodaterol,Olodaterol may decrease the antihypertensive activities of Rescinnamine.,decrease,no risk
Rescinnamine,Olsalazine,The risk or severity of renal failure can be increased when Olsalazine is combined with Rescinnamine.,increase,risk
Rescinnamine,Opicapone,Opicapone may increase the hypotensive activities of Rescinnamine.,increase,no risk
Rescinnamine,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Rescinnamine.,decrease,no risk
Rescinnamine,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxaprozin is combined with Rescinnamine.",increase,risk
Rescinnamine,Oxprenolol,Rescinnamine may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Rescinnamine,Oxymetazoline,The therapeutic efficacy of Rescinnamine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Rescinnamine,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Rescinnamine.",increase,risk
Rescinnamine,Quetiapine,Quetiapine may increase the hypotensive activities of Rescinnamine.,increase,no risk
Rescinnamine,Quinapril,The risk or severity of angioedema can be increased when Quinapril is combined with Rescinnamine.,increase,risk
Rescinnamine,Quinethazone,The risk or severity of hypotension can be increased when Quinethazone is combined with Rescinnamine.,increase,risk
Rescinnamine,Quinidine,Quinidine may decrease the antihypertensive activities of Rescinnamine.,decrease,no risk
Rescinnamine,Quinine,Quinine may increase the hypotensive activities of Rescinnamine.,increase,no risk
Rescinnamine,Quinupramine,Quinupramine may decrease the antihypertensive activities of Rescinnamine.,decrease,no risk
Rescinnamine,Udenafil,Udenafil may increase the antihypertensive activities of Rescinnamine.,increase,no risk
Rescinnamine,Unoprostone,Rescinnamine may increase the hypotensive activities of Unoprostone.,increase,no risk
Rescinnamine,Urochloa mutica pollen,The risk or severity of adverse effects can be increased when Rescinnamine is combined with Urochloa mutica pollen.,increase,risk
Rescinnamine,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Rescinnamine.,increase,risk
Rescinnamine,Valdecoxib,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valdecoxib is combined with Rescinnamine.",increase,risk
Rescinnamine,Valsartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Rescinnamine is combined with Valsartan.",increase,risk
Rescinnamine,Vardenafil,Vardenafil may increase the antihypertensive activities of Rescinnamine.,increase,no risk
Rescinnamine,Verapamil,Verapamil may increase the hypotensive activities of Rescinnamine.,increase,no risk
Rescinnamine,Vericiguat,Vericiguat may increase the hypotensive activities of Rescinnamine.,increase,no risk
Rescinnamine,Vilanterol,Vilanterol may decrease the antihypertensive activities of Rescinnamine.,decrease,no risk
Rescinnamine,Vilazodone,Vilazodone may decrease the antihypertensive activities of Rescinnamine.,decrease,no risk
Rescinnamine,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Rescinnamine.,increase,risk
Rescinnamine,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Rescinnamine.,decrease,no risk
Rescinnamine,Xamoterol,Xamoterol may decrease the antihypertensive activities of Rescinnamine.,decrease,no risk
Rescinnamine,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Rescinnamine.,decrease,no risk
Rescinnamine,Yohimbine,Yohimbine may decrease the antihypertensive activities of Rescinnamine.,decrease,no risk
Rescinnamine,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Rescinnamine.,increase,no risk
Rescinnamine,Zofenopril,The risk or severity of angioedema can be increased when Rescinnamine is combined with Zofenopril.,increase,risk
Rescinnamine,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Rescinnamine.,decrease,no risk
Rescinnamine,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Rescinnamine.,increase,risk
Rescinnamine,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Rescinnamine.,decrease,no risk
Ifosfamide,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Ifosfamide.,increase,risk
Ifosfamide,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Ifosfamide.,decrease,no risk
Ifosfamide,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Ifosfamide.,increase,risk
Ifosfamide,Bacitracin,Bacitracin may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,decrease,no risk
Ifosfamide,Baclofen,Baclofen may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,decrease,no risk
Ifosfamide,Balsalazide,Balsalazide may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,decrease,no risk
Ifosfamide,Baricitinib,The risk or severity of adverse effects can be increased when Ifosfamide is combined with Baricitinib.,increase,risk
Ifosfamide,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Ifosfamide.,increase,risk
Ifosfamide,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Ifosfamide.,increase,risk
Ifosfamide,Beclomethasone dipropionate,The metabolism of Ifosfamide can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Ifosfamide,Belatacept,The risk or severity of adverse effects can be increased when Ifosfamide is combined with Belatacept.,increase,risk
Ifosfamide,Belimumab,The risk or severity of adverse effects can be increased when Ifosfamide is combined with Belimumab.,increase,risk
Ifosfamide,Belinostat,The risk or severity of adverse effects can be increased when Ifosfamide is combined with Belinostat.,increase,risk
Ifosfamide,Belumosudil,The risk or severity of adverse effects can be increased when Ifosfamide is combined with Belumosudil.,increase,risk
Ifosfamide,Belzutifan,The serum concentration of Ifosfamide can be decreased when it is combined with Belzutifan.,decrease,no risk
Ifosfamide,Bemiparin,The risk or severity of bleeding can be increased when Ifosfamide is combined with Bemiparin.,increase,risk
Ifosfamide,Bendamustine,The risk or severity of adverse effects can be increased when Ifosfamide is combined with Bendamustine.,increase,risk
Ifosfamide,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Ifosfamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ifosfamide,Benorilate,Benorilate may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,decrease,no risk
Ifosfamide,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,decrease,no risk
Ifosfamide,Benserazide,Ifosfamide may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Ifosfamide,Benzatropine,Benzatropine may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,decrease,no risk
Ifosfamide,Benznidazole,Ifosfamide may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Ifosfamide,Benzocaine,The risk or severity of methemoglobinemia can be increased when Ifosfamide is combined with Benzocaine.,increase,risk
Ifosfamide,Benzphetamine,The metabolism of Ifosfamide can be decreased when combined with Benzphetamine.,decrease,no risk
Ifosfamide,Benzthiazide,Benzthiazide may increase the excretion rate of Ifosfamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ifosfamide,Benzydamine,Benzydamine may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,decrease,no risk
Ifosfamide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Ifosfamide is combined with Benzyl alcohol.,increase,risk
Ifosfamide,Bepotastine,Ifosfamide may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Ifosfamide,Berotralstat,The serum concentration of Ifosfamide can be increased when it is combined with Berotralstat.,increase,no risk
Ifosfamide,Betamethasone,The metabolism of Ifosfamide can be increased when combined with Betamethasone.,increase,no risk
Ifosfamide,Betamethasone phosphate,The metabolism of Ifosfamide can be increased when combined with Betamethasone phosphate.,increase,no risk
Ifosfamide,Betrixaban,The risk or severity of bleeding can be increased when Ifosfamide is combined with Betrixaban.,increase,risk
Ifosfamide,Bevacizumab,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Ifosfamide.,increase,risk
Ifosfamide,Bexarotene,The metabolism of Ifosfamide can be increased when combined with Bexarotene.,increase,no risk
Ifosfamide,Bezafibrate,The metabolism of Ifosfamide can be decreased when combined with Bezafibrate.,decrease,no risk
Ifosfamide,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Ifosfamide.,increase,no risk
Ifosfamide,Bicisate,Ifosfamide may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Ifosfamide,Bifonazole,The metabolism of Ifosfamide can be decreased when combined with Bifonazole.,decrease,no risk
Ifosfamide,Bimekizumab,The metabolism of Ifosfamide can be increased when combined with Bimekizumab.,increase,no risk
Ifosfamide,Bismuth subgallate,Ifosfamide may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Ifosfamide,Bisoprolol,Bisoprolol may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,decrease,no risk
Ifosfamide,Bisoxatin,Ifosfamide may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Ifosfamide,Bivalirudin,The risk or severity of bleeding can be increased when Ifosfamide is combined with Bivalirudin.,increase,risk
Ifosfamide,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Ifosfamide.,increase,risk
Ifosfamide,Blinatumomab,The risk or severity of adverse effects can be increased when Ifosfamide is combined with Blinatumomab.,increase,risk
Ifosfamide,Boceprevir,The metabolism of Ifosfamide can be decreased when combined with Boceprevir.,decrease,no risk
Ifosfamide,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Ifosfamide.",decrease,no risk
Ifosfamide,Bortezomib,The metabolism of Bortezomib can be increased when combined with Ifosfamide.,increase,no risk
Ifosfamide,Bosentan,The metabolism of Ifosfamide can be increased when combined with Bosentan.,increase,no risk
Ifosfamide,Bosutinib,The metabolism of Bosutinib can be increased when combined with Ifosfamide.,increase,no risk
Ifosfamide,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Ifosfamide.,increase,no risk
Ifosfamide,Brigatinib,The metabolism of Ifosfamide can be increased when combined with Brigatinib.,increase,no risk
Ifosfamide,Brivaracetam,The metabolism of Ifosfamide can be decreased when combined with Brivaracetam.,decrease,no risk
Ifosfamide,Brodalumab,The risk or severity of adverse effects can be increased when Ifosfamide is combined with Brodalumab.,increase,risk
Ifosfamide,Bromazepam,Ifosfamide may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Ifosfamide,Bromotheophylline,Bromotheophylline may increase the excretion rate of Ifosfamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ifosfamide,Brompheniramine,The metabolism of Ifosfamide can be decreased when combined with Brompheniramine.,decrease,no risk
Ifosfamide,Budesonide,The metabolism of Ifosfamide can be increased when combined with Budesonide.,increase,no risk
Ifosfamide,Bumadizone,Bumadizone may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,decrease,no risk
Ifosfamide,Bumetanide,Bumetanide may increase the excretion rate of Ifosfamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ifosfamide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ifosfamide is combined with Bupivacaine.,increase,risk
Ifosfamide,Buprenorphine,The metabolism of Ifosfamide can be decreased when combined with Buprenorphine.,decrease,no risk
Ifosfamide,Bupropion,The metabolism of Ifosfamide can be decreased when combined with Bupropion.,decrease,no risk
Ifosfamide,Buspirone,The metabolism of Ifosfamide can be decreased when combined with Buspirone.,decrease,no risk
Ifosfamide,Busulfan,The risk or severity of hemorrhagic cystitis can be increased when Busulfan is combined with Ifosfamide.,increase,risk
Ifosfamide,Butabarbital,Butabarbital may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,decrease,no risk
Ifosfamide,Butacaine,The risk or severity of methemoglobinemia can be increased when Ifosfamide is combined with Butacaine.,increase,risk
Ifosfamide,Butalbital,The metabolism of Ifosfamide can be increased when combined with Butalbital.,increase,no risk
Ifosfamide,Butamben,The risk or severity of methemoglobinemia can be increased when Ifosfamide is combined with Butamben.,increase,risk
Propafenone,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Benzphetamine,The therapeutic efficacy of Propafenone can be decreased when used in combination with Benzphetamine.,decrease,no risk
Propafenone,Benzydamine,Benzydamine may decrease the antihypertensive activities of Propafenone.,decrease,no risk
Propafenone,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Bepridil,Propafenone may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Propafenone,Beractant,Propafenone may increase the bradycardic activities of Beractant.,increase,no risk
Propafenone,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Betaine,Betaine may increase the bradycardic activities of Propafenone.,increase,no risk
Propafenone,Betaxolol,The risk or severity of adverse effects can be increased when Propafenone is combined with Betaxolol.,increase,risk
Propafenone,Bethanechol,The risk or severity of adverse effects can be increased when Propafenone is combined with Bethanechol.,increase,risk
Propafenone,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Propafenone.,decrease,no risk
Propafenone,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Propafenone.,increase,no risk
Propafenone,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Propafenone.,increase,risk
Propafenone,Bimekizumab,The metabolism of Propafenone can be increased when combined with Bimekizumab.,increase,no risk
Propafenone,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Bioallethrin,Propafenone may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Propafenone,Biperiden,The metabolism of Propafenone can be decreased when combined with Biperiden.,decrease,no risk
Propafenone,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Propafenone.,increase,risk
Propafenone,Boceprevir,The metabolism of Propafenone can be decreased when combined with Boceprevir.,decrease,no risk
Propafenone,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Bosentan,Propafenone may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Propafenone,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Bouteloua gracilis pollen,The risk of a hypersensitivity reaction to Bouteloua gracilis pollen is increased when it is combined with Propafenone.,increase,risk
Propafenone,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Bretylium,Bretylium may increase the arrhythmogenic activities of Propafenone.,increase,no risk
Propafenone,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Propafenone.,increase,no risk
Propafenone,Bromotheophylline,The serum concentration of Bromotheophylline can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Propafenone.,increase,risk
Propafenone,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Propafenone.,increase,risk
Propafenone,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Propafenone.,increase,risk
Propafenone,Bumadizone,Bumadizone may decrease the antihypertensive activities of Propafenone.,decrease,no risk
Propafenone,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Bupropion,The metabolism of Propafenone can be decreased when combined with Bupropion.,decrease,no risk
Propafenone,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Propafenone.,increase,risk
Propafenone,Buspirone,The metabolism of Buspirone can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Butabarbital,The serum concentration of Propafenone can be decreased when it is combined with Butabarbital.,decrease,no risk
Propafenone,Butalbital,The serum concentration of Propafenone can be decreased when it is combined with Butalbital.,decrease,no risk
Propafenone,Butaperazine,The serum concentration of Propafenone can be increased when it is combined with Butaperazine.,increase,no risk
Propafenone,Butriptyline,The risk or severity of QTc prolongation can be increased when Propafenone is combined with Butriptyline.,increase,risk
Propafenone,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Propafenone.,increase,risk
Propafenone,Galantamine,The metabolism of Galantamine can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Propafenone.,increase,no risk
Propafenone,Gatifloxacin,The metabolism of Propafenone can be decreased when combined with Gatifloxacin.,decrease,no risk
Propafenone,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Gemfibrozil,The metabolism of Propafenone can be decreased when combined with Gemfibrozil.,decrease,no risk
Propafenone,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Propafenone.,increase,risk
Propafenone,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Propafenone.,increase,risk
Propafenone,Gilteritinib,The risk or severity of QTc prolongation can be increased when Propafenone is combined with Gilteritinib.,increase,risk
Propafenone,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Propafenone.,increase,no risk
Propafenone,Givosiran,The serum concentration of Propafenone can be increased when it is combined with Givosiran.,increase,no risk
Propafenone,Glasdegib,The risk or severity of QTc prolongation can be increased when Propafenone is combined with Glasdegib.,increase,risk
Propafenone,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Propafenone.,increase,no risk
Propafenone,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Propafenone.,increase,no risk
Propafenone,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Propafenone.,increase,no risk
Propafenone,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Propafenone.,increase,no risk
Propafenone,Glofitamab,The serum concentration of Propafenone can be increased when it is combined with Glofitamab.,increase,no risk
Propafenone,Glucagon,The therapeutic efficacy of Propafenone can be decreased when used in combination with Glucagon.,decrease,no risk
Propafenone,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Propafenone.,increase,no risk
Propafenone,Glycerol phenylbutyrate,The metabolism of Propafenone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Propafenone,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Propafenone.,decrease,no risk
Propafenone,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Propafenone.,increase,no risk
Propafenone,Golimumab,The metabolism of Propafenone can be increased when combined with Golimumab.,increase,no risk
Propafenone,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Propafenone.,increase,risk
Propafenone,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Propafenone.,increase,risk
Propafenone,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Propafenone is combined with Grepafloxacin.,increase,risk
Propafenone,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Propafenone.,decrease,no risk
Propafenone,Guanadrel,Propafenone may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Propafenone,Guanethidine,Guanethidine may increase the hypotensive activities of Propafenone.,increase,no risk
Propafenone,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Propafenone.,decrease,no risk
Propafenone,Guanoxan,Propafenone may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Propafenone,Halofantrine,The risk or severity of QTc prolongation can be increased when Propafenone is combined with Halofantrine.,increase,risk
Propafenone,Haloperidol,The risk or severity of QTc prolongation can be increased when Propafenone is combined with Haloperidol.,increase,risk
Propafenone,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Propafenone.,increase,risk
Propafenone,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Propafenone.,increase,risk
Propafenone,Hexafluronium,Hexafluronium may increase the bradycardic activities of Propafenone.,increase,no risk
Propafenone,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Propafenone.,increase,risk
Propafenone,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Propafenone.,increase,risk
Propafenone,Huperzine A,Huperzine A may increase the bradycardic activities of Propafenone.,increase,no risk
Propafenone,Hydralazine,Propafenone may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Propafenone,Hydrochlorothiazide,Propafenone may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Propafenone,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Hydroflumethiazide,Propafenone may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Propafenone,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Propafenone is combined with Hydroxyzine.,increase,risk
Propafenone,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Propafenone.,increase,no risk
Propafenone,Ketamine,Ketamine may increase the bradycardic activities of Propafenone.,increase,no risk
Propafenone,Ketoconazole,The metabolism of Propafenone can be decreased when combined with Ketoconazole.,decrease,no risk
Propafenone,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Propafenone.,decrease,no risk
Propafenone,Ketorolac,Ketorolac may decrease the antihypertensive activities of Propafenone.,decrease,no risk
Propafenone,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Propafenone.,increase,risk
Propafenone,Obeticholic acid,The metabolism of Propafenone can be decreased when combined with Obeticholic acid.,decrease,no risk
Propafenone,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Propafenone.,increase,no risk
Propafenone,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Propafenone.,increase,risk
Propafenone,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Olmesartan,Propafenone may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Propafenone,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Propafenone.,decrease,no risk
Propafenone,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Omaveloxolone,The serum concentration of Propafenone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Propafenone,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Opium,The metabolism of Opium can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Propafenone.,decrease,no risk
Propafenone,Oritavancin,The metabolism of Propafenone can be decreased when combined with Oritavancin.,decrease,no risk
Propafenone,Orlistat,Orlistat can cause a decrease in the absorption of Propafenone resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Propafenone,Orphenadrine,The metabolism of Propafenone can be decreased when combined with Orphenadrine.,decrease,no risk
Propafenone,Osilodrostat,The metabolism of Propafenone can be decreased when combined with Osilodrostat.,decrease,no risk
Propafenone,Osimertinib,The serum concentration of Propafenone can be decreased when it is combined with Osimertinib.,decrease,no risk
Propafenone,Ospemifene,The metabolism of Propafenone can be decreased when combined with Ospemifene.,decrease,no risk
Propafenone,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Propafenone.,increase,risk
Propafenone,Oxamniquine,The metabolism of Propafenone can be decreased when combined with Oxamniquine.,decrease,no risk
Propafenone,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Propafenone.,decrease,no risk
Propafenone,Oxatomide,The risk or severity of QTc prolongation can be increased when Propafenone is combined with Oxatomide.,increase,risk
Propafenone,Oxprenolol,The risk or severity of adverse effects can be increased when Propafenone is combined with Oxprenolol.,increase,risk
Propafenone,Oxtriphylline,The serum concentration of Oxtriphylline can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Oxybutynin,The metabolism of Propafenone can be decreased when combined with Oxybutynin.,decrease,no risk
Propafenone,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Propafenone.,decrease,no risk
Propafenone,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Propafenone.,decrease,no risk
Propafenone,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Propafenone.,increase,risk
Propafenone,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Quinapril,Propafenone may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Propafenone,Quinidine,Quinidine may increase the QTc-prolonging activities of Propafenone.,increase,no risk
Propafenone,Quinine,The metabolism of Propafenone can be decreased when combined with Quinine.,decrease,no risk
Propafenone,Quinupramine,The risk or severity of hypertension can be increased when Propafenone is combined with Quinupramine.,increase,risk
Propafenone,Quizartinib,The risk or severity of QTc prolongation can be increased when Propafenone is combined with Quizartinib.,increase,risk
Propafenone,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Urochloa mutica pollen,The risk of a hypersensitivity reaction to Urochloa mutica pollen is increased when it is combined with Propafenone.,increase,risk
Propafenone,Vadadustat,The serum concentration of Propafenone can be increased when it is combined with Vadadustat.,increase,no risk
Propafenone,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Valdecoxib,Valdecoxib may decrease the antihypertensive activities of Propafenone.,decrease,no risk
Propafenone,Valproic acid,The risk or severity of QTc prolongation can be increased when Propafenone is combined with Valproic acid.,increase,risk
Propafenone,Valsartan,Propafenone may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Propafenone,Vandetanib,The risk or severity of QTc prolongation can be increased when Propafenone is combined with Vandetanib.,increase,risk
Propafenone,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Varenicline,The risk or severity of adverse effects can be increased when Propafenone is combined with Varenicline.,increase,risk
Propafenone,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Vemurafenib,The serum concentration of Propafenone can be increased when it is combined with Vemurafenib.,increase,no risk
Propafenone,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Venlafaxine,The serum concentration of Venlafaxine can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Propafenone.,increase,risk
Propafenone,Vernakalant,Propafenone may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Propafenone,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Propafenone.,decrease,no risk
Propafenone,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Propafenone.,decrease,no risk
Propafenone,Vilazodone,The metabolism of Propafenone can be decreased when combined with Vilazodone.,decrease,no risk
Propafenone,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Propafenone.,increase,no risk
Propafenone,Viloxazine,The metabolism of Propafenone can be decreased when combined with Viloxazine.,decrease,no risk
Propafenone,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Vincristine,The excretion of Vincristine can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Vinorelbine,The metabolism of Propafenone can be decreased when combined with Vinorelbine.,decrease,no risk
Propafenone,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Voriconazole,The metabolism of Propafenone can be decreased when combined with Voriconazole.,decrease,no risk
Propafenone,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Propafenone.,increase,risk
Propafenone,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Propafenone.,increase,no risk
Propafenone,Warfarin,The metabolism of Warfarin can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Propafenone.,decrease,no risk
Propafenone,Xylometazoline,Propafenone may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Propafenone,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Ziconotide,Propafenone may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Propafenone,Zileuton,The metabolism of Propafenone can be decreased when combined with Zileuton.,decrease,no risk
Propafenone,Zimelidine,The serum concentration of Propafenone can be increased when it is combined with Zimelidine.,increase,no risk
Propafenone,Ziprasidone,The risk or severity of QTc prolongation can be increased when Propafenone is combined with Ziprasidone.,increase,risk
Propafenone,Zofenopril,Propafenone may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Propafenone,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Propafenone.,increase,no risk
Propafenone,Zotepine,The metabolism of Zotepine can be decreased when combined with Propafenone.,decrease,no risk
Propafenone,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Propafenone is combined with Zuclopenthixol.,increase,risk
Naloxone,Gabapentin enacarbil,Naloxone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Naloxone,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Gadodiamide,Gadodiamide may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Gadofosveset trisodium,Naloxone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Naloxone,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Gadoteric acid,Naloxone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Naloxone,Gadoteridol,Gadoteridol may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Ganciclovir,Ganciclovir may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Gemcitabine,Gemcitabine may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Gemfibrozil,The metabolism of Naloxone can be decreased when combined with Gemfibrozil.,decrease,no risk
Naloxone,Gentamicin,Naloxone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Naloxone,Gimeracil,Naloxone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Naloxone,Givosiran,Givosiran may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Glecaprevir,The metabolism of Naloxone can be decreased when combined with Glecaprevir.,decrease,no risk
Naloxone,Glipizide,Glipizide may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Glycerol phenylbutyrate,Naloxone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Naloxone,Golodirsen,Naloxone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Naloxone,Goserelin,Goserelin may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Guanethidine,Guanethidine may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Guanfacine,Guanfacine may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Haloperidol,Haloperidol may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Hydralazine,Naloxone may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Naloxone,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Naloxone,Hydrocodone,The therapeutic efficacy of Hydrocodone can be decreased when used in combination with Naloxone.,decrease,no risk
Naloxone,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Naloxone,Hydromorphone,The therapeutic efficacy of Hydromorphone can be decreased when used in combination with Naloxone.,decrease,no risk
Naloxone,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Hydroxyethyl Starch,Naloxone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Naloxone,Kanamycin,Naloxone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Naloxone,Ketamine,Naloxone may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Naloxone,Ketazolam,Naloxone may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Naloxone,Ketoconazole,The metabolism of Naloxone can be decreased when combined with Ketoconazole.,decrease,no risk
Naloxone,Ketoprofen,Ketoprofen may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Ketorolac,Ketorolac may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Octinoxate,Naloxone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Naloxone,Oliceridine,The therapeutic efficacy of Oliceridine can be decreased when used in combination with Naloxone.,decrease,no risk
Naloxone,Olsalazine,Olsalazine may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Ombitasvir,The metabolism of Naloxone can be decreased when combined with Ombitasvir.,decrease,no risk
Naloxone,Opium,The therapeutic efficacy of Opium can be decreased when used in combination with Naloxone.,decrease,no risk
Naloxone,Oseltamivir,Oseltamivir may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Oxacillin,Oxacillin may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Oxaprozin,Oxaprozin may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Oxazepam,Oxazepam may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Oxybenzone,Naloxone may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Naloxone,Oxymorphone,The therapeutic efficacy of Oxymorphone can be decreased when used in combination with Naloxone.,decrease,no risk
Naloxone,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Oxyquinoline,Naloxone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Naloxone,Quetiapine,Naloxone may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Naloxone,Quinethazone,Quinethazone may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Naloxone,Quinidine,Naloxone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Naloxone,Quizartinib,The metabolism of Naloxone can be decreased when combined with Quizartinib.,decrease,no risk
Naloxone,Vaborbactam,Naloxone may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Naloxone,Valaciclovir,Valaciclovir may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Valbenazine,Naloxone may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Naloxone,Valdecoxib,Valdecoxib may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Valganciclovir,Naloxone may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Naloxone,Valproic acid,The metabolism of Naloxone can be decreased when combined with Valproic acid.,decrease,no risk
Naloxone,Vancomycin,Naloxone may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Naloxone,Varenicline,Naloxone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Naloxone,Venlafaxine,Venlafaxine may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Verapamil,Verapamil may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Vilanterol,Naloxone may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Naloxone,Viloxazine,Naloxone may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Naloxone,Vortioxetine,Naloxone may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Naloxone,Warfarin,Naloxone may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Naloxone,Zaleplon,Zaleplon may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Zanamivir,Zanamivir may decrease the excretion rate of Naloxone which could result in a higher serum level.,decrease,no risk
Naloxone,Zidovudine,The metabolism of Naloxone can be increased when combined with Zidovudine.,increase,no risk
Naloxone,Zonisamide,Zonisamide may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Domperidone,Buclizine,The therapeutic efficacy of Domperidone can be decreased when used in combination with Buclizine.,decrease,no risk
Domperidone,Budesonide,The metabolism of Domperidone can be increased when combined with Budesonide.,increase,no risk
Domperidone,Bupivacaine,The metabolism of Domperidone can be decreased when combined with Bupivacaine.,decrease,no risk
Domperidone,Buprenorphine,The metabolism of Domperidone can be decreased when combined with Buprenorphine.,decrease,no risk
Domperidone,Bupropion,The metabolism of Domperidone can be decreased when combined with Bupropion.,decrease,no risk
Domperidone,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Domperidone.,increase,risk
Domperidone,Buspirone,The metabolism of Domperidone can be decreased when combined with Buspirone.,decrease,no risk
Domperidone,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Domperidone.,increase,risk
Domperidone,Butylscopolamine,The therapeutic efficacy of Domperidone can be decreased when used in combination with Butylscopolamine.,decrease,no risk
Domperidone,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Domperidone.,increase,risk
Domperidone,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Domperidone.,increase,risk
Domperidone,Gallamine triethiodide,The therapeutic efficacy of Domperidone can be decreased when used in combination with Gallamine triethiodide.,decrease,no risk
Domperidone,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Domperidone.,increase,risk
Domperidone,Gefitinib,The metabolism of Domperidone can be decreased when combined with Gefitinib.,decrease,no risk
Domperidone,Gemfibrozil,The metabolism of Domperidone can be decreased when combined with Gemfibrozil.,decrease,no risk
Domperidone,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Domperidone.,increase,risk
Domperidone,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Domperidone.,increase,risk
Domperidone,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Domperidone.,increase,risk
Domperidone,Givosiran,The serum concentration of Domperidone can be increased when it is combined with Givosiran.,increase,no risk
Domperidone,Glasdegib,The risk or severity of QTc prolongation can be increased when Domperidone is combined with Glasdegib.,increase,risk
Domperidone,Glofitamab,The serum concentration of Domperidone can be increased when it is combined with Glofitamab.,increase,no risk
Domperidone,Glyburide,The metabolism of Domperidone can be decreased when combined with Glyburide.,decrease,no risk
Domperidone,Glycerol phenylbutyrate,The metabolism of Domperidone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Domperidone,Glycopyrronium,The therapeutic efficacy of Domperidone can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Domperidone,Golimumab,The metabolism of Domperidone can be increased when combined with Golimumab.,increase,no risk
Domperidone,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Domperidone.,increase,risk
Domperidone,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Domperidone.,increase,risk
Domperidone,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Domperidone.,increase,risk
Domperidone,Guanabenz,The metabolism of Domperidone can be decreased when combined with Guanabenz.,decrease,no risk
Domperidone,Halofantrine,The metabolism of Domperidone can be decreased when combined with Halofantrine.,decrease,no risk
Domperidone,Haloperidol,The risk or severity of QTc prolongation can be increased when Domperidone is combined with Haloperidol.,increase,risk
Domperidone,Halothane,The metabolism of Domperidone can be decreased when combined with Halothane.,decrease,no risk
Domperidone,Hexocyclium,The therapeutic efficacy of Domperidone can be decreased when used in combination with Hexocyclium.,decrease,no risk
Domperidone,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Domperidone.,increase,risk
Domperidone,Homatropine methylbromide,The therapeutic efficacy of Domperidone can be decreased when used in combination with Homatropine methylbromide.,decrease,no risk
Domperidone,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Domperidone.,increase,risk
Domperidone,Hydrocodone,The metabolism of Domperidone can be decreased when combined with Hydrocodone.,decrease,no risk
Domperidone,Hydrocortisone,The metabolism of Domperidone can be increased when combined with Hydrocortisone.,increase,no risk
Domperidone,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Domperidone.,increase,risk
Domperidone,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Domperidone is combined with Hydroxyzine.,increase,risk
Domperidone,Hyoscyamine,The therapeutic efficacy of Domperidone can be decreased when used in combination with Hyoscyamine.,decrease,no risk
Domperidone,Ketamine,The metabolism of Ketamine can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Domperidone.,increase,risk
Domperidone,Ketoprofen,The metabolism of Domperidone can be decreased when combined with Ketoprofen.,decrease,no risk
Domperidone,Ketorolac,The metabolism of Domperidone can be decreased when combined with Ketorolac.,decrease,no risk
Domperidone,Obeticholic acid,The metabolism of Domperidone can be decreased when combined with Obeticholic acid.,decrease,no risk
Domperidone,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Domperidone.,increase,risk
Domperidone,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Domperidone.,increase,risk
Domperidone,Olanzapine,The therapeutic efficacy of Domperidone can be decreased when used in combination with Olanzapine.,decrease,no risk
Domperidone,Olaparib,The metabolism of Olaparib can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Domperidone.,increase,risk
Domperidone,Omaveloxolone,The serum concentration of Domperidone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Domperidone,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Domperidone.,increase,risk
Domperidone,Opium,The metabolism of Opium can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Oritavancin,The metabolism of Domperidone can be decreased when combined with Oritavancin.,decrease,no risk
Domperidone,Orphenadrine,The therapeutic efficacy of Domperidone can be decreased when used in combination with Orphenadrine.,decrease,no risk
Domperidone,Osilodrostat,The metabolism of Domperidone can be decreased when combined with Osilodrostat.,decrease,no risk
Domperidone,Osimertinib,The serum concentration of Domperidone can be decreased when it is combined with Osimertinib.,decrease,no risk
Domperidone,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Domperidone.,increase,risk
Domperidone,Oxamniquine,The metabolism of Domperidone can be decreased when combined with Oxamniquine.,decrease,no risk
Domperidone,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Domperidone.,increase,risk
Domperidone,Oxcarbazepine,The metabolism of Domperidone can be increased when combined with Oxcarbazepine.,increase,no risk
Domperidone,Oxprenolol,The metabolism of Domperidone can be decreased when combined with Oxprenolol.,decrease,no risk
Domperidone,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Oxybutynin,The therapeutic efficacy of Domperidone can be decreased when used in combination with Oxybutynin.,decrease,no risk
Domperidone,Oxycodone,The metabolism of Domperidone can be decreased when combined with Oxycodone.,decrease,no risk
Domperidone,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Oxyphencyclimine,The therapeutic efficacy of Domperidone can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Domperidone,Oxyphenonium,The therapeutic efficacy of Domperidone can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Domperidone,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Domperidone.,increase,risk
Domperidone,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Quetiapine,The therapeutic efficacy of Domperidone can be decreased when used in combination with Quetiapine.,decrease,no risk
Domperidone,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Domperidone.,decrease,no risk
Domperidone,Quinidine,The therapeutic efficacy of Domperidone can be decreased when used in combination with Quinidine.,decrease,no risk
Domperidone,Quinine,The metabolism of Domperidone can be decreased when combined with Quinine.,decrease,no risk
Domperidone,Quizartinib,The risk or severity of QTc prolongation can be increased when Domperidone is combined with Quizartinib.,increase,risk
Domperidone,Udenafil,The metabolism of Udenafil can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Umeclidinium,The therapeutic efficacy of Domperidone can be decreased when used in combination with Umeclidinium.,decrease,no risk
Domperidone,Vadadustat,The serum concentration of Domperidone can be decreased when it is combined with Vadadustat.,decrease,no risk
Domperidone,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Domperidone.,increase,risk
Domperidone,Vandetanib,The risk or severity of QTc prolongation can be increased when Domperidone is combined with Vandetanib.,increase,risk
Domperidone,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Domperidone.,increase,risk
Domperidone,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Vemurafenib,The serum concentration of Domperidone can be increased when it is combined with Vemurafenib.,increase,no risk
Domperidone,Venetoclax,The metabolism of Domperidone can be decreased when combined with Venetoclax.,decrease,no risk
Domperidone,Venlafaxine,The metabolism of Domperidone can be decreased when combined with Venlafaxine.,decrease,no risk
Domperidone,Verapamil,The metabolism of Domperidone can be decreased when combined with Verapamil.,decrease,no risk
Domperidone,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Domperidone.,increase,risk
Domperidone,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Domperidone.,increase,risk
Domperidone,Vilazodone,The metabolism of Domperidone can be decreased when combined with Vilazodone.,decrease,no risk
Domperidone,Viloxazine,The metabolism of Domperidone can be decreased when combined with Viloxazine.,decrease,no risk
Domperidone,Vinblastine,The metabolism of Domperidone can be decreased when combined with Vinblastine.,decrease,no risk
Domperidone,Vincristine,The metabolism of Vincristine can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Vinorelbine,The metabolism of Domperidone can be decreased when combined with Vinorelbine.,decrease,no risk
Domperidone,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Voriconazole,The metabolism of Domperidone can be decreased when combined with Voriconazole.,decrease,no risk
Domperidone,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Domperidone.,increase,risk
Domperidone,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Warfarin,The metabolism of Domperidone can be decreased when combined with Warfarin.,decrease,no risk
Domperidone,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Zaleplon,The metabolism of Domperidone can be decreased when combined with Zaleplon.,decrease,no risk
Domperidone,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Zidovudine,The metabolism of Domperidone can be decreased when combined with Zidovudine.,decrease,no risk
Domperidone,Zileuton,The metabolism of Domperidone can be decreased when combined with Zileuton.,decrease,no risk
Domperidone,Zimelidine,The metabolism of Domperidone can be decreased when combined with Zimelidine.,decrease,no risk
Domperidone,Ziprasidone,The risk or severity of QTc prolongation can be increased when Domperidone is combined with Ziprasidone.,increase,risk
Domperidone,Zolmitriptan,The metabolism of Domperidone can be decreased when combined with Zolmitriptan.,decrease,no risk
Domperidone,Zolpidem,The metabolism of Domperidone can be decreased when combined with Zolpidem.,decrease,no risk
Domperidone,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Domperidone.,increase,risk
Domperidone,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Zotepine,The metabolism of Zotepine can be decreased when combined with Domperidone.,decrease,no risk
Domperidone,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Domperidone is combined with Zuclopenthixol.,increase,risk
Fluoxymesterone,Vamorolone,The risk or severity of fluid retention can be increased when Vamorolone is combined with Fluoxymesterone.,increase,risk
Fluoxymesterone,Vildagliptin,Fluoxymesterone may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Fluoxymesterone,Warfarin,Fluoxymesterone may increase the anticoagulant activities of Warfarin.,increase,no risk
Pergolide,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Pergolide.,increase,risk
Pergolide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Pergolide is combined with Gabapentin enacarbil.,increase,risk
Pergolide,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Pergolide.,increase,risk
Pergolide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Pergolide is combined with Ganaxolone.",increase,risk
Pergolide,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Pergolide.,increase,risk
Pergolide,Gilteritinib,The therapeutic efficacy of Pergolide can be decreased when used in combination with Gilteritinib.,decrease,no risk
Pergolide,Glutethimide,The risk or severity of CNS depression can be increased when Pergolide is combined with Glutethimide.,increase,risk
Pergolide,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Pergolide.,increase,risk
Desflurane,Bumetanide,The risk or severity of adverse effects can be increased when Bumetanide is combined with Desflurane.,increase,risk
Desflurane,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Desflurane.,increase,risk
Desflurane,Buprenorphine,Desflurane may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Desflurane,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Desflurane.,increase,risk
Desflurane,Buserelin,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Buserelin.,increase,risk
Desflurane,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Desflurane.,increase,risk
Desflurane,Butabarbital,Butabarbital may increase the hypotensive activities of Desflurane.,increase,no risk
Desflurane,Butalbital,Butalbital may increase the hypotensive activities of Desflurane.,increase,no risk
Desflurane,Butaperazine,The risk or severity of CNS depression can be increased when Desflurane is combined with Butaperazine.,increase,risk
Desflurane,Butobarbital,The risk or severity of CNS depression can be increased when Desflurane is combined with Butobarbital.,increase,risk
Desflurane,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Desflurane.,increase,risk
Desflurane,Butriptyline,The risk or severity of CNS depression can be increased when Desflurane is combined with Butriptyline.,increase,risk
Desflurane,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Desflurane.,increase,risk
Desflurane,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Desflurane is combined with Gabapentin enacarbil.,increase,risk
Desflurane,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Gadobenic acid.,increase,risk
Desflurane,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Desflurane.,increase,risk
Desflurane,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Desflurane.,increase,risk
Desflurane,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Desflurane is combined with Ganaxolone.",increase,risk
Desflurane,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Desflurane.,increase,risk
Desflurane,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Gemifloxacin.,increase,risk
Desflurane,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Desflurane.,increase,risk
Desflurane,Gilteritinib,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Gilteritinib.,increase,risk
Desflurane,Glasdegib,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Glasdegib.,increase,risk
Desflurane,Glutethimide,The risk or severity of CNS depression can be increased when Desflurane is combined with Glutethimide.,increase,risk
Desflurane,Goserelin,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Goserelin.,increase,risk
Desflurane,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Desflurane.,increase,risk
Desflurane,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Grepafloxacin.,increase,risk
Desflurane,Guanabenz,Desflurane may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Desflurane,Guanadrel,Desflurane may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Desflurane,Guanethidine,Desflurane may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Desflurane,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Desflurane.,increase,risk
Desflurane,Guanoxan,Desflurane may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Desflurane,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Desflurane.,increase,risk
Desflurane,Halofantrine,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Halofantrine.,increase,risk
Desflurane,Haloperidol,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Haloperidol.,increase,risk
Desflurane,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Desflurane.,increase,risk
Desflurane,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Desflurane.,increase,risk
Desflurane,Histrelin,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Histrelin.,increase,risk
Desflurane,Hydralazine,Desflurane may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Desflurane,Hydrochlorothiazide,Desflurane may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Desflurane,Hydrocodone,Desflurane may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Desflurane,Hydroflumethiazide,Desflurane may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Desflurane,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Desflurane.,increase,risk
Desflurane,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Hydroxychloroquine.,increase,risk
Desflurane,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Hydroxyzine.,increase,risk
Desflurane,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Desflurane.,increase,risk
Desflurane,Ketamine,The risk or severity of CNS depression can be increased when Desflurane is combined with Ketamine.,increase,risk
Desflurane,Ketazolam,The risk or severity of CNS depression can be increased when Desflurane is combined with Ketazolam.,increase,risk
Desflurane,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Desflurane.,increase,risk
Desflurane,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Desflurane.,increase,risk
Desflurane,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Desflurane.,increase,risk
Desflurane,Obinutuzumab,The risk or severity of adverse effects can be increased when Desflurane is combined with Obinutuzumab.,increase,risk
Desflurane,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Desflurane.,increase,risk
Desflurane,Ofloxacin,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Ofloxacin.,increase,risk
Desflurane,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Desflurane.,increase,risk
Desflurane,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Desflurane is combined with Oliceridine.",increase,risk
Desflurane,Olmesartan,Desflurane may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Desflurane,Olodaterol,The risk or severity of hypertension can be increased when Desflurane is combined with Olodaterol.,increase,risk
Desflurane,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Desflurane.,increase,risk
Desflurane,Opicapone,The risk or severity of adverse effects can be increased when Desflurane is combined with Opicapone.,increase,risk
Desflurane,Opium,The risk or severity of CNS depression can be increased when Desflurane is combined with Opium.,increase,risk
Desflurane,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Desflurane.,increase,risk
Desflurane,Orphenadrine,Desflurane may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Desflurane,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Desflurane.,increase,risk
Desflurane,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Desflurane.,increase,risk
Desflurane,Oxatomide,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Oxatomide.,increase,risk
Desflurane,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Desflurane.,increase,risk
Desflurane,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Desflurane.,increase,risk
Desflurane,Oxitriptan,The risk or severity of CNS depression can be increased when Desflurane is combined with Oxitriptan.,increase,risk
Desflurane,Oxprenolol,The risk or severity of CNS depression can be increased when Desflurane is combined with Oxprenolol.,increase,risk
Desflurane,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Desflurane.,increase,risk
Desflurane,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Desflurane.,increase,risk
Desflurane,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Desflurane.,increase,risk
Desflurane,Oxymorphone,The risk or severity of CNS depression can be increased when Desflurane is combined with Oxymorphone.,increase,risk
Desflurane,Oxyphenbutazone,The risk or severity of hypertension can be increased when Desflurane is combined with Oxyphenbutazone.,increase,risk
Desflurane,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Desflurane.,increase,risk
Desflurane,Quazepam,The risk or severity of CNS depression can be increased when Desflurane is combined with Quazepam.,increase,risk
Desflurane,Quetiapine,The risk or severity of CNS depression can be increased when Desflurane is combined with Quetiapine.,increase,risk
Desflurane,Quinapril,Desflurane may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Desflurane,Quinidine,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Quinidine.,increase,risk
Desflurane,Quinine,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Quinine.,increase,risk
Desflurane,Quinupramine,The risk or severity of CNS depression can be increased when Desflurane is combined with Quinupramine.,increase,risk
Desflurane,Quizartinib,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Quizartinib.,increase,risk
Desflurane,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Desflurane.,increase,risk
Desflurane,Urethane,The risk or severity of CNS depression can be increased when Desflurane is combined with Urethane.,increase,risk
Desflurane,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Desflurane.,increase,risk
Desflurane,Valproic acid,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Valproic acid.,increase,risk
Desflurane,Valsartan,Desflurane may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Desflurane,Vandetanib,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Vandetanib.,increase,risk
Desflurane,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Desflurane.,increase,risk
Desflurane,Vecuronium,The risk or severity of CNS depression can be increased when Desflurane is combined with Vecuronium.,increase,risk
Desflurane,Vemurafenib,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Vemurafenib.,increase,risk
Desflurane,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Desflurane.,increase,risk
Desflurane,Verapamil,The risk or severity of myocardial depression can be increased when Verapamil is combined with Desflurane.,increase,risk
Desflurane,Vericiguat,The risk or severity of adverse effects can be increased when Desflurane is combined with Vericiguat.,increase,risk
Desflurane,Vernakalant,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Vernakalant.,increase,risk
Desflurane,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Desflurane.,increase,risk
Desflurane,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Desflurane.,increase,risk
Desflurane,Vilazodone,The risk or severity of CNS depression can be increased when Desflurane is combined with Vilazodone.,increase,risk
Desflurane,Viloxazine,The risk or severity of CNS depression can be increased when Desflurane is combined with Viloxazine.,increase,risk
Desflurane,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Desflurane.,increase,risk
Desflurane,Vorinostat,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Vorinostat.,increase,risk
Desflurane,Vortioxetine,The risk or severity of CNS depression can be increased when Desflurane is combined with Vortioxetine.,increase,risk
Desflurane,Xamoterol,The risk or severity of hypertension can be increased when Desflurane is combined with Xamoterol.,increase,risk
Desflurane,Xylometazoline,The risk or severity of hypertension can be increased when Desflurane is combined with Xylometazoline.,increase,risk
Desflurane,Yohimbine,The risk or severity of CNS depression can be increased when Desflurane is combined with Yohimbine.,increase,risk
Desflurane,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Desflurane.,increase,risk
Desflurane,Ziconotide,The risk or severity of CNS depression can be increased when Desflurane is combined with Ziconotide.,increase,risk
Desflurane,Zimelidine,The risk or severity of adverse effects can be increased when Desflurane is combined with Zimelidine.,increase,risk
Desflurane,Ziprasidone,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Ziprasidone.,increase,risk
Desflurane,Zofenopril,Desflurane may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Desflurane,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Desflurane.,increase,risk
Desflurane,Zolpidem,Desflurane may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Desflurane,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Desflurane.,increase,risk
Desflurane,Zopiclone,The risk or severity of adverse effects can be increased when Desflurane is combined with Zopiclone.,increase,risk
Desflurane,Zotepine,The risk or severity of CNS depression can be increased when Desflurane is combined with Zotepine.,increase,risk
Desflurane,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Desflurane is combined with Zuclopenthixol.,increase,risk
Desflurane,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Desflurane.,increase,risk
Clindamycin,Gallamine triethiodide,The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Gallamine triethiodide.,increase,risk
Clindamycin,Gefitinib,The metabolism of Clindamycin can be decreased when combined with Gefitinib.,decrease,no risk
Clindamycin,Gentamicin,The risk or severity of neuromuscular blockade can be increased when Gentamicin is combined with Clindamycin.,increase,risk
Clindamycin,Glecaprevir,The metabolism of Clindamycin can be decreased when combined with Glecaprevir.,decrease,no risk
Clindamycin,Glofitamab,The serum concentration of Clindamycin can be increased when it is combined with Glofitamab.,increase,no risk
Clindamycin,Glyburide,The metabolism of Clindamycin can be decreased when combined with Glyburide.,decrease,no risk
Clindamycin,Glycerol phenylbutyrate,The metabolism of Clindamycin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Clindamycin,Golimumab,The metabolism of Clindamycin can be increased when combined with Golimumab.,increase,no risk
Clindamycin,Grapefruit,The metabolism of Clindamycin can be decreased when combined with Grapefruit.,decrease,no risk
Clindamycin,Griseofulvin,The metabolism of Clindamycin can be increased when combined with Griseofulvin.,increase,no risk
Clindamycin,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Clindamycin.,decrease,no risk
Clindamycin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Clindamycin.,increase,no risk
Clindamycin,Hydrocortamate,The metabolism of Clindamycin can be increased when combined with Hydrocortamate.,increase,no risk
Clindamycin,Hydrocortisone,The metabolism of Clindamycin can be increased when combined with Hydrocortisone.,increase,no risk
Clindamycin,Hydrocortisone acetate,The metabolism of Clindamycin can be increased when combined with Hydrocortisone acetate.,increase,no risk
Clindamycin,Hydrocortisone butyrate,The metabolism of Clindamycin can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Clindamycin,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Clindamycin.,decrease,no risk
Clindamycin,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Clindamycin.,decrease,no risk
Clindamycin,Hydrocortisone probutate,The metabolism of Clindamycin can be increased when combined with Hydrocortisone probutate.,increase,no risk
Clindamycin,Hydrocortisone succinate,The metabolism of Clindamycin can be increased when combined with Hydrocortisone succinate.,increase,no risk
Clindamycin,Hydrocortisone valerate,The metabolism of Clindamycin can be increased when combined with Hydrocortisone valerate.,increase,no risk
Clindamycin,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Clindamycin.,decrease,no risk
Clindamycin,Hydroxyzine,The metabolism of Clindamycin can be decreased when combined with Hydroxyzine.,decrease,no risk
Clindamycin,Kanamycin,The risk or severity of neuromuscular blockade can be increased when Kanamycin is combined with Clindamycin.,increase,risk
Clindamycin,Kaolin,Kaolin can cause a decrease in the absorption of Clindamycin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Clindamycin,Ketamine,The metabolism of Clindamycin can be increased when combined with Ketamine.,increase,no risk
Clindamycin,Ketoconazole,The metabolism of Clindamycin can be decreased when combined with Ketoconazole.,decrease,no risk
Clindamycin,Olaparib,The metabolism of Olaparib can be decreased when combined with Clindamycin.,decrease,no risk
Clindamycin,Olutasidenib,The metabolism of Clindamycin can be increased when combined with Olutasidenib.,increase,no risk
Clindamycin,Omaveloxolone,The metabolism of Clindamycin can be increased when combined with Omaveloxolone.,increase,no risk
Clindamycin,Ondansetron,The metabolism of Clindamycin can be decreased when combined with Ondansetron.,decrease,no risk
Clindamycin,Oritavancin,The metabolism of Clindamycin can be increased when combined with Oritavancin.,increase,no risk
Clindamycin,Osilodrostat,The metabolism of Clindamycin can be decreased when combined with Osilodrostat.,decrease,no risk
Clindamycin,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Clindamycin.,increase,no risk
Clindamycin,Oxcarbazepine,The metabolism of Clindamycin can be increased when combined with Oxcarbazepine.,increase,no risk
Clindamycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Oxetacaine.,increase,risk
Clindamycin,Oxiconazole,The metabolism of Clindamycin can be increased when combined with Oxiconazole.,increase,no risk
Clindamycin,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Clindamycin.,decrease,no risk
Clindamycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Oxybuprocaine.,increase,risk
Clindamycin,Oxybutynin,The metabolism of Clindamycin can be decreased when combined with Oxybutynin.,decrease,no risk
Clindamycin,Oxycodone,The metabolism of Clindamycin can be decreased when combined with Oxycodone.,decrease,no risk
Clindamycin,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Clindamycin.,increase,risk
Clindamycin,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Clindamycin.,decrease,no risk
Clindamycin,Quinidine,The metabolism of Clindamycin can be decreased when combined with Quinidine.,decrease,no risk
Clindamycin,Quinine,The metabolism of Clindamycin can be increased when combined with Quinine.,increase,no risk
Clindamycin,Quinupramine,Clindamycin may increase the neurotoxic activities of Quinupramine.,increase,no risk
Clindamycin,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Clindamycin.,decrease,no risk
Clindamycin,Udenafil,The metabolism of Udenafil can be decreased when combined with Clindamycin.,decrease,no risk
Clindamycin,Vadadustat,The serum concentration of Clindamycin can be increased when it is combined with Vadadustat.,increase,no risk
Clindamycin,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Clindamycin.,decrease,no risk
Clindamycin,Valproate bismuth,Clindamycin may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Clindamycin,Vancomycin,The risk or severity of neuromuscular blockade can be increased when Vancomycin is combined with Clindamycin.,increase,risk
Clindamycin,Vardenafil,The metabolism of Clindamycin can be decreased when combined with Vardenafil.,decrease,no risk
Clindamycin,Vecuronium,The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Vecuronium.,increase,risk
Clindamycin,Vemurafenib,The metabolism of Clindamycin can be increased when combined with Vemurafenib.,increase,no risk
Clindamycin,Venetoclax,The metabolism of Clindamycin can be decreased when combined with Venetoclax.,decrease,no risk
Clindamycin,Verapamil,The metabolism of Clindamycin can be decreased when combined with Verapamil.,decrease,no risk
Clindamycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Clindamycin.,decrease,no risk
Clindamycin,Viloxazine,The metabolism of Clindamycin can be decreased when combined with Viloxazine.,decrease,no risk
Clindamycin,Vinblastine,The metabolism of Clindamycin can be increased when combined with Vinblastine.,increase,no risk
Clindamycin,Vincristine,The metabolism of Vincristine can be decreased when combined with Clindamycin.,decrease,no risk
Clindamycin,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Clindamycin.,increase,no risk
Clindamycin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Clindamycin.,increase,no risk
Clindamycin,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Clindamycin.,increase,no risk
Clindamycin,Viomycin,The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Viomycin.,increase,risk
Clindamycin,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Clindamycin.,decrease,no risk
Clindamycin,Voriconazole,The metabolism of Clindamycin can be decreased when combined with Voriconazole.,decrease,no risk
Clindamycin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Clindamycin.,decrease,no risk
Clindamycin,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Clindamycin.,increase,no risk
Clindamycin,Zafirlukast,The metabolism of Clindamycin can be decreased when combined with Zafirlukast.,decrease,no risk
Clindamycin,Zaleplon,The metabolism of Clindamycin can be decreased when combined with Zaleplon.,decrease,no risk
Clindamycin,Zimelidine,The metabolism of Clindamycin can be decreased when combined with Zimelidine.,decrease,no risk
Clindamycin,Ziprasidone,The metabolism of Clindamycin can be decreased when combined with Ziprasidone.,decrease,no risk
Clindamycin,Zonisamide,The metabolism of Clindamycin can be decreased when combined with Zonisamide.,decrease,no risk
Clindamycin,Zotepine,Clindamycin may increase the neurotoxic activities of Zotepine.,increase,no risk
Clindamycin,Zuclopenthixol,Clindamycin may increase the neurotoxic activities of Zuclopenthixol.,increase,no risk
Dexfenfluramine,Galantamine,The metabolism of Galantamine can be decreased when combined with Dexfenfluramine.,decrease,no risk
Dexfenfluramine,Gatifloxacin,The metabolism of Dexfenfluramine can be decreased when combined with Gatifloxacin.,decrease,no risk
Dexfenfluramine,Gefitinib,The metabolism of Dexfenfluramine can be decreased when combined with Gefitinib.,decrease,no risk
Dexfenfluramine,Gemfibrozil,The metabolism of Dexfenfluramine can be decreased when combined with Gemfibrozil.,decrease,no risk
Dexfenfluramine,Gemifloxacin,The metabolism of Dexfenfluramine can be decreased when combined with Gemifloxacin.,decrease,no risk
Dexfenfluramine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Dexfenfluramine.,increase,risk
Dexfenfluramine,Givosiran,The serum concentration of Dexfenfluramine can be increased when it is combined with Givosiran.,increase,no risk
Dexfenfluramine,Glofitamab,The serum concentration of Dexfenfluramine can be increased when it is combined with Glofitamab.,increase,no risk
Dexfenfluramine,Glycerol phenylbutyrate,The metabolism of Dexfenfluramine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Dexfenfluramine,Golimumab,The metabolism of Dexfenfluramine can be increased when combined with Golimumab.,increase,no risk
Dexfenfluramine,Granisetron,The risk or severity of serotonin syndrome can be increased when Granisetron is combined with Dexfenfluramine.,increase,risk
Dexfenfluramine,Grepafloxacin,The metabolism of Dexfenfluramine can be decreased when combined with Grepafloxacin.,decrease,no risk
Dexfenfluramine,Guanabenz,The metabolism of Dexfenfluramine can be decreased when combined with Guanabenz.,decrease,no risk
Dexfenfluramine,Halofantrine,The metabolism of Dexfenfluramine can be decreased when combined with Halofantrine.,decrease,no risk
Dexfenfluramine,Haloperidol,The serum concentration of Dexfenfluramine can be increased when it is combined with Haloperidol.,increase,no risk
Dexfenfluramine,Halothane,The metabolism of Halothane can be decreased when combined with Dexfenfluramine.,decrease,no risk
Dexfenfluramine,Hydrocodone,The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Dexfenfluramine.,increase,risk
Dexfenfluramine,Hydromorphone,The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Dexfenfluramine.,increase,risk
Dexfenfluramine,Hydroxychloroquine,The metabolism of Dexfenfluramine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Dexfenfluramine,Hydroxyzine,The metabolism of Dexfenfluramine can be decreased when combined with Hydroxyzine.,decrease,no risk
Dexfenfluramine,Ketoconazole,The metabolism of Dexfenfluramine can be decreased when combined with Ketoconazole.,decrease,no risk
Dexfenfluramine,Obeticholic acid,The metabolism of Dexfenfluramine can be decreased when combined with Obeticholic acid.,decrease,no risk
Dexfenfluramine,Olanzapine,The metabolism of Dexfenfluramine can be decreased when combined with Olanzapine.,decrease,no risk
Dexfenfluramine,Oliceridine,The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Oliceridine.,increase,risk
Dexfenfluramine,Ondansetron,The metabolism of Dexfenfluramine can be decreased when combined with Ondansetron.,decrease,no risk
Dexfenfluramine,Opium,The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Opium.,increase,risk
Dexfenfluramine,Oritavancin,The metabolism of Dexfenfluramine can be decreased when combined with Oritavancin.,decrease,no risk
Dexfenfluramine,Orphenadrine,The metabolism of Dexfenfluramine can be decreased when combined with Orphenadrine.,decrease,no risk
Dexfenfluramine,Osilodrostat,The metabolism of Dexfenfluramine can be decreased when combined with Osilodrostat.,decrease,no risk
Dexfenfluramine,Osimertinib,The serum concentration of Dexfenfluramine can be decreased when it is combined with Osimertinib.,decrease,no risk
Dexfenfluramine,Ospemifene,The metabolism of Dexfenfluramine can be decreased when combined with Ospemifene.,decrease,no risk
Dexfenfluramine,Oxamniquine,The metabolism of Dexfenfluramine can be decreased when combined with Oxamniquine.,decrease,no risk
Dexfenfluramine,Oxprenolol,The metabolism of Dexfenfluramine can be decreased when combined with Oxprenolol.,decrease,no risk
Dexfenfluramine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Dexfenfluramine.,decrease,no risk
Dexfenfluramine,Oxybutynin,The metabolism of Dexfenfluramine can be decreased when combined with Oxybutynin.,decrease,no risk
Dexfenfluramine,Oxycodone,The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Dexfenfluramine.,increase,risk
Dexfenfluramine,Oxymorphone,The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Oxymorphone.,increase,risk
Dexfenfluramine,Quetiapine,The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Quetiapine.,increase,risk
Dexfenfluramine,Quinidine,The metabolism of Dexfenfluramine can be decreased when combined with Quinidine.,decrease,no risk
Dexfenfluramine,Quinine,The metabolism of Dexfenfluramine can be decreased when combined with Quinine.,decrease,no risk
Dexfenfluramine,Quinupramine,The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Quinupramine.,increase,risk
Dexfenfluramine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Dexfenfluramine.,decrease,no risk
Dexfenfluramine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Dexfenfluramine.,decrease,no risk
Dexfenfluramine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Valproate bismuth.,increase,risk
Dexfenfluramine,Valproic acid,The metabolism of Dexfenfluramine can be decreased when combined with Valproic acid.,decrease,no risk
Dexfenfluramine,Vemurafenib,The serum concentration of Dexfenfluramine can be increased when it is combined with Vemurafenib.,increase,no risk
Dexfenfluramine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Venlafaxine.,increase,risk
Dexfenfluramine,Verapamil,The metabolism of Dexfenfluramine can be decreased when combined with Verapamil.,decrease,no risk
Dexfenfluramine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Dexfenfluramine.,decrease,no risk
Dexfenfluramine,Vilazodone,The metabolism of Dexfenfluramine can be decreased when combined with Vilazodone.,decrease,no risk
Dexfenfluramine,Viloxazine,The metabolism of Dexfenfluramine can be decreased when combined with Viloxazine.,decrease,no risk
Dexfenfluramine,Vinblastine,The metabolism of Dexfenfluramine can be decreased when combined with Vinblastine.,decrease,no risk
Dexfenfluramine,Vinorelbine,The metabolism of Dexfenfluramine can be decreased when combined with Vinorelbine.,decrease,no risk
Dexfenfluramine,Vortioxetine,The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Vortioxetine.,increase,risk
Dexfenfluramine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Dexfenfluramine.,decrease,no risk
Dexfenfluramine,Warfarin,The metabolism of Dexfenfluramine can be decreased when combined with Warfarin.,decrease,no risk
Dexfenfluramine,Yohimbine,The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Yohimbine.,increase,risk
Dexfenfluramine,Zileuton,The metabolism of Dexfenfluramine can be decreased when combined with Zileuton.,decrease,no risk
Dexfenfluramine,Zimelidine,The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Zimelidine.,increase,risk
Dexfenfluramine,Ziprasidone,The risk or severity of serotonin syndrome can be increased when Ziprasidone is combined with Dexfenfluramine.,increase,risk
Dexfenfluramine,Zolmitriptan,The metabolism of Dexfenfluramine can be decreased when combined with Zolmitriptan.,decrease,no risk
Dexfenfluramine,Zolpidem,The metabolism of Dexfenfluramine can be decreased when combined with Zolpidem.,decrease,no risk
Dexfenfluramine,Zotepine,The metabolism of Zotepine can be decreased when combined with Dexfenfluramine.,decrease,no risk
Dexfenfluramine,Zuclopenthixol,The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Zuclopenthixol.,increase,risk
Oxymorphone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Oxymorphone.,increase,risk
Oxymorphone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Gabapentin enacarbil.,increase,risk
Oxymorphone,Galantamine,The metabolism of Oxymorphone can be decreased when combined with Galantamine.,decrease,no risk
Oxymorphone,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Oxymorphone.,increase,risk
Oxymorphone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Oxymorphone is combined with Ganaxolone.",increase,risk
Oxymorphone,Gefitinib,The metabolism of Oxymorphone can be decreased when combined with Gefitinib.,decrease,no risk
Oxymorphone,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Oxymorphone.,increase,risk
Oxymorphone,Givosiran,The serum concentration of Oxymorphone can be increased when it is combined with Givosiran.,increase,no risk
Oxymorphone,Glofitamab,The serum concentration of Oxymorphone can be increased when it is combined with Glofitamab.,increase,no risk
Oxymorphone,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Oxymorphone.,decrease,no risk
Oxymorphone,Glutethimide,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Glutethimide.,increase,risk
Oxymorphone,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Oxymorphone.,decrease,no risk
Oxymorphone,Glycerol phenylbutyrate,The metabolism of Oxymorphone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Oxymorphone,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Oxymorphone.,increase,risk
Oxymorphone,Golimumab,The metabolism of Oxymorphone can be increased when combined with Golimumab.,increase,no risk
Oxymorphone,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Oxymorphone.,increase,risk
Oxymorphone,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Oxymorphone.,increase,risk
Oxymorphone,Halazepam,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Halazepam.,increase,risk
Oxymorphone,Halofantrine,The metabolism of Oxymorphone can be decreased when combined with Halofantrine.,decrease,no risk
Oxymorphone,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Oxymorphone.,increase,risk
Oxymorphone,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Oxymorphone.,increase,risk
Oxymorphone,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Oxymorphone.,increase,risk
Oxymorphone,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Oxymorphone.,increase,risk
Oxymorphone,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Oxymorphone.,increase,risk
Oxymorphone,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Oxymorphone.,decrease,no risk
Oxymorphone,Hydrocodone,Oxymorphone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Oxymorphone,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Oxymorphone.,decrease,no risk
Oxymorphone,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Oxymorphone.,increase,risk
Oxymorphone,Hydroxychloroquine,The metabolism of Oxymorphone can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Oxymorphone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxymorphone.,increase,no risk
Oxymorphone,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Oxymorphone.,increase,risk
Oxymorphone,Ketamine,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Ketamine.,increase,risk
Oxymorphone,Ketazolam,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Ketazolam.,increase,risk
Oxymorphone,Ketoconazole,The metabolism of Oxymorphone can be decreased when combined with Ketoconazole.,decrease,no risk
Oxymorphone,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Oxymorphone.,increase,risk
Oxymorphone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Oxymorphone is combined with Oliceridine.",increase,risk
Oxymorphone,Omaveloxolone,The serum concentration of Oxymorphone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Oxymorphone,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Oxymorphone.,increase,risk
Oxymorphone,Opium,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Opium.,increase,risk
Oxymorphone,Oritavancin,The metabolism of Oxymorphone can be decreased when combined with Oritavancin.,decrease,no risk
Oxymorphone,Orphenadrine,Oxymorphone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Oxymorphone,Osilodrostat,The metabolism of Oxymorphone can be decreased when combined with Osilodrostat.,decrease,no risk
Oxymorphone,Ospemifene,The metabolism of Oxymorphone can be decreased when combined with Ospemifene.,decrease,no risk
Oxymorphone,Oxamniquine,The metabolism of Oxymorphone can be decreased when combined with Oxamniquine.,decrease,no risk
Oxymorphone,Oxazepam,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Oxazepam.,increase,risk
Oxymorphone,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Oxymorphone.,increase,risk
Oxymorphone,Oxitriptan,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Oxitriptan.,increase,risk
Oxymorphone,Oxprenolol,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Oxprenolol.,increase,risk
Oxymorphone,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Oxymorphone.,increase,risk
Oxymorphone,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Oxymorphone.,increase,risk
Oxymorphone,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Oxymorphone.,increase,risk
Oxymorphone,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Oxymorphone.,increase,risk
Oxymorphone,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Oxymorphone.,decrease,no risk
Oxymorphone,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Oxymorphone.,increase,risk
Oxymorphone,Quazepam,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Quazepam.,increase,risk
Oxymorphone,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Oxymorphone.,increase,risk
Oxymorphone,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Oxymorphone.,decrease,no risk
Oxymorphone,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Oxymorphone.,increase,risk
Oxymorphone,Quinine,The metabolism of Oxymorphone can be decreased when combined with Quinine.,decrease,no risk
Oxymorphone,Quinupramine,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Quinupramine.,increase,risk
Acebutolol,Brexpiprazole,Acebutolol may increase the orthostatic hypotensive activities of Brexpiprazole.,increase,no risk
Acebutolol,Brimonidine,Brimonidine may increase the antihypertensive activities of Acebutolol.,increase,no risk
Acebutolol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Acebutolol.,increase,no risk
Acebutolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Acebutolol is combined with Bromotheophylline.,increase,risk
Acebutolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Acebutolol.,increase,risk
Acebutolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Acebutolol.,decrease,no risk
Acebutolol,Bumetanide,The risk or severity of adverse effects can be increased when Bumetanide is combined with Acebutolol.,increase,risk
Acebutolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Acebutolol.,increase,no risk
Acebutolol,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Acebutolol.,decrease,no risk
Acebutolol,Bupropion,The metabolism of Acebutolol can be decreased when combined with Bupropion.,decrease,no risk
Acebutolol,Buspirone,The metabolism of Buspirone can be decreased when combined with Acebutolol.,decrease,no risk
Acebutolol,Butabarbital,Butabarbital may increase the hypotensive activities of Acebutolol.,increase,no risk
Acebutolol,Butalbital,Butalbital may increase the hypotensive activities of Acebutolol.,increase,no risk
Acebutolol,Butaperazine,The serum concentration of Acebutolol can be increased when it is combined with Butaperazine.,increase,no risk
Acebutolol,Butriptyline,Butriptyline may decrease the antihypertensive activities of Acebutolol.,decrease,no risk
Acebutolol,Galantamine,Galantamine may increase the bradycardic activities of Acebutolol.,increase,no risk
Acebutolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Acebutolol.,increase,no risk
Acebutolol,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Acebutolol.,decrease,no risk
Acebutolol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Acebutolol.,increase,risk
Acebutolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Acebutolol.,increase,no risk
Acebutolol,Givosiran,The serum concentration of Acebutolol can be increased when it is combined with Givosiran.,increase,no risk
Acebutolol,Glasdegib,The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Glasdegib.,increase,risk
Acebutolol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Acebutolol.,increase,no risk
Acebutolol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Acebutolol.,increase,no risk
Acebutolol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Acebutolol.,increase,no risk
Acebutolol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Acebutolol.,increase,no risk
Acebutolol,Glucagon,The therapeutic efficacy of Acebutolol can be decreased when used in combination with Glucagon.,decrease,no risk
Acebutolol,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Acebutolol.,decrease,no risk
Acebutolol,Glycerol phenylbutyrate,The metabolism of Acebutolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Acebutolol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Acebutolol.,decrease,no risk
Acebutolol,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Acebutolol.,increase,no risk
Acebutolol,Golimumab,The metabolism of Acebutolol can be increased when combined with Golimumab.,increase,no risk
Acebutolol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Acebutolol.,decrease,no risk
Acebutolol,Guanadrel,Guanadrel may increase the hypotensive activities of Acebutolol.,increase,no risk
Acebutolol,Guanethidine,Guanethidine may increase the hypotensive activities of Acebutolol.,increase,no risk
Acebutolol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Acebutolol.,decrease,no risk
Acebutolol,Guanoxan,Acebutolol may increase the hypotensive activities of Guanoxan.,increase,no risk
Acebutolol,Halofantrine,The metabolism of Acebutolol can be decreased when combined with Halofantrine.,decrease,no risk
Acebutolol,Haloperidol,The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Haloperidol.,increase,risk
Acebutolol,Halothane,Halothane may decrease the antihypertensive activities of Acebutolol.,decrease,no risk
Acebutolol,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Acebutolol.,increase,risk
Acebutolol,Hexafluronium,Hexafluronium may increase the bradycardic activities of Acebutolol.,increase,no risk
Acebutolol,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Acebutolol.,increase,risk
Acebutolol,Huperzine A,Huperzine A may increase the bradycardic activities of Acebutolol.,increase,no risk
Acebutolol,Hydralazine,Acebutolol may increase the hypotensive activities of Hydralazine.,increase,no risk
Acebutolol,Hydrochlorothiazide,The therapeutic efficacy of Acebutolol can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Acebutolol,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Acebutolol.,decrease,no risk
Acebutolol,Hydroflumethiazide,The therapeutic efficacy of Acebutolol can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Acebutolol,Hydroxychloroquine,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Acebutolol.,decrease,risk
Acebutolol,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Hydroxyzine.,increase,risk
Acebutolol,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Acebutolol.,increase,no risk
Acebutolol,Ketamine,Ketamine may increase the bradycardic activities of Acebutolol.,increase,no risk
Acebutolol,Ketoconazole,The metabolism of Acebutolol can be decreased when combined with Ketoconazole.,decrease,no risk
Acebutolol,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Acebutolol.,decrease,no risk
Acebutolol,Ketorolac,Ketorolac may decrease the antihypertensive activities of Acebutolol.,decrease,no risk
Acebutolol,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Acebutolol.,increase,risk
Acebutolol,Obinutuzumab,Acebutolol may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Acebutolol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Acebutolol.,increase,no risk
Acebutolol,Olanzapine,Acebutolol may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Acebutolol,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Acebutolol.,decrease,no risk
Acebutolol,Olmesartan,Olmesartan may increase the hypotensive activities of Acebutolol.,increase,no risk
Acebutolol,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Acebutolol.,decrease,no risk
Acebutolol,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Acebutolol.,decrease,no risk
Acebutolol,Opicapone,The risk or severity of adverse effects can be increased when Acebutolol is combined with Opicapone.,increase,risk
Acebutolol,Opium,The metabolism of Opium can be decreased when combined with Acebutolol.,decrease,no risk
Acebutolol,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Acebutolol.,decrease,no risk
Acebutolol,Oritavancin,The metabolism of Acebutolol can be decreased when combined with Oritavancin.,decrease,no risk
Acebutolol,Orphenadrine,The metabolism of Acebutolol can be decreased when combined with Orphenadrine.,decrease,no risk
Acebutolol,Osilodrostat,The metabolism of Acebutolol can be decreased when combined with Osilodrostat.,decrease,no risk
Acebutolol,Ospemifene,The metabolism of Acebutolol can be decreased when combined with Ospemifene.,decrease,no risk
Acebutolol,Ouabain,Acebutolol may increase the bradycardic activities of Ouabain.,increase,no risk
Acebutolol,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Acebutolol.,increase,risk
Acebutolol,Oxamniquine,The metabolism of Acebutolol can be decreased when combined with Oxamniquine.,decrease,no risk
Acebutolol,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Acebutolol.,decrease,no risk
Acebutolol,Oxprenolol,Acebutolol may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Acebutolol,Oxtriphylline,The risk or severity of adverse effects can be increased when Acebutolol is combined with Oxtriphylline.,increase,risk
Acebutolol,Oxybutynin,The metabolism of Acebutolol can be decreased when combined with Oxybutynin.,decrease,no risk
Acebutolol,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Acebutolol.,decrease,no risk
Acebutolol,Oxymetazoline,The therapeutic efficacy of Acebutolol can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Acebutolol,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Acebutolol.,decrease,no risk
Acebutolol,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Acebutolol.,decrease,no risk
Acebutolol,Quetiapine,Quetiapine may increase the hypotensive activities of Acebutolol.,increase,no risk
Acebutolol,Quinapril,Quinapril may increase the hypotensive activities of Acebutolol.,increase,no risk
Acebutolol,Quinidine,Quinidine may increase the arrhythmogenic activities of Acebutolol.,increase,no risk
Acebutolol,Quinine,The metabolism of Acebutolol can be decreased when combined with Quinine.,decrease,no risk
Acebutolol,Quinupramine,Quinupramine may decrease the antihypertensive activities of Acebutolol.,decrease,no risk
Acebutolol,Quizartinib,The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Quizartinib.,increase,risk
Acebutolol,Udenafil,Udenafil may increase the antihypertensive activities of Acebutolol.,increase,no risk
Acebutolol,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Acebutolol.,decrease,no risk
Acebutolol,Unoprostone,Acebutolol may increase the hypotensive activities of Unoprostone.,increase,no risk
Acebutolol,Urochloa mutica pollen,The risk of a hypersensitivity reaction to Urochloa mutica pollen is increased when it is combined with Acebutolol.,increase,risk
Acebutolol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Acebutolol.,decrease,no risk
Acebutolol,Valdecoxib,Valdecoxib may decrease the antihypertensive activities of Acebutolol.,decrease,no risk
Acebutolol,Valsartan,Valsartan may increase the hypotensive activities of Acebutolol.,increase,no risk
Acebutolol,Vardenafil,Vardenafil may increase the antihypertensive activities of Acebutolol.,increase,no risk
Acebutolol,Varenicline,The risk or severity of adverse effects can be increased when Acebutolol is combined with Varenicline.,increase,risk
Acebutolol,Vemurafenib,The metabolism of Acebutolol can be decreased when combined with Vemurafenib.,decrease,no risk
Acebutolol,Venlafaxine,The metabolism of Acebutolol can be decreased when combined with Venlafaxine.,decrease,no risk
Acebutolol,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Acebutolol.,increase,risk
Acebutolol,Vericiguat,The risk or severity of adverse effects can be increased when Acebutolol is combined with Vericiguat.,increase,risk
Acebutolol,Vernakalant,Acebutolol may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Acebutolol,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Acebutolol.,decrease,no risk
Acebutolol,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Acebutolol.,decrease,no risk
Acebutolol,Vilazodone,The metabolism of Acebutolol can be decreased when combined with Vilazodone.,decrease,no risk
Acebutolol,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Acebutolol.,increase,no risk
Acebutolol,Viloxazine,The metabolism of Acebutolol can be decreased when combined with Viloxazine.,decrease,no risk
Acebutolol,Vinblastine,The metabolism of Acebutolol can be decreased when combined with Vinblastine.,decrease,no risk
Acebutolol,Vinorelbine,The metabolism of Acebutolol can be decreased when combined with Vinorelbine.,decrease,no risk
Acebutolol,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Acebutolol.,decrease,no risk
Acebutolol,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Acebutolol.,decrease,no risk
Acebutolol,Xylometazoline,Acebutolol may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Acebutolol,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Acebutolol.,decrease,no risk
Acebutolol,Ziconotide,Acebutolol may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Acebutolol,Zimelidine,The serum concentration of Acebutolol can be increased when it is combined with Zimelidine.,increase,no risk
Acebutolol,Ziprasidone,The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Ziprasidone.,increase,risk
Acebutolol,Zofenopril,Acebutolol may increase the hypotensive activities of Zofenopril.,increase,no risk
Acebutolol,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Acebutolol.,decrease,no risk
Acebutolol,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Acebutolol.,decrease,no risk
Acebutolol,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Acebutolol.,increase,no risk
Acebutolol,Zuclopenthixol,Acebutolol may increase the orthostatic hypotensive activities of Zuclopenthixol.,increase,no risk
Brinzolamide,Balsalazide,The risk or severity of electrolyte abnormality can be increased when Brinzolamide is combined with Balsalazide.,increase,risk
Brinzolamide,Benzylpenicillin,Brinzolamide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Brinzolamide,Bismuth subsalicylate,The risk or severity of electrolyte abnormality can be increased when Brinzolamide is combined with Bismuth subsalicylate.,increase,risk
Brinzolamide,Glofitamab,The serum concentration of Brinzolamide can be increased when it is combined with Glofitamab.,increase,no risk
Brinzolamide,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Brinzolamide.,increase,no risk
Brinzolamide,Oliceridine,The therapeutic efficacy of Brinzolamide can be decreased when used in combination with Oliceridine.,decrease,no risk
Brinzolamide,Olsalazine,The risk or severity of electrolyte abnormality can be increased when Brinzolamide is combined with Olsalazine.,increase,risk
Brinzolamide,Omaveloxolone,The serum concentration of Brinzolamide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Brinzolamide,Vadadustat,The serum concentration of Brinzolamide can be decreased when it is combined with Vadadustat.,decrease,no risk
Brinzolamide,Viloxazine,The metabolism of Brinzolamide can be decreased when combined with Viloxazine.,decrease,no risk
Brinzolamide,Ziconotide,The risk or severity of CNS depression can be increased when Brinzolamide is combined with Ziconotide.,increase,risk
Brinzolamide,Zonisamide,The risk or severity of adverse effects can be increased when Brinzolamide is combined with Zonisamide.,increase,risk
Flecainide,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Flecainide.,increase,risk
Flecainide,Galantamine,The metabolism of Flecainide can be decreased when combined with Galantamine.,decrease,no risk
Flecainide,Ganciclovir,The excretion of Flecainide can be decreased when combined with Ganciclovir.,decrease,no risk
Flecainide,Gatifloxacin,The metabolism of Flecainide can be decreased when combined with Gatifloxacin.,decrease,no risk
Flecainide,Gefitinib,The metabolism of Flecainide can be decreased when combined with Gefitinib.,decrease,no risk
Flecainide,Gemfibrozil,The metabolism of Flecainide can be decreased when combined with Gemfibrozil.,decrease,no risk
Flecainide,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Flecainide.,increase,risk
Flecainide,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Flecainide.,increase,risk
Flecainide,Gilteritinib,The risk or severity of QTc prolongation can be increased when Flecainide is combined with Gilteritinib.,increase,risk
Flecainide,Givosiran,The serum concentration of Flecainide can be increased when it is combined with Givosiran.,increase,no risk
Flecainide,Glasdegib,The risk or severity of QTc prolongation can be increased when Flecainide is combined with Glasdegib.,increase,risk
Flecainide,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Flecainide.,decrease,no risk
Flecainide,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Flecainide.,decrease,no risk
Flecainide,Glipizide,The metabolism of Glipizide can be decreased when combined with Flecainide.,decrease,no risk
Flecainide,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Flecainide.,decrease,no risk
Flecainide,Glofitamab,The serum concentration of Flecainide can be increased when it is combined with Glofitamab.,increase,no risk
Flecainide,Glyburide,The metabolism of Glyburide can be decreased when combined with Flecainide.,decrease,no risk
Flecainide,Glycerol phenylbutyrate,The metabolism of Flecainide can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Flecainide,Golimumab,The metabolism of Flecainide can be increased when combined with Golimumab.,increase,no risk
Flecainide,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Flecainide.,increase,risk
Flecainide,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Flecainide.,increase,risk
Flecainide,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Flecainide is combined with Grepafloxacin.,increase,risk
Flecainide,Guanabenz,The metabolism of Flecainide can be decreased when combined with Guanabenz.,decrease,no risk
Flecainide,Guanidine,The excretion of Flecainide can be decreased when combined with Guanidine.,decrease,no risk
Flecainide,Halofantrine,The metabolism of Flecainide can be decreased when combined with Halofantrine.,decrease,no risk
Flecainide,Haloperidol,The risk or severity of QTc prolongation can be increased when Flecainide is combined with Haloperidol.,increase,risk
Flecainide,Halothane,The metabolism of Halothane can be decreased when combined with Flecainide.,decrease,no risk
Flecainide,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Flecainide.,increase,risk
Flecainide,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Flecainide.,increase,risk
Flecainide,Hydrocodone,The metabolism of Flecainide can be decreased when combined with Hydrocodone.,decrease,no risk
Flecainide,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Flecainide.,decrease,no risk
Flecainide,Hydroxychloroquine,The metabolism of Flecainide can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Flecainide,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Flecainide is combined with Hydroxyzine.,increase,risk
Flecainide,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Flecainide.,increase,no risk
Flecainide,Ketamine,The metabolism of Ketamine can be decreased when combined with Flecainide.,decrease,no risk
Flecainide,Ketoconazole,The metabolism of Flecainide can be decreased when combined with Ketoconazole.,decrease,no risk
Flecainide,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Flecainide.,decrease,no risk
Flecainide,Obeticholic acid,The metabolism of Flecainide can be decreased when combined with Obeticholic acid.,decrease,no risk
Flecainide,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Flecainide.,increase,risk
Flecainide,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Flecainide.,increase,risk
Flecainide,Olanzapine,The metabolism of Flecainide can be decreased when combined with Olanzapine.,decrease,no risk
Flecainide,Oliceridine,The metabolism of Flecainide can be decreased when combined with Oliceridine.,decrease,no risk
Flecainide,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Flecainide.,decrease,no risk
Flecainide,Ondansetron,The metabolism of Flecainide can be decreased when combined with Ondansetron.,decrease,no risk
Flecainide,Opium,The metabolism of Flecainide can be decreased when combined with Opium.,decrease,no risk
Flecainide,Oritavancin,The metabolism of Flecainide can be decreased when combined with Oritavancin.,decrease,no risk
Flecainide,Orphenadrine,The metabolism of Flecainide can be decreased when combined with Orphenadrine.,decrease,no risk
Flecainide,Osilodrostat,The metabolism of Flecainide can be decreased when combined with Osilodrostat.,decrease,no risk
Flecainide,Osimertinib,The serum concentration of Flecainide can be decreased when it is combined with Osimertinib.,decrease,no risk
Flecainide,Ospemifene,The metabolism of Flecainide can be decreased when combined with Ospemifene.,decrease,no risk
Flecainide,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Flecainide.,increase,risk
Flecainide,Oxamniquine,The metabolism of Flecainide can be decreased when combined with Oxamniquine.,decrease,no risk
Flecainide,Oxatomide,The risk or severity of QTc prolongation can be increased when Flecainide is combined with Oxatomide.,increase,risk
Flecainide,Oxprenolol,Flecainide may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Flecainide,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Flecainide.,decrease,no risk
Flecainide,Oxybutynin,The metabolism of Flecainide can be decreased when combined with Oxybutynin.,decrease,no risk
Captopril,Butriptyline,Butriptyline may decrease the antihypertensive activities of Captopril.,decrease,no risk
Captopril,Ganciclovir,The excretion of Captopril can be decreased when combined with Ganciclovir.,decrease,no risk
Captopril,Gemfibrozil,The excretion of Captopril can be decreased when combined with Gemfibrozil.,decrease,no risk
Captopril,Gentamicin,The excretion of Captopril can be decreased when combined with Gentamicin.,decrease,no risk
Captopril,Glyburide,The excretion of Captopril can be decreased when combined with Glyburide.,decrease,no risk
Captopril,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Glycol salicylate is combined with Captopril.",increase,risk
Captopril,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Captopril.,decrease,no risk
Captopril,Guanabenz,Guanabenz may decrease the antihypertensive activities of Captopril.,decrease,no risk
Captopril,Guanadrel,Guanadrel may increase the hypotensive activities of Captopril.,increase,no risk
Captopril,Guanethidine,Guanethidine may increase the hypotensive activities of Captopril.,increase,no risk
Captopril,Guanfacine,Guanfacine may decrease the antihypertensive activities of Captopril.,decrease,no risk
Captopril,Guanidine,The excretion of Captopril can be decreased when combined with Guanidine.,decrease,no risk
Captopril,Guanoxan,Captopril may increase the hypotensive activities of Guanoxan.,increase,no risk
Captopril,Halothane,Halothane may decrease the antihypertensive activities of Captopril.,decrease,no risk
Captopril,Heparin,The risk or severity of hyperkalemia can be increased when Captopril is combined with Heparin.,increase,risk
Captopril,Holcus lanatus pollen,The risk or severity of adverse effects can be increased when Captopril is combined with Holcus lanatus pollen.,increase,risk
Captopril,Hydralazine,Captopril may increase the hypotensive activities of Hydralazine.,increase,no risk
Captopril,Hydroflumethiazide,The therapeutic efficacy of Captopril can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Captopril,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Captopril,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Captopril.,increase,risk
Captopril,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketoprofen is combined with Captopril.",increase,risk
Captopril,Ketorolac,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketorolac is combined with Captopril.",increase,risk
Captopril,Koeleria macrantha pollen,The risk or severity of adverse effects can be increased when Captopril is combined with Koeleria macrantha pollen.,increase,risk
Captopril,Obinutuzumab,Captopril may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Captopril,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ofloxacin is combined with Captopril.",increase,risk
Captopril,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Captopril.,increase,risk
Captopril,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Captopril is combined with Olmesartan.",increase,risk
Captopril,Olodaterol,Olodaterol may decrease the antihypertensive activities of Captopril.,decrease,no risk
Captopril,Olsalazine,The risk or severity of renal failure can be increased when Olsalazine is combined with Captopril.,increase,risk
Captopril,Omeprazole,Omeprazole can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Captopril,Opicapone,The risk or severity of adverse effects can be increased when Captopril is combined with Opicapone.,increase,risk
Captopril,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Captopril.,decrease,no risk
Captopril,Ouabain,The excretion of Captopril can be decreased when combined with Ouabain.,decrease,no risk
Captopril,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxaprozin is combined with Captopril.",increase,risk
Captopril,Oxprenolol,Captopril may increase the hypotensive activities of Oxprenolol.,increase,no risk
Captopril,Oxymetazoline,The therapeutic efficacy of Captopril can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Captopril,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Captopril.",increase,risk
Captopril,Oxytetracycline,The excretion of Captopril can be decreased when combined with Oxytetracycline.,decrease,no risk
Captopril,Quetiapine,Quetiapine may increase the hypotensive activities of Captopril.,increase,no risk
Captopril,Quinapril,The risk or severity of angioedema can be increased when Quinapril is combined with Captopril.,increase,risk
Captopril,Quinethazone,The risk or severity of hypotension can be increased when Quinethazone is combined with Captopril.,increase,risk
Captopril,Quinidine,The excretion of Captopril can be decreased when combined with Quinidine.,decrease,no risk
Captopril,Quinine,Quinine may increase the hypotensive activities of Captopril.,increase,no risk
Captopril,Quinupramine,Quinupramine may decrease the antihypertensive activities of Captopril.,decrease,no risk
Captopril,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Ubidecarenone.",increase,risk
Captopril,Udenafil,Udenafil may increase the antihypertensive activities of Captopril.,increase,no risk
Captopril,Unoprostone,Captopril may increase the hypotensive activities of Unoprostone.,increase,no risk
Captopril,Urochloa mutica pollen,The risk or severity of adverse effects can be increased when Captopril is combined with Urochloa mutica pollen.,increase,risk
Captopril,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Captopril.,increase,risk
Captopril,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Captopril.,increase,no risk
Captopril,Valdecoxib,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valdecoxib is combined with Captopril.",increase,risk
Captopril,Valproic acid,The excretion of Captopril can be decreased when combined with Valproic acid.,decrease,no risk
Captopril,Valsartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Captopril is combined with Valsartan.",increase,risk
Captopril,Vardenafil,Vardenafil may increase the antihypertensive activities of Captopril.,increase,no risk
Captopril,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Captopril.,increase,risk
Captopril,Vericiguat,The risk or severity of adverse effects can be increased when Captopril is combined with Vericiguat.,increase,risk
Captopril,Vilanterol,Vilanterol may decrease the antihypertensive activities of Captopril.,decrease,no risk
Captopril,Vilazodone,Vilazodone may decrease the antihypertensive activities of Captopril.,decrease,no risk
Captopril,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Captopril.,increase,risk
Captopril,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Captopril.",increase,risk
Captopril,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Captopril,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Captopril.,decrease,no risk
Captopril,Xamoterol,Xamoterol may decrease the antihypertensive activities of Captopril.,decrease,no risk
Captopril,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Captopril.,decrease,no risk
Captopril,Yohimbine,Yohimbine may decrease the antihypertensive activities of Captopril.,decrease,no risk
Captopril,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Captopril.,decrease,no risk
Captopril,Zidovudine,The excretion of Captopril can be decreased when combined with Zidovudine.,decrease,no risk
Captopril,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Captopril.,increase,no risk
Captopril,Zofenopril,The risk or severity of angioedema can be increased when Captopril is combined with Zofenopril.,increase,risk
Captopril,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Captopril.,decrease,no risk
Captopril,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Captopril.,increase,risk
Captopril,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Captopril.,decrease,no risk
Zopiclone,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Zopiclone.,increase,risk
Zopiclone,Butriptyline,The risk or severity of adverse effects can be increased when Butriptyline is combined with Zopiclone.,increase,risk
Zopiclone,Gabapentin,The risk or severity of adverse effects can be increased when Gabapentin is combined with Zopiclone.,increase,risk
Zopiclone,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Zopiclone.,increase,risk
Zopiclone,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Zopiclone.,increase,risk
Zopiclone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Zopiclone is combined with Ganaxolone.",increase,risk
Zopiclone,Gemfibrozil,The metabolism of Zopiclone can be decreased when combined with Gemfibrozil.,decrease,no risk
Zopiclone,Gepirone,The risk or severity of adverse effects can be increased when Gepirone is combined with Zopiclone.,increase,risk
Zopiclone,Ginkgo biloba,The metabolism of Zopiclone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Zopiclone,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Zopiclone.,decrease,no risk
Zopiclone,Gliclazide,The metabolism of Zopiclone can be decreased when combined with Gliclazide.,decrease,no risk
Zopiclone,Glimepiride,The metabolism of Zopiclone can be decreased when combined with Glimepiride.,decrease,no risk
Zopiclone,Glipizide,The metabolism of Zopiclone can be decreased when combined with Glipizide.,decrease,no risk
Zopiclone,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Zopiclone.,decrease,no risk
Zopiclone,Glofitamab,The serum concentration of Zopiclone can be increased when it is combined with Glofitamab.,increase,no risk
Zopiclone,Glutethimide,The risk or severity of adverse effects can be increased when Glutethimide is combined with Zopiclone.,increase,risk
Zopiclone,Glyburide,The metabolism of Zopiclone can be decreased when combined with Glyburide.,decrease,no risk
Zopiclone,Golimumab,The metabolism of Zopiclone can be increased when combined with Golimumab.,increase,no risk
Zopiclone,Granisetron,The risk or severity of adverse effects can be increased when Granisetron is combined with Zopiclone.,increase,risk
Zopiclone,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Zopiclone.,increase,risk
Zopiclone,Halazepam,The risk or severity of adverse effects can be increased when Halazepam is combined with Zopiclone.,increase,risk
Zopiclone,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Zopiclone.,decrease,no risk
Zopiclone,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Zopiclone.,increase,risk
Zopiclone,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Zopiclone.,increase,risk
Zopiclone,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Zopiclone.,increase,risk
Zopiclone,Hydralazine,The metabolism of Zopiclone can be decreased when combined with Hydralazine.,decrease,no risk
Zopiclone,Hydrocodone,Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Zopiclone,Hydrocortisone,The metabolism of Zopiclone can be increased when combined with Hydrocortisone.,increase,no risk
Zopiclone,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Zopiclone.,increase,risk
Zopiclone,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Zopiclone.,decrease,no risk
Zopiclone,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Zopiclone.,increase,risk
Zopiclone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.,increase,no risk
Zopiclone,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Zopiclone.,increase,risk
Zopiclone,Ketazolam,The metabolism of Zopiclone can be decreased when combined with Ketazolam.,decrease,no risk
Zopiclone,Ketoconazole,The metabolism of Zopiclone can be decreased when combined with Ketoconazole.,decrease,no risk
Zopiclone,Ketoprofen,The metabolism of Zopiclone can be decreased when combined with Ketoprofen.,decrease,no risk
Zopiclone,Ketorolac,The metabolism of Zopiclone can be decreased when combined with Ketorolac.,decrease,no risk
Zopiclone,Octreotide,The metabolism of Zopiclone can be decreased when combined with Octreotide.,decrease,no risk
Zopiclone,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Zopiclone.,increase,risk
Zopiclone,Olaparib,The metabolism of Zopiclone can be decreased when combined with Olaparib.,decrease,no risk
Zopiclone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Zopiclone is combined with Oliceridine.",increase,risk
Zopiclone,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Zopiclone.,decrease,no risk
Zopiclone,Omaveloxolone,The serum concentration of Zopiclone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Zopiclone,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Zopiclone.,decrease,no risk
Zopiclone,Ondansetron,The risk or severity of adverse effects can be increased when Ondansetron is combined with Zopiclone.,increase,risk
Zopiclone,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Zopiclone.,increase,risk
Zopiclone,Oritavancin,The metabolism of Zopiclone can be decreased when combined with Oritavancin.,decrease,no risk
Zopiclone,Orphenadrine,Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Zopiclone,Osilodrostat,The metabolism of Zopiclone can be decreased when combined with Osilodrostat.,decrease,no risk
Zopiclone,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Zopiclone.,decrease,no risk
Zopiclone,Oxandrolone,The metabolism of Zopiclone can be decreased when combined with Oxandrolone.,decrease,no risk
Zopiclone,Oxazepam,The risk or severity of adverse effects can be increased when Oxazepam is combined with Zopiclone.,increase,risk
Zopiclone,Oxcarbazepine,The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Zopiclone.,increase,risk
Zopiclone,Oxetacaine,The metabolism of Zopiclone can be decreased when combined with Oxetacaine.,decrease,no risk
Zopiclone,Oxitriptan,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Zopiclone.,increase,risk
Zopiclone,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Zopiclone.,increase,risk
Zopiclone,Oxybuprocaine,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Zopiclone.,increase,risk
Zopiclone,Oxybutynin,The metabolism of Zopiclone can be decreased when combined with Oxybutynin.,decrease,no risk
Zopiclone,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Zopiclone.,increase,risk
Zopiclone,Oxymetholone,The metabolism of Zopiclone can be decreased when combined with Oxymetholone.,decrease,no risk
Zopiclone,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Zopiclone.,increase,risk
Zopiclone,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Zopiclone.,decrease,no risk
Zopiclone,Quazepam,The risk or severity of adverse effects can be increased when Quazepam is combined with Zopiclone.,increase,risk
Zopiclone,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Zopiclone.,increase,risk
Zopiclone,Quinidine,The metabolism of Zopiclone can be decreased when combined with Quinidine.,decrease,no risk
Zopiclone,Quinine,The metabolism of Zopiclone can be decreased when combined with Quinine.,decrease,no risk
Zopiclone,Quinupramine,The risk or severity of adverse effects can be increased when Quinupramine is combined with Zopiclone.,increase,risk
Zopiclone,Quinupristin,The metabolism of Zopiclone can be decreased when combined with Quinupristin.,decrease,no risk
Zopiclone,Urethane,The risk or severity of adverse effects can be increased when Urethane is combined with Zopiclone.,increase,risk
Zopiclone,Vadadustat,The serum concentration of Zopiclone can be increased when it is combined with Vadadustat.,increase,no risk
Zopiclone,Valdecoxib,The metabolism of Zopiclone can be decreased when combined with Valdecoxib.,decrease,no risk
Zopiclone,Valproic acid,The metabolism of Zopiclone can be decreased when combined with Valproic acid.,decrease,no risk
Zopiclone,Valsartan,The metabolism of Zopiclone can be decreased when combined with Valsartan.,decrease,no risk
Zopiclone,Vardenafil,The metabolism of Zopiclone can be decreased when combined with Vardenafil.,decrease,no risk
Zopiclone,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Zopiclone.,increase,risk
Zopiclone,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Zopiclone.,decrease,no risk
Zopiclone,Vemurafenib,The metabolism of Zopiclone can be decreased when combined with Vemurafenib.,decrease,no risk
Zopiclone,Venetoclax,The metabolism of Zopiclone can be decreased when combined with Venetoclax.,decrease,no risk
Zopiclone,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Zopiclone.,increase,risk
Zopiclone,Verapamil,The metabolism of Zopiclone can be decreased when combined with Verapamil.,decrease,no risk
Zopiclone,Vigabatrin,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Zopiclone.,increase,risk
Zopiclone,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Zopiclone.,increase,risk
Zopiclone,Viloxazine,The metabolism of Zopiclone can be decreased when combined with Viloxazine.,decrease,no risk
Zopiclone,Vinblastine,The metabolism of Zopiclone can be decreased when combined with Vinblastine.,decrease,no risk
Zopiclone,Voriconazole,The metabolism of Zopiclone can be decreased when combined with Voriconazole.,decrease,no risk
Zopiclone,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Zopiclone.,increase,risk
Zopiclone,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Zopiclone.,decrease,no risk
Zopiclone,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Zopiclone.,decrease,no risk
Zopiclone,Warfarin,The metabolism of Zopiclone can be increased when combined with Warfarin.,increase,no risk
Zopiclone,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Zopiclone.,decrease,no risk
Zopiclone,Yohimbine,The risk or severity of adverse effects can be increased when Yohimbine is combined with Zopiclone.,increase,risk
Zopiclone,Zafirlukast,The metabolism of Zopiclone can be decreased when combined with Zafirlukast.,decrease,no risk
Zopiclone,Zaleplon,The risk or severity of adverse effects can be increased when Zaleplon is combined with Zopiclone.,increase,risk
Zopiclone,Ziconotide,The risk or severity of CNS depression can be increased when Zopiclone is combined with Ziconotide.,increase,risk
Zopiclone,Zidovudine,The metabolism of Zopiclone can be decreased when combined with Zidovudine.,decrease,no risk
Zopiclone,Zileuton,The metabolism of Zopiclone can be decreased when combined with Zileuton.,decrease,no risk
Zopiclone,Zimelidine,The metabolism of Zopiclone can be decreased when combined with Zimelidine.,decrease,no risk
Zopiclone,Ziprasidone,The risk or severity of adverse effects can be increased when Zopiclone is combined with Ziprasidone.,increase,risk
Zopiclone,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Zopiclone.,increase,risk
Zopiclone,Zolpidem,Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zopiclone,Zonisamide,The risk or severity of adverse effects can be increased when Zonisamide is combined with Zopiclone.,increase,risk
Zopiclone,Zotepine,The risk or severity of adverse effects can be increased when Zotepine is combined with Zopiclone.,increase,risk
Zopiclone,Zuclopenthixol,The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Zopiclone.,increase,risk
Zopiclone,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Zopiclone.,increase,risk
Bromocriptine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Bromocriptine.,increase,risk
Bromocriptine,Bretylium,Bromocriptine may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Bromocriptine,Brexanolone,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Brexanolone.,increase,risk
Bromocriptine,Brexpiprazole,The risk or severity of adverse effects can be decreased when Bromocriptine is combined with Brexpiprazole.,decrease,risk
Bromocriptine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Bromocriptine.,increase,no risk
Bromocriptine,Brivaracetam,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Brivaracetam.,increase,risk
Bromocriptine,Bromazepam,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Bromazepam.,increase,risk
Bromocriptine,Bromperidol,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Bromperidol.,increase,risk
Bromocriptine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Bromocriptine.,increase,risk
Bromocriptine,Buclizine,The risk or severity of Tachycardia can be increased when Buclizine is combined with Bromocriptine.,increase,risk
Bromocriptine,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Bromocriptine.,increase,risk
Bromocriptine,Bumadizone,The risk or severity of hypertension can be increased when Bromocriptine is combined with Bumadizone.,increase,risk
Bromocriptine,Bumetanide,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Bumetanide.,decrease,no risk
Bromocriptine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Bromocriptine.,increase,risk
Bromocriptine,Buprenorphine,Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Bromocriptine,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Bromocriptine.,increase,risk
Bromocriptine,Buserelin,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Buserelin.,decrease,no risk
Bromocriptine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Bromocriptine.,increase,risk
Bromocriptine,Butabarbital,Butabarbital may increase the hypotensive activities of Bromocriptine.,increase,no risk
Bromocriptine,Butalbital,Butalbital may increase the hypotensive activities of Bromocriptine.,increase,no risk
Bromocriptine,Butaperazine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Butaperazine.,increase,risk
Bromocriptine,Butobarbital,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Butobarbital.,increase,risk
Bromocriptine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Bromocriptine.,increase,risk
Bromocriptine,Butriptyline,Butriptyline may increase the vasopressor activities of Bromocriptine.,increase,no risk
Bromocriptine,Butylscopolamine,The risk or severity of Tachycardia can be increased when Bromocriptine is combined with Butylscopolamine.,increase,risk
Bromocriptine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Bromocriptine.,increase,risk
Bromocriptine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Gabapentin enacarbil.,increase,risk
Bromocriptine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Bromocriptine.,increase,risk
Bromocriptine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Bromocriptine is combined with Ganaxolone.",increase,risk
Bromocriptine,Gatifloxacin,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Gatifloxacin.,increase,no risk
Bromocriptine,Gefapixant,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Gefapixant.,increase,no risk
Bromocriptine,Gemifloxacin,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Gemifloxacin.,increase,no risk
Bromocriptine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Bromocriptine.,increase,no risk
Bromocriptine,Gilteritinib,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Bromocriptine,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Bromocriptine.,increase,risk
Bromocriptine,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Bromocriptine.,increase,risk
Bromocriptine,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Bromocriptine.,increase,risk
Bromocriptine,Gliquidone,The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Gliquidone.,increase,risk
Bromocriptine,Glofitamab,The serum concentration of Bromocriptine can be increased when it is combined with Glofitamab.,increase,no risk
Bromocriptine,Glutethimide,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Glutethimide.,increase,risk
Bromocriptine,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Bromocriptine.,increase,risk
Bromocriptine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Bromocriptine.,increase,risk
Bromocriptine,Glymidine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Glymidine.,increase,no risk
Bromocriptine,Goserelin,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Goserelin.,decrease,no risk
Bromocriptine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Bromocriptine.,increase,risk
Bromocriptine,Grepafloxacin,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Grepafloxacin.,increase,no risk
Bromocriptine,Guanabenz,Bromocriptine may increase the hypertensive and vasoconstricting activities of Guanabenz.,increase,no risk
Bromocriptine,Guanadrel,Bromocriptine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Bromocriptine,Guanethidine,Bromocriptine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Bromocriptine,Guanfacine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Guanfacine.,increase,no risk
Bromocriptine,Guanoxan,Bromocriptine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Bromocriptine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Bromocriptine.,increase,risk
Bromocriptine,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Bromocriptine.,increase,risk
Bromocriptine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Bromocriptine.,increase,risk
Bromocriptine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Bromocriptine.,increase,risk
Bromocriptine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Bromocriptine.,increase,risk
Bromocriptine,Hexocyclium,The risk or severity of Tachycardia can be increased when Bromocriptine is combined with Hexocyclium.,increase,risk
Bromocriptine,Histrelin,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Histrelin.,decrease,no risk
Bromocriptine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Bromocriptine.,increase,risk
Bromocriptine,Hydralazine,Bromocriptine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Bromocriptine,Hydrochlorothiazide,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Bromocriptine,Hydrocodone,Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Bromocriptine,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Bromocriptine.,increase,risk
Bromocriptine,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Bromocriptine.,increase,risk
Bromocriptine,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Bromocriptine.,increase,risk
Bromocriptine,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Bromocriptine.,increase,risk
Bromocriptine,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Bromocriptine.,increase,risk
Bromocriptine,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Bromocriptine.,increase,risk
Bromocriptine,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Bromocriptine.,increase,risk
Bromocriptine,Hydroflumethiazide,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Bromocriptine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Bromocriptine.,increase,risk
Bromocriptine,Hydroxychloroquine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Bromocriptine,Hydroxyprogesterone caproate,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Bromocriptine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Bromocriptine.,increase,no risk
Bromocriptine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Bromocriptine.,increase,risk
Bromocriptine,Ketamine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Ketamine.,increase,risk
Bromocriptine,Ketazolam,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Ketazolam.,increase,risk
Bromocriptine,Ketoconazole,The serum concentration of Bromocriptine can be increased when it is combined with Ketoconazole.,increase,no risk
Bromocriptine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Bromocriptine.,increase,risk
Bromocriptine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Bromocriptine.,increase,risk
Bromocriptine,Obinutuzumab,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Obinutuzumab.,increase,risk
Bromocriptine,Octreotide,The risk or severity of adverse effects can be increased when Octreotide is combined with Bromocriptine.,increase,risk
Bromocriptine,Ofloxacin,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Ofloxacin.,increase,no risk
Bromocriptine,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bromocriptine.",increase,no risk
Bromocriptine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Bromocriptine is combined with Oliceridine.",increase,risk
Bromocriptine,Olmesartan,Bromocriptine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Bromocriptine,Olodaterol,Bromocriptine may increase the hypertensive and vasoconstricting activities of Olodaterol.,increase,no risk
Bromocriptine,Olsalazine,Olsalazine may increase the hypoglycemic activities of Bromocriptine.,increase,no risk
Bromocriptine,Omaveloxolone,The serum concentration of Bromocriptine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Bromocriptine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Bromocriptine.,increase,risk
Bromocriptine,Opicapone,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Opicapone.,increase,risk
Bromocriptine,Opium,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Opium.,increase,risk
Bromocriptine,Orciprenaline,Bromocriptine may increase the hypertensive and vasoconstricting activities of Orciprenaline.,increase,no risk
Bromocriptine,Orphenadrine,Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Bromocriptine,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Bromocriptine.,increase,no risk
Bromocriptine,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Bromocriptine.,increase,risk
Bromocriptine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Bromocriptine.,increase,risk
Bromocriptine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Bromocriptine.,increase,risk
Bromocriptine,Oxitriptan,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Oxitriptan.,increase,risk
Bromocriptine,Oxprenolol,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Oxprenolol.,increase,no risk
Bromocriptine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Bromocriptine.,increase,risk
Bromocriptine,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Bromocriptine.,increase,risk
Bromocriptine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Bromocriptine.,increase,risk
Bromocriptine,Oxymetazoline,Bromocriptine may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Bromocriptine,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Bromocriptine.,increase,no risk
Bromocriptine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Bromocriptine.,increase,risk
Bromocriptine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Bromocriptine is combined with Oxyphenbutazone.,increase,risk
Bromocriptine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Bromocriptine.,increase,risk
Bromocriptine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Bromocriptine.,increase,risk
Bromocriptine,Quazepam,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Quazepam.,increase,risk
Bromocriptine,Quetiapine,"Bromocriptine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.",increase,no risk
Bromocriptine,Quinagolide,The risk or severity of adverse effects can be decreased when Bromocriptine is combined with Quinagolide.,decrease,risk
Bromocriptine,Quinapril,Bromocriptine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Bromocriptine,Quinethazone,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Quinethazone.,decrease,no risk
Bromocriptine,Quinidine,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bromocriptine.",increase,no risk
Bromocriptine,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Bromocriptine.,increase,risk
Bromocriptine,Quinupramine,Quinupramine may increase the vasopressor activities of Bromocriptine.,increase,no risk
Bromocriptine,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Bromocriptine.,increase,risk
Bromocriptine,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Bromocriptine.,increase,risk
Bromocriptine,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Bromocriptine.,increase,risk
Bromocriptine,Umeclidinium,The risk or severity of Tachycardia can be increased when Bromocriptine is combined with Umeclidinium.,increase,risk
Bromocriptine,Urethane,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Urethane.,increase,risk
Bromocriptine,Vadadustat,The serum concentration of Bromocriptine can be increased when it is combined with Vadadustat.,increase,no risk
Bromocriptine,Valdecoxib,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Valdecoxib.,increase,no risk
Bromocriptine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Bromocriptine.,increase,risk
Bromocriptine,Valsartan,Bromocriptine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Bromocriptine,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Bromocriptine.,increase,risk
Bromocriptine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Bromocriptine.,decrease,no risk
Bromocriptine,Vecuronium,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Vecuronium.,increase,risk
Bromocriptine,Vemurafenib,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Vemurafenib.,increase,no risk
Bromocriptine,Venetoclax,The metabolism of Bromocriptine can be decreased when combined with Venetoclax.,decrease,no risk
Bromocriptine,Venlafaxine,Venlafaxine may increase the tachycardic activities of Bromocriptine.,increase,no risk
Bromocriptine,Verapamil,The metabolism of Bromocriptine can be decreased when combined with Verapamil.,decrease,no risk
Bromocriptine,Vericiguat,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Vericiguat.,increase,risk
Bromocriptine,Vibegron,Bromocriptine may increase the hypertensive and vasoconstricting activities of Vibegron.,increase,no risk
Bromocriptine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Bromocriptine.,increase,risk
Bromocriptine,Vilanterol,Bromocriptine may increase the hypertensive and vasoconstricting activities of Vilanterol.,increase,no risk
Bromocriptine,Vilazodone,Bromocriptine may increase the vasoconstricting activities of Vilazodone.,increase,no risk
Bromocriptine,Vildagliptin,The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Vildagliptin.,increase,risk
Bromocriptine,Viloxazine,The metabolism of Bromocriptine can be decreased when combined with Viloxazine.,decrease,no risk
Bromocriptine,Voriconazole,The serum concentration of Bromocriptine can be increased when it is combined with Voriconazole.,increase,no risk
Bromocriptine,Vorinostat,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Vorinostat.,decrease,no risk
Bromocriptine,Vortioxetine,Bromocriptine may increase the vasoconstricting activities of Vortioxetine.,increase,no risk
Bromocriptine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Bromocriptine.,increase,no risk
Bromocriptine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Bromocriptine.,increase,no risk
Bromocriptine,Xamoterol,Bromocriptine may increase the hypertensive and vasoconstricting activities of Xamoterol.,increase,no risk
Bromocriptine,Xylometazoline,Bromocriptine may increase the hypertensive and vasoconstricting activities of Xylometazoline.,increase,no risk
Bromocriptine,Yohimbine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Yohimbine.,increase,risk
Bromocriptine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Bromocriptine.,increase,risk
Bromocriptine,Ziconotide,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Ziconotide.,increase,risk
Bromocriptine,Zimelidine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Zimelidine.,increase,risk
Bromocriptine,Ziprasidone,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Ziprasidone.,increase,risk
Bromocriptine,Zofenopril,Bromocriptine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Bromocriptine,Zolmitriptan,Bromocriptine may increase the vasoconstricting activities of Zolmitriptan.,increase,no risk
Bromocriptine,Zolpidem,Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Bromocriptine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Bromocriptine.,increase,risk
Bromocriptine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Bromocriptine.,decrease,no risk
Bromocriptine,Zotepine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Zotepine.,decrease,no risk
Bromocriptine,Zuclopenthixol,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Rifapentine,Galantamine,The metabolism of Galantamine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Ganaxolone,The metabolism of Ganaxolone can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Gefitinib,The metabolism of Gefitinib can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Gemfibrozil,The metabolism of Gemfibrozil can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Gepirone,The serum concentration of Gepirone can be decreased when it is combined with Rifapentine.,decrease,no risk
Rifapentine,Gestrinone,The metabolism of Gestrinone can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Glasdegib,The serum concentration of Glasdegib can be decreased when it is combined with Rifapentine.,decrease,no risk
Rifapentine,Gliclazide,The metabolism of Gliclazide can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Glofitamab,The serum concentration of Rifapentine can be increased when it is combined with Glofitamab.,increase,no risk
Rifapentine,Glyburide,The metabolism of Glyburide can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Granisetron,The metabolism of Granisetron can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Grazoprevir,The metabolism of Grazoprevir can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Guanfacine,The metabolism of Guanfacine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Halofantrine,The metabolism of Halofantrine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Rifapentine.,increase,no risk
Rifapentine,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Ketamine,The metabolism of Ketamine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Ketazolam,The metabolism of Ketazolam can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Ketoconazole,The metabolism of Rifapentine can be decreased when combined with Ketoconazole.,decrease,no risk
Rifapentine,Ketorolac,The metabolism of Ketorolac can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Olaparib,The metabolism of Olaparib can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Rifapentine.,decrease,no risk
Rifapentine,Olodaterol,The metabolism of Olodaterol can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Olutasidenib,The therapeutic efficacy of Olutasidenib can be decreased when used in combination with Rifapentine.,decrease,no risk
Rifapentine,Omaveloxolone,The therapeutic efficacy of Omaveloxolone can be decreased when used in combination with Rifapentine.,decrease,no risk
Rifapentine,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Omeprazole,The metabolism of Omeprazole can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Ondansetron,The metabolism of Ondansetron can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Opium,The metabolism of Opium can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Orphenadrine,The metabolism of Orphenadrine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Osilodrostat,The serum concentration of Osilodrostat can be decreased when it is combined with Rifapentine.,decrease,no risk
Rifapentine,Osimertinib,The metabolism of Osimertinib can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Ospemifene,The metabolism of Ospemifene can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Rifapentine is combined with Oxetacaine.,increase,risk
Rifapentine,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Rifapentine is combined with Oxybuprocaine.,increase,risk
Rifapentine,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Oxycodone,The metabolism of Oxycodone can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Ozanimod,The metabolism of Ozanimod can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Quazepam,The metabolism of Quazepam can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Quetiapine,The metabolism of Quetiapine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Quinidine,The metabolism of Quinidine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Quinine,The metabolism of Quinine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Quizartinib,The serum concentration of Quizartinib can be decreased when it is combined with Rifapentine.,decrease,no risk
Rifapentine,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Rifapentine.,decrease,no risk
Rifapentine,Udenafil,The metabolism of Udenafil can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Ulipristal,The metabolism of Ulipristal can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Upadacitinib,The metabolism of Upadacitinib can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Vadadustat,The serum concentration of Rifapentine can be increased when it is combined with Vadadustat.,increase,no risk
Rifapentine,Valbenazine,The serum concentration of Valbenazine can be decreased when it is combined with Rifapentine.,decrease,no risk
Rifapentine,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Valproic acid,The metabolism of Valproic acid can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Vamorolone,The metabolism of Vamorolone can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Vandetanib,The metabolism of Vandetanib can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Vardenafil,The metabolism of Vardenafil can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Venetoclax,The metabolism of Venetoclax can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Verapamil,The metabolism of Verapamil can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Rifapentine.,decrease,no risk
Rifapentine,Vilanterol,The metabolism of Vilanterol can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Vilazodone,The metabolism of Vilazodone can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Viloxazine,The metabolism of Rifapentine can be decreased when combined with Viloxazine.,decrease,no risk
Rifapentine,Vinblastine,The metabolism of Vinblastine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Vincristine,The metabolism of Vincristine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Vindesine,The metabolism of Vindesine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Vinflunine,The metabolism of Vinflunine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Vitamin D,The metabolism of Vitamin D can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Vitamin E,The metabolism of Vitamin E can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Voclosporin,The metabolism of Voclosporin can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Vonoprazan,The therapeutic efficacy of Vonoprazan can be decreased when used in combination with Rifapentine.,decrease,no risk
Rifapentine,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Voriconazole,The metabolism of Rifapentine can be decreased when combined with Voriconazole.,decrease,no risk
Rifapentine,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Voxelotor,The serum concentration of Voxelotor can be decreased when it is combined with Rifapentine.,decrease,no risk
Rifapentine,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Warfarin,The metabolism of Warfarin can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Yohimbine,The metabolism of Yohimbine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Zaleplon,The metabolism of Zaleplon can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Zidovudine,The metabolism of Zidovudine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Zileuton,The metabolism of Zileuton can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Zimelidine,The metabolism of Rifapentine can be decreased when combined with Zimelidine.,decrease,no risk
Rifapentine,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Zolpidem,The metabolism of Zolpidem can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Zonisamide,The metabolism of Zonisamide can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Zopiclone,The metabolism of Zopiclone can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Zotepine,The metabolism of Zotepine can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Rifapentine.,increase,no risk
Rifapentine,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Rifapentine.,decrease,no risk
Levetiracetam,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Levetiracetam.,increase,risk
Levetiracetam,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Gabapentin enacarbil.,increase,risk
Levetiracetam,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Levetiracetam.,increase,risk
Levetiracetam,Gamolenic acid,The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Levetiracetam,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Levetiracetam is combined with Ganaxolone.",increase,risk
Levetiracetam,Ganciclovir,The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Ganciclovir.,decrease,no risk
Levetiracetam,Gepirone,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Gepirone.,increase,risk
Levetiracetam,Gestrinone,The metabolism of Gestrinone can be increased when combined with Levetiracetam.,increase,no risk
Levetiracetam,Glutethimide,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Glutethimide.,increase,risk
Levetiracetam,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Levetiracetam.,increase,risk
Levetiracetam,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Levetiracetam.,increase,risk
Levetiracetam,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Levetiracetam.,increase,risk
Levetiracetam,Halofantrine,The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Halofantrine.,decrease,no risk
Levetiracetam,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Levetiracetam.,increase,risk
Levetiracetam,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Levetiracetam.,increase,risk
Levetiracetam,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Levetiracetam.,increase,risk
Levetiracetam,Hydrocodone,Levetiracetam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Levetiracetam,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Levetiracetam.,increase,risk
Levetiracetam,Hydroxychloroquine,The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Levetiracetam,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Levetiracetam.,increase,no risk
Levetiracetam,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Levetiracetam.,increase,no risk
Levetiracetam,Ketamine,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Ketamine.,increase,risk
Levetiracetam,Ketazolam,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Ketazolam.,increase,risk
Levetiracetam,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Levetiracetam.,increase,risk
Levetiracetam,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Levetiracetam is combined with Oliceridine.",increase,risk
Levetiracetam,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Levetiracetam.,increase,risk
Levetiracetam,Opium,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Opium.,increase,risk
Levetiracetam,Orlistat,Orlistat can cause a decrease in the absorption of Levetiracetam resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Levetiracetam,Orphenadrine,Levetiracetam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Levetiracetam,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Levetiracetam.,increase,risk
Levetiracetam,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Levetiracetam.,increase,risk
Levetiracetam,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Levetiracetam is combined with Oxetacaine.,increase,risk
Levetiracetam,Oxitriptan,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Oxitriptan.,increase,risk
Levetiracetam,Oxprenolol,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Oxprenolol.,increase,risk
Levetiracetam,Oxtriphylline,Levetiracetam may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levetiracetam,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Levetiracetam is combined with Oxybuprocaine.,increase,risk
Levetiracetam,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Levetiracetam.,increase,risk
Levetiracetam,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Levetiracetam.,increase,risk
Levetiracetam,Quazepam,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Quazepam.,increase,risk
Levetiracetam,Quetiapine,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Quetiapine.,increase,risk
Levetiracetam,Quinidine,The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Quinidine.,decrease,no risk
Levetiracetam,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Levetiracetam.,increase,risk
Levetiracetam,Quinupramine,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Quinupramine.,increase,risk
Levetiracetam,Ulipristal,The metabolism of Ulipristal can be increased when combined with Levetiracetam.,increase,no risk
Levetiracetam,Urethane,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Urethane.,increase,risk
Levetiracetam,Valganciclovir,The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Valganciclovir.,decrease,no risk
Levetiracetam,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Levetiracetam.,increase,risk
Levetiracetam,Vecuronium,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Vecuronium.,increase,risk
Levetiracetam,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Levetiracetam.,increase,risk
Levetiracetam,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Levetiracetam.,increase,risk
Levetiracetam,Vilazodone,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Vilazodone.,increase,risk
Levetiracetam,Viloxazine,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Viloxazine.,increase,risk
Levetiracetam,Vortioxetine,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Vortioxetine.,increase,risk
Levetiracetam,Yohimbine,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Yohimbine.,increase,risk
Levetiracetam,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Levetiracetam.,increase,risk
Levetiracetam,Ziconotide,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Ziconotide.,increase,risk
Levetiracetam,Zimelidine,The risk or severity of adverse effects can be increased when Levetiracetam is combined with Zimelidine.,increase,risk
Levetiracetam,Ziprasidone,The risk or severity of adverse effects can be increased when Levetiracetam is combined with Ziprasidone.,increase,risk
Levetiracetam,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Levetiracetam.,increase,risk
Levetiracetam,Zolpidem,Levetiracetam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Levetiracetam,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Levetiracetam.,increase,risk
Levetiracetam,Zopiclone,The risk or severity of adverse effects can be increased when Levetiracetam is combined with Zopiclone.,increase,risk
Levetiracetam,Zotepine,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Zotepine.,increase,risk
Levetiracetam,Zuclopenthixol,The risk or severity of CNS depression can be increased when Levetiracetam is combined with Zuclopenthixol.,increase,risk
Levetiracetam,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Levetiracetam.,increase,risk
Nadolol,Bemiparin,The risk or severity of hyperkalemia can be increased when Nadolol is combined with Bemiparin.,increase,risk
Nadolol,Benazepril,Benazepril may increase the hypotensive activities of Nadolol.,increase,no risk
Nadolol,Benorilate,Benorilate may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Nadolol,Benoxaprofen,Benoxaprofen may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Nadolol,Benserazide,Nadolol may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Nadolol,Benzatropine,Benzatropine may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Nadolol,Benznidazole,Nadolol may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Nadolol,Benzocaine,The metabolism of Nadolol can be decreased when combined with Benzocaine.,decrease,no risk
Nadolol,Benzphetamine,The therapeutic efficacy of Nadolol can be decreased when used in combination with Benzphetamine.,decrease,no risk
Nadolol,Benzthiazide,The therapeutic efficacy of Nadolol can be increased when used in combination with Benzthiazide.,increase,no risk
Nadolol,Benzydamine,Benzydamine may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Nadolol,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Nadolol.,decrease,no risk
Nadolol,Bepotastine,Nadolol may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Nadolol,Bepridil,Nadolol may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Nadolol,Beractant,Nadolol may increase the bradycardic activities of Beractant.,increase,no risk
Nadolol,Berotralstat,The metabolism of Nadolol can be decreased when combined with Berotralstat.,decrease,no risk
Nadolol,Betaine,Betaine may increase the bradycardic activities of Nadolol.,increase,no risk
Nadolol,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Nadolol.,increase,no risk
Nadolol,Bethanechol,The risk or severity of adverse effects can be increased when Nadolol is combined with Bethanechol.,increase,risk
Nadolol,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Nadolol.,decrease,no risk
Nadolol,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Nadolol.,increase,no risk
Nadolol,Bicisate,Nadolol may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Nadolol,Bictegravir,The excretion of Nadolol can be decreased when combined with Bictegravir.,decrease,no risk
Nadolol,Bimatoprost,Bimatoprost may increase the hypotensive activities of Nadolol.,increase,no risk
Nadolol,Bimekizumab,The metabolism of Nadolol can be increased when combined with Bimekizumab.,increase,no risk
Nadolol,Bioallethrin,Nadolol may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Nadolol,Biperiden,The metabolism of Nadolol can be decreased when combined with Biperiden.,decrease,no risk
Nadolol,Bismuth subgallate,Nadolol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Nadolol,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Nadolol.,increase,risk
Nadolol,Bisoxatin,Nadolol may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Nadolol,Bleomycin,Bleomycin may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Nadolol,Bortezomib,The metabolism of Nadolol can be decreased when combined with Bortezomib.,decrease,no risk
Nadolol,Bosentan,Bosentan may increase the hypotensive activities of Nadolol.,increase,no risk
Nadolol,Bouteloua gracilis pollen,The risk of a hypersensitivity reaction to Bouteloua gracilis pollen is increased when it is combined with Nadolol.,increase,risk
Nadolol,Bretylium,Bretylium may increase the arrhythmogenic activities of Nadolol.,increase,no risk
Nadolol,Brexpiprazole,Nadolol may increase the orthostatic hypotensive activities of Brexpiprazole.,increase,no risk
Nadolol,Brigatinib,The excretion of Nadolol can be decreased when combined with Brigatinib.,decrease,no risk
Nadolol,Brimonidine,Brimonidine may increase the antihypertensive activities of Nadolol.,increase,no risk
Nadolol,Brivaracetam,Nadolol may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Nadolol,Bromazepam,Nadolol may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Nadolol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Nadolol.,increase,no risk
Nadolol,Bromotheophylline,Bromotheophylline may increase the excretion rate of Nadolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nadolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Nadolol.,increase,risk
Nadolol,Budesonide,Nadolol may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Nadolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Nadolol,Bumetanide,Bumetanide may increase the excretion rate of Nadolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nadolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Nadolol.,increase,no risk
Nadolol,Buprenorphine,The metabolism of Nadolol can be decreased when combined with Buprenorphine.,decrease,no risk
Nadolol,Bupropion,The metabolism of Nadolol can be decreased when combined with Bupropion.,decrease,no risk
Nadolol,Buspirone,Buspirone may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Nadolol,Butabarbital,Butabarbital may increase the hypotensive activities of Nadolol.,increase,no risk
Nadolol,Butalbital,Butalbital may increase the hypotensive activities of Nadolol.,increase,no risk
Nadolol,Butaperazine,The serum concentration of Nadolol can be increased when it is combined with Butaperazine.,increase,no risk
Nadolol,Butriptyline,Butriptyline may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Nadolol,Gabapentin enacarbil,Nadolol may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Nadolol,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Nadolol,Gadodiamide,Gadodiamide may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Nadolol,Gadofosveset trisodium,Nadolol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Nadolol,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Nadolol,Gadoteric acid,Nadolol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Nadolol,Gadoteridol,Gadoteridol may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Nadolol,Galantamine,Galantamine may increase the bradycardic activities of Nadolol.,increase,no risk
Nadolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Nadolol.,increase,no risk
Nadolol,Ganciclovir,The excretion of Nadolol can be decreased when combined with Ganciclovir.,decrease,no risk
Nadolol,Gefitinib,The metabolism of Nadolol can be decreased when combined with Gefitinib.,decrease,no risk
Nadolol,Gemcitabine,Gemcitabine may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Nadolol,Gemfibrozil,Nadolol may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Nadolol,Gentamicin,Nadolol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Nadolol,Gilteritinib,The excretion of Nadolol can be decreased when combined with Gilteritinib.,decrease,no risk
Nadolol,Gimeracil,Nadolol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Nadolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Nadolol.,increase,no risk
Nadolol,Givosiran,The serum concentration of Nadolol can be increased when it is combined with Givosiran.,increase,no risk
Nadolol,Glasdegib,The excretion of Nadolol can be decreased when combined with Glasdegib.,decrease,no risk
Nadolol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Nadolol.,increase,no risk
Nadolol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Nadolol.,increase,no risk
Nadolol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Nadolol.,increase,no risk
Nadolol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Nadolol.,increase,no risk
Nadolol,Glucagon,The therapeutic efficacy of Nadolol can be decreased when used in combination with Glucagon.,decrease,no risk
Nadolol,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Nadolol.,increase,no risk
Nadolol,Glycerol phenylbutyrate,The metabolism of Nadolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Nadolol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Nadolol,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Nadolol.,increase,no risk
Nadolol,Golimumab,The metabolism of Nadolol can be increased when combined with Golimumab.,increase,no risk
Nadolol,Golodirsen,Nadolol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Nadolol,Goserelin,Goserelin may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Nadolol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Nadolol.,decrease,no risk
Nadolol,Guanadrel,Guanadrel may increase the hypotensive activities of Nadolol.,increase,no risk
Nadolol,Guanethidine,Guanethidine may increase the hypotensive activities of Nadolol.,increase,no risk
Nadolol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Nadolol.,decrease,no risk
Nadolol,Guanidine,The excretion of Nadolol can be decreased when combined with Guanidine.,decrease,no risk
Nadolol,Guanoxan,Nadolol may increase the hypotensive activities of Guanoxan.,increase,no risk
Nadolol,Halofantrine,The metabolism of Nadolol can be decreased when combined with Halofantrine.,decrease,no risk
Nadolol,Haloperidol,The serum concentration of Nadolol can be increased when it is combined with Haloperidol.,increase,no risk
Nadolol,Halothane,Halothane may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Nadolol,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Nadolol.,increase,risk
Nadolol,Hexafluronium,Hexafluronium may increase the bradycardic activities of Nadolol.,increase,no risk
Nadolol,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Nadolol.,increase,risk
Nadolol,Huperzine A,Huperzine A may increase the bradycardic activities of Nadolol.,increase,no risk
Nadolol,Hydralazine,Nadolol may increase the hypotensive activities of Hydralazine.,increase,no risk
Nadolol,Hydrochlorothiazide,The therapeutic efficacy of Nadolol can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Nadolol,Hydroflumethiazide,The therapeutic efficacy of Nadolol can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Nadolol,Hydromorphone,Hydromorphone may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Nadolol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Nadolol,Hydroxychloroquine,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Nadolol.,decrease,risk
Nadolol,Hydroxyethyl Starch,Nadolol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Nadolol,Hydroxyzine,The metabolism of Nadolol can be decreased when combined with Hydroxyzine.,decrease,no risk
Nadolol,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Nadolol.,increase,no risk
Nadolol,Kanamycin,Nadolol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Nadolol,Ketamine,Ketamine may increase the bradycardic activities of Nadolol.,increase,no risk
Nadolol,Ketazolam,Nadolol may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Nadolol,Ketoconazole,The metabolism of Nadolol can be decreased when combined with Ketoconazole.,decrease,no risk
Nadolol,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Nadolol,Ketorolac,Ketorolac may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Nadolol,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Nadolol.,increase,risk
Nadolol,Obinutuzumab,Nadolol may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Nadolol,Octinoxate,Nadolol may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Nadolol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Nadolol.,increase,no risk
Nadolol,Olanzapine,Nadolol may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Nadolol,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Nadolol.,decrease,no risk
Nadolol,Olmesartan,Olmesartan may increase the hypotensive activities of Nadolol.,increase,no risk
Nadolol,Olodaterol,Nadolol may decrease the bronchodilatory activities of Olodaterol.,decrease,no risk
Nadolol,Olsalazine,Olsalazine may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Nadolol,Ondansetron,The metabolism of Nadolol can be decreased when combined with Ondansetron.,decrease,no risk
Nadolol,Opicapone,The risk or severity of adverse effects can be increased when Nadolol is combined with Opicapone.,increase,risk
Nadolol,Opium,Nadolol may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Nadolol,Orciprenaline,Nadolol may decrease the bronchodilatory activities of Orciprenaline.,decrease,no risk
Nadolol,Oritavancin,The metabolism of Nadolol can be decreased when combined with Oritavancin.,decrease,no risk
Nadolol,Orphenadrine,The metabolism of Nadolol can be decreased when combined with Orphenadrine.,decrease,no risk
Nadolol,Oseltamivir,Oseltamivir may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Nadolol,Osilodrostat,The metabolism of Nadolol can be decreased when combined with Osilodrostat.,decrease,no risk
Nadolol,Ospemifene,The metabolism of Nadolol can be decreased when combined with Ospemifene.,decrease,no risk
Nadolol,Ouabain,Nadolol may increase the bradycardic activities of Ouabain.,increase,no risk
Nadolol,Oxacillin,Oxacillin may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Nadolol,Oxamniquine,The metabolism of Nadolol can be decreased when combined with Oxamniquine.,decrease,no risk
Nadolol,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Nadolol,Oxazepam,Oxazepam may decrease the excretion rate of Nadolol which could result in a higher serum level.,decrease,no risk
Nadolol,Oxprenolol,Nadolol may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Nadolol,Oxybenzone,Nadolol may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Nadolol,Oxybutynin,The metabolism of Nadolol can be decreased when combined with Oxybutynin.,decrease,no risk
Nadolol,Oxycodone,The metabolism of Nadolol can be decreased when combined with Oxycodone.,decrease,no risk
Nadolol,Oxymetazoline,The risk or severity of cardiovascular complications can be increased when Nadolol is combined with Oxymetazoline.,increase,risk
Nadolol,Oxymorphone,The metabolism of Nadolol can be decreased when combined with Oxymorphone.,decrease,no risk
Nadolol,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Nadolol,Oxyquinoline,Nadolol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Nadolol,Quetiapine,Quetiapine may increase the hypotensive activities of Nadolol.,increase,no risk
Nadolol,Quinapril,Quinapril may increase the hypotensive activities of Nadolol.,increase,no risk
Nadolol,Quinethazone,Quinethazone may increase the excretion rate of Nadolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nadolol,Quinidine,Quinidine may increase the arrhythmogenic activities of Nadolol.,increase,no risk
Nadolol,Quinine,The metabolism of Nadolol can be decreased when combined with Quinine.,decrease,no risk
Nadolol,Quinupramine,Quinupramine may decrease the antihypertensive activities of Nadolol.,decrease,no risk
Flumazenil,Gabapentin enacarbil,Flumazenil may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Flumazenil,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Gadodiamide,Gadodiamide may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Gadofosveset trisodium,Flumazenil may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Flumazenil,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Gadoteric acid,Flumazenil may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Flumazenil,Gadoteridol,Gadoteridol may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Ganciclovir,Ganciclovir may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Gemcitabine,Gemcitabine may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Gemfibrozil,Flumazenil may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Flumazenil,Gentamicin,Flumazenil may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Flumazenil,Gimeracil,Flumazenil may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Flumazenil,Givosiran,Givosiran may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Glipizide,Glipizide may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Glycerol phenylbutyrate,Flumazenil may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Flumazenil,Golodirsen,Flumazenil may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Flumazenil,Goserelin,Goserelin may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Guanethidine,Guanethidine may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Guanfacine,Guanfacine may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Haloperidol,Haloperidol may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Hydralazine,Flumazenil may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Flumazenil,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Flumazenil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Flumazenil,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Flumazenil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Flumazenil,Hydromorphone,Hydromorphone may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Hydroxyethyl Starch,Flumazenil may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Flumazenil,Kanamycin,Flumazenil may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Flumazenil,Ketamine,Flumazenil may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Flumazenil,Ketazolam,Flumazenil may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Flumazenil,Ketoprofen,Ketoprofen may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Ketorolac,Ketorolac may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Octinoxate,Flumazenil may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Flumazenil,Olsalazine,Olsalazine may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Opium,Flumazenil may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Flumazenil,Oseltamivir,Oseltamivir may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Oxacillin,Oxacillin may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Oxaprozin,Oxaprozin may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Oxazepam,Flumazenil may decrease the sedative activities of Oxazepam.,decrease,no risk
Flumazenil,Oxybenzone,Flumazenil may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Flumazenil,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Oxyquinoline,Flumazenil may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Flumazenil,Quazepam,Flumazenil may decrease the sedative activities of Quazepam.,decrease,no risk
Flumazenil,Quetiapine,Flumazenil may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Flumazenil,Quinethazone,Quinethazone may increase the excretion rate of Flumazenil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Flumazenil,Quinidine,Flumazenil may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Flumazenil,Vaborbactam,Flumazenil may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Flumazenil,Valaciclovir,Valaciclovir may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Valbenazine,Flumazenil may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Flumazenil,Valdecoxib,Valdecoxib may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Valganciclovir,Flumazenil may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Flumazenil,Vancomycin,Flumazenil may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Flumazenil,Varenicline,Flumazenil may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Flumazenil,Venlafaxine,Venlafaxine may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Verapamil,Verapamil may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Vilanterol,Flumazenil may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Flumazenil,Viloxazine,Flumazenil may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Flumazenil,Vortioxetine,Flumazenil may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Flumazenil,Warfarin,Flumazenil may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Flumazenil,Zaleplon,Flumazenil may decrease the sedative activities of Zaleplon.,decrease,no risk
Flumazenil,Zanamivir,Zanamivir may decrease the excretion rate of Flumazenil which could result in a higher serum level.,decrease,no risk
Flumazenil,Zolpidem,Flumazenil may decrease the sedative activities of Zolpidem.,decrease,no risk
Flumazenil,Zonisamide,Zonisamide may increase the excretion rate of Flumazenil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Flumazenil,Zopiclone,Flumazenil may decrease the sedative activities of Zopiclone.,decrease,no risk
Lomustine,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Lomustine.,increase,risk
Lomustine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Lomustine.,increase,risk
Lomustine,Glatiramer,The risk or severity of adverse effects can be increased when Lomustine is combined with Glatiramer.,increase,risk
Lomustine,Golimumab,The risk or severity of adverse effects can be increased when Lomustine is combined with Golimumab.,increase,risk
Lomustine,Guselkumab,The risk or severity of adverse effects can be increased when Lomustine is combined with Guselkumab.,increase,risk
Lomustine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Lomustine.,decrease,no risk
Lomustine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Lomustine.,increase,risk
Lomustine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Lomustine.,decrease,no risk
Lomustine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Lomustine.,decrease,no risk
Lomustine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Lomustine.,increase,risk
Lomustine,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Lomustine.,increase,risk
Lomustine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Lomustine is combined with Hydrocortisone acetate.,increase,risk
Lomustine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Lomustine is combined with Hydrocortisone butyrate.,increase,risk
Lomustine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Lomustine is combined with Hydrocortisone succinate.,increase,risk
Lomustine,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Lomustine.,increase,risk
Lomustine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Lomustine is combined with Hydroxychloroquine.,increase,risk
Lomustine,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Lomustine.,increase,risk
Lomustine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Lomustine.,decrease,no risk
Lomustine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Lomustine.,decrease,no risk
Lomustine,Obinutuzumab,The risk or severity of adverse effects can be increased when Lomustine is combined with Obinutuzumab.,increase,risk
Lomustine,Ocrelizumab,The risk or severity of adverse effects can be increased when Lomustine is combined with Ocrelizumab.,increase,risk
Lomustine,Ofatumumab,The risk or severity of adverse effects can be increased when Lomustine is combined with Ofatumumab.,increase,risk
Lomustine,Olaparib,The risk or severity of adverse effects can be increased when Lomustine is combined with Olaparib.,increase,risk
Lomustine,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Lomustine.,increase,risk
Lomustine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Lomustine is combined with Oxetacaine.,increase,risk
Lomustine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Lomustine is combined with Oxybuprocaine.,increase,risk
Lomustine,Ozanimod,The risk or severity of adverse effects can be increased when Lomustine is combined with Ozanimod.,increase,risk
Lomustine,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Lomustine.,increase,risk
Lomustine,Upadacitinib,The risk or severity of adverse effects can be increased when Lomustine is combined with Upadacitinib.,increase,risk
Lomustine,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Lomustine.,increase,risk
Lomustine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Lomustine.,increase,risk
Lomustine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Lomustine.,decrease,no risk
Lomustine,Vedolizumab,The risk or severity of adverse effects can be increased when Lomustine is combined with Vedolizumab.,increase,risk
Lomustine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Lomustine.,decrease,no risk
Lomustine,Vilanterol,The risk or severity of adverse effects can be increased when Lomustine is combined with Vilanterol.,increase,risk
Lomustine,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Lomustine.,increase,risk
Lomustine,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Lomustine.,increase,risk
Lomustine,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Lomustine.,increase,risk
Lomustine,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Lomustine.,increase,risk
Lomustine,Voclosporin,The risk or severity of adverse effects can be increased when Lomustine is combined with Voclosporin.,increase,risk
Lomustine,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Lomustine.,increase,risk
Lomustine,Vorinostat,The risk or severity of adverse effects can be increased when Lomustine is combined with Vorinostat.,increase,risk
Lomustine,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Lomustine.,increase,risk
Lomustine,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Lomustine.,increase,risk
Lomustine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Lomustine.,increase,risk
Lomustine,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Lomustine.,increase,risk
Ridogrel,Gemcitabine,The risk or severity of bleeding can be increased when Ridogrel is combined with Gemcitabine.,increase,risk
Ridogrel,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Ridogrel is combined with Gemtuzumab ozogamicin.,increase,risk
Ridogrel,Ginkgo biloba,Ginkgo biloba may increase the antiplatelet activities of Ridogrel.,increase,no risk
Ridogrel,Glucosamine,Glucosamine may increase the antiplatelet activities of Ridogrel.,increase,no risk
Ridogrel,Glycol salicylate,The risk or severity of bleeding can be increased when Glycol salicylate is combined with Ridogrel.,increase,risk
Ridogrel,Heparin,The risk or severity of bleeding can be increased when Ridogrel is combined with Heparin.,increase,risk
Ridogrel,Hydroxyurea,The risk or severity of bleeding can be increased when Ridogrel is combined with Hydroxyurea.,increase,risk
Ridogrel,Ketoprofen,The risk or severity of bleeding can be increased when Ketoprofen is combined with Ridogrel.,increase,risk
Ridogrel,Ketorolac,The risk or severity of bleeding can be increased when Ketorolac is combined with Ridogrel.,increase,risk
Ridogrel,Obeticholic acid,The risk or severity of adverse effects can be increased when Ridogrel is combined with Obeticholic acid.,increase,risk
Ridogrel,Obinutuzumab,The risk or severity of adverse effects can be increased when Ridogrel is combined with Obinutuzumab.,increase,risk
Ridogrel,Olaparib,The risk or severity of bleeding can be increased when Ridogrel is combined with Olaparib.,increase,risk
Ridogrel,Olsalazine,The risk or severity of bleeding can be increased when Ridogrel is combined with Olsalazine.,increase,risk
Ridogrel,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Ridogrel.,increase,no risk
Ridogrel,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Ridogrel.,increase,risk
Ridogrel,Oxaliplatin,The risk or severity of bleeding can be increased when Ridogrel is combined with Oxaliplatin.,increase,risk
Ridogrel,Oxaprozin,The risk or severity of bleeding can be increased when Oxaprozin is combined with Ridogrel.,increase,risk
Ridogrel,Oxyphenbutazone,The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Ridogrel.,increase,risk
Ridogrel,Urokinase,Ridogrel may increase the anticoagulant activities of Urokinase.,increase,no risk
Ridogrel,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Ridogrel is combined with Ursodeoxycholic acid.,increase,risk
Ridogrel,Valdecoxib,The risk or severity of bleeding can be increased when Valdecoxib is combined with Ridogrel.,increase,risk
Ridogrel,Venlafaxine,The risk or severity of bleeding can be increased when Ridogrel is combined with Venlafaxine.,increase,risk
Ridogrel,Vinblastine,The risk or severity of bleeding can be increased when Ridogrel is combined with Vinblastine.,increase,risk
Ridogrel,Vindesine,The risk or severity of bleeding can be increased when Ridogrel is combined with Vindesine.,increase,risk
Ridogrel,Vinorelbine,The risk or severity of bleeding can be increased when Ridogrel is combined with Vinorelbine.,increase,risk
Ridogrel,Vitamin E,Vitamin E may increase the antiplatelet activities of Ridogrel.,increase,no risk
Ridogrel,Vorapaxar,The risk or severity of bleeding can be increased when Ridogrel is combined with Vorapaxar.,increase,risk
Ridogrel,Vorinostat,The risk or severity of bleeding can be increased when Ridogrel is combined with Vorinostat.,increase,risk
Ridogrel,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Ridogrel.,increase,risk
Ridogrel,Warfarin,The risk or severity of bleeding can be increased when Ridogrel is combined with Warfarin.,increase,risk
Ridogrel,Ximelagatran,The risk or severity of bleeding can be increased when Ridogrel is combined with Ximelagatran.,increase,risk
Ridogrel,Zidovudine,The risk or severity of bleeding can be increased when Ridogrel is combined with Zidovudine.,increase,risk
Ridogrel,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Ridogrel.,increase,risk
Sparfloxacin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Glasdegib,The risk or severity of QTc prolongation can be increased when Sparfloxacin is combined with Glasdegib.,increase,risk
Sparfloxacin,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Sparfloxacin.,increase,no risk
Sparfloxacin,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Sparfloxacin.,increase,no risk
Sparfloxacin,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Sparfloxacin.,increase,no risk
Sparfloxacin,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Sparfloxacin.,increase,no risk
Sparfloxacin,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Sparfloxacin.,increase,no risk
Sparfloxacin,Glycol salicylate,Glycol salicylate may increase the neuroexcitatory activities of Sparfloxacin.,increase,no risk
Sparfloxacin,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Sparfloxacin.,increase,no risk
Sparfloxacin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Halofantrine,The risk or severity of QTc prolongation can be increased when Sparfloxacin is combined with Halofantrine.,increase,risk
Sparfloxacin,Haloperidol,The risk or severity of QTc prolongation can be increased when Sparfloxacin is combined with Haloperidol.,increase,risk
Sparfloxacin,Hetacillin,The serum concentration of Sparfloxacin can be increased when it is combined with Hetacillin.,increase,no risk
Sparfloxacin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Hydrocortisone,The risk or severity of tendinopathy can be increased when Hydrocortisone is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Hydrocortisone acetate,The risk or severity of tendinopathy can be increased when Hydrocortisone acetate is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Hydrocortisone butyrate,The risk or severity of tendinopathy can be increased when Hydrocortisone butyrate is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Hydrocortisone cypionate,The risk or severity of tendinopathy can be increased when Hydrocortisone cypionate is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Hydrocortisone succinate,The risk or severity of tendinopathy can be increased when Hydrocortisone succinate is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sparfloxacin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Sparfloxacin is combined with Hydroxyzine.,increase,risk
Sparfloxacin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Ketoprofen,Ketoprofen may increase the neuroexcitatory activities of Sparfloxacin.,increase,no risk
Sparfloxacin,Ketorolac,Ketorolac may increase the neuroexcitatory activities of Sparfloxacin.,increase,no risk
Sparfloxacin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Oxacillin,The serum concentration of Sparfloxacin can be increased when it is combined with Oxacillin.,increase,no risk
Sparfloxacin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Oxaprozin,Oxaprozin may increase the neuroexcitatory activities of Sparfloxacin.,increase,no risk
Sparfloxacin,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Sparfloxacin is combined with Oxetacaine.,increase,risk
Sparfloxacin,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Sparfloxacin.,decrease,no risk
Sparfloxacin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Sparfloxacin is combined with Oxybuprocaine.,increase,risk
Sparfloxacin,Oxyphenbutazone,Oxyphenbutazone may increase the neuroexcitatory activities of Sparfloxacin.,increase,no risk
Sparfloxacin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Quinapril,Quinapril can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sparfloxacin,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Quizartinib,The risk or severity of QTc prolongation can be increased when Sparfloxacin is combined with Quizartinib.,increase,risk
Sparfloxacin,Valdecoxib,Valdecoxib may increase the neuroexcitatory activities of Sparfloxacin.,increase,no risk
Sparfloxacin,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Vamorolone,The risk or severity of tendinopathy can be increased when Vamorolone is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Vandetanib,The risk or severity of QTc prolongation can be increased when Sparfloxacin is combined with Vandetanib.,increase,risk
Sparfloxacin,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Sparfloxacin is combined with Vemurafenib.,increase,risk
Sparfloxacin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Sparfloxacin.,decrease,no risk
Sparfloxacin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sparfloxacin.,increase,no risk
Sparfloxacin,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Sparfloxacin.,increase,risk
Sparfloxacin,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Sparfloxacin.,increase,no risk
Sparfloxacin,Zinc,Zinc can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sparfloxacin,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sparfloxacin,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sparfloxacin,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sparfloxacin,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sparfloxacin,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sparfloxacin,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sparfloxacin,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Sparfloxacin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Sparfloxacin is combined with Ziprasidone.,increase,risk
Sparfloxacin,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Sparfloxacin.,decrease,no risk
Sparfloxacin,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Sparfloxacin.,increase,risk
Dezocine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Dezocine.,increase,risk
Dezocine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Dezocine is combined with Gabapentin enacarbil.,increase,risk
Dezocine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Dezocine.,increase,risk
Dezocine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Dezocine is combined with Ganaxolone.",increase,risk
Dezocine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Dezocine.,increase,risk
Dezocine,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Dezocine.,decrease,no risk
Dezocine,Glutethimide,The risk or severity of CNS depression can be increased when Dezocine is combined with Glutethimide.,increase,risk
Dezocine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Dezocine.,decrease,no risk
Dezocine,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Dezocine.,increase,risk
Dezocine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Dezocine.,increase,risk
Dezocine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Dezocine.,increase,risk
Dezocine,Halazepam,The risk or severity of adverse effects can be increased when Dezocine is combined with Halazepam.,increase,risk
Dezocine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Dezocine.,increase,risk
Dezocine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Dezocine.,increase,risk
Dezocine,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Dezocine.,increase,risk
Dezocine,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Dezocine.,increase,risk
Dezocine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Dezocine.,increase,risk
Dezocine,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Dezocine.,decrease,no risk
Dezocine,Hydrocodone,Dezocine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Dezocine,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Dezocine.,decrease,no risk
Dezocine,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Dezocine.,increase,risk
Dezocine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dezocine.,increase,no risk
Dezocine,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Dezocine.,increase,risk
Dezocine,Ketamine,The risk or severity of CNS depression can be increased when Dezocine is combined with Ketamine.,increase,risk
Dezocine,Ketazolam,The risk or severity of adverse effects can be increased when Dezocine is combined with Ketazolam.,increase,risk
Dezocine,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Dezocine.,increase,risk
Dezocine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Dezocine is combined with Oliceridine.",increase,risk
Dezocine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Dezocine.,increase,risk
Dezocine,Opium,The risk or severity of adverse effects can be increased when Dezocine is combined with Opium.,increase,risk
Dezocine,Orphenadrine,Dezocine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Dezocine,Oxazepam,The risk or severity of adverse effects can be increased when Dezocine is combined with Oxazepam.,increase,risk
Dezocine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Dezocine.,increase,risk
Dezocine,Oxitriptan,The risk or severity of CNS depression can be increased when Dezocine is combined with Oxitriptan.,increase,risk
Dezocine,Oxprenolol,The risk or severity of CNS depression can be increased when Dezocine is combined with Oxprenolol.,increase,risk
Dezocine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Dezocine.,increase,risk
Dezocine,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Dezocine.,increase,risk
Dezocine,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Dezocine.,increase,risk
Dezocine,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Dezocine.,increase,risk
Dezocine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Dezocine.,increase,risk
Dezocine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Dezocine.,decrease,no risk
Dezocine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Dezocine.,increase,risk
Dezocine,Quazepam,The risk or severity of adverse effects can be increased when Dezocine is combined with Quazepam.,increase,risk
Dezocine,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Dezocine.,increase,risk
Dezocine,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Dezocine.,decrease,no risk
Dezocine,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Dezocine.,increase,risk
Dezocine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Dezocine.,increase,risk
Dezocine,Quinupramine,The risk or severity of CNS depression can be increased when Dezocine is combined with Quinupramine.,increase,risk
Dezocine,Umeclidinium,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Dezocine.,increase,risk
Dezocine,Urethane,The risk or severity of CNS depression can be increased when Dezocine is combined with Urethane.,increase,risk
Dezocine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Valproate bismuth.,increase,risk
Dezocine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Dezocine.,increase,risk
Dezocine,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Dezocine.,increase,risk
Dezocine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Venlafaxine.,increase,risk
Dezocine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Dezocine.,increase,risk
Dezocine,Vilazodone,The risk or severity of CNS depression can be increased when Dezocine is combined with Vilazodone.,increase,risk
Dezocine,Viloxazine,The risk or severity of CNS depression can be increased when Dezocine is combined with Viloxazine.,increase,risk
Dezocine,Vortioxetine,The risk or severity of CNS depression can be increased when Dezocine is combined with Vortioxetine.,increase,risk
Dezocine,Yohimbine,The risk or severity of CNS depression can be increased when Dezocine is combined with Yohimbine.,increase,risk
Dezocine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Dezocine.,increase,risk
Dezocine,Ziconotide,The risk or severity of adverse effects can be increased when Dezocine is combined with Ziconotide.,increase,risk
Dezocine,Zimelidine,The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Zimelidine.,increase,risk
Dezocine,Ziprasidone,The risk or severity of adverse effects can be increased when Dezocine is combined with Ziprasidone.,increase,risk
Dezocine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Dezocine.,increase,risk
Dezocine,Zolpidem,Dezocine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Dezocine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Dezocine.,increase,risk
Dezocine,Zopiclone,The risk or severity of adverse effects can be increased when Dezocine is combined with Zopiclone.,increase,risk
Dezocine,Zotepine,The risk or severity of CNS depression can be increased when Dezocine is combined with Zotepine.,increase,risk
Dezocine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Dezocine is combined with Zuclopenthixol.,increase,risk
Dezocine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Dezocine.,increase,risk
Levobunolol,Givosiran,The serum concentration of Levobunolol can be increased when it is combined with Givosiran.,increase,no risk
Levobunolol,Haloperidol,The serum concentration of Levobunolol can be increased when it is combined with Haloperidol.,increase,no risk
Levobunolol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Levobunolol.,increase,no risk
Levobunolol,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Levobunolol.,increase,risk
Levobunolol,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Levobunolol.,increase,risk
Levobunolol,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Levobunolol.,increase,risk
Levobunolol,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Levobunolol.,decrease,no risk
Levobunolol,Viloxazine,The metabolism of Levobunolol can be decreased when combined with Viloxazine.,decrease,no risk
Clarithromycin,Bisoprolol,The metabolism of Bisoprolol can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Boceprevir,The serum concentration of Boceprevir can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Bosentan,"The serum concentration of 14-OH-Clarithromycin, an active metabolite of Bosentan, can be increased when used in combination with Clarithromycin.",increase,no risk
Clarithromycin,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Clarithromycin.,increase,risk
Clarithromycin,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Clarithromycin.,increase,risk
Clarithromycin,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Clarithromycin.,increase,risk
Clarithromycin,Budesonide,The metabolism of Budesonide can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Clarithromycin.,increase,risk
Clarithromycin,Buspirone,The metabolism of Buspirone can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Busulfan,The metabolism of Busulfan can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Clarithromycin is combined with Butacaine.,increase,risk
Clarithromycin,Butamben,The risk or severity of methemoglobinemia can be increased when Clarithromycin is combined with Butamben.,increase,risk
Clarithromycin,Butriptyline,The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Butriptyline.,increase,risk
Clarithromycin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Clarithromycin.,increase,risk
Clarithromycin,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Galantamine,The metabolism of Galantamine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Clarithromycin.,increase,risk
Clarithromycin,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Clarithromycin.,increase,risk
Clarithromycin,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Gliclazide,The serum concentration of Gliclazide can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Glimepiride,The serum concentration of Glimepiride can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Glipizide,The serum concentration of Glipizide can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Gliquidone,The serum concentration of Gliquidone can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Glofitamab,The serum concentration of Clarithromycin can be increased when it is combined with Glofitamab.,increase,no risk
Clarithromycin,Glyburide,The serum concentration of Glyburide can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Glycyrrhizic acid,Clarithromycin may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Clarithromycin,Golimumab,The metabolism of Clarithromycin can be increased when combined with Golimumab.,increase,no risk
Clarithromycin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Clarithromycin.,increase,risk
Clarithromycin,Granisetron,The metabolism of Granisetron can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Haloperidol,The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Haloperidol.,increase,risk
Clarithromycin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Clarithromycin.,increase,risk
Clarithromycin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Clarithromycin.,increase,risk
Clarithromycin,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Hydroxyzine.,increase,risk
Clarithromycin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Clarithromycin.,increase,risk
Clarithromycin,Ketamine,The metabolism of Ketamine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Ketoconazole,The metabolism of Clarithromycin can be decreased when combined with Ketoconazole.,decrease,no risk
Clarithromycin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Clarithromycin.,increase,risk
Clarithromycin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Clarithromycin.,increase,risk
Clarithromycin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Clarithromycin.,increase,risk
Clarithromycin,Olaparib,The metabolism of Olaparib can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Olmesartan,Olmesartan may decrease the excretion rate of Clarithromycin which could result in a higher serum level.,decrease,no risk
Clarithromycin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Clarithromycin.,increase,risk
Clarithromycin,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Opium,The metabolism of Opium can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Clarithromycin.,increase,risk
Clarithromycin,Oxatomide,The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Oxatomide.,increase,risk
Clarithromycin,Oxcarbazepine,The metabolism of Clarithromycin can be increased when combined with Oxcarbazepine.,increase,no risk
Clarithromycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Clarithromycin is combined with Oxetacaine.,increase,risk
Clarithromycin,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Clarithromycin is combined with Oxybuprocaine.,increase,risk
Clarithromycin,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Clarithromycin.,increase,risk
Clarithromycin,Quazepam,The metabolism of Quazepam can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Quinidine,The metabolism of Quinidine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Quinine,The serum concentration of Quinine can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Udenafil,The metabolism of Udenafil can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Clarithromycin which could result in a higher serum level.,decrease,no risk
Clarithromycin,Vadadustat,The serum concentration of Clarithromycin can be increased when it is combined with Vadadustat.,increase,no risk
Clarithromycin,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Valproic acid,The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Valproic acid.,increase,risk
Clarithromycin,Valsartan,The excretion of Valsartan can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Clarithromycin.,increase,risk
Clarithromycin,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Verapamil,The risk or severity of adverse effects can be increased when Clarithromycin is combined with Verapamil.,increase,risk
Clarithromycin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Clarithromycin.,increase,risk
Clarithromycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Clarithromycin.,decrease,no risk
Clarithromycin,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Viloxazine,The metabolism of Clarithromycin can be decreased when combined with Viloxazine.,decrease,no risk
Clarithromycin,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Vincristine,The excretion of Vincristine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Vindesine,The metabolism of Vindesine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Voriconazole,The metabolism of Clarithromycin can be decreased when combined with Voriconazole.,decrease,no risk
Clarithromycin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Clarithromycin.,increase,risk
Clarithromycin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Warfarin,The metabolism of Warfarin can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Xylometazoline,The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Xylometazoline.,increase,risk
Clarithromycin,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Clarithromycin.,increase,no risk
Clarithromycin,Ziconotide,The risk or severity of QTc prolongation and hypotension can be increased when Clarithromycin is combined with Ziconotide.,increase,risk
Clarithromycin,Zidovudine,Clarithromycin may increase the myelosuppressive activities of Zidovudine.,increase,no risk
Clarithromycin,Zileuton,The metabolism of Zileuton can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Zimelidine,The metabolism of Clarithromycin can be decreased when combined with Zimelidine.,decrease,no risk
Clarithromycin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Ziprasidone.,increase,risk
Clarithromycin,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Zotepine,The metabolism of Zotepine can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Clarithromycin.,decrease,no risk
Clarithromycin,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Clarithromycin.,increase,no risk
Ceftriaxone,Gabapentin enacarbil,Ceftriaxone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Gadobenic acid,Ceftriaxone may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Gadodiamide,Ceftriaxone may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Gadofosveset trisodium,Ceftriaxone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Gadopentetic acid,Ceftriaxone may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Gadoteric acid,Ceftriaxone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Gadoteridol,Ceftriaxone may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Ganciclovir,Ceftriaxone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Gemcitabine,Ceftriaxone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Gemfibrozil,Ceftriaxone may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Gentamicin,Ceftriaxone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Gimeracil,Ceftriaxone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Givosiran,The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Givosiran.,increase,risk
Ceftriaxone,Glipizide,Ceftriaxone may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Glycerol phenylbutyrate,Ceftriaxone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Golodirsen,Ceftriaxone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Goserelin,Ceftriaxone may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Ceftriaxone.,decrease,no risk
Ceftriaxone,Guanethidine,Ceftriaxone may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Guanfacine,Ceftriaxone may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Haloperidol,Ceftriaxone may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Ceftriaxone.,decrease,no risk
Ceftriaxone,Hydralazine,Ceftriaxone may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Ceftriaxone.,decrease,no risk
Ceftriaxone,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Ceftriaxone.,decrease,no risk
Ceftriaxone,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ceftriaxone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ceftriaxone,Hydromorphone,Ceftriaxone may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Hydroxocobalamin,Ceftriaxone may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Hydroxyethyl Starch,Ceftriaxone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Kanamycin,Ceftriaxone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Ketamine,Ceftriaxone may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Ketazolam,Ceftriaxone may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Ceftriaxone.,increase,risk
Ceftriaxone,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Ceftriaxone.,increase,risk
Ceftriaxone,Octinoxate,Ceftriaxone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Olsalazine,The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Olsalazine.,increase,risk
Ceftriaxone,Opium,Ceftriaxone may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Ceftriaxone.,decrease,no risk
Ceftriaxone,Oxacillin,Ceftriaxone may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Ceftriaxone.,increase,risk
Ceftriaxone,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Ceftriaxone.,increase,risk
Ceftriaxone,Oxazepam,Ceftriaxone may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ceftriaxone is combined with Oxetacaine.,increase,risk
Ceftriaxone,Oxybenzone,Ceftriaxone may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ceftriaxone is combined with Oxybuprocaine.,increase,risk
Ceftriaxone,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Oxyphenbutazone.,increase,risk
Ceftriaxone,Oxyquinoline,Ceftriaxone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Ceftriaxone.,decrease,no risk
Ceftriaxone,Quetiapine,Ceftriaxone may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Ceftriaxone,Quinapril,The excretion of Quinapril can be decreased when combined with Ceftriaxone.,decrease,no risk
Ceftriaxone,Quinethazone,Quinethazone may increase the excretion rate of Ceftriaxone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ceftriaxone,Quinidine,Ceftriaxone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Fomepizole,Gabapentin enacarbil,Fomepizole may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Fomepizole,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Gadodiamide,Gadodiamide may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Gadofosveset trisodium,Fomepizole may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Fomepizole,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Gadoteric acid,Fomepizole may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Fomepizole,Gadoteridol,Gadoteridol may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Ganciclovir,Ganciclovir may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Gemcitabine,Gemcitabine may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Gemfibrozil,Fomepizole may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Fomepizole,Gentamicin,Fomepizole may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Fomepizole,Gimeracil,Fomepizole may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Fomepizole,Givosiran,Givosiran may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Glipizide,Glipizide may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Glycerol phenylbutyrate,Fomepizole may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Fomepizole,Golodirsen,Fomepizole may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Fomepizole,Goserelin,Goserelin may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Guanethidine,Guanethidine may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Guanfacine,Guanfacine may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Haloperidol,Haloperidol may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Halothane,The metabolism of Halothane can be decreased when combined with Fomepizole.,decrease,no risk
Fomepizole,Hydralazine,Fomepizole may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Fomepizole,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Fomepizole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fomepizole,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Fomepizole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fomepizole,Hydromorphone,Hydromorphone may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Hydroxyethyl Starch,Fomepizole may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Fomepizole,Kanamycin,Fomepizole may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Fomepizole,Ketamine,Fomepizole may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Fomepizole,Ketazolam,Fomepizole may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Fomepizole,Ketoprofen,Ketoprofen may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Ketorolac,Ketorolac may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Octinoxate,Fomepizole may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Fomepizole,Olsalazine,Olsalazine may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Opium,Fomepizole may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Fomepizole,Oseltamivir,Oseltamivir may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Oxacillin,Oxacillin may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Oxaprozin,Oxaprozin may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Oxazepam,Oxazepam may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Oxybenzone,Fomepizole may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Fomepizole,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Oxyquinoline,Fomepizole may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Fomepizole,Quetiapine,Fomepizole may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Fomepizole,Quinethazone,Quinethazone may increase the excretion rate of Fomepizole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fomepizole,Quinidine,Fomepizole may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Fomepizole,Vaborbactam,Fomepizole may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Fomepizole,Valaciclovir,Valaciclovir may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Valbenazine,Fomepizole may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Fomepizole,Valdecoxib,Valdecoxib may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Valganciclovir,Fomepizole may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Fomepizole,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Fomepizole.,decrease,no risk
Fomepizole,Vancomycin,Fomepizole may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Fomepizole,Varenicline,Fomepizole may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Fomepizole,Venlafaxine,Venlafaxine may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Verapamil,Verapamil may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Vilanterol,Fomepizole may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Fomepizole,Viloxazine,Fomepizole may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Fomepizole,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Fomepizole.,decrease,no risk
Fomepizole,Warfarin,Fomepizole may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Fomepizole,Zaleplon,Zaleplon may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Zanamivir,Zanamivir may decrease the excretion rate of Fomepizole which could result in a higher serum level.,decrease,no risk
Fomepizole,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Fomepizole.,decrease,no risk
Fomepizole,Zonisamide,Zonisamide may increase the excretion rate of Fomepizole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Estazolam,Borage oil,The therapeutic efficacy of Estazolam can be decreased when used in combination with Borage oil.,decrease,no risk
Estazolam,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Estazolam.,increase,risk
Estazolam,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Estazolam.,increase,risk
Estazolam,Brexanolone,The risk or severity of CNS depression can be increased when Estazolam is combined with Brexanolone.,increase,risk
Estazolam,Brexpiprazole,The risk or severity of CNS depression can be increased when Estazolam is combined with Brexpiprazole.,increase,risk
Estazolam,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Estazolam.,increase,no risk
Estazolam,Brivaracetam,The risk or severity of CNS depression can be increased when Estazolam is combined with Brivaracetam.,increase,risk
Estazolam,Bromazepam,The risk or severity of CNS depression can be increased when Estazolam is combined with Bromazepam.,increase,risk
Estazolam,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Estazolam.,increase,risk
Estazolam,Bromotheophylline,The therapeutic efficacy of Estazolam can be decreased when used in combination with Bromotheophylline.,decrease,no risk
Estazolam,Bromperidol,The risk or severity of CNS depression can be increased when Estazolam is combined with Bromperidol.,increase,risk
Estazolam,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Estazolam.,increase,risk
Estazolam,Budesonide,Estazolam may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Estazolam,Bumadizone,Bumadizone may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Bumetanide,Bumetanide may increase the excretion rate of Estazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Estazolam,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Estazolam is combined with Bupivacaine.,increase,risk
Estazolam,Buprenorphine,Estazolam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Estazolam,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Estazolam.,increase,risk
Estazolam,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Estazolam.,increase,risk
Estazolam,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Estazolam.,increase,risk
Estazolam,Butacaine,The risk or severity of methemoglobinemia can be increased when Estazolam is combined with Butacaine.,increase,risk
Estazolam,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Estazolam.,increase,risk
Estazolam,Butamben,The risk or severity of methemoglobinemia can be increased when Estazolam is combined with Butamben.,increase,risk
Estazolam,Butaperazine,The risk or severity of CNS depression can be increased when Estazolam is combined with Butaperazine.,increase,risk
Estazolam,Butobarbital,The risk or severity of CNS depression can be increased when Estazolam is combined with Butobarbital.,increase,risk
Estazolam,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Estazolam.,increase,risk
Estazolam,Butriptyline,The risk or severity of CNS depression can be increased when Estazolam is combined with Butriptyline.,increase,risk
Estazolam,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Estazolam.,increase,risk
Estazolam,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Estazolam is combined with Gabapentin enacarbil.,increase,risk
Estazolam,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Gadodiamide,Gadodiamide may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Gadofosveset trisodium,Estazolam may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Estazolam,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Gadoteric acid,Estazolam may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Estazolam,Gadoteridol,Gadoteridol may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Estazolam.,increase,risk
Estazolam,Gamolenic acid,The therapeutic efficacy of Estazolam can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Estazolam,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Estazolam is combined with Ganaxolone.",increase,risk
Estazolam,Ganciclovir,The therapeutic efficacy of Estazolam can be decreased when used in combination with Ganciclovir.,decrease,no risk
Estazolam,Gemcitabine,Gemcitabine may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Gemfibrozil,Estazolam may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Estazolam,Gentamicin,Estazolam may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Estazolam,Gepirone,The risk or severity of CNS depression can be increased when Estazolam is combined with Gepirone.,increase,risk
Estazolam,Gestrinone,The metabolism of Gestrinone can be increased when combined with Estazolam.,increase,no risk
Estazolam,Gimeracil,Estazolam may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Estazolam,Givosiran,Givosiran may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Glipizide,Glipizide may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Glofitamab,The serum concentration of Estazolam can be increased when it is combined with Glofitamab.,increase,no risk
Estazolam,Glutethimide,The risk or severity of CNS depression can be increased when Estazolam is combined with Glutethimide.,increase,risk
Estazolam,Glycerol phenylbutyrate,Estazolam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Estazolam,Golodirsen,Estazolam may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Estazolam,Goserelin,Goserelin may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Estazolam.,increase,risk
Estazolam,Guanethidine,Guanethidine may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Estazolam.,increase,risk
Estazolam,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Estazolam.,increase,risk
Estazolam,Halofantrine,The therapeutic efficacy of Estazolam can be decreased when used in combination with Halofantrine.,decrease,no risk
Estazolam,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Estazolam.,increase,risk
Estazolam,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Estazolam.,increase,risk
Estazolam,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Estazolam.,increase,risk
Estazolam,Hydralazine,Estazolam may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Estazolam,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Estazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Estazolam,Hydrocodone,Estazolam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Estazolam,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Estazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Estazolam,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Estazolam.,increase,risk
Estazolam,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Hydroxychloroquine,The therapeutic efficacy of Estazolam can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Estazolam,Hydroxyethyl Starch,Estazolam may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Estazolam,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Estazolam.,increase,no risk
Estazolam,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Estazolam.,increase,no risk
Estazolam,Kanamycin,Estazolam may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Estazolam,Ketamine,The risk or severity of CNS depression can be increased when Estazolam is combined with Ketamine.,increase,risk
Estazolam,Ketazolam,The risk or severity of CNS depression can be increased when Estazolam is combined with Ketazolam.,increase,risk
Estazolam,Ketoconazole,The metabolism of Estazolam can be decreased when combined with Ketoconazole.,decrease,no risk
Estazolam,Ketoprofen,Ketoprofen may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Ketorolac,Ketorolac may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Octinoxate,Estazolam may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Estazolam,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Estazolam.,increase,risk
Estazolam,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Estazolam is combined with Oliceridine.",increase,risk
Estazolam,Olsalazine,Olsalazine may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Omaveloxolone,The serum concentration of Estazolam can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Estazolam,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Estazolam.,increase,risk
Estazolam,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Estazolam.,increase,risk
Estazolam,Orlistat,Orlistat can cause a decrease in the absorption of Estazolam resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Estazolam,Orphenadrine,Estazolam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Estazolam,Oseltamivir,Oseltamivir may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Oxacillin,Oxacillin may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Oxaprozin,Oxaprozin may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Estazolam.,increase,risk
Estazolam,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Estazolam.,increase,risk
Estazolam,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Estazolam is combined with Oxetacaine.,increase,risk
Estazolam,Oxitriptan,The risk or severity of CNS depression can be increased when Estazolam is combined with Oxitriptan.,increase,risk
Estazolam,Oxprenolol,The risk or severity of CNS depression can be increased when Estazolam is combined with Oxprenolol.,increase,risk
Estazolam,Oxtriphylline,The therapeutic efficacy of Estazolam can be decreased when used in combination with Oxtriphylline.,decrease,no risk
Estazolam,Oxybenzone,Estazolam may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Estazolam,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Estazolam is combined with Oxybuprocaine.,increase,risk
Estazolam,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Estazolam.,increase,risk
Estazolam,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Estazolam.,increase,risk
Estazolam,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Oxyquinoline,Estazolam may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Estazolam,Quazepam,The risk or severity of CNS depression can be increased when Estazolam is combined with Quazepam.,increase,risk
Estazolam,Quetiapine,The risk or severity of CNS depression can be increased when Estazolam is combined with Quetiapine.,increase,risk
Estazolam,Quinethazone,Quinethazone may increase the excretion rate of Estazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Estazolam,Quinidine,Estazolam may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Estazolam,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Estazolam.,increase,risk
Estazolam,Quinupramine,The risk or severity of CNS depression can be increased when Estazolam is combined with Quinupramine.,increase,risk
Estazolam,Ulipristal,The metabolism of Ulipristal can be increased when combined with Estazolam.,increase,no risk
Estazolam,Urethane,The risk or severity of CNS depression can be increased when Estazolam is combined with Urethane.,increase,risk
Estazolam,Vaborbactam,Estazolam may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Estazolam,Vadadustat,The serum concentration of Estazolam can be increased when it is combined with Vadadustat.,increase,no risk
Estazolam,Valaciclovir,Valaciclovir may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Valbenazine,Estazolam may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Estazolam,Valdecoxib,Valdecoxib may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Valganciclovir,The therapeutic efficacy of Estazolam can be decreased when used in combination with Valganciclovir.,decrease,no risk
Estazolam,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Estazolam.,increase,risk
Estazolam,Vancomycin,Estazolam may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Estazolam,Varenicline,Estazolam may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Estazolam,Vecuronium,The risk or severity of CNS depression can be increased when Estazolam is combined with Vecuronium.,increase,risk
Estazolam,Venetoclax,The metabolism of Estazolam can be decreased when combined with Venetoclax.,decrease,no risk
Estazolam,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Estazolam.,increase,risk
Estazolam,Verapamil,The metabolism of Estazolam can be decreased when combined with Verapamil.,decrease,no risk
Estazolam,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Estazolam.,increase,risk
Estazolam,Vilanterol,Estazolam may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Estazolam,Vilazodone,The risk or severity of CNS depression can be increased when Estazolam is combined with Vilazodone.,increase,risk
Estazolam,Viloxazine,The metabolism of Estazolam can be decreased when combined with Viloxazine.,decrease,no risk
Estazolam,Voriconazole,The serum concentration of Estazolam can be increased when it is combined with Voriconazole.,increase,no risk
Estazolam,Vortioxetine,The risk or severity of CNS depression can be increased when Estazolam is combined with Vortioxetine.,increase,risk
Estazolam,Warfarin,Estazolam may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Estazolam,Yohimbine,The therapeutic efficacy of Estazolam can be increased when used in combination with Yohimbine.,increase,no risk
Estazolam,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Estazolam.,increase,risk
Estazolam,Zanamivir,Zanamivir may decrease the excretion rate of Estazolam which could result in a higher serum level.,decrease,no risk
Estazolam,Ziconotide,The risk or severity of CNS depression can be increased when Estazolam is combined with Ziconotide.,increase,risk
Estazolam,Zimelidine,The risk or severity of adverse effects can be increased when Estazolam is combined with Zimelidine.,increase,risk
Estazolam,Ziprasidone,The risk or severity of adverse effects can be increased when Estazolam is combined with Ziprasidone.,increase,risk
Estazolam,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Estazolam.,increase,risk
Estazolam,Zolpidem,Estazolam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Estazolam,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Estazolam.,increase,risk
Estazolam,Zopiclone,The risk or severity of adverse effects can be increased when Estazolam is combined with Zopiclone.,increase,risk
Estazolam,Zotepine,The risk or severity of CNS depression can be increased when Estazolam is combined with Zotepine.,increase,risk
Estazolam,Zuclopenthixol,The risk or severity of CNS depression can be increased when Estazolam is combined with Zuclopenthixol.,increase,risk
Estazolam,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Estazolam.,increase,risk
Finasteride,Gefitinib,The metabolism of Finasteride can be decreased when combined with Gefitinib.,decrease,no risk
Finasteride,Glofitamab,The serum concentration of Finasteride can be increased when it is combined with Glofitamab.,increase,no risk
Finasteride,Glyburide,The metabolism of Finasteride can be decreased when combined with Glyburide.,decrease,no risk
Finasteride,Golimumab,The metabolism of Finasteride can be increased when combined with Golimumab.,increase,no risk
Finasteride,Guanabenz,Finasteride may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Finasteride,Guanadrel,Finasteride may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Finasteride,Guanethidine,Finasteride may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Finasteride,Guanfacine,Finasteride may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Finasteride,Guanoxan,Finasteride may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Finasteride,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Finasteride.,decrease,no risk
Finasteride,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Finasteride.,increase,no risk
Finasteride,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Finasteride.,increase,risk
Finasteride,Hydralazine,Finasteride may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Finasteride,Hydrochlorothiazide,Finasteride may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Finasteride,Hydrocortisone,The metabolism of Finasteride can be decreased when combined with Hydrocortisone.,decrease,no risk
Finasteride,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Finasteride.,decrease,no risk
Finasteride,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Finasteride.,decrease,no risk
Finasteride,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Finasteride.,decrease,no risk
Finasteride,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Finasteride.,decrease,no risk
Finasteride,Hydroflumethiazide,Finasteride may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Finasteride,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Finasteride.,decrease,no risk
Finasteride,Hydroxyzine,The metabolism of Finasteride can be decreased when combined with Hydroxyzine.,decrease,no risk
Finasteride,Ketoconazole,The metabolism of Finasteride can be decreased when combined with Ketoconazole.,decrease,no risk
Finasteride,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Finasteride.,increase,risk
Finasteride,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Finasteride.,increase,risk
Finasteride,Olaparib,The metabolism of Olaparib can be decreased when combined with Finasteride.,decrease,no risk
Finasteride,Olmesartan,Finasteride may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Finasteride,Olodaterol,The risk or severity of hypertension can be increased when Finasteride is combined with Olodaterol.,increase,risk
Finasteride,Omaveloxolone,The serum concentration of Finasteride can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Finasteride,Ondansetron,The metabolism of Finasteride can be decreased when combined with Ondansetron.,decrease,no risk
Finasteride,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Finasteride.,increase,risk
Finasteride,Osilodrostat,The metabolism of Finasteride can be decreased when combined with Osilodrostat.,decrease,no risk
Finasteride,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Finasteride.,increase,risk
Finasteride,Oxcarbazepine,The metabolism of Finasteride can be increased when combined with Oxcarbazepine.,increase,no risk
Finasteride,Oxprenolol,Finasteride may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Finasteride,Oxybutynin,The metabolism of Finasteride can be decreased when combined with Oxybutynin.,decrease,no risk
Finasteride,Oxycodone,The metabolism of Finasteride can be decreased when combined with Oxycodone.,decrease,no risk
Finasteride,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Finasteride.,increase,risk
Finasteride,Oxyphenbutazone,The risk or severity of hypertension can be increased when Finasteride is combined with Oxyphenbutazone.,increase,risk
Finasteride,Quetiapine,The risk or severity of hypertension can be increased when Finasteride is combined with Quetiapine.,increase,risk
Finasteride,Quinapril,Finasteride may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Finasteride,Quinidine,The metabolism of Quinidine can be decreased when combined with Finasteride.,decrease,no risk
Finasteride,Quinine,The metabolism of Finasteride can be decreased when combined with Quinine.,decrease,no risk
Finasteride,Quinupramine,The risk or severity of hypertension can be increased when Finasteride is combined with Quinupramine.,increase,risk
Finasteride,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Finasteride.,decrease,no risk
Finasteride,Udenafil,The metabolism of Udenafil can be decreased when combined with Finasteride.,decrease,no risk
Finasteride,Vadadustat,The serum concentration of Finasteride can be increased when it is combined with Vadadustat.,increase,no risk
Finasteride,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Finasteride.,decrease,no risk
Finasteride,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Finasteride.,increase,risk
Finasteride,Valsartan,Finasteride may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Finasteride,Vardenafil,The metabolism of Finasteride can be decreased when combined with Vardenafil.,decrease,no risk
Finasteride,Venetoclax,The metabolism of Finasteride can be decreased when combined with Venetoclax.,decrease,no risk
Finasteride,Verapamil,The metabolism of Finasteride can be decreased when combined with Verapamil.,decrease,no risk
Finasteride,Vilanterol,The risk or severity of hypertension can be increased when Finasteride is combined with Vilanterol.,increase,risk
Finasteride,Vilazodone,The risk or severity of hypertension can be increased when Finasteride is combined with Vilazodone.,increase,risk
Finasteride,Viloxazine,The metabolism of Finasteride can be decreased when combined with Viloxazine.,decrease,no risk
Finasteride,Vincristine,The metabolism of Vincristine can be decreased when combined with Finasteride.,decrease,no risk
Finasteride,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Finasteride.,decrease,no risk
Finasteride,Voriconazole,The metabolism of Finasteride can be decreased when combined with Voriconazole.,decrease,no risk
Finasteride,Vortioxetine,The risk or severity of hypertension can be increased when Finasteride is combined with Vortioxetine.,increase,risk
Finasteride,Xamoterol,The risk or severity of hypertension can be increased when Finasteride is combined with Xamoterol.,increase,risk
Finasteride,Xylometazoline,The risk or severity of hypertension can be increased when Finasteride is combined with Xylometazoline.,increase,risk
Finasteride,Yohimbine,The risk or severity of hypertension can be increased when Finasteride is combined with Yohimbine.,increase,risk
Finasteride,Zaleplon,The metabolism of Finasteride can be decreased when combined with Zaleplon.,decrease,no risk
Finasteride,Zimelidine,The metabolism of Finasteride can be decreased when combined with Zimelidine.,decrease,no risk
Finasteride,Ziprasidone,The metabolism of Finasteride can be decreased when combined with Ziprasidone.,decrease,no risk
Finasteride,Zofenopril,Finasteride may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Finasteride,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Finasteride.,increase,risk
Finasteride,Zonisamide,The metabolism of Finasteride can be decreased when combined with Zonisamide.,decrease,no risk
Finasteride,Zuclopenthixol,The risk or severity of hypertension can be increased when Finasteride is combined with Zuclopenthixol.,increase,risk
Anastrozole,Gemfibrozil,The metabolism of Anastrozole can be decreased when combined with Gemfibrozil.,decrease,no risk
Anastrozole,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Anastrozole.,decrease,no risk
Anastrozole,Golimumab,The metabolism of Anastrozole can be increased when combined with Golimumab.,increase,no risk
Anastrozole,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Anastrozole.,decrease,no risk
Anastrozole,Hydrocortisone,The metabolism of Anastrozole can be increased when combined with Hydrocortisone.,increase,no risk
Anastrozole,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Anastrozole.,decrease,no risk
Anastrozole,Ketamine,The metabolism of Ketamine can be decreased when combined with Anastrozole.,decrease,no risk
Anastrozole,Ketoconazole,The metabolism of Anastrozole can be decreased when combined with Ketoconazole.,decrease,no risk
Anastrozole,Ketoprofen,The metabolism of Anastrozole can be decreased when combined with Ketoprofen.,decrease,no risk
Anastrozole,Ketorolac,The metabolism of Anastrozole can be decreased when combined with Ketorolac.,decrease,no risk
Anastrozole,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Anastrozole.,decrease,no risk
Anastrozole,Omaveloxolone,The serum concentration of Anastrozole can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Anastrozole,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Anastrozole.,decrease,no risk
Anastrozole,Ouabain,Ouabain may decrease the cardiotoxic activities of Anastrozole.,decrease,no risk
Anastrozole,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Anastrozole is combined with Oxetacaine.,increase,risk
Anastrozole,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Anastrozole is combined with Oxybuprocaine.,increase,risk
Anastrozole,Oxybutynin,The metabolism of Anastrozole can be decreased when combined with Oxybutynin.,decrease,no risk
Anastrozole,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Anastrozole.,decrease,no risk
Anastrozole,Quinestrol,The therapeutic efficacy of Anastrozole can be decreased when used in combination with Quinestrol.,decrease,no risk
Anastrozole,Quinidine,The metabolism of Anastrozole can be decreased when combined with Quinidine.,decrease,no risk
Anastrozole,Quinine,The metabolism of Anastrozole can be decreased when combined with Quinine.,decrease,no risk
Anastrozole,Vadadustat,The serum concentration of Anastrozole can be increased when it is combined with Vadadustat.,increase,no risk
Anastrozole,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Anastrozole.,decrease,no risk
Anastrozole,Vemurafenib,The metabolism of Anastrozole can be decreased when combined with Vemurafenib.,decrease,no risk
Anastrozole,Vinblastine,The risk or severity of cardiotoxicity can be increased when Vinblastine is combined with Anastrozole.,increase,risk
Anastrozole,Vincristine,The risk or severity of cardiotoxicity can be increased when Vincristine is combined with Anastrozole.,increase,risk
Anastrozole,Vindesine,The risk or severity of cardiotoxicity can be increased when Vindesine is combined with Anastrozole.,increase,risk
Anastrozole,Vinorelbine,The risk or severity of cardiotoxicity can be increased when Vinorelbine is combined with Anastrozole.,increase,risk
Anastrozole,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Anastrozole.,decrease,no risk
Anastrozole,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Anastrozole.,decrease,no risk
Anastrozole,Zidovudine,The metabolism of Anastrozole can be decreased when combined with Zidovudine.,decrease,no risk
Anastrozole,Zopiclone,The metabolism of Anastrozole can be decreased when combined with Zopiclone.,decrease,no risk
Halofantrine,Buspirone,The metabolism of Buspirone can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Butacaine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Butacaine.,increase,risk
Halofantrine,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Halofantrine.,decrease,no risk
Halofantrine,Butamben,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Butamben.,increase,risk
Halofantrine,Butaperazine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Butaperazine.,increase,risk
Halofantrine,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Halofantrine.,increase,risk
Halofantrine,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Halofantrine.,decrease,no risk
Halofantrine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Halofantrine.,increase,risk
Halofantrine,Galantamine,The metabolism of Galantamine can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Halofantrine.,decrease,no risk
Halofantrine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Halofantrine.,increase,risk
Halofantrine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Gemfibrozil,The metabolism of Halofantrine can be decreased when combined with Gemfibrozil.,decrease,no risk
Halofantrine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Halofantrine.,increase,risk
Halofantrine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Halofantrine.,increase,risk
Halofantrine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Halofantrine.,increase,risk
Halofantrine,Glasdegib,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Glasdegib.,increase,risk
Halofantrine,Glofitamab,The serum concentration of Halofantrine can be increased when it is combined with Glofitamab.,increase,no risk
Halofantrine,Glyburide,The metabolism of Halofantrine can be decreased when combined with Glyburide.,decrease,no risk
Halofantrine,Golimumab,The metabolism of Halofantrine can be increased when combined with Golimumab.,increase,no risk
Halofantrine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Halofantrine.,increase,risk
Halofantrine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Halofantrine.,increase,risk
Halofantrine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Halofantrine.,increase,risk
Halofantrine,Haloperidol,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Haloperidol.,increase,risk
Halofantrine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Halofantrine.,increase,risk
Halofantrine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Halofantrine.,increase,risk
Halofantrine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Hydrocortisone,The metabolism of Halofantrine can be increased when combined with Hydrocortisone.,increase,no risk
Halofantrine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Halofantrine,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Halofantrine.,increase,risk
Halofantrine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Hydroxyzine.,increase,risk
Halofantrine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Halofantrine.,increase,risk
Halofantrine,Kaolin,Kaolin can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Halofantrine,Ketamine,The metabolism of Ketamine can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Ketoconazole,The metabolism of Halofantrine can be decreased when combined with Ketoconazole.,decrease,no risk
Halofantrine,Ketoprofen,The metabolism of Halofantrine can be decreased when combined with Ketoprofen.,decrease,no risk
Halofantrine,Ketorolac,The metabolism of Halofantrine can be decreased when combined with Ketorolac.,decrease,no risk
Halofantrine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Halofantrine.,increase,risk
Halofantrine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Halofantrine.,increase,risk
Halofantrine,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Olaparib,The metabolism of Olaparib can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Halofantrine.,increase,no risk
Halofantrine,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Halofantrine.,increase,risk
Halofantrine,Omaveloxolone,The serum concentration of Halofantrine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Halofantrine,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Halofantrine.,increase,risk
Halofantrine,Opium,The metabolism of Opium can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Halofantrine.,increase,risk
Halofantrine,Osilodrostat,The metabolism of Halofantrine can be decreased when combined with Osilodrostat.,decrease,no risk
Halofantrine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Halofantrine.,increase,risk
Halofantrine,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Halofantrine.,increase,risk
Halofantrine,Oxcarbazepine,The metabolism of Halofantrine can be increased when combined with Oxcarbazepine.,increase,no risk
Halofantrine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Oxetacaine.,increase,risk
Halofantrine,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Oxybuprocaine.,increase,risk
Halofantrine,Oxybutynin,The metabolism of Halofantrine can be decreased when combined with Oxybutynin.,decrease,no risk
Halofantrine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Halofantrine.,increase,risk
Halofantrine,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Halofantrine.,increase,risk
Halofantrine,Quinidine,"The risk or severity of QTc prolongation, ventricular arrhythmias, torsade de pointes, and convulsion can be increased when Quinidine is combined with Halofantrine.",increase,risk
Halofantrine,Quinine,"The risk or severity of QTc prolongation, ventricular arrhythmias, torsade de pointes, and convulsion can be increased when Quinine is combined with Halofantrine.",increase,risk
Halofantrine,Quizartinib,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Quizartinib.,increase,risk
Halofantrine,Udenafil,The metabolism of Udenafil can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Vadadustat,The serum concentration of Halofantrine can be increased when it is combined with Vadadustat.,increase,no risk
Halofantrine,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Halofantrine.,increase,no risk
Halofantrine,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Halofantrine.,increase,risk
Halofantrine,Vandetanib,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Vandetanib.,increase,risk
Halofantrine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Halofantrine.,increase,risk
Halofantrine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Halofantrine.,increase,risk
Halofantrine,Venetoclax,The metabolism of Halofantrine can be decreased when combined with Venetoclax.,decrease,no risk
Halofantrine,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Verapamil,The metabolism of Halofantrine can be decreased when combined with Verapamil.,decrease,no risk
Halofantrine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Halofantrine.,decrease,no risk
Halofantrine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Halofantrine.,increase,risk
Halofantrine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Viloxazine,The metabolism of Halofantrine can be decreased when combined with Viloxazine.,decrease,no risk
Halofantrine,Vincristine,The metabolism of Vincristine can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Voriconazole,The metabolism of Halofantrine can be decreased when combined with Voriconazole.,decrease,no risk
Halofantrine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Halofantrine.,increase,risk
Halofantrine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Zaleplon,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Halofantrine.,decrease,no risk
Halofantrine,Zidovudine,The metabolism of Halofantrine can be decreased when combined with Zidovudine.,decrease,no risk
Halofantrine,Zimelidine,The metabolism of Halofantrine can be decreased when combined with Zimelidine.,decrease,no risk
Halofantrine,Zinc,Zinc can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Halofantrine,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Halofantrine,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Halofantrine,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Halofantrine,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Halofantrine,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Halofantrine,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Halofantrine,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Halofantrine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Ziprasidone.,increase,risk
Halofantrine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Halofantrine.,decrease,no risk
Halofantrine,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Halofantrine.,increase,risk
Halofantrine,Zopiclone,The metabolism of Halofantrine can be decreased when combined with Zopiclone.,decrease,no risk
Halofantrine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Halofantrine.,decrease,no risk
Dantrolene,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Dantrolene.,increase,risk
Dantrolene,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Dantrolene is combined with Gabapentin enacarbil.,increase,risk
Dantrolene,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Dantrolene.,increase,no risk
Dantrolene,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Dantrolene is combined with Ganaxolone.",increase,risk
Dantrolene,Gentamicin,The risk or severity of neuromuscular blockade can be increased when Gentamicin is combined with Dantrolene.,increase,risk
Dantrolene,Gepirone,The risk or severity of CNS depression can be increased when Dantrolene is combined with Gepirone.,increase,risk
Dantrolene,Glutethimide,The risk or severity of CNS depression can be increased when Dantrolene is combined with Glutethimide.,increase,risk
Dantrolene,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Dantrolene.,increase,risk
Dantrolene,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Dantrolene.,increase,risk
Dantrolene,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Dantrolene.,increase,risk
Dantrolene,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Dantrolene.,increase,risk
Dantrolene,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Dantrolene.,increase,risk
Dantrolene,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Dantrolene.,increase,risk
Dantrolene,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Dantrolene.,increase,risk
Dantrolene,Hydrocodone,Dantrolene may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Dantrolene,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Dantrolene.,increase,risk
Dantrolene,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dantrolene.,increase,no risk
Dantrolene,Kanamycin,The risk or severity of neuromuscular blockade can be increased when Kanamycin is combined with Dantrolene.,increase,risk
Dantrolene,Ketamine,The risk or severity of CNS depression can be increased when Dantrolene is combined with Ketamine.,increase,risk
Dantrolene,Ketazolam,The risk or severity of CNS depression can be increased when Dantrolene is combined with Ketazolam.,increase,risk
Dantrolene,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Dantrolene.,increase,risk
Dantrolene,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Dantrolene.,increase,risk
Dantrolene,Ketorolac,The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Dantrolene.,increase,risk
Dantrolene,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Dantrolene.,increase,risk
Dantrolene,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Dantrolene is combined with Oliceridine.",increase,risk
Dantrolene,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Dantrolene.,increase,risk
Dantrolene,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Dantrolene.,increase,risk
Dantrolene,Opium,The risk or severity of CNS depression can be increased when Dantrolene is combined with Opium.,increase,risk
Dantrolene,Orphenadrine,Dantrolene may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Dantrolene,Oxandrolone,The therapeutic efficacy of Dantrolene can be increased when used in combination with Oxandrolone.,increase,no risk
Dantrolene,Oxaprozin,The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Dantrolene.,increase,risk
Dantrolene,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Dantrolene.,increase,risk
Dantrolene,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Dantrolene.,increase,risk
Dantrolene,Oxitriptan,The risk or severity of CNS depression can be increased when Dantrolene is combined with Oxitriptan.,increase,risk
Dantrolene,Oxprenolol,The risk or severity of CNS depression can be increased when Dantrolene is combined with Oxprenolol.,increase,risk
Dantrolene,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Dantrolene.,increase,risk
Dantrolene,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Dantrolene.,increase,risk
Dantrolene,Oxymetholone,The therapeutic efficacy of Dantrolene can be increased when used in combination with Oxymetholone.,increase,no risk
Dantrolene,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Dantrolene.,increase,risk
Dantrolene,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Oxyphenbutazone.,increase,risk
Dantrolene,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Dantrolene.,increase,risk
Rifaximin,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Rifaximin.,decrease,no risk
Rifaximin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Rifaximin is combined with Oxetacaine.,increase,risk
Rifaximin,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Rifaximin.,increase,no risk
Rifaximin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Rifaximin is combined with Oxybuprocaine.,increase,risk
Rifaximin,Quinidine,The serum concentration of Rifaximin can be increased when it is combined with Quinidine.,increase,no risk
Rifaximin,Quinine,The serum concentration of Rifaximin can be increased when it is combined with Quinine.,increase,no risk
Rifaximin,Quizartinib,The serum concentration of Rifaximin can be increased when it is combined with Quizartinib.,increase,no risk
Rifaximin,Umbralisib,The serum concentration of Rifaximin can be increased when it is combined with Umbralisib.,increase,no risk
Rifaximin,Vandetanib,The serum concentration of Rifaximin can be increased when it is combined with Vandetanib.,increase,no risk
Rifaximin,Vardenafil,The serum concentration of Rifaximin can be increased when it is combined with Vardenafil.,increase,no risk
Rifaximin,Velpatasvir,The serum concentration of Rifaximin can be increased when it is combined with Velpatasvir.,increase,no risk
Rifaximin,Vemurafenib,The serum concentration of Rifaximin can be increased when it is combined with Vemurafenib.,increase,no risk
Rifaximin,Venetoclax,The serum concentration of Rifaximin can be increased when it is combined with Venetoclax.,increase,no risk
Rifaximin,Verapamil,The serum concentration of Rifaximin can be increased when it is combined with Verapamil.,increase,no risk
Rifaximin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Rifaximin.,decrease,no risk
Rifaximin,Voclosporin,The serum concentration of Rifaximin can be increased when it is combined with Voclosporin.,increase,no risk
Rifaximin,Vorapaxar,The serum concentration of Rifaximin can be increased when it is combined with Vorapaxar.,increase,no risk
Rifaximin,Voxilaprevir,The serum concentration of Rifaximin can be increased when it is combined with Voxilaprevir.,increase,no risk
Rifaximin,Warfarin,The metabolism of Warfarin can be increased when combined with Rifaximin.,increase,no risk
Rifaximin,Zonisamide,The serum concentration of Rifaximin can be increased when it is combined with Zonisamide.,increase,no risk
Rifaximin,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Rifaximin.,decrease,no risk
Ketamine,Bacitracin,Bacitracin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ketamine.,increase,no risk
Ketamine,Balsalazide,Balsalazide may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Baricitinib,Ketamine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Ketamine,Beclomethasone dipropionate,The therapeutic efficacy of Ketamine can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Ketamine,Belladonna,The therapeutic efficacy of Belladonna can be decreased when used in combination with Ketamine.,decrease,no risk
Ketamine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ketamine,Benorilate,Benorilate may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Benperidol,The risk or severity of CNS depression can be increased when Ketamine is combined with Benperidol.,increase,risk
Ketamine,Benserazide,Ketamine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Ketamine,Benzatropine,The therapeutic efficacy of Benzatropine can be decreased when used in combination with Ketamine.,decrease,no risk
Ketamine,Benznidazole,Ketamine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Ketamine,Benzocaine,The risk or severity of CNS depression can be increased when Benzocaine is combined with Ketamine.,increase,risk
Ketamine,Benzonatate,Ketamine may increase the neuromuscular blocking activities of Benzonatate.,increase,no risk
Ketamine,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Ketamine.,increase,risk
Ketamine,Benzthiazide,Benzthiazide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ketamine,Benzydamine,Benzydamine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Benzyl alcohol,The risk or severity of CNS depression can be increased when Ketamine is combined with Benzyl alcohol.,increase,risk
Ketamine,Bepotastine,Ketamine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Ketamine,Berotralstat,The metabolism of Ketamine can be decreased when combined with Berotralstat.,decrease,no risk
Ketamine,Betamethasone,The therapeutic efficacy of Ketamine can be decreased when used in combination with Betamethasone.,decrease,no risk
Ketamine,Betamethasone phosphate,The therapeutic efficacy of Ketamine can be decreased when used in combination with Betamethasone phosphate.,decrease,no risk
Ketamine,Betaxolol,Ketamine may increase the bradycardic activities of Betaxolol.,increase,no risk
Ketamine,Bethanechol,The risk or severity of adverse effects can be increased when Ketamine is combined with Bethanechol.,increase,risk
Ketamine,Bethanidine,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Ketamine.,increase,risk
Ketamine,Bexarotene,The metabolism of Ketamine can be decreased when combined with Bexarotene.,decrease,no risk
Ketamine,Bezafibrate,The metabolism of Ketamine can be decreased when combined with Bezafibrate.,decrease,no risk
Ketamine,Bicisate,Ketamine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Ketamine,Bimekizumab,The metabolism of Ketamine can be increased when combined with Bimekizumab.,increase,no risk
Ketamine,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Ketamine.,decrease,no risk
Ketamine,Bismuth subgallate,Ketamine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Ketamine,Bisoprolol,Ketamine may increase the bradycardic activities of Bisoprolol.,increase,no risk
Ketamine,Bisoxatin,Ketamine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Ketamine,Bleomycin,Bleomycin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Boceprevir,The metabolism of Ketamine can be decreased when combined with Boceprevir.,decrease,no risk
Ketamine,Bortezomib,The metabolism of Ketamine can be decreased when combined with Bortezomib.,decrease,no risk
Ketamine,Bosentan,The metabolism of Ketamine can be increased when combined with Bosentan.,increase,no risk
Ketamine,Bosutinib,The metabolism of Ketamine can be decreased when combined with Bosutinib.,decrease,no risk
Ketamine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Ketamine.,increase,risk
Ketamine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Ketamine.,increase,risk
Ketamine,Brexanolone,The risk or severity of CNS depression can be increased when Ketamine is combined with Brexanolone.,increase,risk
Ketamine,Brexpiprazole,The risk or severity of CNS depression can be increased when Ketamine is combined with Brexpiprazole.,increase,risk
Ketamine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Ketamine.,decrease,no risk
Ketamine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Ketamine.,increase,no risk
Ketamine,Brivaracetam,The risk or severity of CNS depression can be increased when Ketamine is combined with Brivaracetam.,increase,risk
Ketamine,Bromazepam,The risk or severity of CNS depression can be increased when Ketamine is combined with Bromazepam.,increase,risk
Ketamine,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Ketamine.,increase,risk
Ketamine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ketamine,Bromperidol,The risk or severity of CNS depression can be increased when Ketamine is combined with Bromperidol.,increase,risk
Ketamine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Ketamine.,increase,risk
Ketamine,Buclizine,The therapeutic efficacy of Buclizine can be decreased when used in combination with Ketamine.,decrease,no risk
Ketamine,Budesonide,The therapeutic efficacy of Ketamine can be decreased when used in combination with Budesonide.,decrease,no risk
Ketamine,Bumadizone,Bumadizone may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Bumetanide,Bumetanide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ketamine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Ketamine.,increase,risk
Ketamine,Buprenorphine,Ketamine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Ketamine,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Ketamine.,increase,risk
Ketamine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Ketamine.,increase,risk
Ketamine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Ketamine.,increase,risk
Ketamine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Ketamine.,increase,risk
Ketamine,Butaperazine,The risk or severity of CNS depression can be increased when Ketamine is combined with Butaperazine.,increase,risk
Ketamine,Butobarbital,The risk or severity of CNS depression can be increased when Ketamine is combined with Butobarbital.,increase,risk
Ketamine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Ketamine.,increase,risk
Ketamine,Butriptyline,The risk or severity of CNS depression can be increased when Ketamine is combined with Butriptyline.,increase,risk
Ketamine,Butylscopolamine,The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with Ketamine.,decrease,no risk
Ketamine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Ketamine.,increase,risk
Ketamine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Ketamine is combined with Gabapentin enacarbil.,increase,risk
Ketamine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Gadodiamide,Gadodiamide may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Gadofosveset trisodium,Ketamine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ketamine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Gadoteric acid,Ketamine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ketamine,Gadoteridol,Gadoteridol may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Ketamine.,increase,risk
Ketamine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Ketamine is combined with Ganaxolone.",increase,risk
Ketamine,Ganciclovir,Ganciclovir may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Gemcitabine,Gemcitabine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Gemfibrozil,The metabolism of Ketamine can be decreased when combined with Gemfibrozil.,decrease,no risk
Ketamine,Gentamicin,Ketamine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ketamine,Gepirone,The risk or severity of CNS depression can be increased when Ketamine is combined with Gepirone.,increase,risk
Ketamine,Gimeracil,Ketamine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ketamine,Ginkgo biloba,The metabolism of Ketamine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ketamine,Givosiran,Givosiran may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Ketamine.,decrease,no risk
Ketamine,Gliclazide,The metabolism of Ketamine can be decreased when combined with Gliclazide.,decrease,no risk
Ketamine,Glimepiride,The metabolism of Ketamine can be decreased when combined with Glimepiride.,decrease,no risk
Ketamine,Glipizide,Glipizide may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Ketamine.,decrease,no risk
Ketamine,Glofitamab,The serum concentration of Ketamine can be increased when it is combined with Glofitamab.,increase,no risk
Ketamine,Glutethimide,The risk or severity of CNS depression can be increased when Ketamine is combined with Glutethimide.,increase,risk
Ketamine,Glyburide,The metabolism of Ketamine can be decreased when combined with Glyburide.,decrease,no risk
Ketamine,Glycerol phenylbutyrate,Ketamine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ketamine,Glycopyrronium,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Ketamine.,decrease,no risk
Ketamine,Golimumab,The metabolism of Ketamine can be increased when combined with Golimumab.,increase,no risk
Ketamine,Golodirsen,Ketamine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ketamine,Goserelin,Goserelin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Ketamine.,increase,risk
Ketamine,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Ketamine.,increase,risk
Ketamine,Guanethidine,Guanethidine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Ketamine.,increase,risk
Ketamine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Ketamine.,increase,risk
Ketamine,Halofantrine,The metabolism of Ketamine can be decreased when combined with Halofantrine.,decrease,no risk
Ketamine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Ketamine.,increase,risk
Ketamine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Ketamine.,increase,risk
Ketamine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Ketamine.,increase,risk
Ketamine,Hexocyclium,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Ketamine.,decrease,no risk
Ketamine,Homatropine methylbromide,The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Ketamine.,decrease,no risk
Ketamine,Hydralazine,Ketamine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Ketamine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ketamine,Hydrocodone,Ketamine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Ketamine,Hydrocortisone,The therapeutic efficacy of Ketamine can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Ketamine,Hydrocortisone acetate,The therapeutic efficacy of Ketamine can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Ketamine,Hydrocortisone butyrate,The therapeutic efficacy of Ketamine can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Ketamine,Hydrocortisone cypionate,The therapeutic efficacy of Ketamine can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Ketamine,Hydrocortisone succinate,The therapeutic efficacy of Ketamine can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Ketamine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ketamine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Ketamine.,increase,risk
Ketamine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Ketamine.,decrease,no risk
Ketamine,Hydroxyethyl Starch,Ketamine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ketamine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ketamine.,increase,no risk
Ketamine,Hyoscyamine,The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Ketamine.,decrease,no risk
Ketamine,Kanamycin,Ketamine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ketamine,Ketazolam,The risk or severity of CNS depression can be increased when Ketamine is combined with Ketazolam.,increase,risk
Ketamine,Ketoconazole,The metabolism of Ketamine can be decreased when combined with Ketoconazole.,decrease,no risk
Ketamine,Ketoprofen,Ketoprofen may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ketamine,Ketorolac,The metabolism of Ketamine can be decreased when combined with Ketorolac.,decrease,no risk
Budesonide,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Bacitracin,Bacitracin may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Baclofen,Baclofen may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Balsalazide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Balsalazide.,increase,risk
Budesonide,Baricitinib,The risk or severity of adverse effects can be increased when Budesonide is combined with Baricitinib.,increase,risk
Budesonide,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Budesonide.,increase,risk
Budesonide,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Beclomethasone dipropionate,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Budesonide.,increase,risk
Budesonide,Belantamab mafodotin,Budesonide may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.,decrease,no risk
Budesonide,Belatacept,The risk or severity of adverse effects can be increased when Budesonide is combined with Belatacept.,increase,risk
Budesonide,Belimumab,The risk or severity of adverse effects can be increased when Budesonide is combined with Belimumab.,increase,risk
Budesonide,Belinostat,The risk or severity of adverse effects can be increased when Budesonide is combined with Belinostat.,increase,risk
Budesonide,Belumosudil,The risk or severity of adverse effects can be increased when Budesonide is combined with Belumosudil.,increase,risk
Budesonide,Bendamustine,The risk or severity of adverse effects can be increased when Budesonide is combined with Bendamustine.,increase,risk
Budesonide,Bendroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Budesonide is combined with Bendroflumethiazide.,increase,risk
Budesonide,Benorilate,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Benorilate.,increase,risk
Budesonide,Benoxaprofen,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Benoxaprofen.,increase,risk
Budesonide,Benserazide,Budesonide may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Budesonide,Benzatropine,Benzatropine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Benznidazole,Budesonide may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Budesonide,Benzoic acid,The therapeutic efficacy of Benzoic acid can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Benzthiazide,The risk or severity of electrolyte imbalance can be increased when Budesonide is combined with Benzthiazide.,increase,risk
Budesonide,Benzydamine,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Benzydamine.,increase,risk
Budesonide,Bepotastine,Budesonide may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Budesonide,Berotralstat,The metabolism of Budesonide can be decreased when combined with Berotralstat.,decrease,no risk
Budesonide,Betaine,The therapeutic efficacy of Betaine can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Budesonide.,increase,risk
Budesonide,Bexagliflozin,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Bexagliflozin.,increase,risk
Budesonide,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Budesonide.,increase,risk
Budesonide,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Budesonide.,increase,no risk
Budesonide,Bicisate,Budesonide may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Budesonide,Bimekizumab,The risk or severity of adverse effects can be increased when Budesonide is combined with Bimekizumab.,increase,risk
Budesonide,Bismuth subgallate,Budesonide may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Budesonide,Bismuth subsalicylate,The serum concentration of Bismuth subsalicylate can be decreased when it is combined with Budesonide.,decrease,no risk
Budesonide,Bisoprolol,Bisoprolol may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Bisoxatin,Budesonide may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Budesonide,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Budesonide.,increase,risk
Budesonide,Blinatumomab,The risk or severity of adverse effects can be increased when Budesonide is combined with Blinatumomab.,increase,risk
Budesonide,Boceprevir,The metabolism of Budesonide can be decreased when combined with Boceprevir.,decrease,no risk
Budesonide,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Budesonide.",decrease,no risk
Budesonide,Bortezomib,The metabolism of Bortezomib can be increased when combined with Budesonide.,increase,no risk
Budesonide,Bosentan,Bosentan may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Bosutinib,The metabolism of Bosutinib can be increased when combined with Budesonide.,increase,no risk
Budesonide,Botulinum toxin type A,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Budesonide.,increase,risk
Budesonide,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Budesonide.,increase,no risk
Budesonide,Brigatinib,The metabolism of Brigatinib can be increased when combined with Budesonide.,increase,no risk
Budesonide,Brivaracetam,Budesonide may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Budesonide,Brodalumab,The risk or severity of adverse effects can be increased when Budesonide is combined with Brodalumab.,increase,risk
Budesonide,Bromazepam,Budesonide may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Budesonide,Bromocriptine,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Bromocriptine.,increase,risk
Budesonide,Bromotheophylline,Bromotheophylline may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Budesonide,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Bumadizone.,increase,risk
Budesonide,Bumetanide,The risk or severity of hypokalemia can be increased when Budesonide is combined with Bumetanide.,increase,risk
Budesonide,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Budesonide.,increase,no risk
Budesonide,Bupropion,Bupropion may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Buspirone,The metabolism of Buspirone can be increased when combined with Budesonide.,increase,no risk
Budesonide,Busulfan,The metabolism of Busulfan can be increased when combined with Budesonide.,increase,no risk
Budesonide,Butabarbital,Butabarbital may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Gabapentin enacarbil,Budesonide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Budesonide,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Gadodiamide,Gadodiamide may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Gadofosveset trisodium,Budesonide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Budesonide,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Gadoteric acid,Budesonide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Budesonide,Gadoteridol,Gadoteridol may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Ganciclovir,Ganciclovir may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Gatifloxacin,The risk or severity of tendinopathy can be increased when Budesonide is combined with Gatifloxacin.,increase,risk
Budesonide,Gefitinib,The metabolism of Gefitinib can be increased when combined with Budesonide.,increase,no risk
Budesonide,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Budesonide.,increase,risk
Budesonide,Gemfibrozil,Budesonide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Budesonide,Gemifloxacin,The risk or severity of tendinopathy can be increased when Budesonide is combined with Gemifloxacin.,increase,risk
Budesonide,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Budesonide.,increase,risk
Budesonide,Gentamicin,Budesonide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Budesonide,Gestrinone,The serum concentration of Budesonide can be increased when it is combined with Gestrinone.,increase,no risk
Budesonide,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Budesonide.,increase,no risk
Budesonide,Gimeracil,Budesonide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Budesonide,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Givosiran,Givosiran may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Glatiramer,The risk or severity of adverse effects can be increased when Budesonide is combined with Glatiramer.,increase,risk
Budesonide,Gliclazide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Gliclazide.,increase,risk
Budesonide,Glimepiride,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Glimepiride.,increase,risk
Budesonide,Glipizide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Glipizide.,increase,risk
Budesonide,Gliquidone,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Gliquidone.,increase,risk
Budesonide,Glofitamab,The serum concentration of Budesonide can be increased when it is combined with Glofitamab.,increase,no risk
Budesonide,Glyburide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Glyburide.,increase,risk
Budesonide,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Glycol salicylate.,increase,risk
Budesonide,Glycyrrhizic acid,Budesonide may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Budesonide,Glymidine,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Glymidine.,increase,risk
Budesonide,Golimumab,The risk or severity of adverse effects can be increased when Budesonide is combined with Golimumab.,increase,risk
Budesonide,Golodirsen,Budesonide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Budesonide,Goserelin,Goserelin may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Grepafloxacin,The risk or severity of tendinopathy can be increased when Budesonide is combined with Grepafloxacin.,increase,risk
Budesonide,Guanethidine,Guanethidine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Guanfacine,Guanfacine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Guselkumab,The risk or severity of adverse effects can be increased when Budesonide is combined with Guselkumab.,increase,risk
Budesonide,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Halofantrine,The metabolism of Halofantrine can be increased when combined with Budesonide.,increase,no risk
Budesonide,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Budesonide.,increase,no risk
Budesonide,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Hydralazine,Budesonide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Budesonide,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Budesonide is combined with Hydrochlorothiazide.,increase,risk
Budesonide,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Budesonide.,increase,no risk
Budesonide,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Budesonide is combined with Hydrocortisone acetate.,increase,risk
Budesonide,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Budesonide is combined with Hydrocortisone butyrate.,increase,risk
Budesonide,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Budesonide.,increase,no risk
Budesonide,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Budesonide.,increase,no risk
Budesonide,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Budesonide is combined with Hydrocortisone succinate.,increase,risk
Budesonide,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Budesonide is combined with Hydroflumethiazide.,increase,risk
Budesonide,Hydromorphone,Hydromorphone may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Hydrotalcite,The bioavailability of Budesonide can be decreased when combined with Hydrotalcite.,decrease,no risk
Budesonide,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Budesonide is combined with Hydroxychloroquine.,increase,risk
Budesonide,Hydroxyethyl Starch,Budesonide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Budesonide,Hydroxyprogesterone caproate,The serum concentration of Budesonide can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Budesonide,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Budesonide.,increase,risk
Budesonide,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Budesonide.,increase,no risk
Budesonide,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Kanamycin,Budesonide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Budesonide,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Ketazolam,Budesonide may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Budesonide,Ketoconazole,The metabolism of Budesonide can be decreased when combined with Ketoconazole.,decrease,no risk
Budesonide,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Ketoprofen.,increase,risk
Budesonide,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Ketorolac.,increase,risk
Budesonide,Obinutuzumab,The risk or severity of adverse effects can be increased when Budesonide is combined with Obinutuzumab.,increase,risk
Budesonide,Ocrelizumab,The risk or severity of adverse effects can be increased when Budesonide is combined with Ocrelizumab.,increase,risk
Budesonide,Octinoxate,Budesonide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Budesonide,Ofatumumab,The risk or severity of adverse effects can be increased when Budesonide is combined with Ofatumumab.,increase,risk
Budesonide,Ofloxacin,The risk or severity of tendinopathy can be increased when Budesonide is combined with Ofloxacin.,increase,risk
Budesonide,Olanzapine,Olanzapine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Budesonide,Olaparib,The metabolism of Olaparib can be increased when combined with Budesonide.,increase,no risk
Budesonide,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Budesonide.,decrease,no risk
Budesonide,Olmesartan,Olmesartan may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Olodaterol,The risk or severity of hypokalemia can be increased when Budesonide is combined with Olodaterol.,increase,risk
Budesonide,Olsalazine,The serum concentration of Olsalazine can be decreased when it is combined with Budesonide.,decrease,no risk
Budesonide,Olutasidenib,The therapeutic efficacy of Budesonide can be decreased when used in combination with Olutasidenib.,decrease,no risk
Budesonide,Omaveloxolone,The serum concentration of Budesonide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Budesonide,Omeprazole,Omeprazole can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Budesonide,Ondansetron,The metabolism of Ondansetron can be increased when combined with Budesonide.,increase,no risk
Budesonide,Opium,Budesonide may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Budesonide,Orciprenaline,The risk or severity of hypokalemia can be increased when Budesonide is combined with Orciprenaline.,increase,risk
Budesonide,Oseltamivir,Oseltamivir may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Osimertinib,The metabolism of Osimertinib can be increased when combined with Budesonide.,increase,no risk
Budesonide,Oxacillin,Oxacillin may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Budesonide.,increase,risk
Budesonide,Oxandrolone,The risk or severity of fluid retention can be increased when Budesonide is combined with Oxandrolone.,increase,risk
Budesonide,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Oxaprozin.,increase,risk
Budesonide,Oxazepam,Oxazepam may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Oxybenzone,Budesonide may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Budesonide,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Budesonide.,increase,no risk
Budesonide,Oxycodone,The metabolism of Oxycodone can be increased when combined with Budesonide.,increase,no risk
Budesonide,Oxymetazoline,The absorption of Budesonide can be decreased when combined with Oxymetazoline.,decrease,no risk
Budesonide,Oxymetholone,The risk or severity of fluid retention can be increased when Budesonide is combined with Oxymetholone.,increase,risk
Budesonide,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Oxyphenbutazone.,increase,risk
Budesonide,Oxyquinoline,Budesonide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Budesonide,Ozanimod,The risk or severity of adverse effects can be increased when Budesonide is combined with Ozanimod.,increase,risk
Budesonide,Quetiapine,The metabolism of Quetiapine can be increased when combined with Budesonide.,increase,no risk
Budesonide,Quinestrol,The serum concentration of Budesonide can be increased when it is combined with Quinestrol.,increase,no risk
Budesonide,Quinethazone,Budesonide may increase the hypokalemic activities of Quinethazone.,increase,no risk
Budesonide,Quinidine,The metabolism of Quinidine can be increased when combined with Budesonide.,increase,no risk
Budesonide,Quinine,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Quinine.,increase,risk
Budesonide,Quizartinib,The metabolism of Quizartinib can be increased when combined with Budesonide.,increase,no risk
Budesonide,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Budesonide.,increase,risk
Budesonide,Udenafil,The metabolism of Udenafil can be increased when combined with Budesonide.,increase,no risk
Budesonide,Ulipristal,The serum concentration of Budesonide can be increased when it is combined with Ulipristal.,increase,no risk
Budesonide,Upadacitinib,The risk or severity of adverse effects can be increased when Budesonide is combined with Upadacitinib.,increase,risk
Budesonide,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Vaborbactam,Budesonide may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Budesonide,Vadadustat,The serum concentration of Budesonide can be increased when it is combined with Vadadustat.,increase,no risk
Budesonide,Valaciclovir,Valaciclovir may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Valbenazine,The metabolism of Valbenazine can be increased when combined with Budesonide.,increase,no risk
Budesonide,Valdecoxib,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Valdecoxib.,increase,risk
Budesonide,Valganciclovir,Budesonide may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Budesonide,Vancomycin,Budesonide may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Budesonide,Vandetanib,The metabolism of Vandetanib can be increased when combined with Budesonide.,increase,no risk
Budesonide,Vardenafil,The metabolism of Vardenafil can be increased when combined with Budesonide.,increase,no risk
Budesonide,Varenicline,Budesonide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Budesonide,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Vecuronium,The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Budesonide.,increase,risk
Budesonide,Vedolizumab,The risk or severity of adverse effects can be increased when Budesonide is combined with Vedolizumab.,increase,risk
Budesonide,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Budesonide.,increase,no risk
Budesonide,Venetoclax,The metabolism of Venetoclax can be increased when combined with Budesonide.,increase,no risk
Budesonide,Venlafaxine,Venlafaxine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Verapamil,The metabolism of Budesonide can be decreased when combined with Verapamil.,decrease,no risk
Budesonide,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Vilanterol,The risk or severity of adverse effects can be increased when Budesonide is combined with Vilanterol.,increase,risk
Budesonide,Vildagliptin,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Vildagliptin.,increase,risk
Budesonide,Viloxazine,The metabolism of Budesonide can be decreased when combined with Viloxazine.,decrease,no risk
Budesonide,Vinblastine,The metabolism of Vinblastine can be increased when combined with Budesonide.,increase,no risk
Budesonide,Vincristine,The metabolism of Vincristine can be increased when combined with Budesonide.,increase,no risk
Budesonide,Vindesine,The metabolism of Vindesine can be increased when combined with Budesonide.,increase,no risk
Budesonide,Vinflunine,The metabolism of Vinflunine can be increased when combined with Budesonide.,increase,no risk
Budesonide,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Budesonide.,increase,no risk
Budesonide,Vitamin D,The therapeutic efficacy of Vitamin D can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Voclosporin,The risk or severity of adverse effects can be increased when Budesonide is combined with Voclosporin.,increase,risk
Budesonide,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Budesonide.,increase,no risk
Budesonide,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Budesonide.,increase,no risk
Budesonide,Voriconazole,The serum concentration of Budesonide can be increased when it is combined with Voriconazole.,increase,no risk
Budesonide,Vorinostat,The risk or severity of adverse effects can be increased when Budesonide is combined with Vorinostat.,increase,risk
Budesonide,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Budesonide.,increase,no risk
Budesonide,Warfarin,Budesonide may increase the anticoagulant activities of Warfarin.,increase,no risk
Budesonide,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Budesonide.,decrease,no risk
Budesonide,Zaleplon,The metabolism of Zaleplon can be increased when combined with Budesonide.,increase,no risk
Budesonide,Zanamivir,Zanamivir may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Budesonide,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Budesonide.,increase,no risk
Budesonide,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Budesonide.,increase,risk
Budesonide,Zimelidine,The metabolism of Budesonide can be decreased when combined with Zimelidine.,decrease,no risk
Budesonide,Ziprasidone,The metabolism of Budesonide can be decreased when combined with Ziprasidone.,decrease,no risk
Budesonide,Zolpidem,The metabolism of Zolpidem can be increased when combined with Budesonide.,increase,no risk
Budesonide,Zonisamide,Zonisamide may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Budesonide,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Budesonide.,increase,no risk
Budesonide,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Budesonide.,decrease,no risk
Aminophylline,Gabapentin,Gabapentin may increase the excretion rate of Aminophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aminophylline,Ganaxolone,Ganaxolone may increase the excretion rate of Aminophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aminophylline,Gatifloxacin,The metabolism of Aminophylline can be decreased when combined with Gatifloxacin.,decrease,no risk
Aminophylline,Gemfibrozil,The metabolism of Aminophylline can be decreased when combined with Gemfibrozil.,decrease,no risk
Aminophylline,Gemifloxacin,The metabolism of Aminophylline can be decreased when combined with Gemifloxacin.,decrease,no risk
Aminophylline,Gilteritinib,The metabolism of Aminophylline can be decreased when combined with Gilteritinib.,decrease,no risk
Aminophylline,Ginkgo biloba,The metabolism of Aminophylline can be decreased when combined with Ginkgo biloba.,decrease,no risk
Aminophylline,Givosiran,The serum concentration of Aminophylline can be increased when it is combined with Givosiran.,increase,no risk
Aminophylline,Glecaprevir,The metabolism of Aminophylline can be decreased when combined with Glecaprevir.,decrease,no risk
Aminophylline,Glofitamab,The serum concentration of Aminophylline can be increased when it is combined with Glofitamab.,increase,no risk
Aminophylline,Glyburide,The metabolism of Aminophylline can be decreased when combined with Glyburide.,decrease,no risk
Aminophylline,Glycerin,The metabolism of Aminophylline can be increased when combined with Glycerin.,increase,no risk
Aminophylline,Glycerol phenylbutyrate,The metabolism of Aminophylline can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Aminophylline,Golimumab,The metabolism of Aminophylline can be increased when combined with Golimumab.,increase,no risk
Aminophylline,Grapefruit,The serum concentration of Aminophylline can be increased when it is combined with Grapefruit.,increase,no risk
Aminophylline,Grepafloxacin,The metabolism of Aminophylline can be decreased when combined with Grepafloxacin.,decrease,no risk
Aminophylline,Griseofulvin,The metabolism of Aminophylline can be increased when combined with Griseofulvin.,increase,no risk
Aminophylline,Guanabenz,The metabolism of Aminophylline can be decreased when combined with Guanabenz.,decrease,no risk
Aminophylline,Halazepam,The therapeutic efficacy of Halazepam can be decreased when used in combination with Aminophylline.,decrease,no risk
Aminophylline,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Aminophylline.,increase,no risk
Aminophylline,Halothane,The metabolism of Aminophylline can be decreased when combined with Halothane.,decrease,no risk
Aminophylline,Human interferon beta,The metabolism of Aminophylline can be decreased when combined with Human interferon beta.,decrease,no risk
Aminophylline,Hydralazine,The serum concentration of Aminophylline can be increased when it is combined with Hydralazine.,increase,no risk
Aminophylline,Hydrocortamate,The metabolism of Aminophylline can be increased when combined with Hydrocortamate.,increase,no risk
Aminophylline,Hydrocortisone,The metabolism of Aminophylline can be increased when combined with Hydrocortisone.,increase,no risk
Aminophylline,Hydrocortisone acetate,The metabolism of Aminophylline can be increased when combined with Hydrocortisone acetate.,increase,no risk
Aminophylline,Hydrocortisone butyrate,The metabolism of Aminophylline can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Aminophylline,Hydrocortisone succinate,The metabolism of Aminophylline can be increased when combined with Hydrocortisone succinate.,increase,no risk
Aminophylline,Hydroxyamphetamine,The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Aminophylline.,increase,risk
Aminophylline,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Aminophylline.,increase,risk
Aminophylline,Ketazolam,The serum concentration of Aminophylline can be increased when it is combined with Ketazolam.,increase,no risk
Aminophylline,Ketoconazole,The metabolism of Aminophylline can be decreased when combined with Ketoconazole.,decrease,no risk
Aminophylline,Obeticholic acid,The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Aminophylline.,increase,risk
Aminophylline,Octreotide,The serum concentration of Aminophylline can be increased when it is combined with Octreotide.,increase,no risk
Aminophylline,Ofloxacin,The metabolism of Aminophylline can be decreased when combined with Ofloxacin.,decrease,no risk
Aminophylline,Olanzapine,The metabolism of Aminophylline can be decreased when combined with Olanzapine.,decrease,no risk
Aminophylline,Olaparib,The metabolism of Aminophylline can be decreased when combined with Olaparib.,decrease,no risk
Aminophylline,Olodaterol,Aminophylline may increase the hyperkalemic activities of Olodaterol.,increase,no risk
Aminophylline,Olutasidenib,The metabolism of Aminophylline can be increased when combined with Olutasidenib.,increase,no risk
Aminophylline,Omaveloxolone,The serum concentration of Aminophylline can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Aminophylline,Ondansetron,The metabolism of Aminophylline can be decreased when combined with Ondansetron.,decrease,no risk
Aminophylline,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Aminophylline.,increase,risk
Aminophylline,Oritavancin,The metabolism of Aminophylline can be increased when combined with Oritavancin.,increase,no risk
Aminophylline,Orphenadrine,The metabolism of Aminophylline can be decreased when combined with Orphenadrine.,decrease,no risk
Aminophylline,Osilodrostat,The serum concentration of Aminophylline can be increased when it is combined with Osilodrostat.,increase,no risk
Aminophylline,Osimertinib,The serum concentration of Aminophylline can be decreased when it is combined with Osimertinib.,decrease,no risk
Aminophylline,Oxazepam,The therapeutic efficacy of Oxazepam can be decreased when used in combination with Aminophylline.,decrease,no risk
Aminophylline,Oxcarbazepine,The metabolism of Aminophylline can be increased when combined with Oxcarbazepine.,increase,no risk
Aminophylline,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Aminophylline.,increase,risk
Aminophylline,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Aminophylline.,decrease,no risk
Aminophylline,Oxybutynin,The serum concentration of Aminophylline can be increased when it is combined with Oxybutynin.,increase,no risk
Aminophylline,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Aminophylline.,increase,risk
Aminophylline,Quazepam,The therapeutic efficacy of Quazepam can be decreased when used in combination with Aminophylline.,decrease,no risk
Aminophylline,Quinidine,The serum concentration of Aminophylline can be increased when it is combined with Quinidine.,increase,no risk
Aminophylline,Quinine,The serum concentration of Aminophylline can be increased when it is combined with Quinine.,increase,no risk
Aminophylline,Quinupristin,The metabolism of Aminophylline can be decreased when combined with Quinupristin.,decrease,no risk
Aminophylline,Vadadustat,The serum concentration of Aminophylline can be increased when it is combined with Vadadustat.,increase,no risk
Aminophylline,Valproic acid,The serum concentration of Aminophylline can be increased when it is combined with Valproic acid.,increase,no risk
Aminophylline,Vayarin,The metabolism of Aminophylline can be decreased when combined with Vayarin.,decrease,no risk
Aminophylline,Vemurafenib,The serum concentration of Aminophylline can be increased when it is combined with Vemurafenib.,increase,no risk
Aminophylline,Venetoclax,The metabolism of Aminophylline can be decreased when combined with Venetoclax.,decrease,no risk
Aminophylline,Verapamil,The metabolism of Aminophylline can be decreased when combined with Verapamil.,decrease,no risk
Aminophylline,Vigabatrin,Vigabatrin may increase the excretion rate of Aminophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aminophylline,Vilanterol,The risk or severity of hypokalemia can be increased when Aminophylline is combined with Vilanterol.,increase,risk
Aminophylline,Viloxazine,The metabolism of Aminophylline can be decreased when combined with Viloxazine.,decrease,no risk
Aminophylline,Vinblastine,The metabolism of Aminophylline can be increased when combined with Vinblastine.,increase,no risk
Aminophylline,Vitamin E,The metabolism of Aminophylline can be increased when combined with Vitamin E.,increase,no risk
Aminophylline,Vorapaxar,The metabolism of Aminophylline can be decreased when combined with Vorapaxar.,decrease,no risk
Aminophylline,Voriconazole,The metabolism of Aminophylline can be decreased when combined with Voriconazole.,decrease,no risk
Aminophylline,Voxelotor,The serum concentration of Aminophylline can be increased when it is combined with Voxelotor.,increase,no risk
Aminophylline,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Aminophylline.,decrease,no risk
Aminophylline,Warfarin,The metabolism of Aminophylline can be increased when combined with Warfarin.,increase,no risk
Aminophylline,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with Aminophylline.,decrease,no risk
Aminophylline,Zaleplon,Zaleplon may increase the excretion rate of Aminophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aminophylline,Zileuton,The metabolism of Aminophylline can be decreased when combined with Zileuton.,decrease,no risk
Aminophylline,Zimelidine,The metabolism of Aminophylline can be decreased when combined with Zimelidine.,decrease,no risk
Aminophylline,Ziprasidone,The metabolism of Aminophylline can be decreased when combined with Ziprasidone.,decrease,no risk
Aminophylline,Zolmitriptan,The metabolism of Aminophylline can be decreased when combined with Zolmitriptan.,decrease,no risk
Aminophylline,Zolpidem,The metabolism of Aminophylline can be decreased when combined with Zolpidem.,decrease,no risk
Aminophylline,Zonisamide,Zonisamide may increase the excretion rate of Aminophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aminophylline,Zotepine,The metabolism of Zotepine can be decreased when combined with Aminophylline.,decrease,no risk
Aminophylline,Zuclopenthixol,The metabolism of Aminophylline can be decreased when combined with Zuclopenthixol.,decrease,no risk
Quetiapine,Bacitracin,Bacitracin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Quetiapine,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.,increase,no risk
Quetiapine,Balsalazide,The risk or severity of hypertension can be increased when Balsalazide is combined with Quetiapine.,increase,risk
Quetiapine,Baricitinib,Quetiapine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Quetiapine,Beclomethasone dipropionate,The metabolism of Quetiapine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Quetiapine,Bedaquiline,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Bedaquiline.,increase,risk
Quetiapine,Belladonna,The risk or severity of adverse effects can be increased when Quetiapine is combined with Belladonna.,increase,risk
Quetiapine,Benazepril,Quetiapine may increase the hypotensive activities of Benazepril.,increase,no risk
Quetiapine,Bendroflumethiazide,Quetiapine may increase the hypotensive activities of Bendroflumethiazide.,increase,no risk
Quetiapine,Benorilate,The risk or severity of hypertension can be increased when Quetiapine is combined with Benorilate.,increase,risk
Quetiapine,Benoxaprofen,The risk or severity of hypertension can be increased when Quetiapine is combined with Benoxaprofen.,increase,risk
Quetiapine,Benperidol,The risk or severity of CNS depression can be increased when Quetiapine is combined with Benperidol.,increase,risk
Quetiapine,Benserazide,The therapeutic efficacy of Benserazide can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Benzatropine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Benzatropine.,increase,risk
Quetiapine,Benzhydrocodone,The risk or severity of adverse effects can be increased when Quetiapine is combined with Benzhydrocodone.,increase,risk
Quetiapine,Benznidazole,Quetiapine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Quetiapine,Benzocaine,The risk or severity of CNS depression can be increased when Benzocaine is combined with Quetiapine.,increase,risk
Quetiapine,Benzphetamine,Benzphetamine may decrease the sedative activities of Quetiapine.,decrease,no risk
Quetiapine,Benzthiazide,Benzthiazide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Quetiapine,Benzydamine,The risk or severity of hypertension can be increased when Quetiapine is combined with Benzydamine.,increase,risk
Quetiapine,Benzyl alcohol,The risk or severity of CNS depression can be increased when Quetiapine is combined with Benzyl alcohol.,increase,risk
Quetiapine,Benzylpenicilloyl polylysine,Quetiapine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Quetiapine,Bepotastine,Quetiapine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Quetiapine,Bepridil,Quetiapine may increase the hypotensive activities of Bepridil.,increase,no risk
Quetiapine,Berotralstat,The metabolism of Quetiapine can be decreased when combined with Berotralstat.,decrease,no risk
Quetiapine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Betaine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Betaine.,decrease,no risk
Quetiapine,Betamethasone,The metabolism of Quetiapine can be increased when combined with Betamethasone.,increase,no risk
Quetiapine,Betamethasone phosphate,The metabolism of Quetiapine can be increased when combined with Betamethasone phosphate.,increase,no risk
Quetiapine,Betaxolol,Quetiapine may increase the hypotensive activities of Betaxolol.,increase,no risk
Quetiapine,Bethanidine,Quetiapine may increase the hypotensive activities of Bethanidine.,increase,no risk
Quetiapine,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Bicisate,Quetiapine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Quetiapine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Quetiapine.,increase,risk
Quetiapine,Bimatoprost,Quetiapine may increase the hypotensive activities of Bimatoprost.,increase,no risk
Quetiapine,Bimekizumab,The metabolism of Quetiapine can be increased when combined with Bimekizumab.,increase,no risk
Quetiapine,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Bismuth subgallate,Quetiapine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Quetiapine,Bisoprolol,Quetiapine may increase the hypotensive activities of Bisoprolol.,increase,no risk
Quetiapine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Bleomycin,Bleomycin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Quetiapine,Boceprevir,The serum concentration of Quetiapine can be increased when it is combined with Boceprevir.,increase,no risk
Quetiapine,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Quetiapine.,increase,risk
Quetiapine,Bosentan,Quetiapine may increase the hypotensive activities of Bosentan.,increase,no risk
Quetiapine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Quetiapine is combined with Botulinum toxin type A.,increase,risk
Quetiapine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Quetiapine is combined with Botulinum toxin type B.,increase,risk
Quetiapine,Bretylium,Quetiapine may increase the hypotensive activities of Bretylium.,increase,no risk
Quetiapine,Brexanolone,The risk or severity of CNS depression can be increased when Quetiapine is combined with Brexanolone.,increase,risk
Quetiapine,Brexpiprazole,"Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Brexpiprazole.",increase,no risk
Quetiapine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.,increase,no risk
Quetiapine,Brivaracetam,The risk or severity of CNS depression can be increased when Quetiapine is combined with Brivaracetam.,increase,risk
Quetiapine,Bromazepam,The risk or severity of CNS depression can be increased when Quetiapine is combined with Bromazepam.,increase,risk
Quetiapine,Bromocriptine,"Bromocriptine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.",increase,no risk
Quetiapine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Quetiapine,Bromperidol,The risk or severity of CNS depression can be increased when Quetiapine is combined with Bromperidol.,increase,risk
Quetiapine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Quetiapine.,increase,risk
Quetiapine,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Quetiapine.,increase,risk
Quetiapine,Budesonide,The metabolism of Quetiapine can be increased when combined with Budesonide.,increase,no risk
Quetiapine,Bumadizone,The risk or severity of hypertension can be increased when Quetiapine is combined with Bumadizone.,increase,risk
Quetiapine,Bumetanide,Bumetanide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Quetiapine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Quetiapine.,increase,risk
Quetiapine,Buprenorphine,Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Quetiapine,Bupropion,The metabolism of Quetiapine can be decreased when combined with Bupropion.,decrease,no risk
Quetiapine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Quetiapine.,increase,risk
Quetiapine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Quetiapine.,increase,risk
Quetiapine,Butabarbital,Butabarbital may increase the hypotensive activities of Quetiapine.,increase,no risk
Quetiapine,Butalbital,Butalbital may increase the hypotensive activities of Quetiapine.,increase,no risk
Quetiapine,Butaperazine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Butaperazine.,increase,risk
Quetiapine,Butobarbital,The risk or severity of CNS depression can be increased when Quetiapine is combined with Butobarbital.,increase,risk
Quetiapine,Butorphanol,The risk or severity of adverse effects can be increased when Quetiapine is combined with Butorphanol.,increase,risk
Quetiapine,Butriptyline,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Butriptyline.,increase,risk
Quetiapine,Butylscopolamine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Butylscopolamine.,increase,risk
Quetiapine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Quetiapine.,increase,risk
Quetiapine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Quetiapine is combined with Gabapentin enacarbil.,increase,risk
Quetiapine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Quetiapine.,increase,risk
Quetiapine,Gadodiamide,Gadodiamide may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Quetiapine,Gadofosveset trisodium,Quetiapine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Quetiapine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Quetiapine,Gadoteric acid,Quetiapine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Quetiapine,Gadoteridol,Gadoteridol may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Quetiapine,Galantamine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Galantamine.,decrease,no risk
Quetiapine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Quetiapine.,increase,risk
Quetiapine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Quetiapine is combined with Ganaxolone.",increase,risk
Quetiapine,Ganciclovir,Ganciclovir may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Quetiapine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Quetiapine.,increase,risk
Quetiapine,Gefitinib,The metabolism of Quetiapine can be decreased when combined with Gefitinib.,decrease,no risk
Quetiapine,Gemcitabine,Gemcitabine may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Quetiapine,Gemfibrozil,Quetiapine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Quetiapine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Quetiapine.,increase,risk
Quetiapine,Gentamicin,Quetiapine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Quetiapine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Quetiapine.,increase,risk
Quetiapine,Gilteritinib,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Quetiapine,Gimeracil,Quetiapine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Quetiapine,Ginkgo biloba,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Quetiapine,Givosiran,The serum concentration of Quetiapine can be increased when it is combined with Givosiran.,increase,no risk
Quetiapine,Glasdegib,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Glasdegib.,increase,risk
Quetiapine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Glofitamab,The serum concentration of Quetiapine can be increased when it is combined with Glofitamab.,increase,no risk
Quetiapine,Glucagon,Quetiapine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Quetiapine,Glutethimide,The risk or severity of CNS depression can be increased when Quetiapine is combined with Glutethimide.,increase,risk
Quetiapine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Glycerol phenylbutyrate,The metabolism of Quetiapine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Quetiapine,Glycopyrronium,The risk or severity of adverse effects can be increased when Quetiapine is combined with Glycopyrronium.,increase,risk
Quetiapine,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Golimumab,The metabolism of Quetiapine can be increased when combined with Golimumab.,increase,no risk
Quetiapine,Golodirsen,Quetiapine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Quetiapine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Quetiapine.,increase,risk
Quetiapine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Quetiapine.,increase,risk
Quetiapine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Grepafloxacin.,increase,risk
Quetiapine,Guanabenz,Quetiapine may increase the hypotensive activities of Guanabenz.,increase,no risk
Quetiapine,Guanadrel,Quetiapine may increase the hypotensive activities of Guanadrel.,increase,no risk
Quetiapine,Guanethidine,Quetiapine may increase the hypotensive activities of Guanethidine.,increase,no risk
Quetiapine,Guanfacine,Quetiapine may increase the hypotensive activities of Guanfacine.,increase,no risk
Quetiapine,Guanoxan,Quetiapine may increase the hypotensive activities of Guanoxan.,increase,no risk
Quetiapine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Quetiapine.,increase,risk
Quetiapine,Halofantrine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Halofantrine.,increase,risk
Quetiapine,Haloperidol,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Haloperidol.,increase,risk
Quetiapine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Quetiapine.,increase,risk
Quetiapine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Quetiapine.,increase,risk
Quetiapine,Hexocyclium,The risk or severity of adverse effects can be increased when Quetiapine is combined with Hexocyclium.,increase,risk
Quetiapine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Quetiapine.,increase,risk
Quetiapine,Homatropine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Homatropine.,increase,risk
Quetiapine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Quetiapine.,increase,risk
Quetiapine,Huperzine A,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Huperzine A.,decrease,no risk
Quetiapine,Hydralazine,Quetiapine may increase the hypotensive activities of Hydralazine.,increase,no risk
Quetiapine,Hydrochlorothiazide,Quetiapine may increase the hypotensive activities of Hydrochlorothiazide.,increase,no risk
Quetiapine,Hydrocodone,Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Quetiapine,Hydrocortisone,The metabolism of Quetiapine can be decreased when combined with Hydrocortisone.,decrease,no risk
Quetiapine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Quetiapine.,decrease,no risk
Quetiapine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Quetiapine.,decrease,no risk
Quetiapine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Quetiapine.,decrease,no risk
Quetiapine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Quetiapine.,decrease,no risk
Quetiapine,Hydroflumethiazide,Quetiapine may increase the hypotensive activities of Hydroflumethiazide.,increase,no risk
Quetiapine,Hydromorphone,The risk or severity of adverse effects can be increased when Quetiapine is combined with Hydromorphone.,increase,risk
Quetiapine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Quetiapine,Hydroxychloroquine,The metabolism of Quetiapine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Quetiapine,Hydroxyethyl Starch,Quetiapine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Quetiapine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Quetiapine.,decrease,no risk
Quetiapine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Hydroxyzine.,increase,risk
Quetiapine,Hyoscyamine,Quetiapine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Quetiapine,Kanamycin,Quetiapine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Quetiapine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Quetiapine.,increase,risk
Quetiapine,Ketazolam,The risk or severity of CNS depression can be increased when Quetiapine is combined with Ketazolam.,increase,risk
Quetiapine,Ketoconazole,The serum concentration of Quetiapine can be increased when it is combined with Ketoconazole.,increase,no risk
Quetiapine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Quetiapine.,increase,risk
Quetiapine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Quetiapine.,increase,risk
Quetiapine,Obinutuzumab,The risk or severity of adverse effects can be increased when Quetiapine is combined with Obinutuzumab.,increase,risk
Quetiapine,Octinoxate,Quetiapine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Quetiapine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Quetiapine.,increase,risk
Quetiapine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Quetiapine.,increase,risk
Quetiapine,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.",increase,no risk
Quetiapine,Olaparib,The metabolism of Olaparib can be decreased when combined with Quetiapine.,decrease,no risk
Quetiapine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Quetiapine is combined with Oliceridine.",increase,risk
Quetiapine,Olmesartan,Quetiapine may increase the hypotensive activities of Olmesartan.,increase,no risk
Quetiapine,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Olsalazine,Olsalazine may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Quetiapine,Olutasidenib,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Olutasidenib.,decrease,no risk
Quetiapine,Omaveloxolone,The serum concentration of Quetiapine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Quetiapine,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Quetiapine.,increase,risk
Quetiapine,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Opium,The risk or severity of adverse effects can be increased when Quetiapine is combined with Opium.,increase,risk
Quetiapine,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Oritavancin,The metabolism of Quetiapine can be decreased when combined with Oritavancin.,decrease,no risk
Quetiapine,Orphenadrine,Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Quetiapine,Oseltamivir,Oseltamivir may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Quetiapine,Osilodrostat,The metabolism of Quetiapine can be decreased when combined with Osilodrostat.,decrease,no risk
Quetiapine,Ospemifene,The metabolism of Quetiapine can be decreased when combined with Ospemifene.,decrease,no risk
Quetiapine,Oxacillin,Oxacillin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Quetiapine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Quetiapine.,increase,risk
Quetiapine,Oxamniquine,The metabolism of Quetiapine can be decreased when combined with Oxamniquine.,decrease,no risk
Quetiapine,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Quetiapine.,increase,risk
Quetiapine,Oxatomide,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Oxatomide.,increase,risk
Quetiapine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Quetiapine.,increase,risk
Quetiapine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Quetiapine.,increase,risk
Quetiapine,Oxitriptan,The risk or severity of CNS depression can be increased when Quetiapine is combined with Oxitriptan.,increase,risk
Quetiapine,Oxprenolol,Quetiapine may increase the hypotensive activities of Oxprenolol.,increase,no risk
Quetiapine,Oxybenzone,Quetiapine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Quetiapine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Quetiapine.,increase,risk
Quetiapine,Oxybutynin,The metabolism of Quetiapine can be decreased when combined with Oxybutynin.,decrease,no risk
Quetiapine,Oxycodone,The risk or severity of adverse effects can be increased when Quetiapine is combined with Oxycodone.,increase,risk
Quetiapine,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Oxymorphone,The risk or severity of adverse effects can be increased when Quetiapine is combined with Oxymorphone.,increase,risk
Quetiapine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Quetiapine is combined with Oxyphenbutazone.,increase,risk
Quetiapine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Quetiapine.,increase,risk
Quetiapine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Quetiapine.,increase,risk
Quetiapine,Oxyquinoline,Quetiapine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Quetiapine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Quetiapine.,increase,risk
Quetiapine,Quazepam,The risk or severity of CNS depression can be increased when Quetiapine is combined with Quazepam.,increase,risk
Quetiapine,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Quetiapine.,decrease,no risk
Quetiapine,Quinapril,Quetiapine may increase the hypotensive activities of Quinapril.,increase,no risk
Quetiapine,Quinethazone,Quinethazone may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Quetiapine,Quinidine,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.",increase,no risk
Quetiapine,Quinine,The metabolism of Quetiapine can be decreased when combined with Quinine.,decrease,no risk
Quetiapine,Quinupramine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Quinupramine.,increase,risk
Quetiapine,Quizartinib,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Quizartinib.,increase,risk
Enoxaparin,Gemcitabine,The risk or severity of bleeding can be increased when Enoxaparin is combined with Gemcitabine.,increase,risk
Enoxaparin,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Enoxaparin is combined with Gemtuzumab ozogamicin.,increase,risk
Enoxaparin,Gentamicin,The therapeutic efficacy of Gentamicin can be decreased when used in combination with Enoxaparin.,decrease,no risk
Enoxaparin,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Enoxaparin.,increase,risk
Enoxaparin,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Enoxaparin.,increase,no risk
Enoxaparin,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Enoxaparin.,increase,risk
Enoxaparin,Hemin,Hemin may increase the anticoagulant activities of Enoxaparin.,increase,no risk
Enoxaparin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Enoxaparin.,increase,risk
Enoxaparin,Hydrochlorothiazide,The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Enoxaparin,Hydroflumethiazide,The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Enoxaparin,Hydroxyprogesterone caproate,The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Enoxaparin,Hydroxyurea,The risk or severity of bleeding can be increased when Enoxaparin is combined with Hydroxyurea.,increase,risk
Enoxaparin,Kanamycin,The therapeutic efficacy of Kanamycin can be decreased when used in combination with Enoxaparin.,decrease,no risk
Enoxaparin,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Enoxaparin.,increase,risk
Enoxaparin,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Enoxaparin.,increase,risk
Enoxaparin,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Enoxaparin.,increase,risk
Enoxaparin,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Enoxaparin is combined with Obeticholic acid.,increase,risk
Enoxaparin,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Enoxaparin is combined with Obinutuzumab.,increase,risk
Enoxaparin,Olaparib,The risk or severity of bleeding can be increased when Enoxaparin is combined with Olaparib.,increase,risk
Enoxaparin,Olive oil,The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Olive oil.,decrease,no risk
Enoxaparin,Olmesartan,The risk or severity of hyperkalemia can be increased when Enoxaparin is combined with Olmesartan.,increase,risk
Enoxaparin,Olsalazine,The risk or severity of bleeding can be increased when Enoxaparin is combined with Olsalazine.,increase,risk
Enoxaparin,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Enoxaparin is combined with Omacetaxine mepesuccinate.,increase,risk
Enoxaparin,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Enoxaparin.,increase,no risk
Enoxaparin,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Enoxaparin.,increase,risk
Enoxaparin,Omega-3-carboxylic acids,The therapeutic efficacy of Enoxaparin can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Enoxaparin,Oritavancin,The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Oritavancin.,decrease,no risk
Enoxaparin,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Enoxaparin.,increase,risk
Enoxaparin,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Enoxaparin.,increase,risk
Enoxaparin,Oxprenolol,The risk or severity of hyperkalemia can be increased when Enoxaparin is combined with Oxprenolol.,increase,risk
Enoxaparin,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Enoxaparin.,increase,risk
Enoxaparin,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Enoxaparin.,increase,risk
Enoxaparin,Quinestrol,Quinestrol may decrease the anticoagulant activities of Enoxaparin.,decrease,no risk
Enoxaparin,Quinidine,The therapeutic efficacy of Enoxaparin can be increased when used in combination with Quinidine.,increase,no risk
Enoxaparin,Quinine,The therapeutic efficacy of Enoxaparin can be increased when used in combination with Quinine.,increase,no risk
Enoxaparin,Ulipristal,The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Ulipristal.,decrease,no risk
Enoxaparin,Urokinase,Urokinase may increase the anticoagulant activities of Enoxaparin.,increase,no risk
Enoxaparin,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Enoxaparin is combined with Ursodeoxycholic acid.,increase,risk
Enoxaparin,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Enoxaparin.,increase,risk
Enoxaparin,Valsartan,The risk or severity of hyperkalemia can be increased when Enoxaparin is combined with Valsartan.,increase,risk
Enoxaparin,Vasopressin,The therapeutic efficacy of Vasopressin can be decreased when used in combination with Enoxaparin.,decrease,no risk
Enoxaparin,Venlafaxine,The risk or severity of bleeding can be increased when Enoxaparin is combined with Venlafaxine.,increase,risk
Enoxaparin,Vinblastine,The risk or severity of bleeding can be increased when Enoxaparin is combined with Vinblastine.,increase,risk
Enoxaparin,Vindesine,The risk or severity of bleeding can be increased when Enoxaparin is combined with Vindesine.,increase,risk
Enoxaparin,Vinorelbine,The risk or severity of bleeding can be increased when Enoxaparin is combined with Vinorelbine.,increase,risk
Enoxaparin,Vitamin E,Vitamin E may increase the anticoagulant activities of Enoxaparin.,increase,no risk
Enoxaparin,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Enoxaparin.,decrease,no risk
Enoxaparin,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Enoxaparin.,increase,risk
Enoxaparin,Vorinostat,The risk or severity of bleeding can be increased when Enoxaparin is combined with Vorinostat.,increase,risk
Enoxaparin,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Enoxaparin.,increase,risk
Enoxaparin,Ximelagatran,The risk or severity of bleeding can be increased when Enoxaparin is combined with Ximelagatran.,increase,risk
Enoxaparin,Zidovudine,The risk or severity of bleeding can be increased when Enoxaparin is combined with Zidovudine.,increase,risk
Enoxaparin,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Enoxaparin.,increase,risk
Enoxaparin,Zofenopril,The risk or severity of hyperkalemia can be increased when Zofenopril is combined with Enoxaparin.,increase,risk
Enoxaparin,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Enoxaparin.,increase,risk
Mivacurium,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Mivacurium.,increase,risk
Mivacurium,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Mivacurium is combined with Gabapentin enacarbil.,increase,risk
Mivacurium,Galantamine,The therapeutic efficacy of Mivacurium can be decreased when used in combination with Galantamine.,decrease,no risk
Mivacurium,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Mivacurium.,increase,risk
Mivacurium,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Mivacurium is combined with Ganaxolone.",increase,risk
Mivacurium,Gentamicin,The therapeutic efficacy of Mivacurium can be increased when used in combination with Gentamicin.,increase,no risk
Mivacurium,Gepirone,The risk or severity of CNS depression can be increased when Mivacurium is combined with Gepirone.,increase,risk
Mivacurium,Ginkgo biloba,The therapeutic efficacy of Mivacurium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Mivacurium,Glucagon,Mivacurium may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Mivacurium,Glutethimide,The risk or severity of CNS depression can be increased when Mivacurium is combined with Glutethimide.,increase,risk
Mivacurium,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Mivacurium.,decrease,no risk
Mivacurium,Glycopyrronium,The risk or severity of adverse effects can be increased when Mivacurium is combined with Glycopyrronium.,increase,risk
Mivacurium,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Mivacurium.,increase,risk
Levacetylmethadol,Bosentan,The metabolism of Levacetylmethadol can be increased when combined with Bosentan.,increase,no risk
Levacetylmethadol,Bosutinib,The metabolism of Levacetylmethadol can be decreased when combined with Bosutinib.,decrease,no risk
Levacetylmethadol,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Botulinum toxin type A.,increase,risk
Levacetylmethadol,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Botulinum toxin type B.,increase,risk
Levacetylmethadol,Brentuximab vedotin,The serum concentration of Levacetylmethadol can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Levacetylmethadol,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Brexanolone,The risk or severity of CNS depression can be increased when Levacetylmethadol is combined with Brexanolone.,increase,risk
Levacetylmethadol,Brexpiprazole,The risk or severity of CNS depression can be increased when Levacetylmethadol is combined with Brexpiprazole.,increase,risk
Levacetylmethadol,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Levacetylmethadol.,increase,no risk
Levacetylmethadol,Brivaracetam,The risk or severity of CNS depression can be increased when Levacetylmethadol is combined with Brivaracetam.,increase,risk
Levacetylmethadol,Bromazepam,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Bromazepam.,increase,risk
Levacetylmethadol,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Bromotheophylline,The therapeutic efficacy of Bromotheophylline can be decreased when used in combination with Levacetylmethadol.,decrease,no risk
Levacetylmethadol,Bromperidol,The risk or severity of CNS depression can be increased when Levacetylmethadol is combined with Bromperidol.,increase,risk
Levacetylmethadol,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Budesonide,The metabolism of Levacetylmethadol can be increased when combined with Budesonide.,increase,no risk
Levacetylmethadol,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Levacetylmethadol.,decrease,no risk
Levacetylmethadol,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Buprenorphine,Levacetylmethadol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Levacetylmethadol,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Butaperazine,The risk or severity of hypotension and CNS depression can be increased when Butaperazine is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Butorphanol,The therapeutic efficacy of Levacetylmethadol can be decreased when used in combination with Butorphanol.,decrease,no risk
Levacetylmethadol,Butriptyline,The risk or severity of QTc prolongation can be increased when Levacetylmethadol is combined with Butriptyline.,increase,risk
Levacetylmethadol,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Levacetylmethadol is combined with Gabapentin enacarbil.,increase,risk
Levacetylmethadol,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Galantamine,The therapeutic efficacy of Levacetylmethadol can be decreased when used in combination with Galantamine.,decrease,no risk
Levacetylmethadol,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Levacetylmethadol is combined with Ganaxolone.",increase,risk
Levacetylmethadol,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Gilteritinib,The metabolism of Levacetylmethadol can be decreased when combined with Gilteritinib.,decrease,no risk
Levacetylmethadol,Ginkgo biloba,The metabolism of Levacetylmethadol can be decreased when combined with Ginkgo biloba.,decrease,no risk
Levacetylmethadol,Glasdegib,The risk or severity of QTc prolongation can be increased when Levacetylmethadol is combined with Glasdegib.,increase,risk
Levacetylmethadol,Glecaprevir,The metabolism of Levacetylmethadol can be decreased when combined with Glecaprevir.,decrease,no risk
Levacetylmethadol,Glofitamab,The serum concentration of Levacetylmethadol can be increased when it is combined with Glofitamab.,increase,no risk
Levacetylmethadol,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Levacetylmethadol.,decrease,no risk
Levacetylmethadol,Glutethimide,The risk or severity of CNS depression can be increased when Levacetylmethadol is combined with Glutethimide.,increase,risk
Levacetylmethadol,Glyburide,The metabolism of Levacetylmethadol can be decreased when combined with Glyburide.,decrease,no risk
Levacetylmethadol,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Levacetylmethadol.,decrease,no risk
Levacetylmethadol,Glycerol phenylbutyrate,The metabolism of Levacetylmethadol can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Levacetylmethadol,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Golimumab,The metabolism of Levacetylmethadol can be increased when combined with Golimumab.,increase,no risk
Levacetylmethadol,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Grapefruit,The serum concentration of Levacetylmethadol can be increased when it is combined with Grapefruit.,increase,no risk
Levacetylmethadol,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Levacetylmethadol is combined with Grepafloxacin.,increase,risk
Levacetylmethadol,Griseofulvin,The metabolism of Levacetylmethadol can be increased when combined with Griseofulvin.,increase,no risk
Levacetylmethadol,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Halazepam,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Halazepam.,increase,risk
Levacetylmethadol,Halofantrine,The risk or severity of QTc prolongation can be increased when Levacetylmethadol is combined with Halofantrine.,increase,risk
Levacetylmethadol,Haloperidol,The risk or severity of QTc prolongation can be increased when Levacetylmethadol is combined with Haloperidol.,increase,risk
Levacetylmethadol,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Homatropine,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Homatropine.,increase,risk
Levacetylmethadol,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Huperzine A,The therapeutic efficacy of Levacetylmethadol can be decreased when used in combination with Huperzine A.,decrease,no risk
Levacetylmethadol,Hydralazine,The serum concentration of Levacetylmethadol can be increased when it is combined with Hydralazine.,increase,no risk
Levacetylmethadol,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Levacetylmethadol.,decrease,no risk
Levacetylmethadol,Hydrocodone,Levacetylmethadol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Levacetylmethadol,Hydrocortamate,The metabolism of Levacetylmethadol can be increased when combined with Hydrocortamate.,increase,no risk
Levacetylmethadol,Hydrocortisone,The metabolism of Levacetylmethadol can be increased when combined with Hydrocortisone.,increase,no risk
Levacetylmethadol,Hydrocortisone acetate,The metabolism of Levacetylmethadol can be increased when combined with Hydrocortisone acetate.,increase,no risk
Levacetylmethadol,Hydrocortisone butyrate,The metabolism of Levacetylmethadol can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Levacetylmethadol,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Levacetylmethadol.,decrease,no risk
Levacetylmethadol,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Levacetylmethadol.,decrease,no risk
Levacetylmethadol,Hydrocortisone succinate,The metabolism of Levacetylmethadol can be increased when combined with Hydrocortisone succinate.,increase,no risk
Levacetylmethadol,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Levacetylmethadol.,decrease,no risk
Levacetylmethadol,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Levacetylmethadol is combined with Hydroxyzine.,increase,risk
Levacetylmethadol,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Ketazolam,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Ketazolam.,increase,risk
Levacetylmethadol,Ketoconazole,The metabolism of Levacetylmethadol can be decreased when combined with Ketoconazole.,decrease,no risk
Levacetylmethadol,Octreotide,The serum concentration of Levacetylmethadol can be increased when it is combined with Octreotide.,increase,no risk
Levacetylmethadol,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Olaparib,The metabolism of Levacetylmethadol can be decreased when combined with Olaparib.,decrease,no risk
Levacetylmethadol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Levacetylmethadol is combined with Oliceridine.",increase,risk
Levacetylmethadol,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Olutasidenib,The metabolism of Levacetylmethadol can be increased when combined with Olutasidenib.,increase,no risk
Levacetylmethadol,Omaveloxolone,The serum concentration of Levacetylmethadol can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Levacetylmethadol,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Opium,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Opium.,increase,risk
Levacetylmethadol,Oritavancin,The metabolism of Levacetylmethadol can be increased when combined with Oritavancin.,increase,no risk
Levacetylmethadol,Orphenadrine,Levacetylmethadol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Levacetylmethadol,Osilodrostat,The metabolism of Levacetylmethadol can be decreased when combined with Osilodrostat.,decrease,no risk
Levacetylmethadol,Osimertinib,The metabolism of Levacetylmethadol can be decreased when combined with Osimertinib.,decrease,no risk
Levacetylmethadol,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Oxatomide,The risk or severity of QTc prolongation can be increased when Levacetylmethadol is combined with Oxatomide.,increase,risk
Levacetylmethadol,Oxazepam,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Oxazepam.,increase,risk
Levacetylmethadol,Oxcarbazepine,The metabolism of Levacetylmethadol can be increased when combined with Oxcarbazepine.,increase,no risk
Levacetylmethadol,Oxitriptan,The risk or severity of CNS depression can be increased when Levacetylmethadol is combined with Oxitriptan.,increase,risk
Levacetylmethadol,Oxprenolol,The risk or severity of CNS depression can be increased when Levacetylmethadol is combined with Oxprenolol.,increase,risk
Levacetylmethadol,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Levacetylmethadol.,decrease,no risk
Levacetylmethadol,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Levacetylmethadol.,increase,risk
Levacetylmethadol,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Levacetylmethadol.,increase,risk
Encainide,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Encainide is combined with Gadobenic acid.,increase,risk
Encainide,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Encainide.,increase,risk
Encainide,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Encainide.,increase,risk
Encainide,Gefitinib,The metabolism of Encainide can be decreased when combined with Gefitinib.,decrease,no risk
Encainide,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Encainide is combined with Gemifloxacin.,increase,risk
Encainide,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Encainide.,increase,risk
Encainide,Gilteritinib,The risk or severity of QTc prolongation can be increased when Encainide is combined with Gilteritinib.,increase,risk
Encainide,Givosiran,The serum concentration of Encainide can be increased when it is combined with Givosiran.,increase,no risk
Encainide,Glasdegib,The risk or severity of QTc prolongation can be increased when Encainide is combined with Glasdegib.,increase,risk
Encainide,Glycerol phenylbutyrate,The metabolism of Encainide can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Encainide,Golimumab,The metabolism of Encainide can be increased when combined with Golimumab.,increase,no risk
Encainide,Goserelin,The risk or severity of QTc prolongation can be increased when Encainide is combined with Goserelin.,increase,risk
Encainide,Granisetron,The risk or severity of QTc prolongation can be increased when Encainide is combined with Granisetron.,increase,risk
Encainide,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Encainide is combined with Grepafloxacin.,increase,risk
Encainide,Halofantrine,The metabolism of Encainide can be decreased when combined with Halofantrine.,decrease,no risk
Encainide,Haloperidol,The risk or severity of QTc prolongation can be increased when Encainide is combined with Haloperidol.,increase,risk
Encainide,Histrelin,The risk or severity of QTc prolongation can be increased when Encainide is combined with Histrelin.,increase,risk
Encainide,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Encainide.,increase,risk
Encainide,Hydroxychloroquine,The metabolism of Encainide can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Encainide,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Encainide is combined with Hydroxyzine.,increase,risk
Encainide,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Encainide.,increase,no risk
Encainide,Ketoconazole,The metabolism of Encainide can be decreased when combined with Ketoconazole.,decrease,no risk
Paclitaxel,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Paclitaxel.,increase,risk
Paclitaxel,Baclofen,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Paclitaxel.",increase,risk
Paclitaxel,Baricitinib,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Baricitinib.,increase,risk
Paclitaxel,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Paclitaxel.,increase,risk
Paclitaxel,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Paclitaxel.,increase,risk
Paclitaxel,Beclomethasone dipropionate,The metabolism of Paclitaxel can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Paclitaxel,Belantamab mafodotin,Paclitaxel may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.,decrease,no risk
Paclitaxel,Belatacept,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Belatacept.,increase,risk
Paclitaxel,Belimumab,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Belimumab.,increase,risk
Paclitaxel,Belinostat,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Belinostat.,increase,risk
Paclitaxel,Belumosudil,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Belumosudil.,increase,risk
Paclitaxel,Belzutifan,The serum concentration of Paclitaxel can be decreased when it is combined with Belzutifan.,decrease,no risk
Paclitaxel,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Paclitaxel.,increase,risk
Paclitaxel,Bempedoic acid,The excretion of Paclitaxel can be decreased when combined with Bempedoic acid.,decrease,no risk
Paclitaxel,Benazepril,The risk or severity of adverse effects can be increased when Benazepril is combined with Paclitaxel.,increase,risk
Paclitaxel,Bendamustine,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Bendamustine.,increase,risk
Paclitaxel,Bendroflumethiazide,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Paclitaxel.,increase,risk
Paclitaxel,Benperidol,Paclitaxel may increase the neurotoxic activities of Benperidol.,increase,no risk
Paclitaxel,Benzocaine,The risk or severity of methemoglobinemia can be increased when Paclitaxel is combined with Benzocaine.,increase,risk
Paclitaxel,Benzthiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Paclitaxel.,increase,risk
Paclitaxel,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Paclitaxel is combined with Benzyl alcohol.,increase,risk
Paclitaxel,Bepridil,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Bepridil.,increase,risk
Paclitaxel,Berotralstat,The serum concentration of Paclitaxel can be increased when it is combined with Berotralstat.,increase,no risk
Paclitaxel,Betamethasone,The metabolism of Paclitaxel can be increased when combined with Betamethasone.,increase,no risk
Paclitaxel,Betamethasone phosphate,The metabolism of Paclitaxel can be increased when combined with Betamethasone phosphate.,increase,no risk
Paclitaxel,Betaxolol,The risk or severity of adverse effects can be increased when Betaxolol is combined with Paclitaxel.,increase,risk
Paclitaxel,Bethanidine,Paclitaxel may increase the hypotensive activities of Bethanidine.,increase,no risk
Paclitaxel,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Paclitaxel.,increase,risk
Paclitaxel,Bevacizumab,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Paclitaxel.,increase,risk
Paclitaxel,Bexarotene,The serum concentration of Bexarotene can be increased when it is combined with Paclitaxel.,increase,no risk
Paclitaxel,Bezafibrate,The metabolism of Paclitaxel can be decreased when combined with Bezafibrate.,decrease,no risk
Paclitaxel,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Bifonazole,The metabolism of Paclitaxel can be decreased when combined with Bifonazole.,decrease,no risk
Paclitaxel,Bimekizumab,The metabolism of Paclitaxel can be increased when combined with Bimekizumab.,increase,no risk
Paclitaxel,Bismuth subcitrate potassium,Paclitaxel may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Paclitaxel,Bismuth subgallate,Paclitaxel may increase the neurotoxic activities of Bismuth subgallate.,increase,no risk
Paclitaxel,Bismuth subnitrate,Paclitaxel may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Paclitaxel,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Paclitaxel.,increase,risk
Paclitaxel,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Paclitaxel.,increase,risk
Paclitaxel,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Paclitaxel.,increase,risk
Paclitaxel,Blinatumomab,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Blinatumomab.,increase,risk
Paclitaxel,Boceprevir,The metabolism of Paclitaxel can be decreased when combined with Boceprevir.,decrease,no risk
Paclitaxel,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Paclitaxel.",decrease,no risk
Paclitaxel,Bortezomib,The metabolism of Bortezomib can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Bosentan,The metabolism of Paclitaxel can be increased when combined with Bosentan.,increase,no risk
Paclitaxel,Bosutinib,The metabolism of Bosutinib can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Bretylium,The risk or severity of adverse effects can be increased when Bretylium is combined with Paclitaxel.,increase,risk
Paclitaxel,Brexpiprazole,Paclitaxel may increase the neurotoxic activities of Brexpiprazole.,increase,no risk
Paclitaxel,Brigatinib,The metabolism of Brigatinib can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Brodalumab,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Brodalumab.,increase,risk
Paclitaxel,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Paclitaxel.,increase,risk
Paclitaxel,Bromperidol,Paclitaxel may increase the neurotoxic activities of Bromperidol.,increase,no risk
Paclitaxel,Budesonide,The metabolism of Paclitaxel can be increased when combined with Budesonide.,increase,no risk
Paclitaxel,Bumetanide,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Paclitaxel.",increase,risk
Paclitaxel,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Paclitaxel is combined with Bupivacaine.,increase,risk
Paclitaxel,Buprenorphine,The metabolism of Paclitaxel can be decreased when combined with Buprenorphine.,decrease,no risk
Paclitaxel,Buspirone,The metabolism of Paclitaxel can be decreased when combined with Buspirone.,decrease,no risk
Paclitaxel,Busulfan,The metabolism of Busulfan can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Butabarbital,Butabarbital may increase the hypotensive activities of Paclitaxel.,increase,no risk
Paclitaxel,Butacaine,The risk or severity of methemoglobinemia can be increased when Paclitaxel is combined with Butacaine.,increase,risk
Paclitaxel,Butalbital,The metabolism of Paclitaxel can be increased when combined with Butalbital.,increase,no risk
Paclitaxel,Butamben,The risk or severity of methemoglobinemia can be increased when Paclitaxel is combined with Butamben.,increase,risk
Paclitaxel,Butaperazine,Paclitaxel may increase the neurotoxic activities of Butaperazine.,increase,no risk
Paclitaxel,Butriptyline,Paclitaxel may increase the neurotoxic activities of Butriptyline.,increase,no risk
Paclitaxel,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Paclitaxel.",increase,risk
Paclitaxel,Gefitinib,The metabolism of Paclitaxel can be decreased when combined with Gefitinib.,decrease,no risk
Paclitaxel,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Paclitaxel.,increase,risk
Paclitaxel,Gemfibrozil,The metabolism of Paclitaxel can be decreased when combined with Gemfibrozil.,decrease,no risk
Paclitaxel,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Paclitaxel.,increase,risk
Paclitaxel,Gestrinone,The metabolism of Gestrinone can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Gilteritinib,The metabolism of Paclitaxel can be decreased when combined with Gilteritinib.,decrease,no risk
Paclitaxel,Ginkgo biloba,The metabolism of Paclitaxel can be decreased when combined with Ginkgo biloba.,decrease,no risk
Paclitaxel,Glasdegib,The metabolism of Paclitaxel can be decreased when combined with Glasdegib.,decrease,no risk
Paclitaxel,Glatiramer,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Glatiramer.,increase,risk
Paclitaxel,Glecaprevir,The metabolism of Paclitaxel can be decreased when combined with Glecaprevir.,decrease,no risk
Paclitaxel,Glimepiride,Paclitaxel may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Paclitaxel,Glipizide,Paclitaxel may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Paclitaxel,Glofitamab,The serum concentration of Paclitaxel can be increased when it is combined with Glofitamab.,increase,no risk
Paclitaxel,Glyburide,The metabolism of Paclitaxel can be decreased when combined with Glyburide.,decrease,no risk
Paclitaxel,Glycerol phenylbutyrate,The metabolism of Paclitaxel can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Paclitaxel,Glycyrrhizic acid,Paclitaxel may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Paclitaxel,Golimumab,The metabolism of Paclitaxel can be increased when combined with Golimumab.,increase,no risk
Paclitaxel,Grapefruit,The serum concentration of Paclitaxel can be increased when it is combined with Grapefruit.,increase,no risk
Paclitaxel,Griseofulvin,The metabolism of Paclitaxel can be increased when combined with Griseofulvin.,increase,no risk
Paclitaxel,Guanabenz,Paclitaxel may increase the hypotensive activities of Guanabenz.,increase,no risk
Paclitaxel,Guanadrel,Paclitaxel may increase the hypotensive activities of Guanadrel.,increase,no risk
Paclitaxel,Guanethidine,Paclitaxel may increase the hypotensive activities of Guanethidine.,increase,no risk
Paclitaxel,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Paclitaxel.,increase,risk
Paclitaxel,Guanoxan,Paclitaxel may increase the hypotensive activities of Guanoxan.,increase,no risk
Paclitaxel,Guselkumab,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Guselkumab.,increase,risk
Paclitaxel,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Paclitaxel.,decrease,no risk
Paclitaxel,Halofantrine,The metabolism of Paclitaxel can be decreased when combined with Halofantrine.,decrease,no risk
Paclitaxel,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Paclitaxel.,increase,no risk
Paclitaxel,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Paclitaxel.,increase,risk
Paclitaxel,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Paclitaxel.,increase,risk
Paclitaxel,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Paclitaxel.,decrease,no risk
Paclitaxel,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Paclitaxel.,decrease,no risk
Paclitaxel,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Paclitaxel.,increase,risk
Paclitaxel,Hydralazine,The serum concentration of Paclitaxel can be increased when it is combined with Hydralazine.,increase,no risk
Paclitaxel,Hydrochlorothiazide,The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Paclitaxel.,increase,risk
Paclitaxel,Hydrocortamate,The metabolism of Paclitaxel can be increased when combined with Hydrocortamate.,increase,no risk
Paclitaxel,Hydrocortisone,The metabolism of Paclitaxel can be increased when combined with Hydrocortisone.,increase,no risk
Paclitaxel,Hydrocortisone acetate,The metabolism of Paclitaxel can be increased when combined with Hydrocortisone acetate.,increase,no risk
Paclitaxel,Hydrocortisone butyrate,The metabolism of Paclitaxel can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Paclitaxel,Hydrocortisone cypionate,The metabolism of Paclitaxel can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Paclitaxel,Hydrocortisone phosphate,The metabolism of Paclitaxel can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Paclitaxel,Hydrocortisone succinate,The metabolism of Paclitaxel can be increased when combined with Hydrocortisone succinate.,increase,no risk
Paclitaxel,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Paclitaxel.,increase,risk
Paclitaxel,Hydroxychloroquine,The metabolism of Paclitaxel can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Paclitaxel,Hydroxyprogesterone caproate,The metabolism of Paclitaxel can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Paclitaxel,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Paclitaxel.,increase,risk
Paclitaxel,Hydroxyzine,The metabolism of Paclitaxel can be decreased when combined with Hydroxyzine.,decrease,no risk
Paclitaxel,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Paclitaxel.,decrease,no risk
Paclitaxel,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Paclitaxel.,decrease,no risk
Paclitaxel,Ketamine,The metabolism of Paclitaxel can be decreased when combined with Ketamine.,decrease,no risk
Paclitaxel,Ketazolam,The serum concentration of Paclitaxel can be increased when it is combined with Ketazolam.,increase,no risk
Paclitaxel,Ketoconazole,The metabolism of Paclitaxel can be decreased when combined with Ketoconazole.,decrease,no risk
Paclitaxel,Ketoprofen,The metabolism of Paclitaxel can be decreased when combined with Ketoprofen.,decrease,no risk
Paclitaxel,Ketorolac,The metabolism of Paclitaxel can be decreased when combined with Ketorolac.,decrease,no risk
Paclitaxel,Obeticholic acid,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Obeticholic acid.,increase,risk
Paclitaxel,Obinutuzumab,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Obinutuzumab.,increase,risk
Paclitaxel,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Paclitaxel.,increase,no risk
Paclitaxel,Octreotide,The serum concentration of Paclitaxel can be increased when it is combined with Octreotide.,increase,no risk
Paclitaxel,Ofatumumab,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Ofatumumab.,increase,risk
Paclitaxel,Ofloxacin,Paclitaxel may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Paclitaxel,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Paclitaxel.,increase,risk
Paclitaxel,Olaparib,The metabolism of Olaparib can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Paclitaxel.,decrease,no risk
Paclitaxel,Olmesartan,Olmesartan may decrease the excretion rate of Paclitaxel which could result in a higher serum level.,decrease,no risk
Paclitaxel,Olodaterol,The metabolism of Paclitaxel can be decreased when combined with Olodaterol.,decrease,no risk
Paclitaxel,Olutasidenib,The metabolism of Paclitaxel can be increased when combined with Olutasidenib.,increase,no risk
Paclitaxel,Omaveloxolone,The serum concentration of Paclitaxel can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Paclitaxel,Ombitasvir,The metabolism of Paclitaxel can be decreased when combined with Ombitasvir.,decrease,no risk
Paclitaxel,Ondansetron,The metabolism of Paclitaxel can be decreased when combined with Ondansetron.,decrease,no risk
Paclitaxel,Opicapone,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Opicapone.,increase,risk
Paclitaxel,Oritavancin,The metabolism of Paclitaxel can be increased when combined with Oritavancin.,increase,no risk
Paclitaxel,Orphenadrine,The metabolism of Paclitaxel can be decreased when combined with Orphenadrine.,decrease,no risk
Paclitaxel,Osilodrostat,The metabolism of Paclitaxel can be decreased when combined with Osilodrostat.,decrease,no risk
Paclitaxel,Osimertinib,The metabolism of Osimertinib can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Ouabain,Ouabain may decrease the cardiotoxic activities of Paclitaxel.,decrease,no risk
Paclitaxel,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Paclitaxel.,increase,risk
Paclitaxel,Oxcarbazepine,The metabolism of Paclitaxel can be increased when combined with Oxcarbazepine.,increase,no risk
Paclitaxel,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Paclitaxel is combined with Oxetacaine.,increase,risk
Paclitaxel,Oxprenolol,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Oxprenolol.,increase,risk
Paclitaxel,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Paclitaxel is combined with Oxybuprocaine.,increase,risk
Paclitaxel,Oxybutynin,The serum concentration of Paclitaxel can be increased when it is combined with Oxybutynin.,increase,no risk
Paclitaxel,Oxycodone,The metabolism of Paclitaxel can be decreased when combined with Oxycodone.,decrease,no risk
Paclitaxel,Ozanimod,The metabolism of Paclitaxel can be decreased when combined with Ozanimod.,decrease,no risk
Paclitaxel,Quetiapine,The metabolism of Paclitaxel can be decreased when combined with Quetiapine.,decrease,no risk
Paclitaxel,Quinapril,The risk or severity of adverse effects can be increased when Quinapril is combined with Paclitaxel.,increase,risk
Paclitaxel,Quinidine,The metabolism of Quinidine can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Quinine,The metabolism of Paclitaxel can be increased when combined with Quinine.,increase,no risk
Paclitaxel,Quinupramine,Paclitaxel may increase the neurotoxic activities of Quinupramine.,increase,no risk
Paclitaxel,Quinupristin,The metabolism of Paclitaxel can be decreased when combined with Quinupristin.,decrease,no risk
Paclitaxel,Quizartinib,The metabolism of Paclitaxel can be decreased when combined with Quizartinib.,decrease,no risk
Paclitaxel,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Paclitaxel is combined with Ubidecarenone.",increase,risk
Paclitaxel,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Paclitaxel.,increase,risk
Paclitaxel,Udenafil,The metabolism of Paclitaxel can be decreased when combined with Udenafil.,decrease,no risk
Paclitaxel,Ulipristal,The metabolism of Ulipristal can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Upadacitinib,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Upadacitinib.,increase,risk
Paclitaxel,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Paclitaxel.,increase,risk
Paclitaxel,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Paclitaxel which could result in a higher serum level.,decrease,no risk
Paclitaxel,Vadadustat,The serum concentration of Paclitaxel can be increased when it is combined with Vadadustat.,increase,no risk
Paclitaxel,Valbenazine,The metabolism of Paclitaxel can be decreased when combined with Valbenazine.,decrease,no risk
Paclitaxel,Valproate bismuth,Paclitaxel may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Paclitaxel,Valproic acid,The serum concentration of Paclitaxel can be increased when it is combined with Valproic acid.,increase,no risk
Paclitaxel,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Paclitaxel.,increase,risk
Paclitaxel,Vandetanib,The metabolism of Vandetanib can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Vardenafil,The metabolism of Paclitaxel can be decreased when combined with Vardenafil.,decrease,no risk
Paclitaxel,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Paclitaxel.,increase,risk
Paclitaxel,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Paclitaxel.,decrease,no risk
Paclitaxel,Vedolizumab,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Vedolizumab.,increase,risk
Paclitaxel,Velpatasvir,The metabolism of Paclitaxel can be decreased when combined with Velpatasvir.,decrease,no risk
Paclitaxel,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Venetoclax,The metabolism of Venetoclax can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Verapamil,The metabolism of Paclitaxel can be decreased when combined with Verapamil.,decrease,no risk
Paclitaxel,Vericiguat,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Vericiguat.,increase,risk
Paclitaxel,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Paclitaxel.,decrease,no risk
Paclitaxel,Vilanterol,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Vilanterol.,increase,risk
Paclitaxel,Viloxazine,The metabolism of Paclitaxel can be decreased when combined with Viloxazine.,decrease,no risk
Paclitaxel,Vinblastine,The metabolism of Paclitaxel can be increased when combined with Vinblastine.,increase,no risk
Paclitaxel,Vincristine,The metabolism of Vincristine can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Vindesine,The metabolism of Vindesine can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Vinflunine,The metabolism of Vinflunine can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Vinorelbine,Paclitaxel may increase the neurotoxic activities of Vinorelbine.,increase,no risk
Paclitaxel,Viomycin,Paclitaxel may increase the neurotoxic activities of Viomycin.,increase,no risk
Paclitaxel,Vitamin E,The metabolism of Paclitaxel can be increased when combined with Vitamin E.,increase,no risk
Paclitaxel,Voclosporin,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Voclosporin.,increase,risk
Paclitaxel,Vonoprazan,The metabolism of Paclitaxel can be decreased when combined with Vonoprazan.,decrease,no risk
Paclitaxel,Vorapaxar,The metabolism of Paclitaxel can be decreased when combined with Vorapaxar.,decrease,no risk
Paclitaxel,Voriconazole,The metabolism of Paclitaxel can be decreased when combined with Voriconazole.,decrease,no risk
Paclitaxel,Vorinostat,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Vorinostat.,increase,risk
Paclitaxel,Vortioxetine,The metabolism of Paclitaxel can be decreased when combined with Vortioxetine.,decrease,no risk
Paclitaxel,Voxelotor,The serum concentration of Paclitaxel can be increased when it is combined with Voxelotor.,increase,no risk
Paclitaxel,Voxilaprevir,The metabolism of Paclitaxel can be decreased when combined with Voxilaprevir.,decrease,no risk
Paclitaxel,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Paclitaxel.,increase,no risk
Paclitaxel,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Paclitaxel.,increase,risk
Paclitaxel,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Paclitaxel.,increase,risk
Paclitaxel,Zafirlukast,The serum concentration of Paclitaxel can be increased when it is combined with Zafirlukast.,increase,no risk
Paclitaxel,Zaleplon,The metabolism of Paclitaxel can be decreased when combined with Zaleplon.,decrease,no risk
Paclitaxel,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Zidovudine,The metabolism of Paclitaxel can be decreased when combined with Zidovudine.,decrease,no risk
Paclitaxel,Zimelidine,The metabolism of Paclitaxel can be decreased when combined with Zimelidine.,decrease,no risk
Paclitaxel,Ziprasidone,The metabolism of Paclitaxel can be decreased when combined with Ziprasidone.,decrease,no risk
Paclitaxel,Zofenopril,Paclitaxel may increase the hypotensive activities of Zofenopril.,increase,no risk
Paclitaxel,Zolpidem,The metabolism of Zolpidem can be increased when combined with Paclitaxel.,increase,no risk
Paclitaxel,Zonisamide,The metabolism of Paclitaxel can be decreased when combined with Zonisamide.,decrease,no risk
Paclitaxel,Zopiclone,The metabolism of Paclitaxel can be decreased when combined with Zopiclone.,decrease,no risk
Paclitaxel,Zotepine,Paclitaxel may increase the neurotoxic activities of Zotepine.,increase,no risk
Paclitaxel,Zuclopenthixol,The metabolism of Paclitaxel can be decreased when combined with Zuclopenthixol.,decrease,no risk
Paclitaxel,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Paclitaxel.,decrease,no risk
Saquinavir,Belinostat,The serum concentration of Belinostat can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Belumosudil,The metabolism of Belumosudil can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Saquinavir.,increase,risk
Saquinavir,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Benzphetamine,The metabolism of Benzphetamine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Bepridil,Bepridil may increase the QTc-prolonging and arrhythmogenic activities of Saquinavir.,increase,no risk
Saquinavir,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Betamethasone,The metabolism of Betamethasone can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Saquinavir.,decrease,no risk
Saquinavir,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Saquinavir.,increase,risk
Saquinavir,Bimekizumab,The metabolism of Saquinavir can be increased when combined with Bimekizumab.,increase,no risk
Saquinavir,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Saquinavir,Bisoprolol,The metabolism of Bisoprolol can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Boceprevir,The metabolism of Boceprevir can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Bosentan,The serum concentration of Bosentan can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Saquinavir.,increase,risk
Saquinavir,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Saquinavir.,increase,risk
Saquinavir,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Saquinavir.,increase,risk
Saquinavir,Budesonide,The metabolism of Budesonide can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Bumetanide,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Saquinavir.",increase,risk
Saquinavir,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Saquinavir.,increase,risk
Saquinavir,Buspirone,The metabolism of Buspirone can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Busulfan,The metabolism of Busulfan can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Butriptyline,The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Butriptyline.,increase,risk
Saquinavir,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Saquinavir.,increase,risk
Saquinavir,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Galantamine,The metabolism of Galantamine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Saquinavir.",increase,risk
Saquinavir,Garlic,Garlic can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Saquinavir,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Saquinavir.,increase,risk
Saquinavir,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Saquinavir.,increase,risk
Saquinavir,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Glecaprevir,Saquinavir may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Saquinavir,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Saquinavir.,decrease,no risk
Saquinavir,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Saquinavir.,decrease,no risk
Saquinavir,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Saquinavir.,decrease,no risk
Saquinavir,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Saquinavir.,decrease,no risk
Saquinavir,Glofitamab,The serum concentration of Saquinavir can be increased when it is combined with Glofitamab.,increase,no risk
Saquinavir,Glyburide,The metabolism of Glyburide can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Glycyrrhizic acid,Saquinavir may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Saquinavir,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Saquinavir.,decrease,no risk
Saquinavir,Golimumab,The metabolism of Saquinavir can be increased when combined with Golimumab.,increase,no risk
Saquinavir,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Saquinavir.,increase,risk
Saquinavir,Granisetron,The metabolism of Granisetron can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Haloperidol,The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Haloperidol.,increase,risk
Saquinavir,Histamine,The risk or severity of adverse effects can be increased when Saquinavir is combined with Histamine.,increase,risk
Saquinavir,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Saquinavir.,increase,risk
Saquinavir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Saquinavir.,decrease,no risk
Saquinavir,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Saquinavir.,increase,risk
Saquinavir,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Saquinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Saquinavir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Hydroxyzine.,increase,risk
Saquinavir,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Saquinavir.,increase,risk
Saquinavir,Ketamine,The metabolism of Ketamine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Ketoconazole,The serum concentration of Ketoconazole can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Saquinavir.,increase,risk
Saquinavir,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Saquinavir.,increase,risk
Saquinavir,Olanzapine,Olanzapine can cause an increase in the absorption of Saquinavir resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Saquinavir,Olaparib,The metabolism of Olaparib can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Olmesartan,Olmesartan may decrease the excretion rate of Saquinavir which could result in a higher serum level.,decrease,no risk
Saquinavir,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Olutasidenib,The therapeutic efficacy of Saquinavir can be decreased when used in combination with Olutasidenib.,decrease,no risk
Saquinavir,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Omeprazole,The serum concentration of Saquinavir can be increased when it is combined with Omeprazole.,increase,no risk
Saquinavir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Opium,The metabolism of Opium can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Ouabain,The excretion of Ouabain can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Saquinavir.,increase,risk
Saquinavir,Oxatomide,The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Oxatomide.,increase,risk
Saquinavir,Oxcarbazepine,The metabolism of Saquinavir can be increased when combined with Oxcarbazepine.,increase,no risk
Saquinavir,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Saquinavir.,increase,risk
Saquinavir,Ozanimod,Saquinavir may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Saquinavir,Quazepam,The metabolism of Quazepam can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Quinidine,The metabolism of Quinidine can be increased when combined with Saquinavir.,increase,no risk
Saquinavir,Quinine,The metabolism of Quinine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Saquinavir is combined with Ubidecarenone.",increase,risk
Saquinavir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Udenafil,The metabolism of Udenafil can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Umbralisib,The serum concentration of Saquinavir can be increased when it is combined with Umbralisib.,increase,no risk
Saquinavir,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Saquinavir which could result in a higher serum level.,decrease,no risk
Saquinavir,Vadadustat,The serum concentration of Saquinavir can be increased when it is combined with Vadadustat.,increase,no risk
Saquinavir,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Valproic acid,The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Valproic acid.,increase,risk
Saquinavir,Valsartan,The excretion of Valsartan can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Saquinavir.,decrease,no risk
Saquinavir,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Vemurafenib,The serum concentration of Saquinavir can be increased when it is combined with Vemurafenib.,increase,no risk
Saquinavir,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Verapamil,The metabolism of Verapamil can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Saquinavir.,increase,risk
Saquinavir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Saquinavir.,decrease,no risk
Saquinavir,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Saquinavir.,decrease,no risk
Saquinavir,Viloxazine,The metabolism of Saquinavir can be decreased when combined with Viloxazine.,decrease,no risk
Saquinavir,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Vincristine,The excretion of Vincristine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Vindesine,The metabolism of Vindesine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Voriconazole,The serum concentration of Voriconazole can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Saquinavir.,increase,risk
Saquinavir,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Saquinavir.,increase,no risk
Saquinavir,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Warfarin,The metabolism of Warfarin can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Saquinavir.,decrease,no risk
Saquinavir,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Zileuton,The metabolism of Zileuton can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Zimelidine,The metabolism of Saquinavir can be decreased when combined with Zimelidine.,decrease,no risk
Saquinavir,Ziprasidone,The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Ziprasidone.,increase,risk
Saquinavir,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Zotepine,The metabolism of Zotepine can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Saquinavir.,decrease,no risk
Saquinavir,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Saquinavir.,increase,no risk
Metoclopramide,Bacitracin,Bacitracin may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Baclofen,The risk or severity of sedation can be increased when Metoclopramide is combined with Baclofen.,increase,risk
Metoclopramide,Balsalazide,Balsalazide may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Baricitinib,Metoclopramide may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Metoclopramide,Beclomethasone dipropionate,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Metoclopramide,Bedaquiline,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Bedaquiline.,increase,risk
Metoclopramide,Belinostat,The metabolism of Metoclopramide can be increased when combined with Belinostat.,increase,no risk
Metoclopramide,Belladonna,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Belladonna.,decrease,no risk
Metoclopramide,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Metoclopramide.,decrease,no risk
Metoclopramide,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Metoclopramide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Metoclopramide,Benorilate,Benorilate may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Benperidol,The risk or severity of adverse effects can be increased when Metoclopramide is combined with Benperidol.,increase,risk
Metoclopramide,Benserazide,The therapeutic efficacy of Benserazide can be decreased when used in combination with Metoclopramide.,decrease,no risk
Metoclopramide,Benzatropine,The risk or severity of adverse effects can be increased when Metoclopramide is combined with Benzatropine.,increase,risk
Metoclopramide,Benzhydrocodone,The therapeutic efficacy of Benzhydrocodone can be increased when used in combination with Metoclopramide.,increase,no risk
Metoclopramide,Benznidazole,Metoclopramide may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Metoclopramide,Benzocaine,The risk or severity of sedation can be increased when Metoclopramide is combined with Benzocaine.,increase,risk
Metoclopramide,Benzonatate,Metoclopramide may increase the neuromuscular blocking activities of Benzonatate.,increase,no risk
Metoclopramide,Benzphetamine,The risk or severity of sedation can be increased when Metoclopramide is combined with Benzphetamine.,increase,risk
Metoclopramide,Benzthiazide,Benzthiazide may increase the excretion rate of Metoclopramide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Metoclopramide,Benzydamine,Benzydamine may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Benzyl alcohol,The risk or severity of sedation can be increased when Metoclopramide is combined with Benzyl alcohol.,increase,risk
Metoclopramide,Bepotastine,Metoclopramide may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Metoclopramide,Bepridil,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Bepridil.,increase,risk
Metoclopramide,Berotralstat,The metabolism of Metoclopramide can be decreased when combined with Berotralstat.,decrease,no risk
Metoclopramide,Betamethasone,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Betamethasone.,decrease,no risk
Metoclopramide,Betamethasone phosphate,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Betamethasone phosphate.,decrease,no risk
Metoclopramide,Betaxolol,Metoclopramide may increase the bradycardic activities of Betaxolol.,increase,no risk
Metoclopramide,Bethanechol,The risk or severity of adverse effects can be increased when Metoclopramide is combined with Bethanechol.,increase,risk
Metoclopramide,Bezafibrate,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Bezafibrate.",increase,risk
Metoclopramide,Bicisate,Metoclopramide may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Metoclopramide,Bilastine,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Bilastine.,increase,risk
Metoclopramide,Bimekizumab,The metabolism of Metoclopramide can be increased when combined with Bimekizumab.,increase,no risk
Metoclopramide,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Metoclopramide.,decrease,no risk
Metoclopramide,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Metoclopramide.,decrease,no risk
Metoclopramide,Bismuth subgallate,Metoclopramide may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Metoclopramide,Bisoprolol,Metoclopramide may increase the bradycardic activities of Bisoprolol.,increase,no risk
Metoclopramide,Bisoxatin,Metoclopramide may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Metoclopramide,Bleomycin,Bleomycin may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Boceprevir,The metabolism of Metoclopramide can be decreased when combined with Boceprevir.,decrease,no risk
Metoclopramide,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Metoclopramide.,decrease,no risk
Metoclopramide,Botulinum toxin type A,The risk or severity of sedation can be increased when Metoclopramide is combined with Botulinum toxin type A.,increase,risk
Metoclopramide,Botulinum toxin type B,The risk or severity of sedation can be increased when Metoclopramide is combined with Botulinum toxin type B.,increase,risk
Metoclopramide,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Metoclopramide.,increase,risk
Metoclopramide,Brexanolone,The risk or severity of sedation can be increased when Metoclopramide is combined with Brexanolone.,increase,risk
Metoclopramide,Brexpiprazole,The risk or severity of adverse effects can be increased when Metoclopramide is combined with Brexpiprazole.,increase,risk
Metoclopramide,Brimonidine,The risk or severity of sedation can be increased when Metoclopramide is combined with Brimonidine.,increase,risk
Metoclopramide,Brivaracetam,The risk or severity of sedation can be increased when Metoclopramide is combined with Brivaracetam.,increase,risk
Metoclopramide,Bromazepam,The risk or severity of sedation can be increased when Metoclopramide is combined with Bromazepam.,increase,risk
Metoclopramide,Bromocriptine,The risk or severity of sedation can be increased when Metoclopramide is combined with Bromocriptine.,increase,risk
Metoclopramide,Bromotheophylline,Bromotheophylline may increase the excretion rate of Metoclopramide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Metoclopramide,Bromperidol,The risk or severity of adverse effects can be increased when Metoclopramide is combined with Bromperidol.,increase,risk
Metoclopramide,Brompheniramine,The risk or severity of sedation can be increased when Metoclopramide is combined with Brompheniramine.,increase,risk
Metoclopramide,Buclizine,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Buclizine.,decrease,no risk
Metoclopramide,Budesonide,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Budesonide.,decrease,no risk
Metoclopramide,Bumadizone,Bumadizone may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Bumetanide,Bumetanide may increase the excretion rate of Metoclopramide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Metoclopramide,Bupivacaine,The risk or severity of sedation can be increased when Metoclopramide is combined with Bupivacaine.,increase,risk
Metoclopramide,Buprenorphine,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Buprenorphine.,decrease,no risk
Metoclopramide,Bupropion,The risk or severity of sedation can be increased when Metoclopramide is combined with Bupropion.,increase,risk
Metoclopramide,Buserelin,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Buserelin.,increase,risk
Metoclopramide,Buspirone,The risk or severity of sedation can be increased when Metoclopramide is combined with Buspirone.,increase,risk
Metoclopramide,Butabarbital,The risk or severity of sedation can be increased when Metoclopramide is combined with Butabarbital.,increase,risk
Metoclopramide,Butacaine,The risk or severity of methemoglobinemia can be increased when Metoclopramide is combined with Butacaine.,increase,risk
Metoclopramide,Butalbital,The risk or severity of sedation can be increased when Metoclopramide is combined with Butalbital.,increase,risk
Metoclopramide,Butamben,The risk or severity of sedation can be increased when Metoclopramide is combined with Butamben.,increase,risk
Metoclopramide,Butaperazine,The risk or severity of adverse effects can be increased when Metoclopramide is combined with Butaperazine.,increase,risk
Metoclopramide,Butobarbital,The risk or severity of sedation can be increased when Metoclopramide is combined with Butobarbital.,increase,risk
Metoclopramide,Butorphanol,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Butorphanol.,decrease,no risk
Metoclopramide,Butriptyline,The risk or severity of sedation can be increased when Metoclopramide is combined with Butriptyline.,increase,risk
Metoclopramide,Butylscopolamine,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Butylscopolamine.,decrease,no risk
Metoclopramide,Gabapentin,The risk or severity of sedation can be increased when Metoclopramide is combined with Gabapentin.,increase,risk
Metoclopramide,Gabapentin enacarbil,The risk or severity of sedation can be increased when Metoclopramide is combined with Gabapentin enacarbil.,increase,risk
Metoclopramide,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Gadobenic acid.,increase,risk
Metoclopramide,Gadodiamide,Gadodiamide may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Gadofosveset trisodium,Metoclopramide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Metoclopramide,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Gadoteric acid,Metoclopramide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Metoclopramide,Gadoteridol,Gadoteridol may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Galantamine,The metabolism of Galantamine can be decreased when combined with Metoclopramide.,decrease,no risk
Metoclopramide,Gallamine triethiodide,The risk or severity of sedation can be increased when Metoclopramide is combined with Gallamine triethiodide.,increase,risk
Metoclopramide,Ganaxolone,The risk or severity of sedation can be increased when Metoclopramide is combined with Ganaxolone.,increase,risk
Metoclopramide,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Metoclopramide.",increase,risk
Metoclopramide,Gatifloxacin,The metabolism of Metoclopramide can be decreased when combined with Gatifloxacin.,decrease,no risk
Metoclopramide,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Metoclopramide.,decrease,no risk
Metoclopramide,Gemcitabine,Gemcitabine may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Gemfibrozil.",increase,risk
Metoclopramide,Gemifloxacin,The metabolism of Metoclopramide can be decreased when combined with Gemifloxacin.,decrease,no risk
Metoclopramide,Gentamicin,Metoclopramide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Metoclopramide,Gepirone,The risk or severity of sedation can be increased when Metoclopramide is combined with Gepirone.,increase,risk
Metoclopramide,Gilteritinib,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Gilteritinib.,increase,risk
Metoclopramide,Gimeracil,Metoclopramide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Metoclopramide,Givosiran,The serum concentration of Metoclopramide can be increased when it is combined with Givosiran.,increase,no risk
Metoclopramide,Glasdegib,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Glasdegib.,increase,risk
Metoclopramide,Glipizide,Glipizide may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Glofitamab,The serum concentration of Metoclopramide can be increased when it is combined with Glofitamab.,increase,no risk
Metoclopramide,Glutethimide,The risk or severity of sedation can be increased when Metoclopramide is combined with Glutethimide.,increase,risk
Metoclopramide,Glycerol phenylbutyrate,The metabolism of Metoclopramide can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Metoclopramide,Glycopyrronium,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Metoclopramide,Golimumab,The metabolism of Metoclopramide can be increased when combined with Golimumab.,increase,no risk
Metoclopramide,Golodirsen,Metoclopramide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Metoclopramide,Goserelin,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Goserelin.,increase,risk
Metoclopramide,Granisetron,The risk or severity of sedation can be increased when Metoclopramide is combined with Granisetron.,increase,risk
Metoclopramide,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Grepafloxacin.,increase,risk
Metoclopramide,Guanabenz,The metabolism of Metoclopramide can be decreased when combined with Guanabenz.,decrease,no risk
Metoclopramide,Guanethidine,Guanethidine may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Guanfacine,The risk or severity of sedation can be increased when Metoclopramide is combined with Guanfacine.,increase,risk
Metoclopramide,Halazepam,The risk or severity of sedation can be increased when Metoclopramide is combined with Halazepam.,increase,risk
Metoclopramide,Halofantrine,The metabolism of Metoclopramide can be decreased when combined with Halofantrine.,decrease,no risk
Metoclopramide,Haloperidol,The risk or severity of adverse effects can be increased when Metoclopramide is combined with Haloperidol.,increase,risk
Metoclopramide,Halothane,The risk or severity of sedation can be increased when Metoclopramide is combined with Halothane.,increase,risk
Metoclopramide,Hexafluronium,The risk or severity of sedation can be increased when Metoclopramide is combined with Hexafluronium.,increase,risk
Metoclopramide,Hexocyclium,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Hexocyclium.,decrease,no risk
Metoclopramide,Histrelin,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Histrelin.,increase,risk
Metoclopramide,Homatropine,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Homatropine.,decrease,no risk
Metoclopramide,Homatropine methylbromide,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Homatropine methylbromide.,decrease,no risk
Metoclopramide,Hydralazine,Metoclopramide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Metoclopramide,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Metoclopramide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Metoclopramide,Hydrocodone,The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Metoclopramide.,increase,risk
Metoclopramide,Hydrocortisone,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Metoclopramide,Hydrocortisone acetate,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Metoclopramide,Hydrocortisone butyrate,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Metoclopramide,Hydrocortisone cypionate,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Metoclopramide,Hydrocortisone succinate,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Metoclopramide,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Metoclopramide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Metoclopramide,Hydromorphone,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Hydromorphone.,decrease,no risk
Metoclopramide,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Metoclopramide.,decrease,no risk
Metoclopramide,Hydroxyethyl Starch,Metoclopramide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Metoclopramide,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Metoclopramide.,increase,risk
Metoclopramide,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Hydroxyzine.,increase,risk
Metoclopramide,Hyoscyamine,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Hyoscyamine.,decrease,no risk
Metoclopramide,Kanamycin,Metoclopramide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Metoclopramide,Ketamine,The risk or severity of sedation can be increased when Metoclopramide is combined with Ketamine.,increase,risk
Metoclopramide,Ketazolam,The risk or severity of sedation can be increased when Metoclopramide is combined with Ketazolam.,increase,risk
Metoclopramide,Ketoconazole,The metabolism of Metoclopramide can be decreased when combined with Ketoconazole.,decrease,no risk
Metoclopramide,Ketoprofen,Ketoprofen may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Ketorolac,Ketorolac may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Obeticholic acid,The metabolism of Metoclopramide can be decreased when combined with Obeticholic acid.,decrease,no risk
Metoclopramide,Octinoxate,Metoclopramide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Metoclopramide,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Metoclopramide.,increase,risk
Metoclopramide,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ofloxacin is combined with Metoclopramide.",increase,risk
Metoclopramide,Olanzapine,The risk or severity of adverse effects can be increased when Metoclopramide is combined with Olanzapine.,increase,risk
Metoclopramide,Oliceridine,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Oliceridine.,decrease,no risk
Metoclopramide,Olodaterol,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Olodaterol.,increase,risk
Metoclopramide,Olsalazine,Olsalazine may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Omaveloxolone,The serum concentration of Metoclopramide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Metoclopramide,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Metoclopramide.,decrease,no risk
Metoclopramide,Opium,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Opium.,decrease,no risk
Metoclopramide,Oritavancin,The metabolism of Metoclopramide can be decreased when combined with Oritavancin.,decrease,no risk
Metoclopramide,Orphenadrine,The risk or severity of sedation can be increased when Metoclopramide is combined with Orphenadrine.,increase,risk
Metoclopramide,Oseltamivir,Oseltamivir may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Osilodrostat,The metabolism of Metoclopramide can be decreased when combined with Osilodrostat.,decrease,no risk
Metoclopramide,Osimertinib,The serum concentration of Metoclopramide can be decreased when it is combined with Osimertinib.,decrease,no risk
Metoclopramide,Ospemifene,The metabolism of Metoclopramide can be decreased when combined with Ospemifene.,decrease,no risk
Metoclopramide,Oxacillin,Oxacillin may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Metoclopramide.,increase,risk
Metoclopramide,Oxamniquine,The metabolism of Metoclopramide can be decreased when combined with Oxamniquine.,decrease,no risk
Metoclopramide,Oxaprozin,Oxaprozin may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Oxatomide,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Oxatomide.,increase,risk
Metoclopramide,Oxazepam,The risk or severity of sedation can be increased when Metoclopramide is combined with Oxazepam.,increase,risk
Metoclopramide,Oxcarbazepine,The risk or severity of sedation can be increased when Metoclopramide is combined with Oxcarbazepine.,increase,risk
Metoclopramide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Metoclopramide is combined with Oxetacaine.,increase,risk
Metoclopramide,Oxitriptan,The risk or severity of sedation can be increased when Metoclopramide is combined with Oxitriptan.,increase,risk
Metoclopramide,Oxprenolol,The risk or severity of sedation can be increased when Metoclopramide is combined with Oxprenolol.,increase,risk
Metoclopramide,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Metoclopramide.,decrease,no risk
Metoclopramide,Oxybenzone,Metoclopramide may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Metoclopramide,Oxybuprocaine,The risk or severity of sedation can be increased when Metoclopramide is combined with Oxybuprocaine.,increase,risk
Metoclopramide,Oxybutynin,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Oxybutynin.,decrease,no risk
Metoclopramide,Oxycodone,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Oxycodone.,decrease,no risk
Metoclopramide,Oxymorphone,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Oxymorphone.,decrease,no risk
Metoclopramide,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Oxyphencyclimine,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Metoclopramide,Oxyphenonium,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Metoclopramide,Oxyquinoline,Metoclopramide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Metoclopramide,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Metoclopramide.,increase,risk
Metoclopramide,Quazepam,The risk or severity of sedation can be increased when Metoclopramide is combined with Quazepam.,increase,risk
Metoclopramide,Quetiapine,The risk or severity of adverse effects can be increased when Metoclopramide is combined with Quetiapine.,increase,risk
Metoclopramide,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Metoclopramide.,decrease,no risk
Metoclopramide,Quinethazone,Quinethazone may increase the excretion rate of Metoclopramide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Metoclopramide,Quinidine,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Quinidine.,decrease,no risk
Metoclopramide,Quinine,The risk or severity of sedation can be increased when Metoclopramide is combined with Quinine.,increase,risk
Metoclopramide,Quinupramine,The risk or severity of sedation can be increased when Metoclopramide is combined with Quinupramine.,increase,risk
Metoclopramide,Quizartinib,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Quizartinib.,increase,risk
Metoclopramide,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Ubidecarenone.",increase,risk
Metoclopramide,Umeclidinium,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Umeclidinium.,decrease,no risk
Metoclopramide,Urethane,The risk or severity of sedation can be increased when Metoclopramide is combined with Urethane.,increase,risk
Metoclopramide,Vaborbactam,Metoclopramide may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Metoclopramide,Vadadustat,The serum concentration of Metoclopramide can be increased when it is combined with Vadadustat.,increase,no risk
Metoclopramide,Valaciclovir,Valaciclovir may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Metoclopramide.,decrease,no risk
Metoclopramide,Valdecoxib,Valdecoxib may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Valganciclovir,Metoclopramide may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Metoclopramide,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Metoclopramide is combined with Valproate bismuth.,increase,risk
Metoclopramide,Valproic acid,The risk or severity of sedation can be increased when Metoclopramide is combined with Valproic acid.,increase,risk
Metoclopramide,Vamorolone,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Vamorolone.,decrease,no risk
Metoclopramide,Vancomycin,Metoclopramide may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Metoclopramide,Vandetanib,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Vandetanib.,increase,risk
Metoclopramide,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Metoclopramide.,increase,risk
Metoclopramide,Varenicline,The risk or severity of adverse effects can be increased when Metoclopramide is combined with Varenicline.,increase,risk
Metoclopramide,Vecuronium,The risk or severity of sedation can be increased when Metoclopramide is combined with Vecuronium.,increase,risk
Metoclopramide,Vemurafenib,The serum concentration of Metoclopramide can be increased when it is combined with Vemurafenib.,increase,no risk
Metoclopramide,Venetoclax,The metabolism of Metoclopramide can be decreased when combined with Venetoclax.,decrease,no risk
Metoclopramide,Venlafaxine,The risk or severity of adverse effects can be increased when Metoclopramide is combined with Venlafaxine.,increase,risk
Metoclopramide,Verapamil,The metabolism of Metoclopramide can be decreased when combined with Verapamil.,decrease,no risk
Metoclopramide,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Metoclopramide.,decrease,no risk
Metoclopramide,Vigabatrin,The risk or severity of sedation can be increased when Metoclopramide is combined with Vigabatrin.,increase,risk
Metoclopramide,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Metoclopramide.,increase,risk
Metoclopramide,Vilazodone,The risk or severity of sedation can be increased when Metoclopramide is combined with Vilazodone.,increase,risk
Metoclopramide,Viloxazine,The risk or severity of sedation can be increased when Metoclopramide is combined with Viloxazine.,increase,risk
Metoclopramide,Vinblastine,The metabolism of Metoclopramide can be decreased when combined with Vinblastine.,decrease,no risk
Metoclopramide,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Metoclopramide.",increase,risk
Metoclopramide,Vinorelbine,The metabolism of Metoclopramide can be decreased when combined with Vinorelbine.,decrease,no risk
Metoclopramide,Voriconazole,The metabolism of Metoclopramide can be decreased when combined with Voriconazole.,decrease,no risk
Metoclopramide,Vorinostat,The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Vorinostat.,increase,risk
Metoclopramide,Vortioxetine,The risk or severity of sedation can be increased when Metoclopramide is combined with Vortioxetine.,increase,risk
Metoclopramide,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Metoclopramide.,decrease,no risk
Metoclopramide,Warfarin,Metoclopramide may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Metoclopramide,Yohimbine,The risk or severity of sedation can be increased when Metoclopramide is combined with Yohimbine.,increase,risk
Metoclopramide,Zaleplon,The risk or severity of sedation can be increased when Metoclopramide is combined with Zaleplon.,increase,risk
Metoclopramide,Zanamivir,Zanamivir may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,decrease,no risk
Metoclopramide,Ziconotide,The risk or severity of sedation can be increased when Metoclopramide is combined with Ziconotide.,increase,risk
Metoclopramide,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Metoclopramide.",increase,risk
Metoclopramide,Zileuton,The metabolism of Metoclopramide can be decreased when combined with Zileuton.,decrease,no risk
Metoclopramide,Zimelidine,The risk or severity of sedation can be increased when Metoclopramide is combined with Zimelidine.,increase,risk
Metoclopramide,Ziprasidone,The risk or severity of adverse effects can be increased when Metoclopramide is combined with Ziprasidone.,increase,risk
Metoclopramide,Zolmitriptan,The risk or severity of sedation can be increased when Metoclopramide is combined with Zolmitriptan.,increase,risk
Metoclopramide,Zolpidem,The risk or severity of sedation can be increased when Metoclopramide is combined with Zolpidem.,increase,risk
Metoclopramide,Zonisamide,The risk or severity of sedation can be increased when Metoclopramide is combined with Zonisamide.,increase,risk
Metoclopramide,Zopiclone,The risk or severity of sedation can be increased when Metoclopramide is combined with Zopiclone.,increase,risk
Metoclopramide,Zotepine,The risk or severity of adverse effects can be increased when Metoclopramide is combined with Zotepine.,increase,risk
Metoclopramide,Zuclopenthixol,The risk or severity of adverse effects can be increased when Metoclopramide is combined with Zuclopenthixol.,increase,risk
Dexamethasone,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Baclofen,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Dexamethasone.",increase,risk
Dexamethasone,Balsalazide,The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Balsalazide.,increase,risk
Dexamethasone,Baricitinib,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Baricitinib.,increase,risk
Dexamethasone,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Dexamethasone.,increase,risk
Dexamethasone,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Beclomethasone dipropionate,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Dexamethasone.,increase,risk
Dexamethasone,Bedaquiline,The serum concentration of Bedaquiline can be decreased when it is combined with Dexamethasone.,decrease,no risk
Dexamethasone,Belantamab mafodotin,Dexamethasone may increase the excretion rate of Belantamab mafodotin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dexamethasone,Belatacept,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Belatacept.,increase,risk
Dexamethasone,Belimumab,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Belimumab.,increase,risk
Dexamethasone,Belinostat,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Belinostat.,increase,risk
Dexamethasone,Belumosudil,The serum concentration of Belumosudil can be decreased when it is combined with Dexamethasone.,decrease,no risk
Dexamethasone,Bendamustine,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Bendamustine.,increase,risk
Dexamethasone,Bendroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Bendroflumethiazide.,increase,risk
Dexamethasone,Benorilate,The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Benorilate.,increase,risk
Dexamethasone,Benoxaprofen,The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Benoxaprofen.,increase,risk
Dexamethasone,Benzocaine,The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Benzocaine.,increase,risk
Dexamethasone,Benzoic acid,The therapeutic efficacy of Benzoic acid can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Benzphetamine,The metabolism of Benzphetamine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Benzthiazide,The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Benzthiazide.,increase,risk
Dexamethasone,Benzydamine,The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Benzydamine.,increase,risk
Dexamethasone,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Benzyl alcohol.,increase,risk
Dexamethasone,Benzylpenicillin,The excretion of Dexamethasone can be decreased when combined with Benzylpenicillin.,decrease,no risk
Dexamethasone,Bepridil,The metabolism of Bepridil can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Dexamethasone.,increase,no risk
Dexamethasone,Betaine,The therapeutic efficacy of Betaine can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Bexagliflozin,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Bexagliflozin.,increase,risk
Dexamethasone,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Dexamethasone.,increase,risk
Dexamethasone,Bezafibrate,The metabolism of Bezafibrate can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Bictegravir,The metabolism of Bictegravir can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Bimekizumab,The metabolism of Dexamethasone can be increased when combined with Bimekizumab.,increase,no risk
Dexamethasone,Binimetinib,The metabolism of Binimetinib can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Bismuth subsalicylate,The serum concentration of Bismuth subsalicylate can be decreased when it is combined with Dexamethasone.,decrease,no risk
Dexamethasone,Bisoprolol,The metabolism of Bisoprolol can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Dexamethasone.,increase,risk
Dexamethasone,Blinatumomab,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Blinatumomab.,increase,risk
Dexamethasone,Boceprevir,The metabolism of Dexamethasone can be decreased when combined with Boceprevir.,decrease,no risk
Dexamethasone,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Dexamethasone.",decrease,no risk
Dexamethasone,Bortezomib,The serum concentration of Bortezomib can be decreased when it is combined with Dexamethasone.,decrease,no risk
Dexamethasone,Bosentan,The metabolism of Bosentan can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Bosutinib,The serum concentration of Bosutinib can be decreased when it is combined with Dexamethasone.,decrease,no risk
Dexamethasone,Botulinum toxin type A,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Dexamethasone.,increase,risk
Dexamethasone,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Brigatinib,The metabolism of Brigatinib can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Brodalumab,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Brodalumab.,increase,risk
Dexamethasone,Bromocriptine,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Bromocriptine.,increase,risk
Dexamethasone,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Dexamethasone.,increase,risk
Dexamethasone,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Bumadizone.,increase,risk
Dexamethasone,Bumetanide,The excretion of Dexamethasone can be decreased when combined with Bumetanide.,decrease,no risk
Dexamethasone,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Bupivacaine.,increase,risk
Dexamethasone,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Bupropion,The metabolism of Bupropion can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Buspirone,The metabolism of Buspirone can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Busulfan,The metabolism of Busulfan can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Butacaine,The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Butacaine.,increase,risk
Dexamethasone,Butamben,The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Butamben.,increase,risk
Dexamethasone,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Ganaxolone,The metabolism of Ganaxolone can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Ganciclovir,The excretion of Dexamethasone can be decreased when combined with Ganciclovir.,decrease,no risk
Dexamethasone,Gatifloxacin,The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Gatifloxacin.,increase,risk
Dexamethasone,Gefitinib,The metabolism of Gefitinib can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dexamethasone.,increase,risk
Dexamethasone,Gemfibrozil,The metabolism of Gemfibrozil can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Gemifloxacin,The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Gemifloxacin.,increase,risk
Dexamethasone,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dexamethasone.,increase,risk
Dexamethasone,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Dexamethasone.,increase,no risk
Dexamethasone,Gestrinone,The serum concentration of Dexamethasone can be increased when it is combined with Gestrinone.,increase,no risk
Dexamethasone,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Glasdegib,The serum concentration of Glasdegib can be decreased when it is combined with Dexamethasone.,decrease,no risk
Dexamethasone,Glatiramer,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Glatiramer.,increase,risk
Dexamethasone,Glecaprevir,Dexamethasone may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Dexamethasone,Gliclazide,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Gliclazide.,increase,risk
Dexamethasone,Glimepiride,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Glimepiride.,increase,risk
Dexamethasone,Glipizide,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Glipizide.,increase,risk
Dexamethasone,Gliquidone,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Gliquidone.,increase,risk
Dexamethasone,Glofitamab,The serum concentration of Dexamethasone can be increased when it is combined with Glofitamab.,increase,no risk
Dexamethasone,Glyburide,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Glyburide.,increase,risk
Dexamethasone,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Glycol salicylate.,increase,risk
Dexamethasone,Glycyrrhizic acid,Dexamethasone may increase the excretion rate of Glycyrrhizic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dexamethasone,Glymidine,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Glymidine.,increase,risk
Dexamethasone,Golimumab,The metabolism of Dexamethasone can be increased when combined with Golimumab.,increase,no risk
Dexamethasone,Granisetron,The metabolism of Granisetron can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Grazoprevir,The metabolism of Grazoprevir can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Grepafloxacin,The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Grepafloxacin.,increase,risk
Dexamethasone,Guanfacine,The metabolism of Guanfacine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Guanidine,The excretion of Dexamethasone can be decreased when combined with Guanidine.,decrease,no risk
Dexamethasone,Guselkumab,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Guselkumab.,increase,risk
Dexamethasone,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Halofantrine,The metabolism of Halofantrine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Dexamethasone.,increase,no risk
Dexamethasone,Halothane,The metabolism of Halothane can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Hydrochlorothiazide.,increase,risk
Dexamethasone,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Hydrocortisone acetate.,increase,risk
Dexamethasone,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Hydrocortisone butyrate.,increase,risk
Dexamethasone,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Hydrocortisone succinate.,increase,risk
Dexamethasone,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Dexamethasone is combined with Hydroflumethiazide.,increase,risk
Dexamethasone,Hydrotalcite,The bioavailability of Dexamethasone can be decreased when combined with Hydrotalcite.,decrease,no risk
Dexamethasone,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Hydroxychloroquine.,increase,risk
Dexamethasone,Hydroxyprogesterone caproate,The serum concentration of Dexamethasone can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Dexamethasone,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Dexamethasone.,increase,risk
Dexamethasone,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Ketazolam,The metabolism of Ketazolam can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Ketoconazole,The metabolism of Dexamethasone can be decreased when combined with Ketoconazole.,decrease,no risk
Dexamethasone,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Ketoprofen.,increase,risk
Dexamethasone,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Ketorolac.,increase,risk
Dexamethasone,Obinutuzumab,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Obinutuzumab.,increase,risk
Dexamethasone,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Dexamethasone.,increase,no risk
Dexamethasone,Ofatumumab,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Ofatumumab.,increase,risk
Dexamethasone,Ofloxacin,The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Ofloxacin.,increase,risk
Dexamethasone,Olaparib,The metabolism of Olaparib can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Dexamethasone.,decrease,no risk
Dexamethasone,Olodaterol,The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Olodaterol.,increase,risk
Dexamethasone,Olsalazine,The serum concentration of Olsalazine can be decreased when it is combined with Dexamethasone.,decrease,no risk
Dexamethasone,Olutasidenib,The therapeutic efficacy of Olutasidenib can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Omaveloxolone,The therapeutic efficacy of Omaveloxolone can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Ombitasvir,Dexamethasone may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Dexamethasone,Ondansetron,The metabolism of Ondansetron can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Opium,The metabolism of Opium can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Orciprenaline,The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Orciprenaline.,increase,risk
Dexamethasone,Orphenadrine,The metabolism of Orphenadrine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Osilodrostat,The serum concentration of Osilodrostat can be decreased when it is combined with Dexamethasone.,decrease,no risk
Dexamethasone,Osimertinib,The metabolism of Osimertinib can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Ospemifene,The metabolism of Ospemifene can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Ouabain,The excretion of Dexamethasone can be decreased when combined with Ouabain.,decrease,no risk
Dexamethasone,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Dexamethasone.,increase,risk
Dexamethasone,Oxandrolone,The risk or severity of fluid retention can be increased when Dexamethasone is combined with Oxandrolone.,increase,risk
Dexamethasone,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Oxaprozin.,increase,risk
Dexamethasone,Oxcarbazepine,The metabolism of Dexamethasone can be increased when combined with Oxcarbazepine.,increase,no risk
Dexamethasone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Oxetacaine.,increase,risk
Dexamethasone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Oxybuprocaine.,increase,risk
Dexamethasone,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Oxycodone,The metabolism of Oxycodone can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Oxymetazoline,The absorption of Dexamethasone can be decreased when combined with Oxymetazoline.,decrease,no risk
Dexamethasone,Oxymetholone,The risk or severity of fluid retention can be increased when Dexamethasone is combined with Oxymetholone.,increase,risk
Dexamethasone,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Oxyphenbutazone.,increase,risk
Dexamethasone,Oxytetracycline,The excretion of Dexamethasone can be decreased when combined with Oxytetracycline.,decrease,no risk
Dexamethasone,Ozanimod,Dexamethasone may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Dexamethasone,Quazepam,The metabolism of Quazepam can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Quetiapine,The metabolism of Quetiapine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Quinestrol,The serum concentration of Dexamethasone can be increased when it is combined with Quinestrol.,increase,no risk
Dexamethasone,Quinethazone,Dexamethasone may increase the hypokalemic activities of Quinethazone.,increase,no risk
Dexamethasone,Quinidine,The metabolism of Quinidine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Quinine,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Quinine.,increase,risk
Dexamethasone,Quizartinib,The serum concentration of Quizartinib can be decreased when it is combined with Dexamethasone.,decrease,no risk
Dexamethasone,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Ubidecarenone.",increase,risk
Dexamethasone,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Dexamethasone.,increase,risk
Dexamethasone,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Dexamethasone.,decrease,no risk
Dexamethasone,Udenafil,The metabolism of Udenafil can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Ulipristal,The metabolism of Ulipristal can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Upadacitinib,The metabolism of Upadacitinib can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Ursodeoxycholic acid,Dexamethasone may increase the excretion rate of Ursodeoxycholic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dexamethasone,Vadadustat,The serum concentration of Dexamethasone can be increased when it is combined with Vadadustat.,increase,no risk
Dexamethasone,Valbenazine,The serum concentration of Valbenazine can be decreased when it is combined with Dexamethasone.,decrease,no risk
Dexamethasone,Valdecoxib,The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Valdecoxib.,increase,risk
Dexamethasone,Valproic acid,The excretion of Dexamethasone can be decreased when combined with Valproic acid.,decrease,no risk
Dexamethasone,Vamorolone,The metabolism of Vamorolone can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Vandetanib,The metabolism of Vandetanib can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Dexamethasone.,decrease,no risk
Dexamethasone,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Vecuronium,The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Dexamethasone.,increase,risk
Dexamethasone,Vedolizumab,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Vedolizumab.,increase,risk
Dexamethasone,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Venetoclax,The metabolism of Venetoclax can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Verapamil,The metabolism of Verapamil can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Vilanterol,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Vilanterol.,increase,risk
Dexamethasone,Vilazodone,The metabolism of Vilazodone can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Vildagliptin,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Vildagliptin.,increase,risk
Dexamethasone,Viloxazine,The metabolism of Dexamethasone can be decreased when combined with Viloxazine.,decrease,no risk
Dexamethasone,Vinblastine,The metabolism of Vinblastine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Vincristine,The metabolism of Vincristine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Vindesine,The metabolism of Vindesine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Vinflunine,The metabolism of Vinflunine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Vitamin D,The therapeutic efficacy of Vitamin D can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Vitamin E,The metabolism of Vitamin E can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Voclosporin,The metabolism of Voclosporin can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Vonoprazan,The therapeutic efficacy of Vonoprazan can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Voriconazole,The serum concentration of Dexamethasone can be increased when it is combined with Voriconazole.,increase,no risk
Dexamethasone,Vorinostat,The risk or severity of adverse effects can be increased when Dexamethasone is combined with Vorinostat.,increase,risk
Dexamethasone,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Dexamethasone.,increase,no risk
Dexamethasone,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Warfarin,Dexamethasone may increase the anticoagulant activities of Warfarin.,increase,no risk
Dexamethasone,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Dexamethasone.,decrease,no risk
Dexamethasone,Yohimbine,The metabolism of Yohimbine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Zaleplon,The metabolism of Zaleplon can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Dexamethasone.,increase,risk
Dexamethasone,Zileuton,The metabolism of Zileuton can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Zimelidine,The metabolism of Dexamethasone can be decreased when combined with Zimelidine.,decrease,no risk
Dexamethasone,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Zolpidem,The metabolism of Zolpidem can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Zonisamide,The metabolism of Zonisamide can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Dexamethasone.,decrease,no risk
Dexamethasone,Zotepine,The metabolism of Zotepine can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Dexamethasone.,increase,no risk
Dexamethasone,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Dexamethasone.,decrease,no risk
Levodopa,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Levodopa.,increase,risk
Levodopa,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Levodopa is combined with Gabapentin enacarbil.,increase,risk
Levodopa,Gallamine triethiodide,The absorption of Levodopa can be decreased when combined with Gallamine triethiodide.,decrease,no risk
Levodopa,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Levodopa is combined with Ganaxolone.",increase,risk
Levodopa,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Levodopa.,increase,risk
Levodopa,Glutethimide,The risk or severity of CNS depression can be increased when Levodopa is combined with Glutethimide.,increase,risk
Levodopa,Glycopyrronium,The serum concentration of Levodopa can be decreased when it is combined with Glycopyrronium.,decrease,no risk
Levodopa,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Levodopa.,increase,risk
Levodopa,Guanabenz,Levodopa may increase the hypotensive activities of Guanabenz.,increase,no risk
Levodopa,Guanadrel,Levodopa may increase the hypotensive activities of Guanadrel.,increase,no risk
Levodopa,Guanethidine,Levodopa may increase the hypotensive activities of Guanethidine.,increase,no risk
Levodopa,Guanfacine,The risk or severity of hypotension and orthostatic hypotension can be increased when Guanfacine is combined with Levodopa.,increase,risk
Levodopa,Guanoxan,Levodopa may increase the hypotensive activities of Guanoxan.,increase,no risk
Levodopa,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Levodopa.,increase,risk
Levodopa,Haloperidol,The therapeutic efficacy of Levodopa can be decreased when used in combination with Haloperidol.,decrease,no risk
Levodopa,Halothane,The risk or severity of hypotension and orthostatic hypotension can be increased when Halothane is combined with Levodopa.,increase,risk
Levodopa,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Levodopa.,increase,risk
Levodopa,Hexocyclium,The absorption of Levodopa can be decreased when combined with Hexocyclium.,decrease,no risk
Levodopa,Homatropine methylbromide,The absorption of Levodopa can be decreased when combined with Homatropine methylbromide.,decrease,no risk
Levodopa,Hydralazine,The risk or severity of hypotension and orthostatic hypotension can be increased when Hydralazine is combined with Levodopa.,increase,risk
Levodopa,Hydrochlorothiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Hydrochlorothiazide is combined with Levodopa.,increase,risk
Levodopa,Hydrocodone,Levodopa may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Levodopa,Hydroflumethiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Hydroflumethiazide is combined with Levodopa.,increase,risk
Levodopa,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Levodopa.,increase,risk
Levodopa,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Levodopa.,increase,no risk
Levodopa,Hyoscyamine,The absorption of Levodopa can be decreased when combined with Hyoscyamine.,decrease,no risk
Levodopa,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Levodopa.,increase,risk
Levodopa,Ketazolam,The risk or severity of CNS depression can be increased when Levodopa is combined with Ketazolam.,increase,risk
Levodopa,Obinutuzumab,The risk or severity of hypotension and orthostatic hypotension can be increased when Obinutuzumab is combined with Levodopa.,increase,risk
Levodopa,Olanzapine,The risk or severity of hypotension and orthostatic hypotension can be increased when Olanzapine is combined with Levodopa.,increase,risk
Levodopa,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Levodopa is combined with Oliceridine.",increase,risk
Levodopa,Olmesartan,The risk or severity of hypotension and orthostatic hypotension can be increased when Olmesartan is combined with Levodopa.,increase,risk
Levodopa,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Levodopa.,increase,risk
Levodopa,Opicapone,The risk or severity of hypotension and orthostatic hypotension can be increased when Opicapone is combined with Levodopa.,increase,risk
Levodopa,Opium,The risk or severity of CNS depression can be increased when Levodopa is combined with Opium.,increase,risk
Levodopa,Orphenadrine,Levodopa may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Levodopa,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Levodopa.,increase,risk
Levodopa,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Levodopa.,increase,risk
Levodopa,Oxitriptan,The risk or severity of CNS depression can be increased when Levodopa is combined with Oxitriptan.,increase,risk
Levodopa,Oxprenolol,The risk or severity of hypotension and orthostatic hypotension can be increased when Oxprenolol is combined with Levodopa.,increase,risk
Levodopa,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Levodopa.,increase,risk
Levodopa,Oxybutynin,The absorption of Levodopa can be decreased when combined with Oxybutynin.,decrease,no risk
Levodopa,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Levodopa.,increase,risk
Levodopa,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Levodopa.,increase,risk
Levodopa,Oxyphencyclimine,The absorption of Levodopa can be decreased when combined with Oxyphencyclimine.,decrease,no risk
Levodopa,Oxyphenonium,The absorption of Levodopa can be decreased when combined with Oxyphenonium.,decrease,no risk
Levodopa,Quazepam,The risk or severity of CNS depression can be increased when Levodopa is combined with Quazepam.,increase,risk
Levodopa,Quetiapine,The risk or severity of hypotension and orthostatic hypotension can be increased when Quetiapine is combined with Levodopa.,increase,risk
Levodopa,Quinapril,The risk or severity of hypotension and orthostatic hypotension can be increased when Quinapril is combined with Levodopa.,increase,risk
Levodopa,Quinidine,The absorption of Levodopa can be decreased when combined with Quinidine.,decrease,no risk
Levodopa,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Levodopa.,increase,risk
Levodopa,Quinupramine,The risk or severity of CNS depression can be increased when Levodopa is combined with Quinupramine.,increase,risk
Levodopa,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Levodopa.,increase,risk
Levodopa,Umeclidinium,The absorption of Levodopa can be decreased when combined with Umeclidinium.,decrease,no risk
Levodopa,Urethane,The risk or severity of CNS depression can be increased when Levodopa is combined with Urethane.,increase,risk
Levodopa,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Levodopa is combined with Valproate bismuth.,increase,risk
Levodopa,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Levodopa.,increase,risk
Levodopa,Valsartan,The risk or severity of hypotension and orthostatic hypotension can be increased when Valsartan is combined with Levodopa.,increase,risk
Levodopa,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Levodopa.,increase,risk
Levodopa,Vasopressin,Vasopressin may increase the hypertensive activities of Levodopa.,increase,no risk
Levodopa,Vecuronium,The risk or severity of CNS depression can be increased when Levodopa is combined with Vecuronium.,increase,risk
Levodopa,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Levodopa is combined with Venlafaxine.,increase,risk
Levodopa,Verapamil,The risk or severity of hypotension and orthostatic hypotension can be increased when Verapamil is combined with Levodopa.,increase,risk
Levodopa,Vericiguat,The risk or severity of hypotension and orthostatic hypotension can be increased when Vericiguat is combined with Levodopa.,increase,risk
Levodopa,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Levodopa.,increase,risk
Levodopa,Vilazodone,The risk or severity of CNS depression can be increased when Levodopa is combined with Vilazodone.,increase,risk
Levodopa,Viloxazine,The risk or severity of CNS depression can be increased when Levodopa is combined with Viloxazine.,increase,risk
Levodopa,Vortioxetine,The risk or severity of CNS depression can be increased when Levodopa is combined with Vortioxetine.,increase,risk
Levodopa,Yohimbine,The risk or severity of CNS depression can be increased when Levodopa is combined with Yohimbine.,increase,risk
Levodopa,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Levodopa.,increase,risk
Levodopa,Ziconotide,The risk or severity of CNS depression can be increased when Levodopa is combined with Ziconotide.,increase,risk
Levodopa,Zimelidine,The risk or severity of adverse effects can be increased when Levodopa is combined with Zimelidine.,increase,risk
Levodopa,Ziprasidone,The therapeutic efficacy of Levodopa can be decreased when used in combination with Ziprasidone.,decrease,no risk
Levodopa,Zofenopril,Levodopa may increase the hypotensive activities of Zofenopril.,increase,no risk
Levodopa,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Levodopa.,increase,risk
Levodopa,Zolpidem,Levodopa may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Levodopa,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Levodopa.,increase,risk
Levodopa,Zopiclone,The risk or severity of adverse effects can be increased when Levodopa is combined with Zopiclone.,increase,risk
Levodopa,Zotepine,The therapeutic efficacy of Levodopa can be decreased when used in combination with Zotepine.,decrease,no risk
Levodopa,Zuclopenthixol,The therapeutic efficacy of Levodopa can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Levodopa,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Levodopa.,increase,risk
Sevoflurane,Bisoprolol,Sevoflurane may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Sevoflurane,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Sevoflurane.,increase,risk
Sevoflurane,Bosentan,Sevoflurane may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Sevoflurane,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Sevoflurane.,increase,risk
Sevoflurane,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Sevoflurane.,increase,risk
Sevoflurane,Bretylium,Sevoflurane may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Sevoflurane,Brexanolone,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Brexanolone.,increase,risk
Sevoflurane,Brexpiprazole,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Brexpiprazole.,increase,risk
Sevoflurane,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Sevoflurane.,increase,no risk
Sevoflurane,Brivaracetam,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Brivaracetam.,increase,risk
Sevoflurane,Bromazepam,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Bromazepam.,increase,risk
Sevoflurane,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Sevoflurane.,increase,risk
Sevoflurane,Bromperidol,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Bromperidol.,increase,risk
Sevoflurane,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Sevoflurane.,increase,risk
Sevoflurane,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Sevoflurane.,increase,risk
Sevoflurane,Bumadizone,The risk or severity of hypertension can be increased when Sevoflurane is combined with Bumadizone.,increase,risk
Sevoflurane,Bumetanide,The risk or severity of adverse effects can be increased when Bumetanide is combined with Sevoflurane.,increase,risk
Sevoflurane,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Sevoflurane.,increase,risk
Sevoflurane,Buprenorphine,Sevoflurane may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Sevoflurane,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Sevoflurane.,increase,risk
Sevoflurane,Buserelin,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Buserelin.,increase,risk
Sevoflurane,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Sevoflurane.,increase,risk
Sevoflurane,Butabarbital,Butabarbital may increase the hypotensive activities of Sevoflurane.,increase,no risk
Sevoflurane,Butalbital,Butalbital may increase the hypotensive activities of Sevoflurane.,increase,no risk
Sevoflurane,Butaperazine,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Butaperazine.,increase,risk
Sevoflurane,Butobarbital,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Butobarbital.,increase,risk
Sevoflurane,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Sevoflurane.,increase,risk
Sevoflurane,Butriptyline,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Butriptyline.,increase,risk
Sevoflurane,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Sevoflurane.,increase,risk
Sevoflurane,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Gabapentin enacarbil.,increase,risk
Sevoflurane,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Gadobenic acid.,increase,risk
Sevoflurane,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Sevoflurane.,increase,risk
Sevoflurane,Gallamine triethiodide,Sevoflurane may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Sevoflurane,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Sevoflurane is combined with Ganaxolone.",increase,risk
Sevoflurane,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Sevoflurane.,increase,risk
Sevoflurane,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Gemifloxacin.,increase,risk
Sevoflurane,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Sevoflurane.,increase,risk
Sevoflurane,Gilteritinib,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Gilteritinib.,increase,risk
Sevoflurane,Glasdegib,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Glasdegib.,increase,risk
Sevoflurane,Glofitamab,The serum concentration of Sevoflurane can be increased when it is combined with Glofitamab.,increase,no risk
Sevoflurane,Glutethimide,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Glutethimide.,increase,risk
Sevoflurane,Glycerin,The metabolism of Sevoflurane can be increased when combined with Glycerin.,increase,no risk
Sevoflurane,Golimumab,The metabolism of Sevoflurane can be increased when combined with Golimumab.,increase,no risk
Sevoflurane,Goserelin,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Goserelin.,increase,risk
Sevoflurane,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Sevoflurane.,increase,risk
Sevoflurane,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Grepafloxacin.,increase,risk
Sevoflurane,Guanabenz,Sevoflurane may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Sevoflurane,Guanadrel,Sevoflurane may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Sevoflurane,Guanethidine,Sevoflurane may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Sevoflurane,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Sevoflurane.,increase,risk
Sevoflurane,Guanoxan,Sevoflurane may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Sevoflurane,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Sevoflurane.,increase,risk
Sevoflurane,Halofantrine,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Halofantrine.,increase,risk
Sevoflurane,Haloperidol,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Haloperidol.,increase,risk
Sevoflurane,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Sevoflurane.,increase,risk
Sevoflurane,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Sevoflurane.,increase,risk
Sevoflurane,Histrelin,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Histrelin.,increase,risk
Sevoflurane,Hydralazine,Sevoflurane may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Sevoflurane,Hydrochlorothiazide,Sevoflurane may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Sevoflurane,Hydrocodone,Sevoflurane may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Sevoflurane,Hydrocortisone,The metabolism of Sevoflurane can be increased when combined with Hydrocortisone.,increase,no risk
Sevoflurane,Hydroflumethiazide,Sevoflurane may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Sevoflurane,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Sevoflurane.,increase,risk
Sevoflurane,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Hydroxychloroquine.,increase,risk
Sevoflurane,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Hydroxyzine.,increase,risk
Sevoflurane,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Sevoflurane.,increase,risk
Sevoflurane,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Sevoflurane.,increase,risk
Sevoflurane,Ketazolam,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Ketazolam.,increase,risk
Sevoflurane,Ketoconazole,The metabolism of Sevoflurane can be decreased when combined with Ketoconazole.,decrease,no risk
Sevoflurane,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Sevoflurane.,increase,risk
Sevoflurane,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Sevoflurane.,increase,risk
Sevoflurane,Obinutuzumab,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Obinutuzumab.,increase,risk
Sevoflurane,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Sevoflurane.,increase,risk
Sevoflurane,Ofloxacin,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Ofloxacin.,increase,risk
Sevoflurane,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Sevoflurane.,increase,risk
Sevoflurane,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Sevoflurane is combined with Oliceridine.",increase,risk
Sevoflurane,Olmesartan,Sevoflurane may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Sevoflurane,Olodaterol,The risk or severity of hypertension can be increased when Sevoflurane is combined with Olodaterol.,increase,risk
Sevoflurane,Omaveloxolone,The serum concentration of Sevoflurane can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Sevoflurane,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Sevoflurane.,increase,risk
Sevoflurane,Opicapone,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Opicapone.,increase,risk
Sevoflurane,Opium,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Opium.,increase,risk
Sevoflurane,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Sevoflurane.,increase,risk
Sevoflurane,Orphenadrine,Sevoflurane may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Sevoflurane,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Sevoflurane.,decrease,no risk
Sevoflurane,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Sevoflurane.,decrease,no risk
Sevoflurane,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Sevoflurane.,increase,risk
Sevoflurane,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Sevoflurane.,increase,risk
Sevoflurane,Oxatomide,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Oxatomide.,increase,risk
Sevoflurane,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Sevoflurane.,increase,risk
Sevoflurane,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Sevoflurane.,increase,risk
Sevoflurane,Oxitriptan,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Oxitriptan.,increase,risk
Sevoflurane,Oxprenolol,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Oxprenolol.,increase,risk
Sevoflurane,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Sevoflurane.,increase,risk
Sevoflurane,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Sevoflurane.,increase,risk
Sevoflurane,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Sevoflurane.,increase,risk
Sevoflurane,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Sevoflurane.,increase,risk
Sevoflurane,Oxyphenbutazone,The risk or severity of hypertension can be increased when Sevoflurane is combined with Oxyphenbutazone.,increase,risk
Sevoflurane,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Sevoflurane.,increase,risk
Sevoflurane,Quazepam,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Quazepam.,increase,risk
Sevoflurane,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Sevoflurane.,increase,risk
Sevoflurane,Quinapril,Sevoflurane may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Sevoflurane,Quinidine,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Quinidine.,increase,risk
Sevoflurane,Quinine,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Quinine.,increase,risk
Sevoflurane,Quinupramine,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Quinupramine.,increase,risk
Sevoflurane,Quizartinib,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Quizartinib.,increase,risk
Sevoflurane,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Sevoflurane.,increase,risk
Sevoflurane,Urethane,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Urethane.,increase,risk
Sevoflurane,Vadadustat,The serum concentration of Sevoflurane can be decreased when it is combined with Vadadustat.,decrease,no risk
Sevoflurane,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Sevoflurane.,increase,risk
Sevoflurane,Valproic acid,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Valproic acid.,increase,risk
Sevoflurane,Valsartan,Sevoflurane may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Sevoflurane,Vandetanib,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Vandetanib.,increase,risk
Sevoflurane,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Sevoflurane.,increase,risk
Sevoflurane,Vayarin,The metabolism of Sevoflurane can be decreased when combined with Vayarin.,decrease,no risk
Sevoflurane,Vecuronium,Sevoflurane may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Sevoflurane,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Sevoflurane.,decrease,no risk
Sevoflurane,Vemurafenib,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Vemurafenib.,increase,risk
Sevoflurane,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Sevoflurane.,increase,risk
Sevoflurane,Verapamil,The risk or severity of myocardial depression can be increased when Verapamil is combined with Sevoflurane.,increase,risk
Sevoflurane,Vericiguat,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Vericiguat.,increase,risk
Sevoflurane,Vernakalant,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Vernakalant.,increase,risk
Sevoflurane,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Sevoflurane.,increase,risk
Sevoflurane,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Sevoflurane.,increase,risk
Sevoflurane,Vilazodone,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Vilazodone.,increase,risk
Sevoflurane,Viloxazine,The metabolism of Sevoflurane can be decreased when combined with Viloxazine.,decrease,no risk
Sevoflurane,Voriconazole,The metabolism of Sevoflurane can be decreased when combined with Voriconazole.,decrease,no risk
Sevoflurane,Vorinostat,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Vorinostat.,increase,risk
Sevoflurane,Vortioxetine,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Vortioxetine.,increase,risk
Sevoflurane,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Sevoflurane.,decrease,no risk
Sevoflurane,Xamoterol,The risk or severity of hypertension can be increased when Sevoflurane is combined with Xamoterol.,increase,risk
Sevoflurane,Xylometazoline,The risk or severity of hypotension can be increased when Sevoflurane is combined with Xylometazoline.,increase,risk
Sevoflurane,Yohimbine,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Yohimbine.,increase,risk
Sevoflurane,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Sevoflurane.,increase,risk
Sevoflurane,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Sevoflurane.,decrease,no risk
Sevoflurane,Ziconotide,The risk or severity of hypotension can be increased when Sevoflurane is combined with Ziconotide.,increase,risk
Sevoflurane,Zidovudine,The metabolism of Sevoflurane can be decreased when combined with Zidovudine.,decrease,no risk
Sevoflurane,Zimelidine,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Zimelidine.,increase,risk
Sevoflurane,Ziprasidone,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Ziprasidone.,increase,risk
Sevoflurane,Zofenopril,Sevoflurane may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Sevoflurane,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Sevoflurane.,increase,risk
Sevoflurane,Zolpidem,Sevoflurane may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Sevoflurane,Zonisamide,The risk or severity of hypotension can be increased when Sevoflurane is combined with Zonisamide.,increase,risk
Sevoflurane,Zopiclone,The risk or severity of adverse effects can be increased when Sevoflurane is combined with Zopiclone.,increase,risk
Sevoflurane,Zotepine,The risk or severity of CNS depression can be increased when Sevoflurane is combined with Zotepine.,increase,risk
Sevoflurane,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Zuclopenthixol.,increase,risk
Sevoflurane,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Sevoflurane.,increase,risk
Bromodiphenhydramine,Hyoscyamine,Bromodiphenhydramine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Aripiprazole,Bendroflumethiazide,The risk or severity of hypotension can be increased when Aripiprazole is combined with Bendroflumethiazide.,increase,risk
Aripiprazole,Benorilate,The risk or severity of hypertension can be increased when Aripiprazole is combined with Benorilate.,increase,risk
Aripiprazole,Benoxaprofen,The risk or severity of hypertension can be increased when Aripiprazole is combined with Benoxaprofen.,increase,risk
Aripiprazole,Benperidol,The risk or severity of CNS depression can be increased when Aripiprazole is combined with Benperidol.,increase,risk
Aripiprazole,Benserazide,The therapeutic efficacy of Benserazide can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Benzatropine,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Benzatropine.,increase,risk
Aripiprazole,Benzhydrocodone,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Benzhydrocodone.,increase,risk
Aripiprazole,Benzocaine,The risk or severity of CNS depression can be increased when Benzocaine is combined with Aripiprazole.,increase,risk
Aripiprazole,Benzphetamine,Benzphetamine may decrease the sedative activities of Aripiprazole.,decrease,no risk
Aripiprazole,Benzthiazide,The serum concentration of Benzthiazide can be increased when it is combined with Aripiprazole.,increase,no risk
Aripiprazole,Benzydamine,The risk or severity of hypertension can be increased when Aripiprazole is combined with Benzydamine.,increase,risk
Aripiprazole,Benzyl alcohol,The risk or severity of CNS depression can be increased when Aripiprazole is combined with Benzyl alcohol.,increase,risk
Aripiprazole,Benzylpenicilloyl polylysine,Aripiprazole may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Aripiprazole,Bepridil,The risk or severity of hypotension can be increased when Aripiprazole is combined with Bepridil.,increase,risk
Aripiprazole,Berotralstat,The metabolism of Aripiprazole can be decreased when combined with Berotralstat.,decrease,no risk
Aripiprazole,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Betaine,The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Betaine.,decrease,no risk
Aripiprazole,Betamethasone,The metabolism of Aripiprazole can be increased when combined with Betamethasone.,increase,no risk
Aripiprazole,Betamethasone phosphate,The metabolism of Aripiprazole can be increased when combined with Betamethasone phosphate.,increase,no risk
Aripiprazole,Betaxolol,The risk or severity of hypotension can be increased when Aripiprazole is combined with Betaxolol.,increase,risk
Aripiprazole,Bethanidine,The risk or severity of hypotension can be increased when Aripiprazole is combined with Bethanidine.,increase,risk
Aripiprazole,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Bexarotene,The metabolism of Aripiprazole can be increased when combined with Bexarotene.,increase,no risk
Aripiprazole,Bicalutamide,The metabolism of Aripiprazole can be decreased when combined with Bicalutamide.,decrease,no risk
Aripiprazole,Bifonazole,The metabolism of Aripiprazole can be decreased when combined with Bifonazole.,decrease,no risk
Aripiprazole,Bilastine,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Bilastine.,increase,risk
Aripiprazole,Bimekizumab,The metabolism of Aripiprazole can be increased when combined with Bimekizumab.,increase,no risk
Aripiprazole,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Bismuth subcitrate potassium,Aripiprazole may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Aripiprazole,Bismuth subgallate,Aripiprazole may increase the neurotoxic activities of Bismuth subgallate.,increase,no risk
Aripiprazole,Bismuth subnitrate,Aripiprazole may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Aripiprazole,Bisoprolol,The risk or severity of hypotension can be increased when Aripiprazole is combined with Bisoprolol.,increase,risk
Aripiprazole,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Boceprevir,The metabolism of Aripiprazole can be decreased when combined with Boceprevir.,decrease,no risk
Aripiprazole,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Aripiprazole.,increase,risk
Aripiprazole,Bosentan,The metabolism of Aripiprazole can be increased when combined with Bosentan.,increase,no risk
Aripiprazole,Bosutinib,The metabolism of Aripiprazole can be decreased when combined with Bosutinib.,decrease,no risk
Aripiprazole,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Botulinum toxin type A.,increase,risk
Aripiprazole,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Botulinum toxin type B.,increase,risk
Aripiprazole,Brentuximab vedotin,The metabolism of Aripiprazole can be decreased when combined with Brentuximab vedotin.,decrease,no risk
Aripiprazole,Bretylium,The risk or severity of hypotension can be increased when Aripiprazole is combined with Bretylium.,increase,risk
Aripiprazole,Brexanolone,The risk or severity of CNS depression can be increased when Aripiprazole is combined with Brexanolone.,increase,risk
Aripiprazole,Brexpiprazole,The risk or severity of adverse effects can be decreased when Aripiprazole is combined with Brexpiprazole.,decrease,risk
Aripiprazole,Brigatinib,The metabolism of Aripiprazole can be increased when combined with Brigatinib.,increase,no risk
Aripiprazole,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.,increase,no risk
Aripiprazole,Brivaracetam,The risk or severity of CNS depression can be increased when Aripiprazole is combined with Brivaracetam.,increase,risk
Aripiprazole,Bromazepam,The risk or severity of sedation and orthostatic hypotension can be increased when Aripiprazole is combined with Bromazepam.,increase,risk
Aripiprazole,Bromocriptine,The risk or severity of adverse effects can be decreased when Bromocriptine is combined with Aripiprazole.,decrease,risk
Aripiprazole,Bromperidol,The risk or severity of CNS depression can be increased when Aripiprazole is combined with Bromperidol.,increase,risk
Aripiprazole,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Aripiprazole.,increase,risk
Aripiprazole,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Aripiprazole.,increase,risk
Aripiprazole,Budesonide,The metabolism of Aripiprazole can be increased when combined with Budesonide.,increase,no risk
Aripiprazole,Bumadizone,The risk or severity of hypertension can be increased when Aripiprazole is combined with Bumadizone.,increase,risk
Aripiprazole,Bumetanide,Aripiprazole may increase the hypotensive activities of Bumetanide.,increase,no risk
Aripiprazole,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Aripiprazole.,increase,risk
Aripiprazole,Buprenorphine,Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Aripiprazole,Bupropion,The serum concentration of Aripiprazole can be increased when it is combined with Bupropion.,increase,no risk
Aripiprazole,Buserelin,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Buserelin.,increase,risk
Aripiprazole,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Aripiprazole.,increase,risk
Aripiprazole,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Aripiprazole.,increase,risk
Aripiprazole,Butalbital,The metabolism of Aripiprazole can be increased when combined with Butalbital.,increase,no risk
Aripiprazole,Butaperazine,The risk or severity of CNS depression can be increased when Aripiprazole is combined with Butaperazine.,increase,risk
Aripiprazole,Butobarbital,The risk or severity of CNS depression can be increased when Aripiprazole is combined with Butobarbital.,increase,risk
Aripiprazole,Butorphanol,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Butorphanol.,increase,risk
Aripiprazole,Butriptyline,The risk or severity of CNS depression can be increased when Aripiprazole is combined with Butriptyline.,increase,risk
Aripiprazole,Butylscopolamine,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Butylscopolamine.,increase,risk
Aripiprazole,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Aripiprazole.,increase,risk
Aripiprazole,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Aripiprazole is combined with Gabapentin enacarbil.,increase,risk
Aripiprazole,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Gadobenic acid.,increase,risk
Aripiprazole,Galantamine,The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Galantamine.,decrease,no risk
Aripiprazole,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Aripiprazole.,increase,risk
Aripiprazole,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Aripiprazole is combined with Ganaxolone.",increase,risk
Aripiprazole,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Aripiprazole.,increase,risk
Aripiprazole,Gefitinib,The metabolism of Aripiprazole can be decreased when combined with Gefitinib.,decrease,no risk
Aripiprazole,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Gemifloxacin.,increase,risk
Aripiprazole,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Aripiprazole.,increase,risk
Aripiprazole,Gilteritinib,The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Gilteritinib.,decrease,no risk
Aripiprazole,Ginkgo biloba,The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Aripiprazole,Givosiran,The serum concentration of Aripiprazole can be increased when it is combined with Givosiran.,increase,no risk
Aripiprazole,Glasdegib,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Glasdegib.,increase,risk
Aripiprazole,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Glofitamab,The serum concentration of Aripiprazole can be increased when it is combined with Glofitamab.,increase,no risk
Aripiprazole,Glucagon,Aripiprazole may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Aripiprazole,Glutethimide,The risk or severity of CNS depression can be increased when Aripiprazole is combined with Glutethimide.,increase,risk
Aripiprazole,Glyburide,The metabolism of Aripiprazole can be decreased when combined with Glyburide.,decrease,no risk
Aripiprazole,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Glycerol phenylbutyrate,The serum concentration of Aripiprazole can be increased when it is combined with Glycerol phenylbutyrate.,increase,no risk
Aripiprazole,Glycopyrronium,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Glycopyrronium.,increase,risk
Aripiprazole,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Golimumab,The metabolism of Aripiprazole can be increased when combined with Golimumab.,increase,no risk
Aripiprazole,Goserelin,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Goserelin.,increase,risk
Aripiprazole,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Aripiprazole.,increase,risk
Aripiprazole,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Grepafloxacin.,increase,risk
Aripiprazole,Griseofulvin,The metabolism of Aripiprazole can be increased when combined with Griseofulvin.,increase,no risk
Aripiprazole,Guanabenz,The risk or severity of hypotension can be increased when Aripiprazole is combined with Guanabenz.,increase,risk
Aripiprazole,Guanadrel,The risk or severity of hypotension can be increased when Aripiprazole is combined with Guanadrel.,increase,risk
Aripiprazole,Guanethidine,The risk or severity of hypotension can be increased when Aripiprazole is combined with Guanethidine.,increase,risk
Aripiprazole,Guanfacine,The risk or severity of hypotension can be increased when Aripiprazole is combined with Guanfacine.,increase,risk
Aripiprazole,Guanoxan,The risk or severity of hypotension can be increased when Aripiprazole is combined with Guanoxan.,increase,risk
Aripiprazole,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Aripiprazole.,increase,risk
Aripiprazole,Halofantrine,The serum concentration of Aripiprazole can be increased when it is combined with Halofantrine.,increase,no risk
Aripiprazole,Haloperidol,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Haloperidol.,increase,risk
Aripiprazole,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Aripiprazole.,increase,risk
Aripiprazole,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Aripiprazole.,increase,risk
Aripiprazole,Hexocyclium,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Hexocyclium.,increase,risk
Aripiprazole,Histrelin,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Histrelin.,increase,risk
Aripiprazole,Homatropine,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Homatropine.,increase,risk
Aripiprazole,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Aripiprazole.,increase,risk
Aripiprazole,Huperzine A,The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Huperzine A.,decrease,no risk
Aripiprazole,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Hydralazine,The metabolism of Aripiprazole can be decreased when combined with Hydralazine.,decrease,no risk
Aripiprazole,Hydrochlorothiazide,The risk or severity of hypotension can be increased when Aripiprazole is combined with Hydrochlorothiazide.,increase,risk
Aripiprazole,Hydrocodone,Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Aripiprazole,Hydrocortamate,The metabolism of Aripiprazole can be increased when combined with Hydrocortamate.,increase,no risk
Aripiprazole,Hydrocortisone,The metabolism of Aripiprazole can be increased when combined with Hydrocortisone.,increase,no risk
Aripiprazole,Hydrocortisone acetate,The metabolism of Aripiprazole can be increased when combined with Hydrocortisone acetate.,increase,no risk
Aripiprazole,Hydrocortisone butyrate,The metabolism of Aripiprazole can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Aripiprazole,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Aripiprazole.,decrease,no risk
Aripiprazole,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Aripiprazole.,decrease,no risk
Aripiprazole,Hydrocortisone succinate,The metabolism of Aripiprazole can be increased when combined with Hydrocortisone succinate.,increase,no risk
Aripiprazole,Hydroflumethiazide,The risk or severity of hypotension can be increased when Aripiprazole is combined with Hydroflumethiazide.,increase,risk
Aripiprazole,Hydromorphone,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Hydromorphone.,increase,risk
Aripiprazole,Hydroxychloroquine,The metabolism of Aripiprazole can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Aripiprazole,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Aripiprazole.,decrease,no risk
Aripiprazole,Hydroxyurea,The metabolism of Aripiprazole can be decreased when combined with Hydroxyurea.,decrease,no risk
Aripiprazole,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Hydroxyzine.,increase,risk
Aripiprazole,Hyoscyamine,Aripiprazole may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Aripiprazole,Ketamine,The metabolism of Aripiprazole can be increased when combined with Ketamine.,increase,no risk
Aripiprazole,Ketazolam,The metabolism of Aripiprazole can be decreased when combined with Ketazolam.,decrease,no risk
Aripiprazole,Ketoconazole,The metabolism of Aripiprazole can be decreased when combined with Ketoconazole.,decrease,no risk
Aripiprazole,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Aripiprazole.,increase,risk
Aripiprazole,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Aripiprazole.,increase,risk
Aripiprazole,Obinutuzumab,Aripiprazole may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Aripiprazole,Octreotide,The metabolism of Aripiprazole can be decreased when combined with Octreotide.,decrease,no risk
Aripiprazole,Ofloxacin,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Ofloxacin.,increase,risk
Aripiprazole,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.",increase,no risk
Aripiprazole,Olaparib,The metabolism of Aripiprazole can be decreased when combined with Olaparib.,decrease,no risk
Aripiprazole,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Aripiprazole is combined with Oliceridine.",increase,risk
Aripiprazole,Olmesartan,The risk or severity of hypotension can be increased when Aripiprazole is combined with Olmesartan.,increase,risk
Aripiprazole,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Olutasidenib,The metabolism of Aripiprazole can be increased when combined with Olutasidenib.,increase,no risk
Aripiprazole,Omaveloxolone,The serum concentration of Aripiprazole can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Aripiprazole,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Aripiprazole.,increase,risk
Aripiprazole,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Opium,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Opium.,increase,risk
Aripiprazole,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Oritavancin,The metabolism of Aripiprazole can be increased when combined with Oritavancin.,increase,no risk
Aripiprazole,Orphenadrine,The serum concentration of Aripiprazole can be increased when it is combined with Orphenadrine.,increase,no risk
Aripiprazole,Osilodrostat,The metabolism of Aripiprazole can be decreased when combined with Osilodrostat.,decrease,no risk
Aripiprazole,Ospemifene,The metabolism of Aripiprazole can be decreased when combined with Ospemifene.,decrease,no risk
Aripiprazole,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Aripiprazole.,increase,risk
Aripiprazole,Oxamniquine,The metabolism of Aripiprazole can be decreased when combined with Oxamniquine.,decrease,no risk
Aripiprazole,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Aripiprazole.,increase,risk
Aripiprazole,Oxatomide,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Oxatomide.,increase,risk
Aripiprazole,Oxazepam,The risk or severity of sedation and orthostatic hypotension can be increased when Aripiprazole is combined with Oxazepam.,increase,risk
Aripiprazole,Oxcarbazepine,The metabolism of Aripiprazole can be increased when combined with Oxcarbazepine.,increase,no risk
Aripiprazole,Oxetacaine,The metabolism of Aripiprazole can be decreased when combined with Oxetacaine.,decrease,no risk
Aripiprazole,Oxitriptan,The risk or severity of CNS depression can be increased when Aripiprazole is combined with Oxitriptan.,increase,risk
Aripiprazole,Oxprenolol,The risk or severity of hypotension can be increased when Aripiprazole is combined with Oxprenolol.,increase,risk
Aripiprazole,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Aripiprazole.,increase,risk
Aripiprazole,Oxybutynin,The metabolism of Aripiprazole can be decreased when combined with Oxybutynin.,decrease,no risk
Aripiprazole,Oxycodone,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Oxycodone.,increase,risk
Aripiprazole,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Oxymetholone,The metabolism of Aripiprazole can be decreased when combined with Oxymetholone.,decrease,no risk
Aripiprazole,Oxymorphone,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Oxymorphone.,increase,risk
Aripiprazole,Oxyphenbutazone,The risk or severity of hypertension can be increased when Aripiprazole is combined with Oxyphenbutazone.,increase,risk
Aripiprazole,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Aripiprazole.,increase,risk
Aripiprazole,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Aripiprazole.,increase,risk
Aripiprazole,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Aripiprazole.,increase,risk
Aripiprazole,Quazepam,The risk or severity of sedation and orthostatic hypotension can be increased when Aripiprazole is combined with Quazepam.,increase,risk
Aripiprazole,Quetiapine,"Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.",increase,no risk
Aripiprazole,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Quinapril,The risk or severity of hypotension can be increased when Aripiprazole is combined with Quinapril.,increase,risk
Aripiprazole,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Aripiprazole.,increase,no risk
Aripiprazole,Quinidine,Quinidine may decrease the excretion rate of Aripiprazole which could result in a higher serum level.,decrease,no risk
Aripiprazole,Quinine,The metabolism of Aripiprazole can be increased when combined with Quinine.,increase,no risk
Aripiprazole,Quinupramine,The risk or severity of CNS depression can be increased when Aripiprazole is combined with Quinupramine.,increase,risk
Aripiprazole,Quinupristin,The metabolism of Aripiprazole can be decreased when combined with Quinupristin.,decrease,no risk
Aripiprazole,Quizartinib,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Quizartinib.,increase,risk
Aripiprazole,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Aripiprazole.,increase,risk
Aripiprazole,Umeclidinium,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Umeclidinium.,increase,risk
Aripiprazole,Urethane,The risk or severity of CNS depression can be increased when Aripiprazole is combined with Urethane.,increase,risk
Aripiprazole,Vadadustat,The serum concentration of Aripiprazole can be increased when it is combined with Vadadustat.,increase,no risk
Aripiprazole,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Aripiprazole.,decrease,no risk
Aripiprazole,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Aripiprazole.,increase,risk
Aripiprazole,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Aripiprazole is combined with Valproate bismuth.,increase,risk
Aripiprazole,Valproic acid,The metabolism of Aripiprazole can be decreased when combined with Valproic acid.,decrease,no risk
Aripiprazole,Valsartan,The risk or severity of hypotension can be increased when Aripiprazole is combined with Valsartan.,increase,risk
Aripiprazole,Vandetanib,The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Vandetanib.,increase,risk
Aripiprazole,Vardenafil,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Aripiprazole.,increase,risk
Aripiprazole,Vecuronium,The risk or severity of CNS depression can be increased when Aripiprazole is combined with Vecuronium.,increase,risk
Aripiprazole,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Aripiprazole.,increase,risk
Aripiprazole,Venetoclax,The metabolism of Aripiprazole can be decreased when combined with Venetoclax.,decrease,no risk
Aripiprazole,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Aripiprazole is combined with Venlafaxine.,increase,risk
Aripiprazole,Verapamil,The metabolism of Aripiprazole can be decreased when combined with Verapamil.,decrease,no risk
Aripiprazole,Vericiguat,Aripiprazole may increase the hypotensive activities of Vericiguat.,increase,no risk
Aripiprazole,Vernakalant,The metabolism of Aripiprazole can be decreased when combined with Vernakalant.,decrease,no risk
Aripiprazole,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Aripiprazole.,increase,risk
Aripiprazole,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Aripiprazole.,increase,risk
Aripiprazole,Vilazodone,The metabolism of Aripiprazole can be decreased when combined with Vilazodone.,decrease,no risk
Aripiprazole,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Aripiprazole.,decrease,no risk
Aripiprazole,Viloxazine,The metabolism of Aripiprazole can be decreased when combined with Viloxazine.,decrease,no risk
Aripiprazole,Vinblastine,The metabolism of Aripiprazole can be increased when combined with Vinblastine.,increase,no risk
Aripiprazole,Vincristine,The metabolism of Vincristine can be decreased when combined with Aripiprazole.,decrease,no risk
Aripiprazole,Vinorelbine,The metabolism of Aripiprazole can be decreased when combined with Vinorelbine.,decrease,no risk
Chlorprothixene,Butylscopolamine,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Butylscopolamine.,increase,risk
Chlorprothixene,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Gabapentin enacarbil.,increase,risk
Chlorprothixene,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Gadobenic acid.,increase,risk
Chlorprothixene,Galantamine,The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Galantamine.,decrease,no risk
Chlorprothixene,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Chlorprothixene is combined with Ganaxolone.",increase,risk
Chlorprothixene,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Gemifloxacin.,increase,risk
Chlorprothixene,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Gilteritinib,The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Gilteritinib.,decrease,no risk
Chlorprothixene,Ginkgo biloba,The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Chlorprothixene,Glasdegib,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Glasdegib.,increase,risk
Chlorprothixene,Glucagon,Chlorprothixene may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Chlorprothixene,Glutethimide,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Glutethimide.,increase,risk
Chlorprothixene,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Chlorprothixene.,decrease,no risk
Chlorprothixene,Glycopyrronium,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Glycopyrronium.,increase,risk
Chlorprothixene,Goserelin,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Goserelin.,increase,risk
Chlorprothixene,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Grepafloxacin.,increase,risk
Chlorprothixene,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Halofantrine,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Halofantrine.,increase,risk
Chlorprothixene,Haloperidol,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Haloperidol.,increase,risk
Chlorprothixene,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Hexocyclium,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Hexocyclium.,increase,risk
Chlorprothixene,Histrelin,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Histrelin.,increase,risk
Chlorprothixene,Homatropine,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Homatropine.,increase,risk
Chlorprothixene,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Huperzine A,The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Huperzine A.,decrease,no risk
Chlorprothixene,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Chlorprothixene.,increase,no risk
Chlorprothixene,Hydrocodone,Chlorprothixene may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Chlorprothixene,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Chlorprothixene.,increase,no risk
Chlorprothixene,Hydromorphone,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Hydromorphone.,increase,risk
Chlorprothixene,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Hydroxychloroquine.,increase,risk
Chlorprothixene,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Hydroxyzine.,increase,risk
Chlorprothixene,Hyoscyamine,Chlorprothixene may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Chlorprothixene,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Ketazolam,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Ketazolam.,increase,risk
Chlorprothixene,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Ofloxacin,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Ofloxacin.,increase,risk
Chlorprothixene,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Chlorprothixene is combined with Oliceridine.",increase,risk
Chlorprothixene,Olodaterol,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Olodaterol.,increase,risk
Chlorprothixene,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Chlorprothixene.,decrease,no risk
Chlorprothixene,Opium,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Opium.,increase,risk
Chlorprothixene,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Orphenadrine,Chlorprothixene may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Chlorprothixene,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oxatomide,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Oxatomide.,increase,risk
Chlorprothixene,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oxitriptan,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Oxitriptan.,increase,risk
Chlorprothixene,Oxprenolol,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Oxprenolol.,increase,risk
Chlorprothixene,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oxycodone,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Oxycodone.,increase,risk
Chlorprothixene,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oxymorphone,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Oxymorphone.,increase,risk
Chlorprothixene,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Chlorprothixene.,decrease,no risk
Chlorprothixene,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Quazepam,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Quazepam.,increase,risk
Chlorprothixene,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Chlorprothixene.,decrease,no risk
Chlorprothixene,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Chlorprothixene.,increase,no risk
Chlorprothixene,Quinidine,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Quinidine.,increase,risk
Chlorprothixene,Quinine,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Quinine.,increase,risk
Chlorprothixene,Quinupramine,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Quinupramine.,increase,risk
Chlorprothixene,Quizartinib,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Quizartinib.,increase,risk
Chlorprothixene,Umeclidinium,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Umeclidinium.,increase,risk
Chlorprothixene,Urethane,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Urethane.,increase,risk
Chlorprothixene,Valproate bismuth,Chlorprothixene may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Chlorprothixene,Valproic acid,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Valproic acid.,increase,risk
Chlorprothixene,Vandetanib,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Vandetanib.,increase,risk
Chlorprothixene,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Vecuronium,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Vecuronium.,increase,risk
Chlorprothixene,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Vernakalant,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Vernakalant.,increase,risk
Chlorprothixene,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Viloxazine,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Viloxazine.,increase,risk
Chlorprothixene,Vincristine,Vincristine may increase the neurotoxic activities of Chlorprothixene.,increase,no risk
Chlorprothixene,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Chlorprothixene.,increase,no risk
Chlorprothixene,Viomycin,Chlorprothixene may increase the neurotoxic activities of Viomycin.,increase,no risk
Chlorprothixene,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Vorinostat,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Vorinostat.,increase,risk
Chlorprothixene,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Warfarin,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Warfarin.,increase,risk
Chlorprothixene,Xamoterol,The risk or severity of Tachycardia can be increased when Chlorprothixene is combined with Xamoterol.,increase,risk
Chlorprothixene,Xylometazoline,The risk or severity of Tachycardia can be increased when Chlorprothixene is combined with Xylometazoline.,increase,risk
Chlorprothixene,Yohimbine,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Yohimbine.,increase,risk
Chlorprothixene,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Ziconotide,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Ziconotide.,increase,risk
Chlorprothixene,Zimelidine,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Zimelidine.,increase,risk
Chlorprothixene,Ziprasidone,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Ziprasidone.,increase,risk
Chlorprothixene,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Zolpidem,Chlorprothixene may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Chlorprothixene,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Chlorprothixene.,increase,risk
Chlorprothixene,Zopiclone,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Zopiclone.,increase,risk
Chlorprothixene,Zotepine,The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Zotepine.,increase,risk
Chlorprothixene,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Zuclopenthixol.,increase,risk
Chlorprothixene,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Chlorprothixene.,increase,risk
Epoprostenol,Benserazide,Epoprostenol may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Epoprostenol,Benzatropine,Benzatropine may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Benznidazole,Epoprostenol may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Epoprostenol,Benzphetamine,Benzphetamine may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Benzthiazide,The therapeutic efficacy of Epoprostenol can be increased when used in combination with Benzthiazide.,increase,no risk
Epoprostenol,Benzydamine,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Epoprostenol.,increase,risk
Epoprostenol,Bepotastine,Epoprostenol may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Epoprostenol,Bepridil,Epoprostenol may increase the hypotensive activities of Bepridil.,increase,no risk
Epoprostenol,Beroctocog alfa,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Epoprostenol.,decrease,no risk
Epoprostenol,Betaxolol,Epoprostenol may increase the hypotensive activities of Betaxolol.,increase,no risk
Epoprostenol,Bethanidine,Epoprostenol may increase the hypotensive activities of Bethanidine.,increase,no risk
Epoprostenol,Betrixaban,The risk or severity of bleeding can be increased when Epoprostenol is combined with Betrixaban.,increase,risk
Epoprostenol,Bexarotene,The risk or severity of bleeding can be increased when Epoprostenol is combined with Bexarotene.,increase,risk
Epoprostenol,Bicisate,Epoprostenol may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Epoprostenol,Bimatoprost,Bimatoprost may increase the hypotensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Bismuth subgallate,Epoprostenol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Epoprostenol,Bismuth subsalicylate,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Epoprostenol.,increase,risk
Epoprostenol,Bisoprolol,Epoprostenol may increase the hypotensive activities of Bisoprolol.,increase,no risk
Epoprostenol,Bisoxatin,Epoprostenol may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Epoprostenol,Bivalirudin,The risk or severity of bleeding can be increased when Epoprostenol is combined with Bivalirudin.,increase,risk
Epoprostenol,Bleomycin,Bleomycin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Blinatumomab,The risk or severity of bleeding can be increased when Epoprostenol is combined with Blinatumomab.,increase,risk
Epoprostenol,Bortezomib,The risk or severity of bleeding can be increased when Epoprostenol is combined with Bortezomib.,increase,risk
Epoprostenol,Bosentan,Epoprostenol may increase the hypotensive activities of Bosentan.,increase,no risk
Epoprostenol,Bosutinib,The risk or severity of bleeding can be increased when Epoprostenol is combined with Bosutinib.,increase,risk
Epoprostenol,Bretylium,Epoprostenol may increase the hypotensive activities of Bretylium.,increase,no risk
Epoprostenol,Brexpiprazole,Brexpiprazole may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Brimonidine,Brimonidine may increase the antihypertensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Brivaracetam,Epoprostenol may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Epoprostenol,Bromazepam,Epoprostenol may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Epoprostenol,Bromocriptine,Bromocriptine may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Bromotheophylline,Bromotheophylline may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Epoprostenol,Budesonide,Budesonide may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Bumadizone,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Epoprostenol.,increase,risk
Epoprostenol,Bumetanide,Bumetanide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Epoprostenol,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Epoprostenol.,increase,risk
Epoprostenol,Bupropion,Bupropion may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Buspirone,Buspirone may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Busulfan,The risk or severity of bleeding can be increased when Epoprostenol is combined with Busulfan.,increase,risk
Epoprostenol,Butabarbital,Butabarbital may increase the hypotensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Butalbital,Butalbital may increase the hypotensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Butriptyline,Butriptyline may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Gabapentin enacarbil,Epoprostenol may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gadodiamide,Gadodiamide may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gadofosveset trisodium,Epoprostenol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gadoteric acid,Epoprostenol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gadoteridol,Gadoteridol may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Ganciclovir,Ganciclovir may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gemcitabine,The risk or severity of bleeding can be increased when Epoprostenol is combined with Gemcitabine.,increase,risk
Epoprostenol,Gemfibrozil,Epoprostenol may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Epoprostenol is combined with Gemtuzumab ozogamicin.,increase,risk
Epoprostenol,Gentamicin,Epoprostenol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Epoprostenol,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Epoprostenol.,increase,risk
Epoprostenol,Gimeracil,Epoprostenol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Epoprostenol,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Epoprostenol.,increase,no risk
Epoprostenol,Givosiran,Givosiran may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Glipizide,Glipizide may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Glucosamine,Glucosamine may increase the antiplatelet activities of Epoprostenol.,increase,no risk
Epoprostenol,Glycerol phenylbutyrate,Epoprostenol may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Epoprostenol,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Epoprostenol.,increase,risk
Epoprostenol,Golodirsen,Epoprostenol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Epoprostenol,Goserelin,Goserelin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Guanabenz,Epoprostenol may increase the hypotensive activities of Guanabenz.,increase,no risk
Epoprostenol,Guanadrel,Epoprostenol may increase the hypotensive activities of Guanadrel.,increase,no risk
Epoprostenol,Guanethidine,Epoprostenol may increase the hypotensive activities of Guanethidine.,increase,no risk
Epoprostenol,Guanfacine,Epoprostenol may increase the hypotensive activities of Guanfacine.,increase,no risk
Epoprostenol,Guanoxan,Epoprostenol may increase the hypotensive activities of Guanoxan.,increase,no risk
Epoprostenol,Haloperidol,Haloperidol may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Halothane,Halothane may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Hemin,Hemin may increase the anticoagulant activities of Epoprostenol.,increase,no risk
Epoprostenol,Heparin,The risk or severity of bleeding can be increased when Epoprostenol is combined with Heparin.,increase,risk
Epoprostenol,Hydralazine,Epoprostenol may increase the hypotensive activities of Hydralazine.,increase,no risk
Epoprostenol,Hydrochlorothiazide,The therapeutic efficacy of Epoprostenol can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Epoprostenol,Hydroflumethiazide,The therapeutic efficacy of Epoprostenol can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Epoprostenol,Hydromorphone,Hydromorphone may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Hydroxyethyl Starch,Epoprostenol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Epoprostenol,Hydroxyprogesterone caproate,The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Epoprostenol,Hydroxyurea,The risk or severity of bleeding can be increased when Epoprostenol is combined with Hydroxyurea.,increase,risk
Epoprostenol,Kanamycin,Epoprostenol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Epoprostenol,Ketamine,Ketamine may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Ketazolam,Epoprostenol may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Epoprostenol,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Epoprostenol.,increase,risk
Epoprostenol,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Epoprostenol.,increase,risk
Epoprostenol,Obeticholic acid,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Obeticholic acid.,increase,risk
Epoprostenol,Obinutuzumab,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Obinutuzumab.,increase,risk
Epoprostenol,Octinoxate,Epoprostenol may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Epoprostenol,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Epoprostenol.,increase,risk
Epoprostenol,Olaparib,The risk or severity of bleeding can be increased when Epoprostenol is combined with Olaparib.,increase,risk
Epoprostenol,Olive oil,The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Olive oil.,decrease,no risk
Epoprostenol,Olmesartan,Epoprostenol may increase the hypotensive activities of Olmesartan.,increase,no risk
Epoprostenol,Olodaterol,Olodaterol may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Epoprostenol.,increase,risk
Epoprostenol,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Epoprostenol is combined with Omacetaxine mepesuccinate.,increase,risk
Epoprostenol,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Epoprostenol.,increase,no risk
Epoprostenol,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Epoprostenol.,increase,risk
Epoprostenol,Omega-3-carboxylic acids,The therapeutic efficacy of Epoprostenol can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Epoprostenol,Opicapone,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Opicapone.,increase,risk
Epoprostenol,Opium,Epoprostenol may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Epoprostenol,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Oseltamivir,Oseltamivir may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Oxacillin,Oxacillin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Epoprostenol.,increase,risk
Epoprostenol,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Epoprostenol.,increase,risk
Epoprostenol,Oxazepam,Oxazepam may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Oxprenolol,Epoprostenol may increase the hypotensive activities of Oxprenolol.,increase,no risk
Epoprostenol,Oxybenzone,Epoprostenol may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Epoprostenol,Oxymetazoline,Oxymetazoline may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Epoprostenol.,increase,risk
Epoprostenol,Oxyquinoline,Epoprostenol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Epoprostenol,Quetiapine,Quetiapine may increase the hypotensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Quinapril,Epoprostenol may increase the hypotensive activities of Quinapril.,increase,no risk
Epoprostenol,Quinestrol,Quinestrol may decrease the anticoagulant activities of Epoprostenol.,decrease,no risk
Epoprostenol,Quinethazone,Quinethazone may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Epoprostenol,Quinidine,The therapeutic efficacy of Epoprostenol can be increased when used in combination with Quinidine.,increase,no risk
Epoprostenol,Quinine,The therapeutic efficacy of Epoprostenol can be increased when used in combination with Quinine.,increase,no risk
Epoprostenol,Quinupramine,Quinupramine may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Udenafil,Udenafil may increase the antihypertensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Ulipristal,The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Ulipristal.,decrease,no risk
Epoprostenol,Unoprostone,Epoprostenol may increase the hypotensive activities of Unoprostone.,increase,no risk
Epoprostenol,Urokinase,Urokinase may increase the anticoagulant activities of Epoprostenol.,increase,no risk
Epoprostenol,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Ursodeoxycholic acid.,increase,risk
Epoprostenol,Vaborbactam,Epoprostenol may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Epoprostenol,Valaciclovir,Valaciclovir may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Valbenazine,Epoprostenol may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Epoprostenol,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Epoprostenol.,increase,risk
Epoprostenol,Valganciclovir,Epoprostenol may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Epoprostenol,Valsartan,Epoprostenol may increase the hypotensive activities of Valsartan.,increase,no risk
Epoprostenol,Vancomycin,Epoprostenol may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Epoprostenol,Vardenafil,Vardenafil may increase the antihypertensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Varenicline,Epoprostenol may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Epoprostenol,Venlafaxine,The risk or severity of bleeding can be increased when Epoprostenol is combined with Venlafaxine.,increase,risk
Epoprostenol,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Epoprostenol.,increase,risk
Epoprostenol,Vericiguat,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Vericiguat.,increase,risk
Epoprostenol,Vilanterol,Vilanterol may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Vilazodone,Vilazodone may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Viloxazine,Epoprostenol may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Epoprostenol,Vinblastine,The risk or severity of bleeding can be increased when Epoprostenol is combined with Vinblastine.,increase,risk
Epoprostenol,Vindesine,The risk or severity of bleeding can be increased when Epoprostenol is combined with Vindesine.,increase,risk
Epoprostenol,Vinorelbine,The risk or severity of bleeding can be increased when Epoprostenol is combined with Vinorelbine.,increase,risk
Epoprostenol,Vitamin E,Vitamin E may increase the antiplatelet activities of Epoprostenol.,increase,no risk
Epoprostenol,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Epoprostenol.,decrease,no risk
Epoprostenol,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Epoprostenol.,increase,risk
Epoprostenol,Vorinostat,The risk or severity of bleeding can be increased when Epoprostenol is combined with Vorinostat.,increase,risk
Epoprostenol,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Epoprostenol.,increase,risk
Epoprostenol,Warfarin,The risk or severity of bleeding can be increased when Epoprostenol is combined with Warfarin.,increase,risk
Epoprostenol,Xamoterol,Xamoterol may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Ximelagatran,The risk or severity of bleeding can be increased when Epoprostenol is combined with Ximelagatran.,increase,risk
Epoprostenol,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Yohimbine,Yohimbine may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Zaleplon,Zaleplon may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Zanamivir,Zanamivir may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,decrease,no risk
Epoprostenol,Zidovudine,The risk or severity of bleeding can be increased when Epoprostenol is combined with Zidovudine.,increase,risk
Epoprostenol,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Epoprostenol.,increase,risk
Epoprostenol,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Epoprostenol.,increase,no risk
Epoprostenol,Zofenopril,Epoprostenol may increase the hypotensive activities of Zofenopril.,increase,no risk
Epoprostenol,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Epoprostenol,Zonisamide,Zonisamide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Epoprostenol,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Epoprostenol.,decrease,no risk
Gemfibrozil,Bepotastine,Gemfibrozil may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Berotralstat,The metabolism of Gemfibrozil can be decreased when combined with Berotralstat.,decrease,no risk
Gemfibrozil,Betamethasone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Gemfibrozil.",increase,risk
Gemfibrozil,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Bexagliflozin,The metabolism of Bexagliflozin can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Bezafibrate,The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Bezafibrate.,increase,risk
Gemfibrozil,Bicisate,Gemfibrozil may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Bismuth subgallate,Gemfibrozil may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Bisoprolol,Bisoprolol may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Bisoxatin,Gemfibrozil may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Bleomycin,Bleomycin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Boceprevir,The metabolism of Gemfibrozil can be decreased when combined with Boceprevir.,decrease,no risk
Gemfibrozil,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Bosentan,The metabolism of Bosentan can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Gemfibrozil.,increase,no risk
Gemfibrozil,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Bromotheophylline,Bromotheophylline may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gemfibrozil,Budesonide,Budesonide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Bumadizone,Bumadizone may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Bumetanide,The excretion of Bumetanide can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Bupropion,The metabolism of Bupropion can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Buspirone,Buspirone may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Butabarbital,Butabarbital may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gabapentin enacarbil,Gemfibrozil may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gadodiamide,Gadodiamide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gadofosveset trisodium,Gemfibrozil may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gadoteric acid,Gemfibrozil may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gadoteridol,Gadoteridol may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Gemfibrozil.",increase,risk
Gemfibrozil,Gemcitabine,Gemcitabine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gentamicin,Gemfibrozil may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Gimeracil,Gemfibrozil may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Givosiran,Givosiran may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Glecaprevir,The metabolism of Gemfibrozil can be decreased when combined with Glecaprevir.,decrease,no risk
Gemfibrozil,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Glipizide,The metabolism of Glipizide can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Glofitamab,The serum concentration of Gemfibrozil can be increased when it is combined with Glofitamab.,increase,no risk
Gemfibrozil,Glyburide,The metabolism of Glyburide can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Glycerol phenylbutyrate,Gemfibrozil may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Golodirsen,Gemfibrozil may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Goserelin,Goserelin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Guanethidine,Guanethidine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Guanfacine,Guanfacine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Gemfibrozil.,increase,no risk
Gemfibrozil,Halothane,The metabolism of Halothane can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Hydralazine,Gemfibrozil may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gemfibrozil,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Hydroxyethyl Starch,Gemfibrozil may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Kanamycin,Gemfibrozil may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Ketamine,The metabolism of Ketamine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Ketazolam,Gemfibrozil may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Ketoconazole,The metabolism of Gemfibrozil can be decreased when combined with Ketoconazole.,decrease,no risk
Gemfibrozil,Ketoprofen,The metabolism of Ketoprofen can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Obeticholic acid,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Gemfibrozil.,decrease,no risk
Gemfibrozil,Octinoxate,Gemfibrozil may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ofloxacin is combined with Gemfibrozil.",increase,risk
Gemfibrozil,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Olsalazine,Olsalazine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Omaveloxolone,The serum concentration of Gemfibrozil can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Gemfibrozil,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Opium,Gemfibrozil may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Ouabain,The excretion of Ouabain can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Oxacillin,Oxacillin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Oxaprozin,Oxaprozin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Oxazepam,Oxazepam may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Oxybenzone,Gemfibrozil may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Oxyquinoline,Gemfibrozil may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Quetiapine,Quetiapine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Quinapril,The excretion of Quinapril can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Quinethazone,Quinethazone may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gemfibrozil,Quinidine,Gemfibrozil may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Quinine,The metabolism of Quinine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Quizartinib,The metabolism of Gemfibrozil can be decreased when combined with Quizartinib.,decrease,no risk
Gemfibrozil,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Gemfibrozil is combined with Ubidecarenone.",increase,risk
Gemfibrozil,Ursodeoxycholic acid,The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Gemfibrozil.,decrease,no risk
Gemfibrozil,Vaborbactam,Gemfibrozil may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Gemfibrozil.,increase,no risk
Gemfibrozil,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Valbenazine,Gemfibrozil may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Valganciclovir,Gemfibrozil may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Valsartan,The metabolism of Valsartan can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Vancomycin,Gemfibrozil may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Varenicline,Gemfibrozil may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Venetoclax,The metabolism of Gemfibrozil can be decreased when combined with Venetoclax.,decrease,no risk
Gemfibrozil,Venlafaxine,Venlafaxine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Verapamil,The metabolism of Gemfibrozil can be decreased when combined with Verapamil.,decrease,no risk
Gemfibrozil,Vilanterol,Gemfibrozil may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Viloxazine,The metabolism of Gemfibrozil can be decreased when combined with Viloxazine.,decrease,no risk
Gemfibrozil,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Gemfibrozil.",increase,risk
Gemfibrozil,Voriconazole,The metabolism of Gemfibrozil can be decreased when combined with Voriconazole.,decrease,no risk
Gemfibrozil,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Warfarin,The metabolism of Warfarin can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Zaleplon,Zaleplon may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Zanamivir,Zanamivir may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemfibrozil,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Gemfibrozil.,increase,no risk
Gemfibrozil,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Zileuton,The metabolism of Zileuton can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Zimelidine,The metabolism of Gemfibrozil can be decreased when combined with Zimelidine.,decrease,no risk
Gemfibrozil,Ziprasidone,The metabolism of Gemfibrozil can be decreased when combined with Ziprasidone.,decrease,no risk
Gemfibrozil,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Gemfibrozil.,decrease,no risk
Gemfibrozil,Zotepine,The metabolism of Zotepine can be decreased when combined with Gemfibrozil.,decrease,no risk
Clomipramine,Bacitracin,Bacitracin may decrease the excretion rate of Clomipramine which could result in a higher serum level.,decrease,no risk
Clomipramine,Baclofen,The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Clomipramine.,increase,risk
Clomipramine,Balsalazide,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Balsalazide.,increase,risk
Clomipramine,Baricitinib,Clomipramine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Clomipramine,Beclomethasone dipropionate,The metabolism of Clomipramine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Clomipramine,Bedaquiline,The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Bedaquiline.,increase,risk
Clomipramine,Belinostat,The metabolism of Clomipramine can be increased when combined with Belinostat.,increase,no risk
Clomipramine,Belladonna,The risk or severity of adverse effects can be increased when Belladonna is combined with Clomipramine.,increase,risk
Clomipramine,Belzutifan,The serum concentration of Clomipramine can be decreased when it is combined with Belzutifan.,decrease,no risk
Clomipramine,Benazepril,Clomipramine may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Clomipramine,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Clomipramine.,decrease,no risk
Clomipramine,Bendazac,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Bendazac.,increase,risk
Clomipramine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clomipramine,Benorilate,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Benorilate.,increase,risk
Clomipramine,Benoxaprofen,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Benoxaprofen.,increase,risk
Clomipramine,Benperidol,The risk or severity of adverse effects can be increased when Clomipramine is combined with Benperidol.,increase,risk
Clomipramine,Benserazide,Clomipramine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Clomipramine,Benzatropine,The metabolism of Clomipramine can be decreased when combined with Benzatropine.,decrease,no risk
Clomipramine,Benznidazole,Clomipramine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Clomipramine,Benzocaine,The metabolism of Clomipramine can be decreased when combined with Benzocaine.,decrease,no risk
Clomipramine,Benzphetamine,The therapeutic efficacy of Clomipramine can be increased when used in combination with Benzphetamine.,increase,no risk
Clomipramine,Benzthiazide,Benzthiazide may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clomipramine,Benzydamine,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Benzydamine.,increase,risk
Clomipramine,Benzyl alcohol,The metabolism of Clomipramine can be decreased when combined with Benzyl alcohol.,decrease,no risk
Clomipramine,Bepotastine,Clomipramine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Clomipramine,Bepridil,The metabolism of Clomipramine can be decreased when combined with Bepridil.,decrease,no risk
Clomipramine,Berotralstat,The serum concentration of Clomipramine can be increased when it is combined with Berotralstat.,increase,no risk
Clomipramine,Betamethasone,The metabolism of Clomipramine can be increased when combined with Betamethasone.,increase,no risk
Clomipramine,Betamethasone phosphate,The metabolism of Clomipramine can be increased when combined with Betamethasone phosphate.,increase,no risk
Clomipramine,Betaxolol,The metabolism of Clomipramine can be decreased when combined with Betaxolol.,decrease,no risk
Clomipramine,Bethanidine,The risk or severity of hypertension can be increased when Clomipramine is combined with Bethanidine.,increase,risk
Clomipramine,Betulinic Acid,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Betulinic Acid.,increase,risk
Clomipramine,Bexagliflozin,Clomipramine may decrease the hypoglycemic activities of Bexagliflozin.,decrease,no risk
Clomipramine,Bexarotene,The metabolism of Clomipramine can be increased when combined with Bexarotene.,increase,no risk
Clomipramine,Bicalutamide,The metabolism of Clomipramine can be decreased when combined with Bicalutamide.,decrease,no risk
Clomipramine,Bicisate,Clomipramine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Clomipramine,Bifonazole,The metabolism of Clomipramine can be decreased when combined with Bifonazole.,decrease,no risk
Clomipramine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Clomipramine.,increase,risk
Clomipramine,Bimekizumab,The metabolism of Clomipramine can be increased when combined with Bimekizumab.,increase,no risk
Clomipramine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Clomipramine.,decrease,no risk
Clomipramine,Biperiden,The metabolism of Clomipramine can be decreased when combined with Biperiden.,decrease,no risk
Clomipramine,Bismuth subcitrate potassium,Clomipramine may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Clomipramine,Bismuth subgallate,Clomipramine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Clomipramine,Bismuth subnitrate,Clomipramine may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Clomipramine,Bisoprolol,Clomipramine may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Clomipramine,Bisoxatin,Clomipramine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Clomipramine,Bleomycin,Bleomycin may decrease the excretion rate of Clomipramine which could result in a higher serum level.,decrease,no risk
Clomipramine,Boceprevir,The metabolism of Clomipramine can be decreased when combined with Boceprevir.,decrease,no risk
Clomipramine,Bortezomib,The metabolism of Clomipramine can be decreased when combined with Bortezomib.,decrease,no risk
Clomipramine,Bosentan,The metabolism of Clomipramine can be increased when combined with Bosentan.,increase,no risk
Clomipramine,Bosutinib,The metabolism of Clomipramine can be decreased when combined with Bosutinib.,decrease,no risk
Clomipramine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Clomipramine.,increase,risk
Clomipramine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Clomipramine.,increase,risk
Clomipramine,Brentuximab vedotin,The serum concentration of Clomipramine can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Clomipramine,Bretylium,Clomipramine may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Clomipramine,Brexanolone,The risk or severity of CNS depression can be increased when Clomipramine is combined with Brexanolone.,increase,risk
Clomipramine,Brexpiprazole,The metabolism of Clomipramine can be decreased when combined with Brexpiprazole.,decrease,no risk
Clomipramine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Clomipramine.,increase,no risk
Clomipramine,Brivaracetam,The risk or severity of CNS depression can be increased when Clomipramine is combined with Brivaracetam.,increase,risk
Clomipramine,Bromazepam,The risk or severity of CNS depression can be increased when Clomipramine is combined with Bromazepam.,increase,risk
Clomipramine,Bromfenac,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Bromfenac.,increase,risk
Clomipramine,Bromocriptine,Clomipramine may increase the vasopressor activities of Bromocriptine.,increase,no risk
Clomipramine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clomipramine,Bromperidol,The risk or severity of adverse effects can be increased when Clomipramine is combined with Bromperidol.,increase,risk
Clomipramine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Clomipramine.,increase,risk
Clomipramine,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Clomipramine.,increase,risk
Clomipramine,Budesonide,The metabolism of Clomipramine can be increased when combined with Budesonide.,increase,no risk
Clomipramine,Bufexamac,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Bufexamac.,increase,risk
Clomipramine,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Bumadizone.,increase,risk
Clomipramine,Bumetanide,Bumetanide may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clomipramine,Bupivacaine,The metabolism of Clomipramine can be decreased when combined with Bupivacaine.,decrease,no risk
Clomipramine,Buprenorphine,Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Clomipramine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Clomipramine.,increase,risk
Clomipramine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Clomipramine.,increase,risk
Clomipramine,Buspirone,The metabolism of Clomipramine can be decreased when combined with Buspirone.,decrease,no risk
Clomipramine,Butabarbital,The metabolism of Clomipramine can be increased when combined with Butabarbital.,increase,no risk
Clomipramine,Butalbital,The metabolism of Clomipramine can be increased when combined with Butalbital.,increase,no risk
Clomipramine,Butaperazine,"The serum concentration of desmethylclomipramine, an active metabolite of Clomipramine, can be increased when used in combination with Butaperazine.",increase,no risk
Clomipramine,Butobarbital,The risk or severity of CNS depression can be increased when Clomipramine is combined with Butobarbital.,increase,risk
Clomipramine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Clomipramine.,increase,risk
Clomipramine,Butriptyline,The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Butriptyline.,increase,risk
Clomipramine,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Clomipramine.,increase,risk
Bepridil,Bioallethrin,Bepridil may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Bepridil,Biperiden,The metabolism of Bepridil can be decreased when combined with Biperiden.,decrease,no risk
Bepridil,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Bepridil.,decrease,no risk
Bepridil,Bisoprolol,The therapeutic efficacy of Bepridil can be increased when used in combination with Bisoprolol.,increase,no risk
Bepridil,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Bepridil.,decrease,no risk
Bepridil,Boceprevir,The serum concentration of Bepridil can be increased when it is combined with Boceprevir.,increase,no risk
Bepridil,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Bepridil.,increase,risk
Bepridil,Bosentan,Bosentan may increase the hypotensive activities of Bepridil.,increase,no risk
Bepridil,Bretylium,Bretylium may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Bepridil,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Bepridil.,decrease,no risk
Bepridil,Brimonidine,Brimonidine may increase the antihypertensive activities of Bepridil.,increase,no risk
Bepridil,Bromocriptine,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Bromocriptine.,increase,risk
Bepridil,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Bepridil.,increase,risk
Bepridil,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Bepridil.,increase,risk
Bepridil,Bumadizone,The therapeutic efficacy of Bepridil can be decreased when used in combination with Bumadizone.,decrease,no risk
Bepridil,Bumetanide,The risk or severity of adverse effects can be increased when Bumetanide is combined with Bepridil.,increase,risk
Bepridil,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Bepridil.,decrease,no risk
Bepridil,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Bepridil.,decrease,no risk
Bepridil,Bupropion,The metabolism of Bepridil can be decreased when combined with Bupropion.,decrease,no risk
Bepridil,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Bepridil.,increase,risk
Bepridil,Buspirone,The metabolism of Buspirone can be decreased when combined with Bepridil.,decrease,no risk
Bepridil,Butabarbital,Butabarbital may increase the hypotensive activities of Bepridil.,increase,no risk
Bepridil,Butalbital,Butalbital may increase the hypotensive activities of Bepridil.,increase,no risk
Bepridil,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Bepridil.,increase,risk
Bepridil,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Bepridil.,increase,risk
Bepridil,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Bepridil.,increase,risk
Bepridil,Gallamine triethiodide,Bepridil may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Bepridil,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Bepridil.,increase,risk
Bepridil,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Bepridil.,decrease,no risk
Bepridil,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Bepridil.,increase,risk
Bepridil,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Bepridil.,increase,risk
Bepridil,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Bepridil.,increase,risk
Bepridil,Givosiran,The serum concentration of Bepridil can be increased when it is combined with Givosiran.,increase,no risk
Bepridil,Glasdegib,The risk or severity of QTc prolongation can be increased when Bepridil is combined with Glasdegib.,increase,risk
Bepridil,Gliclazide,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Gliclazide.,increase,risk
Bepridil,Glimepiride,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Glimepiride.,increase,risk
Bepridil,Glipizide,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Glipizide.,increase,risk
Bepridil,Gliquidone,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Gliquidone.,increase,risk
Bepridil,Glofitamab,The serum concentration of Bepridil can be increased when it is combined with Glofitamab.,increase,no risk
Bepridil,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Bepridil.,decrease,no risk
Bepridil,Glyburide,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Glyburide.,increase,risk
Bepridil,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Bepridil.,decrease,no risk
Bepridil,Glycerol phenylbutyrate,The metabolism of Bepridil can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Decamethonium,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Decamethonium.,increase,risk
Decamethonium,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Decamethonium is combined with Gabapentin enacarbil.,increase,risk
Decamethonium,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Decamethonium.,increase,risk
Decamethonium,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Decamethonium is combined with Ganaxolone.",increase,risk
Decamethonium,Gentamicin,The therapeutic efficacy of Decamethonium can be increased when used in combination with Gentamicin.,increase,no risk
Decamethonium,Gepirone,The risk or severity of CNS depression can be increased when Decamethonium is combined with Gepirone.,increase,risk
Decamethonium,Glutethimide,The risk or severity of CNS depression can be increased when Decamethonium is combined with Glutethimide.,increase,risk
Decamethonium,Glycopyrronium,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Decamethonium.,decrease,no risk
Decamethonium,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Decamethonium.,increase,risk
Decamethonium,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Decamethonium.,increase,risk
Decamethonium,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Decamethonium.,increase,risk
Decamethonium,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Decamethonium.,increase,risk
Decamethonium,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Decamethonium.,increase,risk
Decamethonium,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Decamethonium.,increase,risk
Decamethonium,Hexocyclium,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Decamethonium.,decrease,no risk
Decamethonium,Homatropine methylbromide,The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Decamethonium.,decrease,no risk
Decamethonium,Hydrocodone,Decamethonium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Decamethonium,Hydrocortisone,The therapeutic efficacy of Decamethonium can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Decamethonium,Hydrocortisone acetate,The therapeutic efficacy of Decamethonium can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Decamethonium,Hydrocortisone butyrate,The therapeutic efficacy of Decamethonium can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Decamethonium,Hydrocortisone cypionate,The therapeutic efficacy of Decamethonium can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Decamethonium,Hydrocortisone succinate,The therapeutic efficacy of Decamethonium can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Decamethonium,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Decamethonium.,increase,risk
Decamethonium,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Decamethonium.,increase,no risk
Decamethonium,Hyoscyamine,The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Decamethonium.,decrease,no risk
Decamethonium,Kanamycin,The therapeutic efficacy of Decamethonium can be increased when used in combination with Kanamycin.,increase,no risk
Decamethonium,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Decamethonium.,increase,risk
Decamethonium,Ketazolam,The risk or severity of CNS depression can be increased when Decamethonium is combined with Ketazolam.,increase,risk
Decamethonium,Ketoconazole,The therapeutic efficacy of Decamethonium can be increased when used in combination with Ketoconazole.,increase,no risk
Decamethonium,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Decamethonium.,increase,risk
Decamethonium,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Decamethonium is combined with Oliceridine.",increase,risk
Decamethonium,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Decamethonium.,increase,risk
Decamethonium,Opium,The risk or severity of CNS depression can be increased when Decamethonium is combined with Opium.,increase,risk
Decamethonium,Orphenadrine,Decamethonium may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Decamethonium,Ouabain,The risk or severity of Cardiac Arrhythmia can be increased when Decamethonium is combined with Ouabain.,increase,risk
Decamethonium,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Decamethonium.,increase,risk
Decamethonium,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Decamethonium.,increase,risk
Decamethonium,Oxitriptan,The risk or severity of CNS depression can be increased when Decamethonium is combined with Oxitriptan.,increase,risk
Decamethonium,Oxprenolol,Decamethonium may increase the bradycardic activities of Oxprenolol.,increase,no risk
Decamethonium,Oxybuprocaine,Decamethonium may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Decamethonium,Oxybutynin,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Decamethonium.,decrease,no risk
Decamethonium,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Decamethonium.,increase,risk
Decamethonium,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Decamethonium.,increase,risk
Decamethonium,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Decamethonium.,decrease,no risk
Decamethonium,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Decamethonium.,decrease,no risk
Decamethonium,Oxytetracycline,The therapeutic efficacy of Decamethonium can be increased when used in combination with Oxytetracycline.,increase,no risk
Decamethonium,Quazepam,The risk or severity of CNS depression can be increased when Decamethonium is combined with Quazepam.,increase,risk
Decamethonium,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Decamethonium.,increase,risk
Decamethonium,Quinidine,The therapeutic efficacy of Decamethonium can be increased when used in combination with Quinidine.,increase,no risk
Decamethonium,Quinine,The therapeutic efficacy of Decamethonium can be increased when used in combination with Quinine.,increase,no risk
Decamethonium,Quinupramine,The risk or severity of CNS depression can be increased when Decamethonium is combined with Quinupramine.,increase,risk
Alimemazine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Alimemazine.,increase,risk
Alimemazine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Alimemazine is combined with Gabapentin enacarbil.,increase,risk
Alimemazine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Gadobenic acid.,increase,risk
Alimemazine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Alimemazine.,increase,risk
Alimemazine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Alimemazine.,increase,risk
Alimemazine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Alimemazine is combined with Ganaxolone.",increase,risk
Alimemazine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Alimemazine.,increase,risk
Alimemazine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Gemifloxacin.,increase,risk
Alimemazine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Alimemazine.,increase,risk
Alimemazine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Gilteritinib.,increase,risk
Alimemazine,Glasdegib,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Glasdegib.,increase,risk
Alimemazine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Alimemazine.,decrease,no risk
Alimemazine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Alimemazine.,decrease,no risk
Alimemazine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Alimemazine.,decrease,no risk
Alimemazine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Alimemazine.,decrease,no risk
Alimemazine,Glutethimide,The risk or severity of CNS depression can be increased when Alimemazine is combined with Glutethimide.,increase,risk
Alimemazine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Alimemazine.,decrease,no risk
Alimemazine,Goserelin,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Goserelin.,increase,risk
Alimemazine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Alimemazine.,increase,risk
Alimemazine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Grepafloxacin.,increase,risk
Alimemazine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Alimemazine.,increase,risk
Alimemazine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Alimemazine.,increase,risk
Alimemazine,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Alimemazine.,increase,risk
Alimemazine,Haloperidol,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Haloperidol.,increase,risk
Alimemazine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Alimemazine.,increase,risk
Alimemazine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Alimemazine.,increase,risk
Alimemazine,Histrelin,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Histrelin.,increase,risk
Alimemazine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Alimemazine.,increase,risk
Alimemazine,Hydrocodone,Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Alimemazine,Hydromorphone,The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Hydromorphone.,increase,risk
Alimemazine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Alimemazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Alimemazine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Alimemazine.,increase,risk
Alimemazine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Hydroxyzine.,increase,risk
Alimemazine,Hyoscyamine,Alimemazine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Alimemazine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Alimemazine.,increase,risk
Alimemazine,Ketazolam,The risk or severity of CNS depression can be increased when Alimemazine is combined with Ketazolam.,increase,risk
Alimemazine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Alimemazine.,increase,risk
Alimemazine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Alimemazine.,increase,risk
Alimemazine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Ofloxacin.,increase,risk
Alimemazine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Alimemazine.,increase,risk
Alimemazine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Alimemazine is combined with Oliceridine.",increase,risk
Alimemazine,Olodaterol,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Olodaterol.,increase,risk
Alimemazine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Alimemazine.,increase,risk
Alimemazine,Opium,The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Opium.,increase,risk
Alimemazine,Orphenadrine,Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Alimemazine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Alimemazine.,increase,risk
Alimemazine,Oxatomide,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Oxatomide.,increase,risk
Alimemazine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Alimemazine.,increase,risk
Alimemazine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Alimemazine.,increase,risk
Alimemazine,Oxitriptan,The risk or severity of CNS depression can be increased when Alimemazine is combined with Oxitriptan.,increase,risk
Alimemazine,Oxprenolol,The serum concentration of Oxprenolol can be increased when it is combined with Alimemazine.,increase,no risk
Alimemazine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Alimemazine.,increase,risk
Alimemazine,Oxycodone,The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Oxycodone.,increase,risk
Alimemazine,Oxymorphone,The risk or severity of hypotension and CNS depression can be increased when Alimemazine is combined with Oxymorphone.,increase,risk
Alimemazine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Alimemazine.,increase,risk
Alimemazine,Quazepam,The risk or severity of CNS depression can be increased when Alimemazine is combined with Quazepam.,increase,risk
Alimemazine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Alimemazine.,increase,risk
Alimemazine,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Alimemazine.,decrease,no risk
Alimemazine,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Alimemazine.,increase,risk
Alimemazine,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Alimemazine.,increase,risk
Alimemazine,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Alimemazine.,increase,no risk
Alimemazine,Quizartinib,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Quizartinib.,increase,risk
Alimemazine,Urethane,The risk or severity of CNS depression can be increased when Alimemazine is combined with Urethane.,increase,risk
Alimemazine,Valproate bismuth,Alimemazine may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Alimemazine,Valproic acid,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Valproic acid.,increase,risk
Alimemazine,Vandetanib,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Vandetanib.,increase,risk
Alimemazine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Alimemazine.,increase,risk
Alimemazine,Vecuronium,The risk or severity of CNS depression can be increased when Alimemazine is combined with Vecuronium.,increase,risk
Alimemazine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Alimemazine.,increase,risk
Alimemazine,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Alimemazine.,increase,risk
Alimemazine,Vernakalant,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Vernakalant.,increase,risk
Alimemazine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Alimemazine.,increase,risk
Alimemazine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Alimemazine.,increase,risk
Alimemazine,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Alimemazine.,increase,risk
Alimemazine,Viloxazine,The risk or severity of CNS depression can be increased when Alimemazine is combined with Viloxazine.,increase,risk
Alimemazine,Vincristine,Vincristine may increase the neurotoxic activities of Alimemazine.,increase,no risk
Alimemazine,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Alimemazine.,increase,no risk
Alimemazine,Viomycin,Alimemazine may increase the neurotoxic activities of Viomycin.,increase,no risk
Alimemazine,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Alimemazine.,increase,risk
Alimemazine,Vorinostat,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Vorinostat.,increase,risk
Alimemazine,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Alimemazine.,increase,risk
Alimemazine,Yohimbine,The risk or severity of CNS depression can be increased when Alimemazine is combined with Yohimbine.,increase,risk
Alimemazine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Alimemazine.,increase,risk
Alimemazine,Ziconotide,The risk or severity of CNS depression can be increased when Alimemazine is combined with Ziconotide.,increase,risk
Alimemazine,Zimelidine,The risk or severity of adverse effects can be increased when Alimemazine is combined with Zimelidine.,increase,risk
Alimemazine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Ziprasidone.,increase,risk
Alimemazine,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Alimemazine.,increase,risk
Alimemazine,Zolpidem,Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Alimemazine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Alimemazine.,increase,risk
Alimemazine,Zopiclone,The risk or severity of adverse effects can be increased when Alimemazine is combined with Zopiclone.,increase,risk
Alimemazine,Zotepine,The risk or severity of CNS depression can be increased when Alimemazine is combined with Zotepine.,increase,risk
Alimemazine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Zuclopenthixol.,increase,risk
Alimemazine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Alimemazine.,increase,risk
Isocarboxazid,Bromocriptine,Isocarboxazid may increase the hypertensive activities of Bromocriptine.,increase,no risk
Isocarboxazid,Bromperidol,The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Bromperidol.,increase,risk
Isocarboxazid,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Isocarboxazid.,increase,risk
Isocarboxazid,Bumadizone,The risk or severity of hypertension can be increased when Isocarboxazid is combined with Bumadizone.,increase,risk
Isocarboxazid,Bumetanide,Isocarboxazid may increase the orthostatic hypotensive activities of Bumetanide.,increase,no risk
Isocarboxazid,Bupivacaine,Isocarboxazid may increase the orthostatic hypotensive activities of Bupivacaine.,increase,no risk
Isocarboxazid,Buprenorphine,Isocarboxazid may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Isocarboxazid,Bupropion,The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Bupropion.,increase,risk
Isocarboxazid,Buspirone,The risk or severity of hypertension can be increased when Isocarboxazid is combined with Buspirone.,increase,risk
Isocarboxazid,Butabarbital,Butabarbital may increase the hypotensive activities of Isocarboxazid.,increase,no risk
Isocarboxazid,Butalbital,Butalbital may increase the hypotensive activities of Isocarboxazid.,increase,no risk
Isocarboxazid,Butaperazine,The risk or severity of extrapyramidal symptoms can be increased when Isocarboxazid is combined with Butaperazine.,increase,risk
Isocarboxazid,Butobarbital,The risk or severity of CNS depression can be increased when Isocarboxazid is combined with Butobarbital.,increase,risk
Isocarboxazid,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Isocarboxazid.,increase,risk
Isocarboxazid,Butriptyline,Isocarboxazid may increase the serotonergic activities of Butriptyline.,increase,no risk
Docetaxel,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Docetaxel.,increase,risk
Docetaxel,Bevacizumab,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Docetaxel.,increase,risk
Docetaxel,Bexarotene,The metabolism of Docetaxel can be increased when combined with Bexarotene.,increase,no risk
Docetaxel,Bezafibrate,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Docetaxel is combined with Bezafibrate.",increase,risk
Docetaxel,Bicalutamide,The metabolism of Docetaxel can be decreased when combined with Bicalutamide.,decrease,no risk
Docetaxel,Bifonazole,The metabolism of Docetaxel can be decreased when combined with Bifonazole.,decrease,no risk
Docetaxel,Bimekizumab,The metabolism of Docetaxel can be increased when combined with Bimekizumab.,increase,no risk
Docetaxel,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Docetaxel.,increase,risk
Docetaxel,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Docetaxel.,increase,risk
Docetaxel,Blinatumomab,The risk or severity of adverse effects can be increased when Docetaxel is combined with Blinatumomab.,increase,risk
Docetaxel,Boceprevir,The metabolism of Docetaxel can be decreased when combined with Boceprevir.,decrease,no risk
Docetaxel,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Docetaxel.",decrease,no risk
Docetaxel,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Bosentan,The metabolism of Docetaxel can be increased when combined with Bosentan.,increase,no risk
Docetaxel,Bosutinib,The metabolism of Docetaxel can be decreased when combined with Bosutinib.,decrease,no risk
Docetaxel,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Brodalumab,The risk or severity of adverse effects can be increased when Docetaxel is combined with Brodalumab.,increase,risk
Docetaxel,Budesonide,The metabolism of Docetaxel can be increased when combined with Budesonide.,increase,no risk
Docetaxel,Bumetanide,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Docetaxel.",increase,risk
Docetaxel,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Docetaxel is combined with Bupivacaine.,increase,risk
Docetaxel,Buprenorphine,The metabolism of Docetaxel can be decreased when combined with Buprenorphine.,decrease,no risk
Docetaxel,Buspirone,The metabolism of Docetaxel can be decreased when combined with Buspirone.,decrease,no risk
Docetaxel,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Butacaine,The risk or severity of methemoglobinemia can be increased when Docetaxel is combined with Butacaine.,increase,risk
Docetaxel,Butalbital,The metabolism of Docetaxel can be increased when combined with Butalbital.,increase,no risk
Docetaxel,Butamben,The risk or severity of methemoglobinemia can be increased when Docetaxel is combined with Butamben.,increase,risk
Docetaxel,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Docetaxel.",increase,risk
Docetaxel,Gefitinib,The metabolism of Docetaxel can be decreased when combined with Gefitinib.,decrease,no risk
Docetaxel,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Docetaxel.,increase,risk
Docetaxel,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Gemfibrozil is combined with Docetaxel.",increase,risk
Docetaxel,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Docetaxel.,increase,risk
Docetaxel,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Gilteritinib,The metabolism of Docetaxel can be decreased when combined with Gilteritinib.,decrease,no risk
Docetaxel,Ginkgo biloba,The metabolism of Docetaxel can be decreased when combined with Ginkgo biloba.,decrease,no risk
Docetaxel,Glatiramer,The risk or severity of adverse effects can be increased when Docetaxel is combined with Glatiramer.,increase,risk
Docetaxel,Glecaprevir,The metabolism of Docetaxel can be decreased when combined with Glecaprevir.,decrease,no risk
Docetaxel,Glofitamab,The serum concentration of Docetaxel can be increased when it is combined with Glofitamab.,increase,no risk
Docetaxel,Glyburide,The metabolism of Docetaxel can be decreased when combined with Glyburide.,decrease,no risk
Docetaxel,Glycerol phenylbutyrate,The metabolism of Docetaxel can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Docetaxel,Golimumab,The metabolism of Docetaxel can be increased when combined with Golimumab.,increase,no risk
Docetaxel,Grapefruit,The serum concentration of Docetaxel can be increased when it is combined with Grapefruit.,increase,no risk
Docetaxel,Griseofulvin,The metabolism of Docetaxel can be increased when combined with Griseofulvin.,increase,no risk
Docetaxel,Guselkumab,The risk or severity of adverse effects can be increased when Docetaxel is combined with Guselkumab.,increase,risk
Docetaxel,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Halofantrine,The metabolism of Docetaxel can be decreased when combined with Halofantrine.,decrease,no risk
Docetaxel,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Docetaxel.,increase,risk
Docetaxel,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Docetaxel.,increase,risk
Docetaxel,Hydralazine,The serum concentration of Docetaxel can be increased when it is combined with Hydralazine.,increase,no risk
Docetaxel,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Docetaxel.,increase,risk
Docetaxel,Hydrocortamate,The metabolism of Docetaxel can be increased when combined with Hydrocortamate.,increase,no risk
Docetaxel,Hydrocortisone,The metabolism of Docetaxel can be increased when combined with Hydrocortisone.,increase,no risk
Docetaxel,Hydrocortisone acetate,The metabolism of Docetaxel can be increased when combined with Hydrocortisone acetate.,increase,no risk
Docetaxel,Hydrocortisone butyrate,The metabolism of Docetaxel can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Docetaxel,Hydrocortisone cypionate,The metabolism of Docetaxel can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Docetaxel,Hydrocortisone phosphate,The metabolism of Docetaxel can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Docetaxel,Hydrocortisone succinate,The metabolism of Docetaxel can be increased when combined with Hydrocortisone succinate.,increase,no risk
Docetaxel,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Docetaxel.,increase,risk
Docetaxel,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Docetaxel is combined with Hydroxychloroquine.,increase,risk
Docetaxel,Hydroxyprogesterone caproate,The metabolism of Docetaxel can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Docetaxel,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Docetaxel.,increase,risk
Docetaxel,Hydroxyzine,The metabolism of Docetaxel can be decreased when combined with Hydroxyzine.,decrease,no risk
Docetaxel,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Ketazolam,The serum concentration of Docetaxel can be increased when it is combined with Ketazolam.,increase,no risk
Docetaxel,Ketoconazole,The metabolism of Docetaxel can be decreased when combined with Ketoconazole.,decrease,no risk
Docetaxel,Obinutuzumab,The risk or severity of adverse effects can be increased when Docetaxel is combined with Obinutuzumab.,increase,risk
Docetaxel,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Docetaxel.,increase,no risk
Docetaxel,Octreotide,The serum concentration of Docetaxel can be increased when it is combined with Octreotide.,increase,no risk
Docetaxel,Ofatumumab,The risk or severity of adverse effects can be increased when Docetaxel is combined with Ofatumumab.,increase,risk
Docetaxel,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ofloxacin is combined with Docetaxel.",increase,risk
Docetaxel,Olaparib,The metabolism of Docetaxel can be decreased when combined with Olaparib.,decrease,no risk
Docetaxel,Olutasidenib,The metabolism of Docetaxel can be increased when combined with Olutasidenib.,increase,no risk
Docetaxel,Omaveloxolone,The serum concentration of Docetaxel can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Docetaxel,Ondansetron,The metabolism of Docetaxel can be decreased when combined with Ondansetron.,decrease,no risk
Docetaxel,Oritavancin,The metabolism of Docetaxel can be increased when combined with Oritavancin.,increase,no risk
Docetaxel,Orphenadrine,The metabolism of Docetaxel can be decreased when combined with Orphenadrine.,decrease,no risk
Docetaxel,Osilodrostat,The metabolism of Docetaxel can be decreased when combined with Osilodrostat.,decrease,no risk
Docetaxel,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Ouabain,Ouabain may decrease the cardiotoxic activities of Docetaxel.,decrease,no risk
Docetaxel,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Docetaxel.,increase,risk
Docetaxel,Oxcarbazepine,The metabolism of Docetaxel can be increased when combined with Oxcarbazepine.,increase,no risk
Docetaxel,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Docetaxel is combined with Oxetacaine.,increase,risk
Docetaxel,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Docetaxel is combined with Oxybuprocaine.,increase,risk
Docetaxel,Oxybutynin,The serum concentration of Docetaxel can be increased when it is combined with Oxybutynin.,increase,no risk
Docetaxel,Oxycodone,The metabolism of Docetaxel can be decreased when combined with Oxycodone.,decrease,no risk
Docetaxel,Ozanimod,The risk or severity of adverse effects can be increased when Docetaxel is combined with Ozanimod.,increase,risk
Docetaxel,Quetiapine,The metabolism of Docetaxel can be decreased when combined with Quetiapine.,decrease,no risk
Docetaxel,Quinidine,The metabolism of Docetaxel can be decreased when combined with Quinidine.,decrease,no risk
Docetaxel,Quinine,The metabolism of Docetaxel can be increased when combined with Quinine.,increase,no risk
Docetaxel,Quinupristin,The metabolism of Docetaxel can be decreased when combined with Quinupristin.,decrease,no risk
Docetaxel,Quizartinib,The metabolism of Docetaxel can be decreased when combined with Quizartinib.,decrease,no risk
Docetaxel,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Docetaxel is combined with Ubidecarenone.",increase,risk
Docetaxel,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Docetaxel.,increase,risk
Docetaxel,Udenafil,The metabolism of Docetaxel can be decreased when combined with Udenafil.,decrease,no risk
Docetaxel,Upadacitinib,The risk or severity of adverse effects can be increased when Docetaxel is combined with Upadacitinib.,increase,risk
Docetaxel,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Docetaxel.,increase,risk
Docetaxel,Vadadustat,The serum concentration of Docetaxel can be increased when it is combined with Vadadustat.,increase,no risk
Docetaxel,Valbenazine,The metabolism of Docetaxel can be decreased when combined with Valbenazine.,decrease,no risk
Docetaxel,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Valproic acid,The serum concentration of Docetaxel can be increased when it is combined with Valproic acid.,increase,no risk
Docetaxel,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Docetaxel.,decrease,no risk
Docetaxel,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Docetaxel.,increase,risk
Docetaxel,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Vedolizumab,The risk or severity of adverse effects can be increased when Docetaxel is combined with Vedolizumab.,increase,risk
Docetaxel,Velpatasvir,The excretion of Docetaxel can be decreased when combined with Velpatasvir.,decrease,no risk
Docetaxel,Vemurafenib,The metabolism of Docetaxel can be increased when combined with Vemurafenib.,increase,no risk
Docetaxel,Venetoclax,The metabolism of Docetaxel can be decreased when combined with Venetoclax.,decrease,no risk
Docetaxel,Verapamil,The metabolism of Docetaxel can be decreased when combined with Verapamil.,decrease,no risk
Docetaxel,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Docetaxel.,decrease,no risk
Docetaxel,Vilanterol,The risk or severity of adverse effects can be increased when Docetaxel is combined with Vilanterol.,increase,risk
Docetaxel,Viloxazine,The metabolism of Docetaxel can be decreased when combined with Viloxazine.,decrease,no risk
Docetaxel,Vinblastine,The metabolism of Docetaxel can be increased when combined with Vinblastine.,increase,no risk
Docetaxel,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Vitamin E,The metabolism of Docetaxel can be increased when combined with Vitamin E.,increase,no risk
Docetaxel,Voclosporin,The risk or severity of adverse effects can be increased when Docetaxel is combined with Voclosporin.,increase,risk
Docetaxel,Vonoprazan,The metabolism of Docetaxel can be decreased when combined with Vonoprazan.,decrease,no risk
Docetaxel,Vorapaxar,The metabolism of Docetaxel can be decreased when combined with Vorapaxar.,decrease,no risk
Docetaxel,Voriconazole,The metabolism of Docetaxel can be decreased when combined with Voriconazole.,decrease,no risk
Docetaxel,Vorinostat,The risk or severity of adverse effects can be increased when Docetaxel is combined with Vorinostat.,increase,risk
Docetaxel,Vortioxetine,The metabolism of Docetaxel can be decreased when combined with Vortioxetine.,decrease,no risk
Docetaxel,Voxelotor,The serum concentration of Docetaxel can be increased when it is combined with Voxelotor.,increase,no risk
Docetaxel,Voxilaprevir,The excretion of Docetaxel can be decreased when combined with Voxilaprevir.,decrease,no risk
Docetaxel,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Docetaxel.,increase,risk
Docetaxel,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Docetaxel.,increase,risk
Docetaxel,Zafirlukast,The serum concentration of Docetaxel can be increased when it is combined with Zafirlukast.,increase,no risk
Docetaxel,Zaleplon,The metabolism of Docetaxel can be decreased when combined with Zaleplon.,decrease,no risk
Docetaxel,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Docetaxel.,increase,no risk
Docetaxel,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Docetaxel.,increase,risk
Docetaxel,Zimelidine,The metabolism of Docetaxel can be decreased when combined with Zimelidine.,decrease,no risk
Docetaxel,Ziprasidone,The metabolism of Docetaxel can be decreased when combined with Ziprasidone.,decrease,no risk
Docetaxel,Zonisamide,The metabolism of Docetaxel can be decreased when combined with Zonisamide.,decrease,no risk
Docetaxel,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Docetaxel.,decrease,no risk
Docetaxel,Zuclopenthixol,The metabolism of Docetaxel can be decreased when combined with Zuclopenthixol.,decrease,no risk
Iodixanol,Gabapentin enacarbil,Iodixanol may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Iodixanol,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Gadodiamide,Gadodiamide may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Gadofosveset trisodium,Iodixanol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Iodixanol,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Gadoteric acid,Iodixanol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Iodixanol,Gadoteridol,Gadoteridol may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Ganciclovir,Ganciclovir may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Gemcitabine,Gemcitabine may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Gentamicin,Iodixanol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Iodixanol,Gimeracil,Iodixanol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Iodixanol,Givosiran,Givosiran may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Glipizide,Glipizide may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Glycerol phenylbutyrate,Iodixanol may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Iodixanol,Golodirsen,Iodixanol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Iodixanol,Goserelin,Goserelin may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Guanethidine,Guanethidine may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Guanfacine,Guanfacine may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Haloperidol,Haloperidol may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Hydralazine,Iodixanol may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Iodixanol,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Iodixanol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Iodixanol,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Iodixanol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Iodixanol,Hydromorphone,Hydromorphone may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Hydroxyethyl Starch,Iodixanol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Iodixanol,Kanamycin,Iodixanol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Iodixanol,Ketamine,Ketamine may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Ketazolam,Iodixanol may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Iodixanol,Ketoprofen,Ketoprofen may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Ketorolac,Ketorolac may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Octinoxate,Iodixanol may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Iodixanol,Olsalazine,Olsalazine may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Opium,Iodixanol may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Iodixanol,Oseltamivir,Oseltamivir may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Oxacillin,Oxacillin may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Oxaprozin,Oxaprozin may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Oxazepam,Oxazepam may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Oxybenzone,Iodixanol may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Iodixanol,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Oxyquinoline,Iodixanol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Iodixanol,Quetiapine,Quetiapine may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Quinethazone,Quinethazone may increase the excretion rate of Iodixanol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Iodixanol,Quinidine,Iodixanol may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Iodixanol,Vaborbactam,Iodixanol may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Iodixanol,Valaciclovir,Valaciclovir may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Valbenazine,Iodixanol may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Iodixanol,Valdecoxib,Valdecoxib may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Valganciclovir,Iodixanol may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Iodixanol,Vancomycin,Iodixanol may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Iodixanol,Varenicline,Iodixanol may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Iodixanol,Venlafaxine,Venlafaxine may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Verapamil,Verapamil may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Vilanterol,Iodixanol may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Iodixanol,Viloxazine,Iodixanol may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Iodixanol,Vortioxetine,Iodixanol may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Iodixanol,Warfarin,Iodixanol may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Iodixanol,Zaleplon,Zaleplon may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Zanamivir,Zanamivir may decrease the excretion rate of Iodixanol which could result in a higher serum level.,decrease,no risk
Iodixanol,Zonisamide,Zonisamide may increase the excretion rate of Iodixanol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Olsalazine,Gabapentin enacarbil,Olsalazine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Olsalazine,Gadobenic acid,Olsalazine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Olsalazine,Gadodiamide,Olsalazine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Olsalazine,Gadofosveset trisodium,Olsalazine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Olsalazine,Gadopentetic acid,Olsalazine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Olsalazine,Gadoteric acid,Olsalazine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Olsalazine,Gadoteridol,Olsalazine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Olsalazine,Ganciclovir,Olsalazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Olsalazine,Gemcitabine,Olsalazine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Olsalazine,Gemfibrozil,Olsalazine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Olsalazine,Gentamicin,The risk or severity of nephrotoxicity can be increased when Gentamicin is combined with Olsalazine.,increase,risk
Olsalazine,Gimeracil,Olsalazine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Olsalazine,Ginkgo biloba,The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Olsalazine.,increase,risk
Olsalazine,Givosiran,The risk or severity of nephrotoxicity can be increased when Givosiran is combined with Olsalazine.,increase,risk
Olsalazine,Gliclazide,Olsalazine may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Olsalazine,Glimepiride,Olsalazine may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Olsalazine,Glipizide,Olsalazine may increase the hypoglycemic activities of Glipizide.,increase,no risk
Olsalazine,Gliquidone,Olsalazine may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Olsalazine,Glyburide,Olsalazine may increase the hypoglycemic activities of Glyburide.,increase,no risk
Olsalazine,Glycerol phenylbutyrate,Olsalazine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Olsalazine,Glymidine,Olsalazine may increase the hypoglycemic activities of Glymidine.,increase,no risk
Olsalazine,Golodirsen,Olsalazine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Olsalazine,Goserelin,Olsalazine may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Olsalazine,Guanethidine,Olsalazine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Olsalazine,Guanfacine,Olsalazine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Olsalazine,Haloperidol,Olsalazine may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Olsalazine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Olsalazine.,increase,risk
Olsalazine,Hydralazine,Olsalazine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Olsalazine,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Olsalazine.,increase,risk
Olsalazine,Hydrocortisone,The serum concentration of Olsalazine can be decreased when it is combined with Hydrocortisone.,decrease,no risk
Olsalazine,Hydromorphone,Olsalazine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Olsalazine,Hydroxocobalamin,Olsalazine may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Olsalazine,Hydroxyethyl Starch,Olsalazine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Olsalazine,Kanamycin,The risk or severity of nephrotoxicity can be increased when Kanamycin is combined with Olsalazine.,increase,risk
Olsalazine,Ketamine,Olsalazine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Olsalazine,Ketazolam,Olsalazine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Olsalazine,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Olsalazine.,increase,risk
Olsalazine,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Olsalazine.,increase,risk
Olsalazine,Octinoxate,Olsalazine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Olsalazine,Opium,Olsalazine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Olsalazine,Oseltamivir,Olsalazine may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Olsalazine,Ouabain,The serum concentration of Ouabain can be decreased when it is combined with Olsalazine.,decrease,no risk
Olsalazine,Oxacillin,Olsalazine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Olsalazine,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Olsalazine.,increase,risk
Olsalazine,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Olsalazine.,increase,risk
Olsalazine,Oxazepam,Olsalazine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Olsalazine,Oxybenzone,Olsalazine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Olsalazine,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Olsalazine.,increase,risk
Olsalazine,Oxyquinoline,Olsalazine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Olsalazine,Quetiapine,Olsalazine may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Olsalazine,Quinapril,The risk or severity of renal failure can be increased when Olsalazine is combined with Quinapril.,increase,risk
Olsalazine,Quinidine,Olsalazine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Olsalazine,Quinine,Olsalazine may increase the hypoglycemic activities of Quinine.,increase,no risk
Olsalazine,Urokinase,The risk or severity of bleeding can be increased when Olsalazine is combined with Urokinase.,increase,risk
Olsalazine,Vaborbactam,Olsalazine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Olsalazine,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Olsalazine.,increase,risk
Olsalazine,Valbenazine,Olsalazine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Olsalazine,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Olsalazine.,increase,risk
Olsalazine,Valganciclovir,Olsalazine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Olsalazine,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Olsalazine.,increase,no risk
Olsalazine,Vancomycin,The risk or severity of nephrotoxicity can be increased when Vancomycin is combined with Olsalazine.,increase,risk
Olsalazine,Varenicline,Olsalazine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Olsalazine,Varicella zoster vaccine (live/attenuated),The risk or severity of Reye's syndrome can be increased when Varicella zoster vaccine (live/attenuated) is combined with Olsalazine.,increase,risk
Olsalazine,Venlafaxine,Olsalazine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Olsalazine,Verapamil,The risk or severity of bleeding can be increased when Verapamil is combined with Olsalazine.,increase,risk
Olsalazine,Vilanterol,Olsalazine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Olsalazine,Vildagliptin,Olsalazine may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Olsalazine,Viloxazine,Olsalazine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Olsalazine,Vorapaxar,The risk or severity of bleeding can be increased when Olsalazine is combined with Vorapaxar.,increase,risk
Olsalazine,Vortioxetine,Olsalazine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Olsalazine,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Olsalazine.,increase,risk
Olsalazine,Ximelagatran,The risk or severity of bleeding can be increased when Olsalazine is combined with Ximelagatran.,increase,risk
Olsalazine,Zaleplon,Olsalazine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Olsalazine,Zanamivir,Olsalazine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Olsalazine,Zofenopril,The risk or severity of renal failure can be increased when Olsalazine is combined with Zofenopril.,increase,risk
Olsalazine,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Olsalazine is combined with Zoledronic acid.,increase,risk
Olsalazine,Zonisamide,The risk or severity of adverse effects can be increased when Olsalazine is combined with Zonisamide.,increase,risk
Gliquidone,Gatifloxacin,The therapeutic efficacy of Gliquidone can be increased when used in combination with Gatifloxacin.,increase,no risk
Gliquidone,Gefapixant,The therapeutic efficacy of Gliquidone can be increased when used in combination with Gefapixant.,increase,no risk
Gliquidone,Gemfibrozil,The metabolism of Gliquidone can be decreased when combined with Gemfibrozil.,decrease,no risk
Gliquidone,Gemifloxacin,The therapeutic efficacy of Gliquidone can be increased when used in combination with Gemifloxacin.,increase,no risk
Gliquidone,Gestrinone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Gestrinone.,decrease,no risk
Gliquidone,Ginkgo biloba,The metabolism of Gliquidone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Gliquidone,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Gliquidone.,increase,risk
Gliquidone,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Gliquidone.,increase,risk
Gliquidone,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Gliquidone.,increase,risk
Gliquidone,Glofitamab,The serum concentration of Gliquidone can be increased when it is combined with Glofitamab.,increase,no risk
Gliquidone,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Gliquidone.,increase,risk
Gliquidone,Glycol salicylate,The protein binding of Gliquidone can be decreased when combined with Glycol salicylate.,decrease,no risk
Gliquidone,Glymidine,The therapeutic efficacy of Gliquidone can be increased when used in combination with Glymidine.,increase,no risk
Gliquidone,Golimumab,The metabolism of Gliquidone can be increased when combined with Golimumab.,increase,no risk
Gliquidone,Goserelin,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Goserelin.,decrease,no risk
Gliquidone,Grepafloxacin,The therapeutic efficacy of Gliquidone can be increased when used in combination with Grepafloxacin.,increase,no risk
Gliquidone,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Gliquidone.,increase,risk
Gliquidone,Haloperidol,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Haloperidol.,decrease,no risk
Gliquidone,Halothane,The metabolism of Gliquidone can be decreased when combined with Halothane.,decrease,no risk
Gliquidone,Histrelin,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Histrelin.,decrease,no risk
Gliquidone,Hydrochlorothiazide,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Gliquidone,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Gliquidone.,increase,risk
Gliquidone,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Gliquidone.,increase,risk
Gliquidone,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Gliquidone.,increase,risk
Gliquidone,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Gliquidone.,increase,risk
Gliquidone,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Gliquidone.,increase,risk
Gliquidone,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Gliquidone.,increase,risk
Gliquidone,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Gliquidone.,increase,risk
Gliquidone,Hydroflumethiazide,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Gliquidone,Hydromorphone,The metabolism of Gliquidone can be decreased when combined with Hydromorphone.,decrease,no risk
Gliquidone,Hydroxychloroquine,The therapeutic efficacy of Gliquidone can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Gliquidone,Hydroxyprogesterone caproate,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Gliquidone,Ketamine,The metabolism of Gliquidone can be decreased when combined with Ketamine.,decrease,no risk
Gliquidone,Ketoprofen,The protein binding of Gliquidone can be decreased when combined with Ketoprofen.,decrease,no risk
Gliquidone,Ketorolac,The protein binding of Gliquidone can be decreased when combined with Ketorolac.,decrease,no risk
Gliquidone,Ketotifen,The risk or severity of thrombocytopenia can be increased when Gliquidone is combined with Ketotifen.,increase,risk
Gliquidone,Octreotide,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Octreotide.,decrease,no risk
Gliquidone,Ofloxacin,The therapeutic efficacy of Gliquidone can be increased when used in combination with Ofloxacin.,increase,no risk
Gliquidone,Olanzapine,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Olanzapine.,decrease,no risk
Gliquidone,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Gliquidone.,decrease,no risk
Gliquidone,Olsalazine,Olsalazine may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Gliquidone,Ondansetron,The metabolism of Gliquidone can be decreased when combined with Ondansetron.,decrease,no risk
Gliquidone,Oritavancin,The metabolism of Gliquidone can be decreased when combined with Oritavancin.,decrease,no risk
Gliquidone,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Gliquidone.,decrease,no risk
Gliquidone,Oxandrolone,The metabolism of Gliquidone can be decreased when combined with Oxandrolone.,decrease,no risk
Gliquidone,Oxaprozin,The protein binding of Gliquidone can be decreased when combined with Oxaprozin.,decrease,no risk
Gliquidone,Oxprenolol,The therapeutic efficacy of Gliquidone can be increased when used in combination with Oxprenolol.,increase,no risk
Gliquidone,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Gliquidone,Oxyphenbutazone,The protein binding of Gliquidone can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Mitiglinide,Gatifloxacin,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Gatifloxacin.,increase,no risk
Mitiglinide,Gefapixant,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Gefapixant.,increase,no risk
Mitiglinide,Gemfibrozil,The metabolism of Mitiglinide can be decreased when combined with Gemfibrozil.,decrease,no risk
Mitiglinide,Gemifloxacin,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Gemifloxacin.,increase,no risk
Mitiglinide,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Mitiglinide.,increase,risk
Mitiglinide,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Mitiglinide.,increase,risk
Mitiglinide,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Mitiglinide.,increase,risk
Mitiglinide,Gliquidone,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Mitiglinide.,increase,risk
Mitiglinide,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Mitiglinide.,increase,risk
Mitiglinide,Glymidine,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Glymidine.,increase,no risk
Mitiglinide,Goserelin,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Goserelin.,decrease,no risk
Mitiglinide,Grepafloxacin,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Grepafloxacin.,increase,no risk
Mitiglinide,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Mitiglinide.,increase,risk
Mitiglinide,Haloperidol,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Haloperidol.,decrease,no risk
Mitiglinide,Histrelin,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Histrelin.,decrease,no risk
Mitiglinide,Hydrochlorothiazide,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Mitiglinide,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Mitiglinide.,increase,risk
Mitiglinide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Mitiglinide.,increase,risk
Mitiglinide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Mitiglinide.,increase,risk
Mitiglinide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Mitiglinide.,increase,risk
Mitiglinide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Mitiglinide.,increase,risk
Mitiglinide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Mitiglinide.,increase,risk
Mitiglinide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Mitiglinide.,increase,risk
Mitiglinide,Hydroflumethiazide,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Mitiglinide,Hydroxychloroquine,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Mitiglinide,Hydroxyprogesterone caproate,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Mitiglinide,Ketoconazole,The metabolism of Mitiglinide can be decreased when combined with Ketoconazole.,decrease,no risk
Mitiglinide,Ketotifen,The risk or severity of thrombocytopenia can be increased when Mitiglinide is combined with Ketotifen.,increase,risk
Mitiglinide,Octreotide,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Octreotide.,decrease,no risk
Mitiglinide,Ofloxacin,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Ofloxacin.,increase,no risk
Mitiglinide,Olanzapine,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Olanzapine.,decrease,no risk
Mitiglinide,Olsalazine,Olsalazine may increase the hypoglycemic activities of Mitiglinide.,increase,no risk
Mitiglinide,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Mitiglinide.,increase,no risk
Mitiglinide,Oxprenolol,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Oxprenolol.,increase,no risk
Mitiglinide,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Mitiglinide.,increase,no risk
Mitiglinide,Quetiapine,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Quetiapine.,decrease,no risk
Mitiglinide,Quinethazone,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Quinethazone.,decrease,no risk
Mitiglinide,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Mitiglinide.,increase,risk
Mitiglinide,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Mitiglinide.,decrease,no risk
Mitiglinide,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Mitiglinide.,increase,risk
Mitiglinide,Udenafil,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Udenafil.,increase,no risk
Mitiglinide,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Mitiglinide.,increase,risk
Mitiglinide,Valdecoxib,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Valdecoxib.,increase,no risk
Mitiglinide,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Mitiglinide.,increase,risk
Mitiglinide,Vemurafenib,The therapeutic efficacy of Mitiglinide can be increased when used in combination with Vemurafenib.,increase,no risk
Mitiglinide,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Mitiglinide.,increase,risk
Mitiglinide,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Mitiglinide.,increase,risk
Mitiglinide,Vildagliptin,The risk or severity of hypoglycemia can be increased when Mitiglinide is combined with Vildagliptin.,increase,risk
Mitiglinide,Vorinostat,The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Vorinostat.,decrease,no risk
Mitiglinide,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Mitiglinide.,increase,risk
Ergometrine,Butriptyline,Butriptyline may increase the vasopressor activities of Ergometrine.,increase,no risk
Ergometrine,Butylscopolamine,The risk or severity of Tachycardia can be increased when Ergometrine is combined with Butylscopolamine.,increase,risk
Ergometrine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Ergometrine.,increase,risk
Ergometrine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Ergometrine is combined with Gabapentin enacarbil.,increase,risk
Ergometrine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Ergometrine.,increase,risk
Ergometrine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Ergometrine is combined with Ganaxolone.",increase,risk
Ergometrine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Ergometrine.,increase,risk
Ergometrine,Gilteritinib,The therapeutic efficacy of Ergometrine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Ergometrine,Glofitamab,The serum concentration of Ergometrine can be increased when it is combined with Glofitamab.,increase,no risk
Ergometrine,Glutethimide,The risk or severity of CNS depression can be increased when Ergometrine is combined with Glutethimide.,increase,risk
Ergometrine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Ergometrine.,increase,risk
Ergometrine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Ergometrine.,increase,risk
Ergometrine,Guanabenz,Ergometrine may increase the hypertensive and vasoconstricting activities of Guanabenz.,increase,no risk
Ergometrine,Guanadrel,Ergometrine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Ergometrine,Guanethidine,Ergometrine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Ergometrine,Guanfacine,Ergometrine may increase the hypertensive and vasoconstricting activities of Guanfacine.,increase,no risk
Ergometrine,Guanoxan,Ergometrine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Ergometrine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Ergometrine.,increase,risk
Ergometrine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Ergometrine.,increase,risk
Ergometrine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Ergometrine.,increase,risk
Ergometrine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Ergometrine.,increase,risk
Ergometrine,Hexocyclium,The risk or severity of Tachycardia can be increased when Ergometrine is combined with Hexocyclium.,increase,risk
Ergometrine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Ergometrine.,increase,risk
Ergometrine,Hyaluronidase,The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Ergometrine.,increase,risk
Ergometrine,Hyaluronidase (human recombinant),The risk or severity of adverse effects can be increased when Hyaluronidase (human recombinant) is combined with Ergometrine.,increase,risk
Ergometrine,Hyaluronidase (ovine),The risk or severity of adverse effects can be increased when Hyaluronidase (ovine) is combined with Ergometrine.,increase,risk
Ergometrine,Hydralazine,Ergometrine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Ergometrine,Hydrochlorothiazide,Ergometrine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Ergometrine,Hydrocodone,Ergometrine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Ergometrine,Hydroflumethiazide,Ergometrine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Ergometrine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Ergometrine.,increase,risk
Ergometrine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ergometrine.,increase,no risk
Ergometrine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Ergometrine.,increase,risk
Ergometrine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Ergometrine.,increase,risk
Ergometrine,Ketazolam,The risk or severity of CNS depression can be increased when Ergometrine is combined with Ketazolam.,increase,risk
Ergometrine,Ketoconazole,The serum concentration of Ergometrine can be increased when it is combined with Ketoconazole.,increase,no risk
Ergometrine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Ergometrine.,increase,risk
Ergometrine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Ergometrine.,increase,risk
Ergometrine,Olanzapine,The therapeutic efficacy of Ergometrine can be decreased when used in combination with Olanzapine.,decrease,no risk
Ergometrine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Ergometrine is combined with Oliceridine.",increase,risk
Ergometrine,Olmesartan,Ergometrine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Ergometrine,Olodaterol,Ergometrine may increase the hypertensive and vasoconstricting activities of Olodaterol.,increase,no risk
Ergometrine,Omaveloxolone,The serum concentration of Ergometrine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ergometrine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Ergometrine.,increase,risk
Ergometrine,Opium,The risk or severity of CNS depression can be increased when Ergometrine is combined with Opium.,increase,risk
Ergometrine,Orciprenaline,Ergometrine may increase the hypertensive and vasoconstricting activities of Orciprenaline.,increase,no risk
Ergometrine,Orphenadrine,Ergometrine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Ergometrine,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Ergometrine.,increase,risk
Ergometrine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Ergometrine.,increase,risk
Ergometrine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Ergometrine.,increase,risk
Ergometrine,Oxitriptan,The risk or severity of CNS depression can be increased when Ergometrine is combined with Oxitriptan.,increase,risk
Ergometrine,Oxprenolol,The therapeutic efficacy of Ergometrine can be decreased when used in combination with Oxprenolol.,decrease,no risk
Ergometrine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Ergometrine.,increase,risk
Ergometrine,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Ergometrine.,increase,risk
Ergometrine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Ergometrine.,increase,risk
Ergometrine,Oxymetazoline,Ergometrine may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Ergometrine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Ergometrine.,increase,risk
Ergometrine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Ergometrine is combined with Oxyphenbutazone.,increase,risk
Ergometrine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Ergometrine.,increase,risk
Ergometrine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Ergometrine.,increase,risk
Ergometrine,Quazepam,The risk or severity of CNS depression can be increased when Ergometrine is combined with Quazepam.,increase,risk
Ergometrine,Quetiapine,The therapeutic efficacy of Ergometrine can be decreased when used in combination with Quetiapine.,decrease,no risk
Ergometrine,Quinapril,Ergometrine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Ergometrine,Quinidine,The therapeutic efficacy of Ergometrine can be decreased when used in combination with Quinidine.,decrease,no risk
Ergometrine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Ergometrine.,increase,risk
Ergometrine,Quinupramine,Quinupramine may increase the vasopressor activities of Ergometrine.,increase,no risk
Ergometrine,Umeclidinium,The risk or severity of Tachycardia can be increased when Ergometrine is combined with Umeclidinium.,increase,risk
Ergometrine,Urethane,The risk or severity of CNS depression can be increased when Ergometrine is combined with Urethane.,increase,risk
Ergometrine,Vadadustat,The serum concentration of Ergometrine can be increased when it is combined with Vadadustat.,increase,no risk
Ergometrine,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Ergometrine.,increase,risk
Ergometrine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Ergometrine is combined with Valproate bismuth.,increase,risk
Ergometrine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Ergometrine.,increase,risk
Ergometrine,Valsartan,Ergometrine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Ergometrine,Vecuronium,The risk or severity of CNS depression can be increased when Ergometrine is combined with Vecuronium.,increase,risk
Ergometrine,Venetoclax,The metabolism of Ergometrine can be decreased when combined with Venetoclax.,decrease,no risk
Ergometrine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Ergometrine is combined with Venlafaxine.,increase,risk
Ergometrine,Verapamil,The metabolism of Ergometrine can be decreased when combined with Verapamil.,decrease,no risk
Ergometrine,Vibegron,Ergometrine may increase the hypertensive and vasoconstricting activities of Vibegron.,increase,no risk
Ergometrine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Ergometrine.,increase,risk
Ergometrine,Vilanterol,Ergometrine may increase the hypertensive and vasoconstricting activities of Vilanterol.,increase,no risk
Ergometrine,Vilazodone,Ergometrine may increase the vasoconstricting activities of Vilazodone.,increase,no risk
Ergometrine,Viloxazine,The metabolism of Ergometrine can be decreased when combined with Viloxazine.,decrease,no risk
Ergometrine,Voriconazole,The serum concentration of Ergometrine can be increased when it is combined with Voriconazole.,increase,no risk
Ergometrine,Vortioxetine,Ergometrine may increase the vasoconstricting activities of Vortioxetine.,increase,no risk
Ergometrine,Warfarin,The risk or severity of adverse effects can be increased when Ergometrine is combined with Warfarin.,increase,risk
Ergometrine,Xamoterol,Ergometrine may increase the hypertensive and vasoconstricting activities of Xamoterol.,increase,no risk
Ergometrine,Xylometazoline,Ergometrine may increase the hypertensive and vasoconstricting activities of Xylometazoline.,increase,no risk
Ergometrine,Yohimbine,The risk or severity of CNS depression can be increased when Ergometrine is combined with Yohimbine.,increase,risk
Ergometrine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Ergometrine.,increase,risk
Ergometrine,Ziconotide,The risk or severity of CNS depression can be increased when Ergometrine is combined with Ziconotide.,increase,risk
Ergometrine,Zimelidine,The risk or severity of adverse effects can be increased when Ergometrine is combined with Zimelidine.,increase,risk
Ergometrine,Ziprasidone,The risk or severity of adverse effects can be increased when Ergometrine is combined with Ziprasidone.,increase,risk
Ergometrine,Zofenopril,Ergometrine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Ergometrine,Zolmitriptan,Ergometrine may increase the vasoconstricting activities of Zolmitriptan.,increase,no risk
Ergometrine,Zolpidem,Ergometrine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Ergometrine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Ergometrine.,increase,risk
Ergometrine,Zopiclone,The risk or severity of adverse effects can be increased when Ergometrine is combined with Zopiclone.,increase,risk
Ergometrine,Zotepine,The risk or severity of adverse effects can be increased when Ergometrine is combined with Zotepine.,increase,risk
Ergometrine,Zuclopenthixol,The therapeutic efficacy of Ergometrine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Ergometrine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Ergometrine.,increase,risk
Dasatinib,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Dasatinib.,increase,risk
Dasatinib,Baricitinib,The risk or severity of adverse effects can be increased when Dasatinib is combined with Baricitinib.,increase,risk
Dasatinib,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Dasatinib.,increase,risk
Dasatinib,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Dasatinib.,increase,risk
Dasatinib,Beclomethasone dipropionate,The metabolism of Dasatinib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Dasatinib,Bedaquiline,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Bedaquiline.,increase,risk
Dasatinib,Belantamab mafodotin,The serum concentration of Dasatinib can be increased when it is combined with Belantamab mafodotin.,increase,no risk
Dasatinib,Belatacept,The risk or severity of adverse effects can be increased when Dasatinib is combined with Belatacept.,increase,risk
Dasatinib,Belimumab,The risk or severity of adverse effects can be increased when Dasatinib is combined with Belimumab.,increase,risk
Dasatinib,Belinostat,The risk or severity of adverse effects can be increased when Dasatinib is combined with Belinostat.,increase,risk
Dasatinib,Belumosudil,The serum concentration of Dasatinib can be increased when it is combined with Belumosudil.,increase,no risk
Dasatinib,Belzutifan,The serum concentration of Dasatinib can be decreased when it is combined with Belzutifan.,decrease,no risk
Dasatinib,Bemiparin,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Bemiparin.,increase,risk
Dasatinib,Bendamustine,The risk or severity of adverse effects can be increased when Dasatinib is combined with Bendamustine.,increase,risk
Dasatinib,Bendroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Dasatinib.,increase,risk
Dasatinib,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dasatinib.,increase,risk
Dasatinib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Dasatinib is combined with Benzocaine.,increase,risk
Dasatinib,Benzthiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Dasatinib.,increase,risk
Dasatinib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Dasatinib is combined with Benzyl alcohol.,increase,risk
Dasatinib,Bepridil,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Bepridil.,increase,risk
Dasatinib,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Dasatinib.,increase,no risk
Dasatinib,Betamethasone,The metabolism of Dasatinib can be increased when combined with Betamethasone.,increase,no risk
Dasatinib,Betamethasone phosphate,The metabolism of Dasatinib can be increased when combined with Betamethasone phosphate.,increase,no risk
Dasatinib,Betaxolol,The metabolism of Dasatinib can be decreased when combined with Betaxolol.,decrease,no risk
Dasatinib,Betrixaban,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Betrixaban.,increase,risk
Dasatinib,Bexarotene,The metabolism of Dasatinib can be increased when combined with Bexarotene.,increase,no risk
Dasatinib,Bicalutamide,The metabolism of Dasatinib can be decreased when combined with Bicalutamide.,decrease,no risk
Dasatinib,Bifonazole,The metabolism of Dasatinib can be decreased when combined with Bifonazole.,decrease,no risk
Dasatinib,Bilastine,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Bilastine.,increase,risk
Dasatinib,Bimekizumab,The metabolism of Dasatinib can be increased when combined with Bimekizumab.,increase,no risk
Dasatinib,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dasatinib,Bisoprolol,The serum concentration of Dasatinib can be increased when it is combined with Bisoprolol.,increase,no risk
Dasatinib,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Bivalirudin.,increase,risk
Dasatinib,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Dasatinib.,increase,risk
Dasatinib,Blinatumomab,The risk or severity of adverse effects can be increased when Dasatinib is combined with Blinatumomab.,increase,risk
Dasatinib,Boceprevir,The metabolism of Dasatinib can be decreased when combined with Boceprevir.,decrease,no risk
Dasatinib,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Dasatinib.",decrease,no risk
Dasatinib,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Bosentan,The metabolism of Dasatinib can be increased when combined with Bosentan.,increase,no risk
Dasatinib,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Dasatinib.,increase,risk
Dasatinib,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Brodalumab,The risk or severity of adverse effects can be increased when Dasatinib is combined with Brodalumab.,increase,risk
Dasatinib,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Dasatinib.,increase,risk
Dasatinib,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Dasatinib.,increase,risk
Dasatinib,Budesonide,The metabolism of Dasatinib can be increased when combined with Budesonide.,increase,no risk
Dasatinib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Dasatinib is combined with Bupivacaine.,increase,risk
Dasatinib,Buprenorphine,The metabolism of Dasatinib can be decreased when combined with Buprenorphine.,decrease,no risk
Dasatinib,Buserelin,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Buserelin.,increase,risk
Dasatinib,Buspirone,The metabolism of Dasatinib can be decreased when combined with Buspirone.,decrease,no risk
Dasatinib,Busulfan,The metabolism of Busulfan can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Dasatinib is combined with Butacaine.,increase,risk
Dasatinib,Butalbital,The metabolism of Dasatinib can be increased when combined with Butalbital.,increase,no risk
Dasatinib,Butamben,The risk or severity of methemoglobinemia can be increased when Dasatinib is combined with Butamben.,increase,risk
Dasatinib,Butriptyline,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Butriptyline.,increase,risk
Dasatinib,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Gadobenic acid.,increase,risk
Dasatinib,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Dasatinib.,increase,risk
Dasatinib,Gatifloxacin,The metabolism of Dasatinib can be decreased when combined with Gatifloxacin.,decrease,no risk
Dasatinib,Gefitinib,The metabolism of Dasatinib can be decreased when combined with Gefitinib.,decrease,no risk
Dasatinib,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Dasatinib.,increase,risk
Dasatinib,Gemfibrozil,The metabolism of Dasatinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Dasatinib,Gemifloxacin,The metabolism of Dasatinib can be decreased when combined with Gemifloxacin.,decrease,no risk
Dasatinib,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dasatinib.,increase,risk
Dasatinib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Dasatinib.,increase,no risk
Dasatinib,Gilteritinib,The metabolism of Dasatinib can be decreased when combined with Gilteritinib.,decrease,no risk
Dasatinib,Ginkgo biloba,The metabolism of Dasatinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Dasatinib,Givosiran,The serum concentration of Dasatinib can be increased when it is combined with Givosiran.,increase,no risk
Dasatinib,Glasdegib,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Glasdegib.,increase,risk
Dasatinib,Glatiramer,The risk or severity of adverse effects can be increased when Dasatinib is combined with Glatiramer.,increase,risk
Dasatinib,Glecaprevir,The serum concentration of Dasatinib can be increased when it is combined with Glecaprevir.,increase,no risk
Dasatinib,Glofitamab,The serum concentration of Dasatinib can be increased when it is combined with Glofitamab.,increase,no risk
Dasatinib,Glyburide,The metabolism of Dasatinib can be decreased when combined with Glyburide.,decrease,no risk
Dasatinib,Glycerol phenylbutyrate,The metabolism of Dasatinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Dasatinib,Golimumab,The metabolism of Dasatinib can be increased when combined with Golimumab.,increase,no risk
Dasatinib,Goserelin,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Goserelin.,increase,risk
Dasatinib,Granisetron,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Granisetron.,increase,risk
Dasatinib,Grapefruit,The serum concentration of Dasatinib can be increased when it is combined with Grapefruit.,increase,no risk
Dasatinib,Grazoprevir,Grazoprevir may decrease the excretion rate of Dasatinib which could result in a higher serum level.,decrease,no risk
Dasatinib,Grepafloxacin,The metabolism of Dasatinib can be decreased when combined with Grepafloxacin.,decrease,no risk
Dasatinib,Griseofulvin,The metabolism of Dasatinib can be increased when combined with Griseofulvin.,increase,no risk
Dasatinib,Guanabenz,The metabolism of Dasatinib can be decreased when combined with Guanabenz.,decrease,no risk
Dasatinib,Guselkumab,The risk or severity of adverse effects can be increased when Dasatinib is combined with Guselkumab.,increase,risk
Dasatinib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Dasatinib.,decrease,no risk
Dasatinib,Halofantrine,The metabolism of Dasatinib can be decreased when combined with Halofantrine.,decrease,no risk
Dasatinib,Haloperidol,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Haloperidol.,increase,risk
Dasatinib,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Heparin.,increase,risk
Dasatinib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Dasatinib.,decrease,no risk
Dasatinib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Dasatinib.,decrease,no risk
Dasatinib,Histrelin,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Histrelin.,increase,risk
Dasatinib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Dasatinib.,increase,risk
Dasatinib,Hydralazine,The serum concentration of Dasatinib can be increased when it is combined with Hydralazine.,increase,no risk
Dasatinib,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Dasatinib.,increase,risk
Dasatinib,Hydrocortamate,The metabolism of Dasatinib can be increased when combined with Hydrocortamate.,increase,no risk
Dasatinib,Hydrocortisone,The metabolism of Dasatinib can be increased when combined with Hydrocortisone.,increase,no risk
Dasatinib,Hydrocortisone acetate,The metabolism of Dasatinib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Dasatinib,Hydrocortisone butyrate,The metabolism of Dasatinib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Dasatinib,Hydrocortisone cypionate,The metabolism of Dasatinib can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Dasatinib,Hydrocortisone phosphate,The metabolism of Dasatinib can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Dasatinib,Hydrocortisone succinate,The metabolism of Dasatinib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Dasatinib,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Dasatinib.,increase,risk
Dasatinib,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dasatinib,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Dasatinib is combined with Hydroxychloroquine.,increase,risk
Dasatinib,Hydroxyprogesterone caproate,The metabolism of Dasatinib can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Dasatinib,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Dasatinib.,increase,risk
Dasatinib,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Hydroxyzine.,increase,risk
Dasatinib,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Dasatinib.,increase,risk
Dasatinib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Dasatinib.,decrease,no risk
Dasatinib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Dasatinib.,decrease,no risk
Dasatinib,Ketazolam,The serum concentration of Dasatinib can be increased when it is combined with Ketazolam.,increase,no risk
Dasatinib,Ketoconazole,The metabolism of Dasatinib can be decreased when combined with Ketoconazole.,decrease,no risk
Dasatinib,Obeticholic acid,The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Dasatinib.,increase,risk
Dasatinib,Obinutuzumab,The risk or severity of adverse effects can be increased when Dasatinib is combined with Obinutuzumab.,increase,risk
Dasatinib,Ocrelizumab,The risk or severity of adverse effects can be increased when Dasatinib is combined with Ocrelizumab.,increase,risk
Dasatinib,Octreotide,The serum concentration of Dasatinib can be increased when it is combined with Octreotide.,increase,no risk
Dasatinib,Ofatumumab,The risk or severity of adverse effects can be increased when Dasatinib is combined with Ofatumumab.,increase,risk
Dasatinib,Ofloxacin,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Ofloxacin.,increase,risk
Dasatinib,Olanzapine,Olanzapine can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dasatinib,Olaparib,The metabolism of Olaparib can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Olodaterol,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Olodaterol.,increase,risk
Dasatinib,Olutasidenib,The therapeutic efficacy of Dasatinib can be decreased when used in combination with Olutasidenib.,decrease,no risk
Dasatinib,Omadacycline,The serum concentration of Dasatinib can be increased when it is combined with Omadacycline.,increase,no risk
Dasatinib,Omaveloxolone,The serum concentration of Dasatinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Dasatinib,Ombitasvir,Dasatinib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Dasatinib,Omeprazole,Omeprazole can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dasatinib,Ondansetron,The metabolism of Dasatinib can be decreased when combined with Ondansetron.,decrease,no risk
Dasatinib,Oritavancin,The metabolism of Dasatinib can be increased when combined with Oritavancin.,increase,no risk
Dasatinib,Orphenadrine,The metabolism of Dasatinib can be decreased when combined with Orphenadrine.,decrease,no risk
Dasatinib,Osilodrostat,The serum concentration of Dasatinib can be increased when it is combined with Osilodrostat.,increase,no risk
Dasatinib,Osimertinib,The serum concentration of Dasatinib can be decreased when it is combined with Osimertinib.,decrease,no risk
Dasatinib,Oteseconazole,The serum concentration of Dasatinib can be increased when it is combined with Oteseconazole.,increase,no risk
Dasatinib,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Dasatinib.,increase,risk
Dasatinib,Oxatomide,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Oxatomide.,increase,risk
Dasatinib,Oxcarbazepine,The metabolism of Dasatinib can be increased when combined with Oxcarbazepine.,increase,no risk
Dasatinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Dasatinib is combined with Oxetacaine.,increase,risk
Dasatinib,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Dasatinib is combined with Oxybuprocaine.,increase,risk
Dasatinib,Oxybutynin,The serum concentration of Dasatinib can be increased when it is combined with Oxybutynin.,increase,no risk
Dasatinib,Oxycodone,The metabolism of Dasatinib can be decreased when combined with Oxycodone.,decrease,no risk
Dasatinib,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Dasatinib.,increase,risk
Dasatinib,Ozanimod,Dasatinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Dasatinib,Quetiapine,The metabolism of Dasatinib can be decreased when combined with Quetiapine.,decrease,no risk
Dasatinib,Quinidine,The serum concentration of Dasatinib can be increased when it is combined with Quinidine.,increase,no risk
Dasatinib,Quinine,The serum concentration of Dasatinib can be increased when it is combined with Quinine.,increase,no risk
Dasatinib,Quinupristin,The metabolism of Dasatinib can be decreased when combined with Quinupristin.,decrease,no risk
Dasatinib,Quizartinib,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Quizartinib.,increase,risk
Dasatinib,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Dasatinib.,increase,risk
Dasatinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Dasatinib.,increase,no risk
Dasatinib,Udenafil,The metabolism of Dasatinib can be decreased when combined with Udenafil.,decrease,no risk
Dasatinib,Umbralisib,The serum concentration of Dasatinib can be increased when it is combined with Umbralisib.,increase,no risk
Dasatinib,Umeclidinium,The serum concentration of Dasatinib can be increased when it is combined with Umeclidinium.,increase,no risk
Dasatinib,Upadacitinib,The risk or severity of adverse effects can be increased when Dasatinib is combined with Upadacitinib.,increase,risk
Dasatinib,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Urokinase.,increase,risk
Dasatinib,Vadadustat,The serum concentration of Dasatinib can be increased when it is combined with Vadadustat.,increase,no risk
Dasatinib,Valbenazine,The metabolism of Dasatinib can be decreased when combined with Valbenazine.,decrease,no risk
Dasatinib,Valproic acid,The serum concentration of Dasatinib can be increased when it is combined with Valproic acid.,increase,no risk
Dasatinib,Vandetanib,The serum concentration of Dasatinib can be increased when it is combined with Vandetanib.,increase,no risk
Dasatinib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Dasatinib.,increase,risk
Dasatinib,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Dasatinib.,decrease,no risk
Dasatinib,Vedolizumab,The risk or severity of adverse effects can be increased when Dasatinib is combined with Vedolizumab.,increase,risk
Dasatinib,Velpatasvir,The serum concentration of Dasatinib can be increased when it is combined with Velpatasvir.,increase,no risk
Dasatinib,Vemurafenib,The serum concentration of Dasatinib can be increased when it is combined with Vemurafenib.,increase,no risk
Dasatinib,Venetoclax,The serum concentration of Dasatinib can be increased when it is combined with Venetoclax.,increase,no risk
Dasatinib,Venlafaxine,Venlafaxine may increase the excretion rate of Dasatinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dasatinib,Verapamil,The serum concentration of Dasatinib can be increased when it is combined with Verapamil.,increase,no risk
Dasatinib,Vernakalant,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Vernakalant.,increase,risk
Dasatinib,Verteporfin,Dasatinib may increase the photosensitizing activities of Verteporfin.,increase,no risk
Dasatinib,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Dasatinib.,decrease,no risk
Dasatinib,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Dasatinib.,increase,risk
Dasatinib,Viloxazine,The metabolism of Dasatinib can be decreased when combined with Viloxazine.,decrease,no risk
Dasatinib,Vinblastine,The metabolism of Dasatinib can be increased when combined with Vinblastine.,increase,no risk
Dasatinib,Vincristine,The metabolism of Vincristine can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Vindesine,The metabolism of Vindesine can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Vismodegib,Vismodegib may decrease the excretion rate of Dasatinib which could result in a higher serum level.,decrease,no risk
Dasatinib,Vitamin E,The metabolism of Dasatinib can be increased when combined with Vitamin E.,increase,no risk
Dasatinib,Voclosporin,The serum concentration of Dasatinib can be increased when it is combined with Voclosporin.,increase,no risk
Dasatinib,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dasatinib,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Vorapaxar.,increase,risk
Dasatinib,Voriconazole,The metabolism of Dasatinib can be decreased when combined with Voriconazole.,decrease,no risk
Dasatinib,Vorinostat,The risk or severity of adverse effects can be increased when Dasatinib is combined with Vorinostat.,increase,risk
Dasatinib,Vortioxetine,The metabolism of Dasatinib can be decreased when combined with Vortioxetine.,decrease,no risk
Dasatinib,Voxelotor,The serum concentration of Dasatinib can be increased when it is combined with Voxelotor.,increase,no risk
Dasatinib,Voxilaprevir,The serum concentration of Dasatinib can be increased when it is combined with Voxilaprevir.,increase,no risk
Dasatinib,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Warfarin.,increase,risk
Dasatinib,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Ximelagatran.,increase,risk
Dasatinib,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Dasatinib.,increase,risk
Dasatinib,Zafirlukast,The serum concentration of Dasatinib can be increased when it is combined with Zafirlukast.,increase,no risk
Dasatinib,Zaleplon,The metabolism of Dasatinib can be decreased when combined with Zaleplon.,decrease,no risk
Dasatinib,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Dasatinib.,increase,risk
Dasatinib,Zileuton,The metabolism of Dasatinib can be decreased when combined with Zileuton.,decrease,no risk
Dasatinib,Zimelidine,The metabolism of Dasatinib can be decreased when combined with Zimelidine.,decrease,no risk
Dasatinib,Ziprasidone,The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Ziprasidone.,increase,risk
Dasatinib,Zolmitriptan,The metabolism of Dasatinib can be decreased when combined with Zolmitriptan.,decrease,no risk
Dasatinib,Zolpidem,The metabolism of Dasatinib can be decreased when combined with Zolpidem.,decrease,no risk
Dasatinib,Zonisamide,The serum concentration of Dasatinib can be increased when it is combined with Zonisamide.,increase,no risk
Dasatinib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Zotepine,The metabolism of Zotepine can be decreased when combined with Dasatinib.,decrease,no risk
Dasatinib,Zuclopenthixol,The metabolism of Dasatinib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Lisdexamfetamine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Gefitinib,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Gefitinib.",increase,no risk
Lisdexamfetamine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Glutamic acid,The serum concentration of Lisdexamfetamine can be decreased when it is combined with Glutamic acid.,decrease,no risk
Lisdexamfetamine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Lisdexamfetamine.,decrease,no risk
Lisdexamfetamine,Glycerol phenylbutyrate,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Glycerol phenylbutyrate.",increase,no risk
Lisdexamfetamine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Granisetron,The risk or severity of serotonin syndrome can be increased when Granisetron is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Guanabenz,Lisdexamfetamine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Lisdexamfetamine,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Lisdexamfetamine.,decrease,no risk
Lisdexamfetamine,Guanethidine,The serum concentration of Lisdexamfetamine can be decreased when it is combined with Guanethidine.,decrease,no risk
Lisdexamfetamine,Guanfacine,Lisdexamfetamine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Lisdexamfetamine,Guanoxan,Lisdexamfetamine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Lisdexamfetamine,Halofantrine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Halofantrine.",increase,no risk
Lisdexamfetamine,Haloperidol,The therapeutic efficacy of Lisdexamfetamine can be decreased when used in combination with Haloperidol.,decrease,no risk
Lisdexamfetamine,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Hexocyclium,The risk or severity of Tachycardia can be increased when Lisdexamfetamine is combined with Hexocyclium.,increase,risk
Lisdexamfetamine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Hydralazine,Lisdexamfetamine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Lisdexamfetamine,Hydrochlorothiazide,Lisdexamfetamine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Lisdexamfetamine,Hydrocodone,The risk or severity of serotonin syndrome can be increased when Hydrocodone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Hydroflumethiazide,Lisdexamfetamine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Lisdexamfetamine,Hydromorphone,The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Hydrotalcite,The serum concentration of Lisdexamfetamine can be increased when it is combined with Hydrotalcite.,increase,no risk
Lisdexamfetamine,Hydroxyamphetamine,The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Hydroxychloroquine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Hydroxychloroquine.",increase,no risk
Lisdexamfetamine,Hydroxyurea,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Hydroxyurea.",increase,no risk
Lisdexamfetamine,Hydroxyzine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Hydroxyzine.",increase,no risk
Lisdexamfetamine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Ketoconazole,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Ketoconazole.",increase,no risk
Lisdexamfetamine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Ketotifen,Lisdexamfetamine may decrease the sedative activities of Ketotifen.,decrease,no risk
Lisdexamfetamine,Olanzapine,The risk or severity of serotonin syndrome can be increased when Olanzapine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Oliceridine,The risk or severity of serotonin syndrome can be increased when Lisdexamfetamine is combined with Oliceridine.,increase,risk
Lisdexamfetamine,Olmesartan,Lisdexamfetamine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Lisdexamfetamine,Olodaterol,The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Olodaterol.,increase,risk
Lisdexamfetamine,Ondansetron,The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Opium,The risk or severity of serotonin syndrome can be increased when Opium is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Oritavancin,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Oritavancin.",increase,no risk
Lisdexamfetamine,Orphenadrine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Orphenadrine.",increase,no risk
Lisdexamfetamine,Osilodrostat,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Osilodrostat.",increase,no risk
Lisdexamfetamine,Ospemifene,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Ospemifene.",increase,no risk
Lisdexamfetamine,Oxamniquine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Oxamniquine.",increase,no risk
Lisdexamfetamine,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Oxatomide,Lisdexamfetamine may decrease the sedative activities of Oxatomide.,decrease,no risk
Lisdexamfetamine,Oxprenolol,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Oxprenolol.",increase,no risk
Lisdexamfetamine,Oxtriphylline,The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Oxtriphylline.,increase,risk
Lisdexamfetamine,Oxybutynin,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Oxybutynin.",increase,no risk
Lisdexamfetamine,Oxycodone,The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Oxymetholone,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Oxymetholone.",increase,no risk
Lisdexamfetamine,Oxymorphone,The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Oxyphenbutazone.,increase,risk
Lisdexamfetamine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Quetiapine,The risk or severity of serotonin syndrome can be increased when Quetiapine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Quinapril,Lisdexamfetamine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Lisdexamfetamine,Quinidine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Quinidine.",increase,no risk
Lisdexamfetamine,Quinine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Quinine.",increase,no risk
Lisdexamfetamine,Quinupramine,The risk or severity of serotonin syndrome can be increased when Quinupramine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Umeclidinium,The risk or severity of Tachycardia can be increased when Lisdexamfetamine is combined with Umeclidinium.,increase,risk
Lisdexamfetamine,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Valproate bismuth is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Valproic acid,The risk or severity of serotonin syndrome can be increased when Valproic acid is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Valsartan,Lisdexamfetamine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Lisdexamfetamine,Vemurafenib,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Vemurafenib.",increase,no risk
Lisdexamfetamine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Verapamil,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Verapamil.",increase,no risk
Lisdexamfetamine,Vernakalant,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Vernakalant.",increase,no risk
Lisdexamfetamine,Vilanterol,The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Vilanterol.,increase,risk
Lisdexamfetamine,Vilazodone,The risk or severity of serotonin syndrome can be increased when Vilazodone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Viloxazine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Viloxazine.",increase,no risk
Lisdexamfetamine,Vinblastine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Vinblastine.",increase,no risk
Lisdexamfetamine,Vinorelbine,"The serum concentration of dextroamphetamine, an active metabolite of Lisdexamfetamine, can be increased when used in combination with Vinorelbine.",increase,no risk
Lisdexamfetamine,Vortioxetine,The risk or severity of serotonin syndrome can be increased when Vortioxetine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Xamoterol,The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Xamoterol.,increase,risk
Lisdexamfetamine,Xylometazoline,The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Xylometazoline.,increase,risk
Lisdexamfetamine,Yohimbine,The risk or severity of serotonin syndrome can be increased when Yohimbine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Zimelidine,The risk or severity of serotonin syndrome can be increased when Zimelidine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Zinc ascorbate,The serum concentration of Lisdexamfetamine can be decreased when it is combined with Zinc ascorbate.,decrease,no risk
Lisdexamfetamine,Ziprasidone,The risk or severity of serotonin syndrome can be increased when Ziprasidone is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Zofenopril,Lisdexamfetamine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Lisdexamfetamine,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Zonisamide,Zonisamide may decrease the excretion rate of Lisdexamfetamine which could result in a higher serum level.,decrease,no risk
Lisdexamfetamine,Zotepine,The risk or severity of serotonin syndrome can be increased when Zotepine is combined with Lisdexamfetamine.,increase,risk
Lisdexamfetamine,Zuclopenthixol,The risk or severity of serotonin syndrome can be increased when Zuclopenthixol is combined with Lisdexamfetamine.,increase,risk
Retapamulin,Glofitamab,The serum concentration of Retapamulin can be increased when it is combined with Glofitamab.,increase,no risk
Retapamulin,Glyburide,The metabolism of Retapamulin can be decreased when combined with Glyburide.,decrease,no risk
Retapamulin,Glycerol phenylbutyrate,The metabolism of Retapamulin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Retapamulin,Griseofulvin,The metabolism of Retapamulin can be increased when combined with Griseofulvin.,increase,no risk
Retapamulin,Haloperidol,The metabolism of Retapamulin can be decreased when combined with Haloperidol.,decrease,no risk
Retapamulin,Hydralazine,The metabolism of Retapamulin can be decreased when combined with Hydralazine.,decrease,no risk
Retapamulin,Hydrocortamate,The metabolism of Retapamulin can be increased when combined with Hydrocortamate.,increase,no risk
Retapamulin,Hydrocortisone,The metabolism of Retapamulin can be increased when combined with Hydrocortisone.,increase,no risk
Retapamulin,Hydrocortisone acetate,The metabolism of Retapamulin can be increased when combined with Hydrocortisone acetate.,increase,no risk
Retapamulin,Hydrocortisone butyrate,The metabolism of Retapamulin can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Retapamulin,Hydrocortisone succinate,The metabolism of Retapamulin can be increased when combined with Hydrocortisone succinate.,increase,no risk
Retapamulin,Ketamine,The metabolism of Retapamulin can be increased when combined with Ketamine.,increase,no risk
Retapamulin,Ketazolam,The metabolism of Retapamulin can be decreased when combined with Ketazolam.,decrease,no risk
Retapamulin,Ketoconazole,The metabolism of Retapamulin can be decreased when combined with Ketoconazole.,decrease,no risk
Retapamulin,Octreotide,The metabolism of Retapamulin can be decreased when combined with Octreotide.,decrease,no risk
Retapamulin,Olaparib,The metabolism of Retapamulin can be decreased when combined with Olaparib.,decrease,no risk
Retapamulin,Olutasidenib,The metabolism of Retapamulin can be increased when combined with Olutasidenib.,increase,no risk
Retapamulin,Omaveloxolone,The metabolism of Retapamulin can be increased when combined with Omaveloxolone.,increase,no risk
Retapamulin,Oritavancin,The metabolism of Retapamulin can be increased when combined with Oritavancin.,increase,no risk
Retapamulin,Orphenadrine,The metabolism of Retapamulin can be decreased when combined with Orphenadrine.,decrease,no risk
Retapamulin,Osilodrostat,The metabolism of Retapamulin can be decreased when combined with Osilodrostat.,decrease,no risk
Retapamulin,Oxcarbazepine,The metabolism of Retapamulin can be increased when combined with Oxcarbazepine.,increase,no risk
Retapamulin,Oxetacaine,The metabolism of Retapamulin can be decreased when combined with Oxetacaine.,decrease,no risk
Retapamulin,Oxybutynin,The metabolism of Retapamulin can be decreased when combined with Oxybutynin.,decrease,no risk
Retapamulin,Oxymetholone,The metabolism of Retapamulin can be decreased when combined with Oxymetholone.,decrease,no risk
Retapamulin,Quinidine,The metabolism of Retapamulin can be decreased when combined with Quinidine.,decrease,no risk
Retapamulin,Quinine,The metabolism of Retapamulin can be decreased when combined with Quinine.,decrease,no risk
Retapamulin,Quinupristin,The metabolism of Retapamulin can be decreased when combined with Quinupristin.,decrease,no risk
Retapamulin,Vadadustat,The serum concentration of Retapamulin can be increased when it is combined with Vadadustat.,increase,no risk
Retapamulin,Valproic acid,The metabolism of Retapamulin can be decreased when combined with Valproic acid.,decrease,no risk
Retapamulin,Vemurafenib,The metabolism of Retapamulin can be increased when combined with Vemurafenib.,increase,no risk
Retapamulin,Venetoclax,The metabolism of Retapamulin can be decreased when combined with Venetoclax.,decrease,no risk
Retapamulin,Verapamil,The metabolism of Retapamulin can be decreased when combined with Verapamil.,decrease,no risk
Retapamulin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Retapamulin.,decrease,no risk
Retapamulin,Viloxazine,The metabolism of Retapamulin can be decreased when combined with Viloxazine.,decrease,no risk
Retapamulin,Vinblastine,The metabolism of Retapamulin can be decreased when combined with Vinblastine.,decrease,no risk
Retapamulin,Vitamin E,The metabolism of Retapamulin can be increased when combined with Vitamin E.,increase,no risk
Retapamulin,Voriconazole,The metabolism of Retapamulin can be decreased when combined with Voriconazole.,decrease,no risk
Retapamulin,Warfarin,The metabolism of Retapamulin can be increased when combined with Warfarin.,increase,no risk
Retapamulin,Zafirlukast,The metabolism of Retapamulin can be decreased when combined with Zafirlukast.,decrease,no risk
Retapamulin,Zimelidine,The metabolism of Retapamulin can be decreased when combined with Zimelidine.,decrease,no risk
Retapamulin,Ziprasidone,The metabolism of Retapamulin can be decreased when combined with Ziprasidone.,decrease,no risk
Eculizumab,Galcanezumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Galcanezumab.,increase,risk
Eculizumab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Eculizumab.,increase,risk
Eculizumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Eculizumab.,increase,risk
Eculizumab,Glatiramer,The risk or severity of adverse effects can be increased when Eculizumab is combined with Glatiramer.,increase,risk
Eculizumab,Glofitamab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Glofitamab.,increase,risk
Eculizumab,Golimumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Golimumab.,increase,risk
Eculizumab,Guselkumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Guselkumab.,increase,risk
Eculizumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Eculizumab.,decrease,no risk
Eculizumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Eculizumab.,decrease,no risk
Eculizumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Eculizumab is combined with Hepatitis B immune globulin.,increase,risk
Eculizumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Eculizumab.,decrease,no risk
Eculizumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Eculizumab.,increase,risk
Eculizumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Eculizumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Eculizumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Eculizumab.,increase,risk
Eculizumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Eculizumab is combined with Human Rho(D) immune globulin.,increase,risk
Eculizumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Eculizumab is combined with Human varicella-zoster immune globulin.,increase,risk
Eculizumab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Eculizumab is combined with Hydrocortisone acetate.,increase,risk
Eculizumab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Eculizumab is combined with Hydrocortisone butyrate.,increase,risk
Eculizumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Eculizumab is combined with Hydrocortisone succinate.,increase,risk
Eculizumab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Eculizumab is combined with Hydroxychloroquine.,increase,risk
Eculizumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Eculizumab.,increase,risk
Eculizumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Eculizumab.,decrease,no risk
Eculizumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Eculizumab.,decrease,no risk
Eculizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Obiltoxaximab.,increase,risk
Eculizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Obinutuzumab.,increase,risk
Eculizumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Eculizumab.,increase,no risk
Eculizumab,Odesivimab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Odesivimab.,increase,risk
Eculizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Ofatumumab.,increase,risk
Eculizumab,Olaparib,The risk or severity of adverse effects can be increased when Eculizumab is combined with Olaparib.,increase,risk
Eculizumab,Olaratumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Olaratumab.,increase,risk
Eculizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Eculizumab.,increase,risk
Eculizumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Eculizumab.,increase,risk
Eculizumab,Ozanimod,The risk or severity of adverse effects can be increased when Eculizumab is combined with Ozanimod.,increase,risk
Eculizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Eculizumab.,increase,no risk
Eculizumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Eculizumab.,increase,risk
Eculizumab,Upadacitinib,The risk or severity of adverse effects can be increased when Eculizumab is combined with Upadacitinib.,increase,risk
Eculizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Ustekinumab.,increase,risk
Eculizumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Eculizumab.,increase,risk
Eculizumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Eculizumab.,decrease,no risk
Eculizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Eculizumab is combined with Vedolizumab.,increase,risk
Eculizumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Eculizumab.,decrease,no risk
Eculizumab,Vilanterol,The risk or severity of adverse effects can be increased when Eculizumab is combined with Vilanterol.,increase,risk
Eculizumab,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Eculizumab.,increase,risk
Eculizumab,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Eculizumab.,increase,risk
Eculizumab,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Eculizumab.,increase,risk
Eculizumab,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Eculizumab.,increase,risk
Eculizumab,Voclosporin,The risk or severity of adverse effects can be increased when Eculizumab is combined with Voclosporin.,increase,risk
Eculizumab,Vorinostat,The risk or severity of adverse effects can be increased when Eculizumab is combined with Vorinostat.,increase,risk
Eculizumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Eculizumab.,increase,risk
Eculizumab,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Eculizumab.,increase,risk
Aliskiren,Glofitamab,The serum concentration of Aliskiren can be increased when it is combined with Glofitamab.,increase,no risk
Aliskiren,Glycol salicylate,The risk or severity of renal failure and hypertension can be increased when Glycol salicylate is combined with Aliskiren.,increase,risk
Aliskiren,Guanabenz,Guanabenz may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Guanadrel,Guanadrel may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Guanethidine,Guanethidine may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Guanfacine,Guanfacine may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Guanoxan,Aliskiren may increase the hypotensive activities of Guanoxan.,increase,no risk
Aliskiren,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Aliskiren.,increase,no risk
Aliskiren,Halothane,Halothane may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Aliskiren.,increase,risk
Aliskiren,Hydralazine,Hydralazine may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Hydroflumethiazide,The therapeutic efficacy of Aliskiren can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Aliskiren,Ketoconazole,The serum concentration of Aliskiren can be increased when it is combined with Ketoconazole.,increase,no risk
Aliskiren,Ketoprofen,The risk or severity of renal failure and hypertension can be increased when Ketoprofen is combined with Aliskiren.,increase,risk
Aliskiren,Ketorolac,The risk or severity of renal failure and hypertension can be increased when Ketorolac is combined with Aliskiren.,increase,risk
Aliskiren,Obinutuzumab,Aliskiren may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Aliskiren,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Aliskiren.,increase,risk
Aliskiren,Olmesartan,The risk or severity of hyperkalemia can be increased when Aliskiren is combined with Olmesartan.,increase,risk
Aliskiren,Olodaterol,Olodaterol may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Omaveloxolone,The serum concentration of Aliskiren can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Aliskiren,Opicapone,The risk or severity of adverse effects can be increased when Aliskiren is combined with Opicapone.,increase,risk
Aliskiren,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Oxaprozin,The risk or severity of renal failure and hypertension can be increased when Oxaprozin is combined with Aliskiren.,increase,risk
Aliskiren,Oxprenolol,Oxprenolol may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Oxymetazoline,The therapeutic efficacy of Aliskiren can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Aliskiren,Oxyphenbutazone,The risk or severity of renal failure and hypertension can be increased when Oxyphenbutazone is combined with Aliskiren.,increase,risk
Aliskiren,Quetiapine,Quetiapine may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Quinapril,"The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Quinapril.",increase,risk
Aliskiren,Quinidine,Quinidine may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Quinine,Quinine may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Quinupramine,Quinupramine may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Udenafil,Udenafil may increase the antihypertensive activities of Aliskiren.,increase,no risk
Aliskiren,Unoprostone,Unoprostone may increase the hypotensive activities of Aliskiren.,increase,no risk
Aliskiren,Vadadustat,The serum concentration of Aliskiren can be increased when it is combined with Vadadustat.,increase,no risk
Aliskiren,Valdecoxib,The risk or severity of renal failure and hypertension can be increased when Valdecoxib is combined with Aliskiren.,increase,risk
Aliskiren,Vardenafil,Vardenafil may increase the antihypertensive activities of Aliskiren.,increase,no risk
Aliskiren,Venetoclax,The metabolism of Aliskiren can be decreased when combined with Venetoclax.,decrease,no risk
Aliskiren,Verapamil,The metabolism of Aliskiren can be decreased when combined with Verapamil.,decrease,no risk
Aliskiren,Vericiguat,The risk or severity of adverse effects can be increased when Aliskiren is combined with Vericiguat.,increase,risk
Aliskiren,Vilanterol,Vilanterol may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Vilazodone,Vilazodone may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Viloxazine,The metabolism of Aliskiren can be decreased when combined with Viloxazine.,decrease,no risk
Aliskiren,Voriconazole,The metabolism of Aliskiren can be decreased when combined with Voriconazole.,decrease,no risk
Aliskiren,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Xamoterol,Xamoterol may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Yohimbine,Yohimbine may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Zimelidine,The metabolism of Aliskiren can be decreased when combined with Zimelidine.,decrease,no risk
Aliskiren,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Aliskiren.,increase,no risk
Aliskiren,Zofenopril,"The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Zofenopril.",increase,risk
Aliskiren,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Aliskiren,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Aliskiren.,increase,risk
Aliskiren,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Aliskiren.,decrease,no risk
Lapatinib,Busulfan,The metabolism of Busulfan can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Lapatinib is combined with Butacaine.,increase,risk
Lapatinib,Butamben,The risk or severity of methemoglobinemia can be increased when Lapatinib is combined with Butamben.,increase,risk
Lapatinib,Butriptyline,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Butriptyline.,increase,risk
Lapatinib,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Gadobenic acid.,increase,risk
Lapatinib,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Lapatinib.,increase,risk
Lapatinib,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Lapatinib.,increase,risk
Lapatinib,Gefitinib,The metabolism of Lapatinib can be decreased when combined with Gefitinib.,decrease,no risk
Lapatinib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Gemfibrozil,The metabolism of Lapatinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Lapatinib,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Gemifloxacin.,increase,risk
Lapatinib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Glasdegib,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Glasdegib.,increase,risk
Lapatinib,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Gliclazide,The metabolism of Lapatinib can be decreased when combined with Gliclazide.,decrease,no risk
Lapatinib,Glofitamab,The serum concentration of Lapatinib can be increased when it is combined with Glofitamab.,increase,no risk
Lapatinib,Glyburide,The metabolism of Lapatinib can be decreased when combined with Glyburide.,decrease,no risk
Lapatinib,Golimumab,The metabolism of Lapatinib can be increased when combined with Golimumab.,increase,no risk
Lapatinib,Goserelin,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Goserelin.,increase,risk
Lapatinib,Granisetron,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Granisetron.,increase,risk
Lapatinib,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Grepafloxacin.,increase,risk
Lapatinib,Halofantrine,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Halofantrine.,increase,risk
Lapatinib,Haloperidol,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Haloperidol.,increase,risk
Lapatinib,Histrelin,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Histrelin.,increase,risk
Lapatinib,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Lapatinib.,increase,risk
Lapatinib,Hydrocortisone,The metabolism of Lapatinib can be increased when combined with Hydrocortisone.,increase,no risk
Lapatinib,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Hydroxyzine.,increase,risk
Lapatinib,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lapatinib.,increase,risk
Lapatinib,Ketamine,The metabolism of Lapatinib can be decreased when combined with Ketamine.,decrease,no risk
Lapatinib,Ketoconazole,The metabolism of Lapatinib can be decreased when combined with Ketoconazole.,decrease,no risk
Lapatinib,Ketoprofen,The metabolism of Lapatinib can be decreased when combined with Ketoprofen.,decrease,no risk
Lapatinib,Ketorolac,The metabolism of Lapatinib can be decreased when combined with Ketorolac.,decrease,no risk
Lapatinib,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Lapatinib.,increase,risk
Lapatinib,Ofloxacin,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ofloxacin.,increase,risk
Lapatinib,Olanzapine,The metabolism of Lapatinib can be decreased when combined with Olanzapine.,decrease,no risk
Lapatinib,Olaparib,The metabolism of Olaparib can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Omaveloxolone,The serum concentration of Lapatinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Lapatinib,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Omeprazole,The metabolism of Lapatinib can be decreased when combined with Omeprazole.,decrease,no risk
Lapatinib,Ondansetron,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ondansetron.,increase,risk
Lapatinib,Oritavancin,The metabolism of Lapatinib can be decreased when combined with Oritavancin.,decrease,no risk
Lapatinib,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Lapatinib.,increase,risk
Lapatinib,Osilodrostat,The metabolism of Lapatinib can be decreased when combined with Osilodrostat.,decrease,no risk
Lapatinib,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Lapatinib.,increase,risk
Lapatinib,Oxatomide,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Oxatomide.,increase,risk
Lapatinib,Oxcarbazepine,The metabolism of Lapatinib can be increased when combined with Oxcarbazepine.,increase,no risk
Lapatinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Lapatinib is combined with Oxetacaine.,increase,risk
Lapatinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Lapatinib is combined with Oxybuprocaine.,increase,risk
Lapatinib,Oxybutynin,The metabolism of Lapatinib can be decreased when combined with Oxybutynin.,decrease,no risk
Lapatinib,Oxycodone,The metabolism of Lapatinib can be decreased when combined with Oxycodone.,decrease,no risk
Lapatinib,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Lapatinib.,increase,risk
Lapatinib,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Quetiapine,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Quetiapine.,increase,risk
Lapatinib,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Quinine,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Quinine.,increase,risk
Lapatinib,Quizartinib,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Quizartinib.,increase,risk
Lapatinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Udenafil,The metabolism of Udenafil can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Vadadustat,The serum concentration of Lapatinib can be increased when it is combined with Vadadustat.,increase,no risk
Lapatinib,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Lapatinib.,decrease,no risk
Lapatinib,Valproic acid,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Valproic acid.,increase,risk
Lapatinib,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Lapatinib.,increase,risk
Lapatinib,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Verapamil,The metabolism of Lapatinib can be decreased when combined with Verapamil.,decrease,no risk
Lapatinib,Vernakalant,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Vernakalant.,increase,risk
Lapatinib,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Lapatinib.,increase,risk
Lapatinib,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Viloxazine,The metabolism of Lapatinib can be decreased when combined with Viloxazine.,decrease,no risk
Lapatinib,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Vincristine,The excretion of Vincristine can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Vindesine,The metabolism of Vindesine can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Vonoprazan,The metabolism of Lapatinib can be decreased when combined with Vonoprazan.,decrease,no risk
Lapatinib,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Voriconazole,The metabolism of Lapatinib can be decreased when combined with Voriconazole.,decrease,no risk
Lapatinib,Vorinostat,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Vorinostat.,increase,risk
Lapatinib,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Lapatinib.,increase,no risk
Lapatinib,Zafirlukast,The metabolism of Lapatinib can be decreased when combined with Zafirlukast.,decrease,no risk
Lapatinib,Zaleplon,The metabolism of Lapatinib can be decreased when combined with Zaleplon.,decrease,no risk
Lapatinib,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Zidovudine,The metabolism of Lapatinib can be decreased when combined with Zidovudine.,decrease,no risk
Lapatinib,Zimelidine,The metabolism of Lapatinib can be decreased when combined with Zimelidine.,decrease,no risk
Lapatinib,Ziprasidone,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ziprasidone.,increase,risk
Lapatinib,Zolpidem,The metabolism of Lapatinib can be decreased when combined with Zolpidem.,decrease,no risk
Lapatinib,Zonisamide,The metabolism of Lapatinib can be decreased when combined with Zonisamide.,decrease,no risk
Lapatinib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Lapatinib.,decrease,no risk
Lapatinib,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Zuclopenthixol.,increase,risk
Desonide,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Desonide.,increase,risk
Desonide,Vadadustat,The serum concentration of Desonide can be increased when it is combined with Vadadustat.,increase,no risk
Desonide,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Desonide.,decrease,no risk
Desonide,Vildagliptin,The risk or severity of hyperglycemia can be increased when Desonide is combined with Vildagliptin.,increase,risk
Desonide,Viloxazine,The metabolism of Desonide can be decreased when combined with Viloxazine.,decrease,no risk
Desonide,Voriconazole,The serum concentration of Desonide can be increased when it is combined with Voriconazole.,increase,no risk
Desonide,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Desonide.,decrease,no risk
Sitagliptin,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Sitagliptin.,increase,no risk
Sitagliptin,Bendroflumethiazide,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Sitagliptin,Benorilate,Benorilate may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Benserazide,Sitagliptin may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Sitagliptin,Benzatropine,Benzatropine may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Benznidazole,Sitagliptin may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Sitagliptin,Benzoic acid,The excretion of Sitagliptin can be decreased when combined with Benzoic acid.,decrease,no risk
Sitagliptin,Benzthiazide,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Benzthiazide.,decrease,no risk
Sitagliptin,Benzydamine,Benzydamine may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Sitagliptin.,decrease,no risk
Sitagliptin,Benzylpenicillin,The excretion of Sitagliptin can be decreased when combined with Benzylpenicillin.,decrease,no risk
Sitagliptin,Bepotastine,Sitagliptin may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Sitagliptin,Bepridil,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Sitagliptin.,increase,risk
Sitagliptin,Berotralstat,The metabolism of Sitagliptin can be decreased when combined with Berotralstat.,decrease,no risk
Sitagliptin,Betamethasone,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Sitagliptin.,increase,risk
Sitagliptin,Betamethasone phosphate,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Sitagliptin.,increase,risk
Sitagliptin,Betaxolol,The therapeutic efficacy of Sitagliptin can be increased when used in combination with Betaxolol.,increase,no risk
Sitagliptin,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Sitagliptin.,increase,no risk
Sitagliptin,Bexagliflozin,Bexagliflozin may increase the hypoglycemic activities of Sitagliptin.,increase,no risk
Sitagliptin,Bexarotene,The metabolism of Sitagliptin can be decreased when combined with Bexarotene.,decrease,no risk
Sitagliptin,Bezafibrate,The metabolism of Sitagliptin can be decreased when combined with Bezafibrate.,decrease,no risk
Sitagliptin,Bicisate,Sitagliptin may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Sitagliptin,Bimekizumab,The metabolism of Sitagliptin can be increased when combined with Bimekizumab.,increase,no risk
Sitagliptin,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Sitagliptin.,increase,no risk
Sitagliptin,Bismuth subgallate,Sitagliptin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Sitagliptin,Bismuth subsalicylate,Bismuth subsalicylate may increase the hypoglycemic activities of Sitagliptin.,increase,no risk
Sitagliptin,Bisoprolol,The therapeutic efficacy of Sitagliptin can be increased when used in combination with Bisoprolol.,increase,no risk
Sitagliptin,Bisoxatin,Sitagliptin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Bleomycin,Bleomycin may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Boceprevir,The metabolism of Sitagliptin can be decreased when combined with Boceprevir.,decrease,no risk
Sitagliptin,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Sitagliptin.,increase,no risk
Sitagliptin,Bosentan,The therapeutic efficacy of Sitagliptin can be increased when used in combination with Bosentan.,increase,no risk
Sitagliptin,Bosutinib,The metabolism of Sitagliptin can be decreased when combined with Bosutinib.,decrease,no risk
Sitagliptin,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Sitagliptin.,increase,no risk
Sitagliptin,Brexpiprazole,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Sitagliptin,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Sitagliptin.,decrease,no risk
Sitagliptin,Brivaracetam,Sitagliptin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Sitagliptin,Bromazepam,Sitagliptin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Sitagliptin,Bromocriptine,The risk or severity of hypoglycemia can be increased when Sitagliptin is combined with Bromocriptine.,increase,risk
Sitagliptin,Bromotheophylline,Bromotheophylline may increase the excretion rate of Sitagliptin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sitagliptin,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Sitagliptin.,increase,risk
Sitagliptin,Bumadizone,Bumadizone may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Bumetanide,The excretion of Sitagliptin can be decreased when combined with Bumetanide.,decrease,no risk
Sitagliptin,Buprenorphine,The metabolism of Sitagliptin can be decreased when combined with Buprenorphine.,decrease,no risk
Sitagliptin,Bupropion,Bupropion may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Buserelin,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Buserelin.,decrease,no risk
Sitagliptin,Buspirone,Buspirone may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Butabarbital,Butabarbital may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,decrease,no risk
Sitagliptin,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Sitagliptin.,decrease,no risk
Decitabine,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Decitabine.,increase,risk
Decitabine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Decitabine.,increase,risk
Decitabine,Glatiramer,The risk or severity of adverse effects can be increased when Decitabine is combined with Glatiramer.,increase,risk
Decitabine,Golimumab,The risk or severity of adverse effects can be increased when Decitabine is combined with Golimumab.,increase,risk
Decitabine,Guselkumab,The risk or severity of adverse effects can be increased when Decitabine is combined with Guselkumab.,increase,risk
Decitabine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Decitabine.,decrease,no risk
Decitabine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Decitabine.,increase,risk
Decitabine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Decitabine.,decrease,no risk
Decitabine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Decitabine.,decrease,no risk
Decitabine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Decitabine.,increase,risk
Decitabine,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Decitabine.,increase,risk
Decitabine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Decitabine is combined with Hydrocortisone acetate.,increase,risk
Decitabine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Decitabine is combined with Hydrocortisone butyrate.,increase,risk
Decitabine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Decitabine is combined with Hydrocortisone succinate.,increase,risk
Decitabine,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Decitabine.,increase,risk
Decitabine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Decitabine is combined with Hydroxychloroquine.,increase,risk
Decitabine,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Decitabine.,increase,risk
Decitabine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Decitabine.,decrease,no risk
Decitabine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Decitabine.,decrease,no risk
Decitabine,Obinutuzumab,The risk or severity of adverse effects can be increased when Decitabine is combined with Obinutuzumab.,increase,risk
Decitabine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Decitabine.,increase,no risk
Decitabine,Ofatumumab,The risk or severity of adverse effects can be increased when Decitabine is combined with Ofatumumab.,increase,risk
Decitabine,Olaparib,The risk or severity of adverse effects can be increased when Decitabine is combined with Olaparib.,increase,risk
Decitabine,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Decitabine.,increase,risk
Decitabine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Decitabine is combined with Oxetacaine.,increase,risk
Decitabine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Decitabine is combined with Oxybuprocaine.,increase,risk
Decitabine,Ozanimod,The risk or severity of adverse effects can be increased when Decitabine is combined with Ozanimod.,increase,risk
Decitabine,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Decitabine.,increase,risk
Decitabine,Upadacitinib,The risk or severity of adverse effects can be increased when Decitabine is combined with Upadacitinib.,increase,risk
Decitabine,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Decitabine.,increase,risk
Decitabine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Decitabine.,increase,risk
Decitabine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Decitabine.,decrease,no risk
Decitabine,Vedolizumab,The risk or severity of adverse effects can be increased when Decitabine is combined with Vedolizumab.,increase,risk
Decitabine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Decitabine.,decrease,no risk
Decitabine,Vilanterol,The risk or severity of adverse effects can be increased when Decitabine is combined with Vilanterol.,increase,risk
Decitabine,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Decitabine.,increase,risk
Decitabine,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Decitabine.,increase,risk
Decitabine,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Decitabine.,increase,risk
Decitabine,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Decitabine.,increase,risk
Decitabine,Voclosporin,The risk or severity of adverse effects can be increased when Decitabine is combined with Voclosporin.,increase,risk
Decitabine,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Decitabine.,increase,risk
Decitabine,Vorinostat,The risk or severity of adverse effects can be increased when Decitabine is combined with Vorinostat.,increase,risk
Decitabine,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Decitabine.,increase,risk
Decitabine,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Decitabine.,increase,risk
Decitabine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Decitabine.,increase,risk
Decitabine,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Decitabine.,increase,risk
Posaconazole,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Posaconazole.,increase,risk
Posaconazole,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Posaconazole.,increase,risk
Posaconazole,Budesonide,The metabolism of Budesonide can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Buserelin,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Buserelin.,increase,risk
Posaconazole,Buspirone,The metabolism of Buspirone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Busulfan,The metabolism of Busulfan can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Butriptyline,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Butriptyline.,increase,risk
Posaconazole,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Gadobenic acid.,increase,risk
Posaconazole,Galantamine,The metabolism of Galantamine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Posaconazole.,increase,risk
Posaconazole,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Gemifloxacin.,increase,risk
Posaconazole,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Glecaprevir,The serum concentration of Posaconazole can be increased when it is combined with Glecaprevir.,increase,no risk
Posaconazole,Glofitamab,The serum concentration of Posaconazole can be increased when it is combined with Glofitamab.,increase,no risk
Posaconazole,Glyburide,The metabolism of Glyburide can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Goserelin,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Goserelin.,increase,risk
Posaconazole,Granisetron,The metabolism of Granisetron can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Haloperidol,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Haloperidol.,increase,risk
Posaconazole,Histrelin,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Histrelin.,increase,risk
Posaconazole,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Posaconazole.,increase,risk
Posaconazole,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Posaconazole,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Hydroxyzine.,increase,risk
Posaconazole,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Posaconazole.,increase,risk
Posaconazole,Ketamine,The metabolism of Ketamine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Ketoconazole,The metabolism of Posaconazole can be decreased when combined with Ketoconazole.,decrease,no risk
Posaconazole,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Posaconazole.,increase,risk
Posaconazole,Ofloxacin,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ofloxacin.,increase,risk
Posaconazole,Olanzapine,Olanzapine can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Posaconazole,Olaparib,The metabolism of Olaparib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Olodaterol,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Olodaterol.,increase,risk
Posaconazole,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Omeprazole,Omeprazole can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Posaconazole,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Opium,The metabolism of Opium can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Posaconazole.,increase,risk
Posaconazole,Oxatomide,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Oxatomide.,increase,risk
Posaconazole,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Posaconazole.,increase,risk
Posaconazole,Quazepam,The metabolism of Quazepam can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Quinidine,The metabolism of Quinidine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Quinine,The metabolism of Quinine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Udenafil,The metabolism of Udenafil can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Umbralisib,The serum concentration of Posaconazole can be increased when it is combined with Umbralisib.,increase,no risk
Posaconazole,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vadadustat,The serum concentration of Posaconazole can be increased when it is combined with Vadadustat.,increase,no risk
Posaconazole,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Valproic acid,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Valproic acid.,increase,risk
Posaconazole,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vemurafenib,The serum concentration of Posaconazole can be increased when it is combined with Vemurafenib.,increase,no risk
Posaconazole,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Verapamil,The metabolism of Verapamil can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vernakalant,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Vernakalant.,increase,risk
Posaconazole,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Viloxazine,The metabolism of Posaconazole can be decreased when combined with Viloxazine.,decrease,no risk
Posaconazole,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vincristine,The metabolism of Vincristine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vindesine,The metabolism of Vindesine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Voriconazole,The metabolism of Posaconazole can be decreased when combined with Voriconazole.,decrease,no risk
Posaconazole,Vorinostat,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Vorinostat.,increase,risk
Posaconazole,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Posaconazole.,increase,no risk
Posaconazole,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Warfarin,The metabolism of Warfarin can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Xylometazoline,The therapeutic efficacy of Posaconazole can be increased when used in combination with Xylometazoline.,increase,no risk
Posaconazole,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Ziconotide,The therapeutic efficacy of Posaconazole can be increased when used in combination with Ziconotide.,increase,no risk
Posaconazole,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zileuton,The metabolism of Zileuton can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zimelidine,The metabolism of Posaconazole can be decreased when combined with Zimelidine.,decrease,no risk
Posaconazole,Ziprasidone,The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ziprasidone.,increase,risk
Posaconazole,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zotepine,The metabolism of Zotepine can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Posaconazole.,decrease,no risk
Posaconazole,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Posaconazole.,increase,no risk
Darunavir,Boceprevir,The serum concentration of Darunavir can be decreased when it is combined with Boceprevir.,decrease,no risk
Darunavir,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Bosentan,The serum concentration of Darunavir can be decreased when it is combined with Bosentan.,decrease,no risk
Darunavir,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Budesonide,The metabolism of Budesonide can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Buprenorphine,The serum concentration of Buprenorphine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Buspirone,The metabolism of Buspirone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Butriptyline,The risk or severity of adverse effects can be increased when Darunavir is combined with Butriptyline.,increase,risk
Darunavir,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Galantamine,The metabolism of Galantamine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Garlic,Garlic can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Darunavir,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Glecaprevir,The serum concentration of Darunavir can be increased when it is combined with Glecaprevir.,increase,no risk
Darunavir,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Glofitamab,The serum concentration of Darunavir can be increased when it is combined with Glofitamab.,increase,no risk
Darunavir,Glyburide,The metabolism of Glyburide can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Granisetron,The metabolism of Granisetron can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Darunavir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Ketamine,The metabolism of Ketamine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Ketoconazole,The serum concentration of Darunavir can be increased when it is combined with Ketoconazole.,increase,no risk
Darunavir,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Darunavir.,increase,risk
Darunavir,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Olutasidenib,The therapeutic efficacy of Darunavir can be decreased when used in combination with Olutasidenib.,decrease,no risk
Darunavir,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Omeprazole,Omeprazole can cause a decrease in the absorption of Darunavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Darunavir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Opium,The metabolism of Opium can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Ouabain,The excretion of Ouabain can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Quazepam,The metabolism of Quazepam can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Quinine,The metabolism of Quinine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Quinupramine,The risk or severity of adverse effects can be increased when Darunavir is combined with Quinupramine.,increase,risk
Darunavir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Udenafil,The metabolism of Udenafil can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Umbralisib,The serum concentration of Darunavir can be increased when it is combined with Umbralisib.,increase,no risk
Darunavir,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Vadadustat,The serum concentration of Darunavir can be increased when it is combined with Vadadustat.,increase,no risk
Darunavir,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Valsartan,The excretion of Valsartan can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Viloxazine,The metabolism of Darunavir can be decreased when combined with Viloxazine.,decrease,no risk
Darunavir,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Voriconazole,The serum concentration of Voriconazole can be decreased when it is combined with Darunavir.,decrease,no risk
Darunavir,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Xylometazoline,The serum concentration of Xylometazoline can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Darunavir.,decrease,no risk
Darunavir,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Ziconotide,The serum concentration of Ziconotide can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zileuton,The metabolism of Zileuton can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zimelidine,The metabolism of Darunavir can be decreased when combined with Zimelidine.,decrease,no risk
Darunavir,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zonisamide,The serum concentration of Zonisamide can be increased when it is combined with Darunavir.,increase,no risk
Darunavir,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zotepine,The metabolism of Zotepine can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Darunavir.,decrease,no risk
Darunavir,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Darunavir.,increase,no risk
Telbivudine,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Telbivudine.,decrease,no risk
Telbivudine,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Telbivudine.,decrease,no risk
Telbivudine,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Telbivudine.,decrease,no risk
Telbivudine,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Telbivudine.,decrease,no risk
Telbivudine,Ganciclovir,The risk or severity of cytopenia can be increased when Ganciclovir is combined with Telbivudine.,increase,risk
Telbivudine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Telbivudine.,decrease,no risk
Telbivudine,Valganciclovir,The risk or severity of cytopenia can be increased when Valganciclovir is combined with Telbivudine.,increase,risk
Telbivudine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Telbivudine.,decrease,no risk
Telbivudine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Telbivudine.,decrease,no risk
Telbivudine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Telbivudine.,decrease,no risk
Paliperidone,Bacitracin,Bacitracin may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Paliperidone.,increase,no risk
Paliperidone,Balsalazide,The risk or severity of hypertension can be increased when Balsalazide is combined with Paliperidone.,increase,risk
Paliperidone,Baricitinib,Paliperidone may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Paliperidone,Beclomethasone dipropionate,The metabolism of Paliperidone can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Paliperidone,Bedaquiline,The risk or severity of QTc prolongation can be increased when Paliperidone is combined with Bedaquiline.,increase,risk
Paliperidone,Belantamab mafodotin,The serum concentration of Belantamab mafodotin can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Belinostat,The serum concentration of Belinostat can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Belumosudil,The serum concentration of Paliperidone can be increased when it is combined with Belumosudil.,increase,no risk
Paliperidone,Benazepril,Paliperidone may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Paliperidone,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Paliperidone,Benorilate,The risk or severity of hypertension can be increased when Paliperidone is combined with Benorilate.,increase,risk
Paliperidone,Benoxaprofen,The risk or severity of hypertension can be increased when Paliperidone is combined with Benoxaprofen.,increase,risk
Paliperidone,Benperidol,The risk or severity of CNS depression can be increased when Paliperidone is combined with Benperidol.,increase,risk
Paliperidone,Benserazide,The therapeutic efficacy of Benserazide can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Benzatropine,The risk or severity of adverse effects can be increased when Paliperidone is combined with Benzatropine.,increase,risk
Paliperidone,Benznidazole,Paliperidone may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Paliperidone,Benzocaine,The risk or severity of CNS depression can be increased when Benzocaine is combined with Paliperidone.,increase,risk
Paliperidone,Benzphetamine,The therapeutic efficacy of Paliperidone can be decreased when used in combination with Benzphetamine.,decrease,no risk
Paliperidone,Benzthiazide,Benzthiazide may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Paliperidone,Benzydamine,The risk or severity of hypertension can be increased when Paliperidone is combined with Benzydamine.,increase,risk
Paliperidone,Benzyl alcohol,The risk or severity of CNS depression can be increased when Paliperidone is combined with Benzyl alcohol.,increase,risk
Paliperidone,Bepotastine,Paliperidone may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Paliperidone,Bepridil,The risk or severity of QTc prolongation can be increased when Bepridil is combined with Paliperidone.,increase,risk
Paliperidone,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Betamethasone,The metabolism of Paliperidone can be increased when combined with Betamethasone.,increase,no risk
Paliperidone,Betamethasone phosphate,The metabolism of Paliperidone can be increased when combined with Betamethasone phosphate.,increase,no risk
Paliperidone,Betaxolol,Betaxolol may increase the orthostatic hypotensive activities of Paliperidone.,increase,no risk
Paliperidone,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Bicisate,Paliperidone may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Paliperidone,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Paliperidone.,increase,risk
Paliperidone,Bimekizumab,The metabolism of Paliperidone can be increased when combined with Bimekizumab.,increase,no risk
Paliperidone,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Bismuth subcitrate potassium,Paliperidone may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Paliperidone,Bismuth subgallate,Paliperidone may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Paliperidone,Bismuth subnitrate,Paliperidone may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Paliperidone,Bisoprolol,Bisoprolol may increase the orthostatic hypotensive activities of Paliperidone.,increase,no risk
Paliperidone,Bisoxatin,Paliperidone may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Paliperidone,Bleomycin,Bleomycin may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Boceprevir,The metabolism of Paliperidone can be decreased when combined with Boceprevir.,decrease,no risk
Paliperidone,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Bosentan,Paliperidone may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Paliperidone,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Paliperidone.,increase,risk
Paliperidone,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Paliperidone.,increase,risk
Paliperidone,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Paliperidone.,increase,risk
Paliperidone,Brexanolone,The risk or severity of CNS depression can be increased when Paliperidone is combined with Brexanolone.,increase,risk
Paliperidone,Brexpiprazole,"Paliperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Brexpiprazole.",increase,no risk
Paliperidone,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Paliperidone.,increase,no risk
Paliperidone,Brivaracetam,The risk or severity of CNS depression can be increased when Paliperidone is combined with Brivaracetam.,increase,risk
Paliperidone,Bromazepam,The risk or severity of CNS depression can be increased when Paliperidone is combined with Bromazepam.,increase,risk
Paliperidone,Bromocriptine,"Bromocriptine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Paliperidone.",increase,no risk
Paliperidone,Bromotheophylline,Bromotheophylline may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Paliperidone,Bromperidol,The risk or severity of CNS depression can be increased when Paliperidone is combined with Bromperidol.,increase,risk
Paliperidone,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Paliperidone.,increase,risk
Paliperidone,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Paliperidone.,increase,risk
Paliperidone,Budesonide,The metabolism of Paliperidone can be increased when combined with Budesonide.,increase,no risk
Paliperidone,Bumadizone,The risk or severity of hypertension can be increased when Paliperidone is combined with Bumadizone.,increase,risk
Paliperidone,Bumetanide,Bumetanide may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Paliperidone,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Paliperidone.,increase,risk
Paliperidone,Buprenorphine,Paliperidone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Paliperidone,Bupropion,The metabolism of Paliperidone can be decreased when combined with Bupropion.,decrease,no risk
Paliperidone,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Paliperidone.,increase,risk
Paliperidone,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Paliperidone.,increase,risk
Paliperidone,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Paliperidone.,increase,risk
Paliperidone,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Paliperidone.,increase,risk
Paliperidone,Butaperazine,The risk or severity of CNS depression can be increased when Paliperidone is combined with Butaperazine.,increase,risk
Paliperidone,Butobarbital,The risk or severity of CNS depression can be increased when Paliperidone is combined with Butobarbital.,increase,risk
Paliperidone,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Paliperidone.,increase,risk
Paliperidone,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Paliperidone.,increase,risk
Paliperidone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Paliperidone.,increase,risk
Paliperidone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Paliperidone is combined with Gabapentin enacarbil.,increase,risk
Paliperidone,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Paliperidone.,increase,risk
Paliperidone,Gadodiamide,Gadodiamide may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Gadofosveset trisodium,Paliperidone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Paliperidone,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Gadoteric acid,Paliperidone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Paliperidone,Gadoteridol,Gadoteridol may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Paliperidone.,increase,risk
Paliperidone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Paliperidone.,increase,risk
Paliperidone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Paliperidone is combined with Ganaxolone.",increase,risk
Paliperidone,Ganciclovir,Ganciclovir may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Paliperidone.,increase,risk
Paliperidone,Gefitinib,The metabolism of Paliperidone can be decreased when combined with Gefitinib.,decrease,no risk
Paliperidone,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Paliperidone.,increase,risk
Paliperidone,Gentamicin,Paliperidone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Paliperidone,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Paliperidone.,increase,risk
Paliperidone,Gilteritinib,The therapeutic efficacy of Paliperidone can be decreased when used in combination with Gilteritinib.,decrease,no risk
Paliperidone,Gimeracil,Paliperidone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Paliperidone,Givosiran,The serum concentration of Paliperidone can be increased when it is combined with Givosiran.,increase,no risk
Paliperidone,Glasdegib,The risk or severity of QTc prolongation can be increased when Paliperidone is combined with Glasdegib.,increase,risk
Paliperidone,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Glofitamab,The serum concentration of Paliperidone can be increased when it is combined with Glofitamab.,increase,no risk
Paliperidone,Glutethimide,The risk or severity of CNS depression can be increased when Paliperidone is combined with Glutethimide.,increase,risk
Paliperidone,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Glycerol phenylbutyrate,The metabolism of Paliperidone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Paliperidone,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Golimumab,The metabolism of Paliperidone can be increased when combined with Golimumab.,increase,no risk
Paliperidone,Golodirsen,Paliperidone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Paliperidone,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Paliperidone.,increase,risk
Paliperidone,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Paliperidone.,increase,risk
Paliperidone,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Paliperidone.,increase,risk
Paliperidone,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Guanadrel,Paliperidone may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Paliperidone,Guanethidine,Paliperidone may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Paliperidone,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Guanoxan,Paliperidone may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Paliperidone,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Paliperidone.,increase,risk
Paliperidone,Halofantrine,The metabolism of Paliperidone can be decreased when combined with Halofantrine.,decrease,no risk
Paliperidone,Haloperidol,The risk or severity of QTc prolongation can be increased when Paliperidone is combined with Haloperidol.,increase,risk
Paliperidone,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Paliperidone.,increase,risk
Paliperidone,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Paliperidone.,increase,risk
Paliperidone,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Paliperidone.,increase,risk
Paliperidone,Hydralazine,Paliperidone may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Paliperidone,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Paliperidone.,increase,risk
Paliperidone,Hydrocodone,Paliperidone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Paliperidone,Hydrocortisone,The metabolism of Paliperidone can be decreased when combined with Hydrocortisone.,decrease,no risk
Paliperidone,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Paliperidone.,decrease,no risk
Paliperidone,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Paliperidone.,decrease,no risk
Paliperidone,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Paliperidone.,decrease,no risk
Paliperidone,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Paliperidone.,decrease,no risk
Paliperidone,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Paliperidone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Paliperidone.,increase,risk
Paliperidone,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Paliperidone.,increase,risk
Paliperidone,Hydroxyethyl Starch,Paliperidone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Paliperidone,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Paliperidone.,decrease,no risk
Paliperidone,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Paliperidone is combined with Hydroxyzine.,increase,risk
Paliperidone,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Paliperidone.,increase,risk
Paliperidone,Kanamycin,Paliperidone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Paliperidone,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Paliperidone.,increase,risk
Paliperidone,Ketazolam,The risk or severity of CNS depression can be increased when Paliperidone is combined with Ketazolam.,increase,risk
Paliperidone,Ketoconazole,The metabolism of Paliperidone can be decreased when combined with Ketoconazole.,decrease,no risk
Paliperidone,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Paliperidone.,increase,risk
Paliperidone,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Paliperidone.,increase,risk
Paliperidone,Octinoxate,Paliperidone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Paliperidone,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Paliperidone.,increase,risk
Paliperidone,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Paliperidone.,increase,risk
Paliperidone,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Paliperidone.",increase,no risk
Paliperidone,Olaparib,The metabolism of Olaparib can be decreased when combined with Paliperidone.,decrease,no risk
Paliperidone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Paliperidone is combined with Oliceridine.",increase,risk
Paliperidone,Olmesartan,Paliperidone may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Paliperidone,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Olsalazine,Olsalazine may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Omaveloxolone,The serum concentration of Paliperidone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Paliperidone,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Paliperidone.,increase,risk
Paliperidone,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Opium,The risk or severity of CNS depression can be increased when Paliperidone is combined with Opium.,increase,risk
Paliperidone,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Paliperidone.,decrease,no risk
Paliperidone,Oritavancin,The metabolism of Paliperidone can be decreased when combined with Oritavancin.,decrease,no risk
Paliperidone,Orphenadrine,Paliperidone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Paliperidone,Oseltamivir,Oseltamivir may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Osilodrostat,The metabolism of Paliperidone can be decreased when combined with Osilodrostat.,decrease,no risk
Paliperidone,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Paliperidone.,increase,no risk
Paliperidone,Ospemifene,The metabolism of Paliperidone can be decreased when combined with Ospemifene.,decrease,no risk
Paliperidone,Oxacillin,Oxacillin may decrease the excretion rate of Paliperidone which could result in a higher serum level.,decrease,no risk
Paliperidone,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Paliperidone.,increase,risk
Sunitinib,Bedaquiline,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Bedaquiline.,increase,risk
Sunitinib,Belatacept,The risk or severity of adverse effects can be increased when Sunitinib is combined with Belatacept.,increase,risk
Sunitinib,Belimumab,The risk or severity of adverse effects can be increased when Sunitinib is combined with Belimumab.,increase,risk
Sunitinib,Belinostat,The risk or severity of adverse effects can be increased when Sunitinib is combined with Belinostat.,increase,risk
Sunitinib,Belumosudil,The risk or severity of adverse effects can be increased when Sunitinib is combined with Belumosudil.,increase,risk
Sunitinib,Belzutifan,The serum concentration of Sunitinib can be decreased when it is combined with Belzutifan.,decrease,no risk
Sunitinib,Benazepril,The risk or severity of hypoglycemia can be increased when Benazepril is combined with Sunitinib.,increase,risk
Sunitinib,Bendamustine,The risk or severity of adverse effects can be increased when Sunitinib is combined with Bendamustine.,increase,risk
Sunitinib,Bendroflumethiazide,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Sunitinib,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Sunitinib.,increase,risk
Sunitinib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Sunitinib is combined with Benzocaine.,increase,risk
Sunitinib,Benzthiazide,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Benzthiazide.,decrease,no risk
Sunitinib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Sunitinib is combined with Benzyl alcohol.,increase,risk
Sunitinib,Bepridil,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Bepridil.,increase,risk
Sunitinib,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Sunitinib.,increase,no risk
Sunitinib,Betamethasone,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Sunitinib.,increase,risk
Sunitinib,Betamethasone phosphate,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Sunitinib.,increase,risk
Sunitinib,Betaxolol,The therapeutic efficacy of Sunitinib can be increased when used in combination with Betaxolol.,increase,no risk
Sunitinib,Bevacizumab,The risk or severity of adverse effects can be increased when Sunitinib is combined with Bevacizumab.,increase,risk
Sunitinib,Bexagliflozin,Bexagliflozin may increase the hypoglycemic activities of Sunitinib.,increase,no risk
Sunitinib,Bexarotene,The metabolism of Sunitinib can be increased when combined with Bexarotene.,increase,no risk
Sunitinib,Bicalutamide,The metabolism of Sunitinib can be decreased when combined with Bicalutamide.,decrease,no risk
Sunitinib,Bifonazole,The metabolism of Sunitinib can be decreased when combined with Bifonazole.,decrease,no risk
Sunitinib,Bilastine,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Bilastine.,increase,risk
Sunitinib,Bimekizumab,The metabolism of Sunitinib can be increased when combined with Bimekizumab.,increase,no risk
Sunitinib,Binimetinib,Sunitinib may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Sunitinib,Bismuth subsalicylate,Bismuth subsalicylate may increase the hypoglycemic activities of Sunitinib.,increase,no risk
Sunitinib,Bisoprolol,The therapeutic efficacy of Sunitinib can be increased when used in combination with Bisoprolol.,increase,no risk
Sunitinib,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Sunitinib.,increase,risk
Sunitinib,Blinatumomab,The risk or severity of adverse effects can be increased when Sunitinib is combined with Blinatumomab.,increase,risk
Sunitinib,Boceprevir,The metabolism of Sunitinib can be decreased when combined with Boceprevir.,decrease,no risk
Sunitinib,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Sunitinib.",decrease,no risk
Sunitinib,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Sunitinib.,increase,risk
Sunitinib,Bosentan,The metabolism of Sunitinib can be increased when combined with Bosentan.,increase,no risk
Sunitinib,Bosutinib,The metabolism of Sunitinib can be decreased when combined with Bosutinib.,decrease,no risk
Sunitinib,Brentuximab vedotin,The serum concentration of Sunitinib can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Sunitinib,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Sunitinib.,increase,risk
Sunitinib,Brexpiprazole,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Sunitinib,Brigatinib,Sunitinib may decrease the excretion rate of Brigatinib which could result in a higher serum level.,decrease,no risk
Sunitinib,Brodalumab,The risk or severity of adverse effects can be increased when Sunitinib is combined with Brodalumab.,increase,risk
Sunitinib,Bromocriptine,The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Bromocriptine.,increase,risk
Sunitinib,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Sunitinib.,increase,risk
Sunitinib,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Sunitinib.,increase,risk
Sunitinib,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Sunitinib.,increase,risk
Sunitinib,Bumetanide,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Bumetanide.,decrease,no risk
Sunitinib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Sunitinib is combined with Bupivacaine.,increase,risk
Sunitinib,Buprenorphine,The metabolism of Sunitinib can be decreased when combined with Buprenorphine.,decrease,no risk
Sunitinib,Buserelin,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Buserelin.,decrease,no risk
Sunitinib,Buspirone,The metabolism of Sunitinib can be decreased when combined with Buspirone.,decrease,no risk
Sunitinib,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Sunitinib.,increase,risk
Sunitinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Sunitinib is combined with Butacaine.,increase,risk
Sunitinib,Butalbital,The metabolism of Sunitinib can be increased when combined with Butalbital.,increase,no risk
Sunitinib,Butamben,The risk or severity of methemoglobinemia can be increased when Sunitinib is combined with Butamben.,increase,risk
Sunitinib,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Sunitinib.,decrease,no risk
Sunitinib,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Gadobenic acid.,increase,risk
Sunitinib,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Sunitinib.,increase,risk
Sunitinib,Gatifloxacin,The therapeutic efficacy of Sunitinib can be increased when used in combination with Gatifloxacin.,increase,no risk
Sunitinib,Gefapixant,The therapeutic efficacy of Sunitinib can be increased when used in combination with Gefapixant.,increase,no risk
Sunitinib,Gefitinib,The metabolism of Sunitinib can be decreased when combined with Gefitinib.,decrease,no risk
Sunitinib,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Sunitinib.,increase,risk
Sunitinib,Gemifloxacin,The therapeutic efficacy of Sunitinib can be increased when used in combination with Gemifloxacin.,increase,no risk
Sunitinib,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Sunitinib.,increase,risk
Sunitinib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Sunitinib.,increase,no risk
Sunitinib,Gilteritinib,The metabolism of Sunitinib can be decreased when combined with Gilteritinib.,decrease,no risk
Sunitinib,Ginkgo biloba,The metabolism of Sunitinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Sunitinib,Glasdegib,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Glasdegib.,increase,risk
Sunitinib,Glatiramer,The risk or severity of adverse effects can be increased when Sunitinib is combined with Glatiramer.,increase,risk
Sunitinib,Glecaprevir,The metabolism of Sunitinib can be decreased when combined with Glecaprevir.,decrease,no risk
Sunitinib,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Sunitinib.,increase,risk
Sunitinib,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Sunitinib.,increase,risk
Sunitinib,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Sunitinib.,increase,risk
Sunitinib,Gliquidone,The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Gliquidone.,increase,risk
Sunitinib,Glofitamab,The serum concentration of Sunitinib can be increased when it is combined with Glofitamab.,increase,no risk
Sunitinib,Glyburide,The metabolism of Sunitinib can be decreased when combined with Glyburide.,decrease,no risk
Sunitinib,Glycerol phenylbutyrate,The metabolism of Sunitinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Sunitinib,Glymidine,The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Glymidine.,increase,risk
Sunitinib,Golimumab,The metabolism of Sunitinib can be increased when combined with Golimumab.,increase,no risk
Sunitinib,Goserelin,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Goserelin.,decrease,no risk
Sunitinib,Granisetron,The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Granisetron.,increase,risk
Sunitinib,Grapefruit,The serum concentration of Sunitinib can be increased when it is combined with Grapefruit.,increase,no risk
Sunitinib,Grepafloxacin,The therapeutic efficacy of Sunitinib can be increased when used in combination with Grepafloxacin.,increase,no risk
Sunitinib,Griseofulvin,The metabolism of Sunitinib can be increased when combined with Griseofulvin.,increase,no risk
Sunitinib,Guselkumab,The risk or severity of adverse effects can be increased when Sunitinib is combined with Guselkumab.,increase,risk
Sunitinib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Sunitinib.,increase,risk
Sunitinib,Halofantrine,The metabolism of Sunitinib can be decreased when combined with Halofantrine.,decrease,no risk
Sunitinib,Haloperidol,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Haloperidol.,increase,risk
Sunitinib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Histrelin,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Histrelin.,decrease,no risk
Sunitinib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Sunitinib.,increase,risk
Sunitinib,Hydralazine,The serum concentration of Sunitinib can be increased when it is combined with Hydralazine.,increase,no risk
Sunitinib,Hydrochlorothiazide,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Sunitinib,Hydrocortamate,The metabolism of Sunitinib can be increased when combined with Hydrocortamate.,increase,no risk
Sunitinib,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Sunitinib.,increase,risk
Sunitinib,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Sunitinib.,increase,risk
Sunitinib,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Sunitinib.,increase,risk
Sunitinib,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Sunitinib.,increase,risk
Sunitinib,Hydrocortisone phosphate,The metabolism of Sunitinib can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Sunitinib,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Sunitinib.,increase,risk
Sunitinib,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Sunitinib.,increase,risk
Sunitinib,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Sunitinib.,increase,risk
Sunitinib,Hydroflumethiazide,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Sunitinib,Hydroxychloroquine,The therapeutic efficacy of Sunitinib can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Sunitinib,Hydroxyprogesterone caproate,The metabolism of Sunitinib can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Sunitinib,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Sunitinib.,increase,risk
Sunitinib,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Hydroxyzine.,increase,risk
Sunitinib,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Sunitinib.,increase,risk
Sunitinib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Ketazolam,The serum concentration of Sunitinib can be increased when it is combined with Ketazolam.,increase,no risk
Sunitinib,Ketoconazole,The metabolism of Sunitinib can be decreased when combined with Ketoconazole.,decrease,no risk
Sunitinib,Obinutuzumab,The risk or severity of adverse effects can be increased when Sunitinib is combined with Obinutuzumab.,increase,risk
Sunitinib,Ocrelizumab,The risk or severity of adverse effects can be increased when Sunitinib is combined with Ocrelizumab.,increase,risk
Sunitinib,Octreotide,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Octreotide.,decrease,no risk
Sunitinib,Ofatumumab,The risk or severity of adverse effects can be increased when Sunitinib is combined with Ofatumumab.,increase,risk
Sunitinib,Ofloxacin,The therapeutic efficacy of Sunitinib can be increased when used in combination with Ofloxacin.,increase,no risk
Sunitinib,Olanzapine,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Olanzapine.,decrease,no risk
Sunitinib,Olaparib,The metabolism of Sunitinib can be decreased when combined with Olaparib.,decrease,no risk
Sunitinib,Olodaterol,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Olodaterol.,increase,risk
Sunitinib,Olsalazine,Olsalazine may increase the hypoglycemic activities of Sunitinib.,increase,no risk
Sunitinib,Olutasidenib,The metabolism of Sunitinib can be increased when combined with Olutasidenib.,increase,no risk
Sunitinib,Omaveloxolone,The serum concentration of Sunitinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Sunitinib,Ombitasvir,Sunitinib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Sunitinib,Ondansetron,The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Ondansetron.,increase,risk
Sunitinib,Oritavancin,The metabolism of Sunitinib can be increased when combined with Oritavancin.,increase,no risk
Sunitinib,Orphenadrine,The metabolism of Sunitinib can be decreased when combined with Orphenadrine.,decrease,no risk
Sunitinib,Osilodrostat,The metabolism of Sunitinib can be decreased when combined with Osilodrostat.,decrease,no risk
Sunitinib,Osimertinib,The metabolism of Sunitinib can be decreased when combined with Osimertinib.,decrease,no risk
Sunitinib,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Sunitinib.,increase,risk
Sunitinib,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Sunitinib.,increase,no risk
Sunitinib,Oxatomide,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Oxatomide.,increase,risk
Sunitinib,Oxcarbazepine,The metabolism of Sunitinib can be increased when combined with Oxcarbazepine.,increase,no risk
Sunitinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Sunitinib is combined with Oxetacaine.,increase,risk
Sunitinib,Oxprenolol,The therapeutic efficacy of Sunitinib can be increased when used in combination with Oxprenolol.,increase,no risk
Sunitinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Sunitinib is combined with Oxybuprocaine.,increase,risk
Sunitinib,Oxybutynin,The serum concentration of Sunitinib can be increased when it is combined with Oxybutynin.,increase,no risk
Sunitinib,Oxycodone,The metabolism of Sunitinib can be decreased when combined with Oxycodone.,decrease,no risk
Sunitinib,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Sunitinib.,increase,no risk
Sunitinib,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Sunitinib.,increase,risk
Sunitinib,Ozanimod,Sunitinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Sunitinib,Quetiapine,The metabolism of Sunitinib can be decreased when combined with Quetiapine.,decrease,no risk
Sunitinib,Quinethazone,The therapeutic efficacy of Sunitinib can be decreased when used in combination with Quinethazone.,decrease,no risk
Sunitinib,Quinidine,The metabolism of Sunitinib can be decreased when combined with Quinidine.,decrease,no risk
Sunitinib,Quinine,The metabolism of Sunitinib can be increased when combined with Quinine.,increase,no risk
Sunitinib,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Sunitinib.,decrease,no risk
Sunitinib,Quinupristin,The metabolism of Sunitinib can be decreased when combined with Quinupristin.,decrease,no risk
Sunitinib,Quizartinib,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Quizartinib.,increase,risk
Sunitinib,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Sunitinib.,increase,risk
Sunitinib,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Sunitinib.,increase,risk
Sunitinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Sunitinib.,increase,no risk
Sunitinib,Udenafil,The metabolism of Sunitinib can be decreased when combined with Udenafil.,decrease,no risk
Sunitinib,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Sunitinib.,increase,risk
Sunitinib,Upadacitinib,The risk or severity of adverse effects can be increased when Sunitinib is combined with Upadacitinib.,increase,risk
Sunitinib,Vadadustat,The serum concentration of Sunitinib can be increased when it is combined with Vadadustat.,increase,no risk
Sunitinib,Valbenazine,The metabolism of Sunitinib can be decreased when combined with Valbenazine.,decrease,no risk
Sunitinib,Valdecoxib,The therapeutic efficacy of Sunitinib can be increased when used in combination with Valdecoxib.,increase,no risk
Sunitinib,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Valproic acid,The serum concentration of Sunitinib can be increased when it is combined with Valproic acid.,increase,no risk
Sunitinib,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Sunitinib.,increase,risk
Sunitinib,Vandetanib,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Vandetanib.,increase,risk
Sunitinib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Sunitinib.,decrease,no risk
Sunitinib,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Sunitinib.,increase,risk
Sunitinib,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Vedolizumab,The risk or severity of adverse effects can be increased when Sunitinib is combined with Vedolizumab.,increase,risk
Sunitinib,Velpatasvir,Sunitinib may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Sunitinib,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Sunitinib.,increase,risk
Sunitinib,Venetoclax,The metabolism of Sunitinib can be decreased when combined with Venetoclax.,decrease,no risk
Sunitinib,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Sunitinib.,increase,risk
Sunitinib,Verapamil,The metabolism of Sunitinib can be decreased when combined with Verapamil.,decrease,no risk
Sunitinib,Vernakalant,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Vernakalant.,increase,risk
Sunitinib,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Sunitinib.,decrease,no risk
Sunitinib,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Sunitinib.,increase,risk
Sunitinib,Vildagliptin,The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Vildagliptin.,increase,risk
Sunitinib,Viloxazine,The metabolism of Sunitinib can be decreased when combined with Viloxazine.,decrease,no risk
Sunitinib,Vinblastine,The metabolism of Sunitinib can be increased when combined with Vinblastine.,increase,no risk
Sunitinib,Vincristine,The metabolism of Sunitinib can be decreased when combined with Vincristine.,decrease,no risk
Sunitinib,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Sunitinib.,increase,risk
Sunitinib,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Sunitinib.,increase,risk
Sunitinib,Vitamin E,The metabolism of Sunitinib can be increased when combined with Vitamin E.,increase,no risk
Sunitinib,Voclosporin,The risk or severity of adverse effects can be increased when Sunitinib is combined with Voclosporin.,increase,risk
Sunitinib,Vonoprazan,The metabolism of Sunitinib can be decreased when combined with Vonoprazan.,decrease,no risk
Sunitinib,Vorapaxar,The metabolism of Sunitinib can be decreased when combined with Vorapaxar.,decrease,no risk
Sunitinib,Voriconazole,The serum concentration of Sunitinib can be increased when it is combined with Voriconazole.,increase,no risk
Sunitinib,Vorinostat,The risk or severity of adverse effects can be increased when Sunitinib is combined with Vorinostat.,increase,risk
Sunitinib,Vortioxetine,The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Vortioxetine.,increase,risk
Sunitinib,Voxelotor,The serum concentration of Sunitinib can be increased when it is combined with Voxelotor.,increase,no risk
Sunitinib,Voxilaprevir,Sunitinib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Sunitinib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Sunitinib.,increase,no risk
Sunitinib,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Sunitinib.,increase,risk
Sunitinib,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Sunitinib.,increase,risk
Sunitinib,Zafirlukast,The serum concentration of Sunitinib can be increased when it is combined with Zafirlukast.,increase,no risk
Sunitinib,Zaleplon,The metabolism of Sunitinib can be decreased when combined with Zaleplon.,decrease,no risk
Sunitinib,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Sunitinib.,increase,risk
Sunitinib,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Sunitinib.,increase,risk
Sunitinib,Zimelidine,The metabolism of Sunitinib can be decreased when combined with Zimelidine.,decrease,no risk
Sunitinib,Ziprasidone,The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Ziprasidone.,increase,risk
Sunitinib,Zoledronic acid,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Sunitinib is combined with Zoledronic acid.,increase,risk
Sunitinib,Zonisamide,The metabolism of Sunitinib can be decreased when combined with Zonisamide.,decrease,no risk
Sunitinib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Sunitinib.,decrease,no risk
Panitumumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Panitumumab is combined with Human varicella-zoster immune globulin.,increase,risk
Panitumumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Obiltoxaximab.,increase,risk
Panitumumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Obinutuzumab.,increase,risk
Panitumumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Ocrelizumab.,increase,risk
Panitumumab,Odesivimab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Odesivimab.,increase,risk
Panitumumab,Ofatumumab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Ofatumumab.,increase,risk
Panitumumab,Olaratumab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Olaratumab.,increase,risk
Panitumumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Panitumumab.,increase,risk
Panitumumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Panitumumab is combined with Oxetacaine.,increase,risk
Panitumumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Panitumumab is combined with Oxybuprocaine.,increase,risk
Panitumumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Panitumumab.,increase,no risk
Panitumumab,Ublituximab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Ublituximab.,increase,risk
Panitumumab,Ustekinumab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Ustekinumab.,increase,risk
Panitumumab,Vedolizumab,The risk or severity of adverse effects can be increased when Panitumumab is combined with Vedolizumab.,increase,risk
Ranibizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Obiltoxaximab.,increase,risk
Ranibizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Obinutuzumab.,increase,risk
Ranibizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Ocrelizumab.,increase,risk
Ranibizumab,Odesivimab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Odesivimab.,increase,risk
Ranibizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Ofatumumab.,increase,risk
Ranibizumab,Olaratumab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Olaratumab.,increase,risk
Ranibizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ranibizumab.,increase,risk
Ranibizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Ranibizumab.,increase,no risk
Ranibizumab,Ublituximab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Ublituximab.,increase,risk
Ranibizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Ustekinumab.,increase,risk
Ranibizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Ranibizumab is combined with Vedolizumab.,increase,risk
Ranibizumab,Zoledronic acid,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Ranibizumab is combined with Zoledronic acid.,increase,risk
Varenicline,Gabapentin enacarbil,Varenicline may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Varenicline,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Gadodiamide,Gadodiamide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Gadofosveset trisodium,Varenicline may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Varenicline,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Gadoteric acid,Varenicline may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Varenicline,Gadoteridol,Gadoteridol may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Galantamine,The risk or severity of adverse effects can be increased when Galantamine is combined with Varenicline.,increase,risk
Varenicline,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Varenicline.,increase,risk
Varenicline,Ganciclovir,Ganciclovir may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Gemcitabine,Gemcitabine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Varenicline.,increase,no risk
Varenicline,Gimeracil,Varenicline may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Varenicline,Ginkgo biloba,The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Varenicline.,increase,risk
Varenicline,Givosiran,Givosiran may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Glipizide,Glipizide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Glycerol phenylbutyrate,Varenicline may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Varenicline,Golodirsen,Varenicline may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Varenicline,Goserelin,Goserelin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Grepafloxacin,The excretion of Varenicline can be decreased when combined with Grepafloxacin.,decrease,no risk
Varenicline,Guanethidine,Guanethidine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Guanfacine,Guanfacine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Guanidine,The excretion of Varenicline can be decreased when combined with Guanidine.,decrease,no risk
Varenicline,Haloperidol,Haloperidol may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Varenicline.,increase,risk
Varenicline,Histamine,The excretion of Varenicline can be decreased when combined with Histamine.,decrease,no risk
Varenicline,Huperzine A,The risk or severity of adverse effects can be increased when Huperzine A is combined with Varenicline.,increase,risk
Varenicline,Hydralazine,Varenicline may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Varenicline,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Varenicline,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Varenicline,Hydromorphone,Hydromorphone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Hydroxyethyl Starch,Varenicline may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Varenicline,Kanamycin,Varenicline may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Varenicline,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Varenicline.,increase,risk
Varenicline,Ketazolam,Varenicline may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Varenicline,Ketoprofen,Ketoprofen may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Ketorolac,Ketorolac may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Octinoxate,Varenicline may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Varenicline,Olsalazine,Olsalazine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Opium,Varenicline may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Varenicline,Oseltamivir,Oseltamivir may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Oxacillin,Oxacillin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Varenicline.,increase,no risk
Varenicline,Oxaprozin,Oxaprozin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Oxazepam,Oxazepam may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Oxprenolol,The excretion of Varenicline can be decreased when combined with Oxprenolol.,decrease,no risk
Varenicline,Oxybenzone,Varenicline may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Varenicline,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Oxyquinoline,Varenicline may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Varenicline,Quetiapine,Quetiapine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Quinethazone,Quinethazone may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Varenicline,Quinidine,The excretion of Varenicline can be decreased when combined with Quinidine.,decrease,no risk
Varenicline,Quinine,The excretion of Varenicline can be decreased when combined with Quinine.,decrease,no risk
Varenicline,Vaborbactam,Varenicline may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Varenicline,Valaciclovir,Valaciclovir may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Valbenazine,Varenicline may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Varenicline,Valdecoxib,Valdecoxib may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Valganciclovir,Varenicline may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Varenicline,Vancomycin,Varenicline may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Varenicline,Vandetanib,The excretion of Varenicline can be decreased when combined with Vandetanib.,decrease,no risk
Varenicline,Venlafaxine,Venlafaxine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Verapamil,Verapamil may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Vilanterol,Varenicline may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Varenicline,Viloxazine,Varenicline may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Varenicline,Vortioxetine,Varenicline may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Varenicline,Warfarin,Varenicline may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Varenicline,Zaleplon,Zaleplon may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Zanamivir,Zanamivir may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Varenicline,Zonisamide,Zonisamide may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Arformoterol,Bacitracin,Bacitracin may decrease the excretion rate of Arformoterol which could result in a higher serum level.,decrease,no risk
Arformoterol,Baclofen,Baclofen may decrease the excretion rate of Arformoterol which could result in a higher serum level.,decrease,no risk
Arformoterol,Balsalazide,The risk or severity of hypertension can be increased when Balsalazide is combined with Arformoterol.,increase,risk
Arformoterol,Baricitinib,Arformoterol may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Arformoterol,Beclomethasone dipropionate,The risk or severity of hypokalemia can be increased when Beclomethasone dipropionate is combined with Arformoterol.,increase,risk
Arformoterol,Bedaquiline,The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Bedaquiline.,increase,risk
Arformoterol,Benazepril,Arformoterol may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Arformoterol,Bendroflumethiazide,The risk or severity of hypokalemia can be increased when Arformoterol is combined with Bendroflumethiazide.,increase,risk
Arformoterol,Benorilate,The risk or severity of hypertension can be increased when Arformoterol is combined with Benorilate.,increase,risk
Arformoterol,Benoxaprofen,The risk or severity of hypertension can be increased when Arformoterol is combined with Benoxaprofen.,increase,risk
Arformoterol,Benserazide,Arformoterol may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Arformoterol,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Arformoterol.,increase,risk
Arformoterol,Benznidazole,Arformoterol may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Arformoterol,Benzocaine,The metabolism of Arformoterol can be decreased when combined with Benzocaine.,decrease,no risk
Arformoterol,Benzphetamine,The risk or severity of hypertension can be increased when Benzphetamine is combined with Arformoterol.,increase,risk
Arformoterol,Benzthiazide,The risk or severity of hypokalemia can be increased when Arformoterol is combined with Benzthiazide.,increase,risk
Arformoterol,Benzydamine,The risk or severity of hypertension can be increased when Arformoterol is combined with Benzydamine.,increase,risk
Arformoterol,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Arformoterol.,decrease,no risk
Arformoterol,Benzylpenicilloyl polylysine,Arformoterol may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Arformoterol,Bepotastine,Arformoterol may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Arformoterol,Bepridil,The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Bepridil.,increase,risk
Arformoterol,Berotralstat,The metabolism of Arformoterol can be decreased when combined with Berotralstat.,decrease,no risk
Arformoterol,Betahistine,The therapeutic efficacy of Arformoterol can be decreased when used in combination with Betahistine.,decrease,no risk
Arformoterol,Betamethasone,The risk or severity of hypokalemia can be increased when Betamethasone is combined with Arformoterol.,increase,risk
Arformoterol,Betamethasone phosphate,The risk or severity of hypokalemia can be increased when Betamethasone phosphate is combined with Arformoterol.,increase,risk
Arformoterol,Betaxolol,The therapeutic efficacy of Arformoterol can be decreased when used in combination with Betaxolol.,decrease,no risk
Arformoterol,Bethanidine,Arformoterol may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Arformoterol,Bexarotene,The metabolism of Arformoterol can be decreased when combined with Bexarotene.,decrease,no risk
Arformoterol,Bicisate,Arformoterol may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Arformoterol,Bilastine,The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Bilastine.,increase,risk
Arformoterol,Bimekizumab,The metabolism of Arformoterol can be increased when combined with Bimekizumab.,increase,no risk
Arformoterol,Biperiden,The metabolism of Arformoterol can be decreased when combined with Biperiden.,decrease,no risk
Arformoterol,Bismuth subgallate,Arformoterol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Arformoterol,Bisoprolol,The therapeutic efficacy of Arformoterol can be decreased when used in combination with Bisoprolol.,decrease,no risk
Arformoterol,Bisoxatin,Arformoterol may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Arformoterol,Bleomycin,Bleomycin may decrease the excretion rate of Arformoterol which could result in a higher serum level.,decrease,no risk
Arformoterol,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Arformoterol.,increase,risk
Arformoterol,Bosentan,The metabolism of Arformoterol can be increased when combined with Bosentan.,increase,no risk
Arformoterol,Bretylium,Arformoterol may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Arformoterol,Brexpiprazole,The therapeutic efficacy of Arformoterol can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Arformoterol,Brivaracetam,Arformoterol may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Arformoterol,Bromazepam,Arformoterol may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Arformoterol,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Arformoterol.,increase,no risk
Arformoterol,Bromotheophylline,Bromotheophylline may increase the excretion rate of Arformoterol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Arformoterol,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Arformoterol.,increase,risk
Arformoterol,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Arformoterol.,increase,risk
Arformoterol,Bumadizone,The risk or severity of hypertension can be increased when Arformoterol is combined with Bumadizone.,increase,risk
Arformoterol,Bumetanide,The risk or severity of hypokalemia can be increased when Arformoterol is combined with Bumetanide.,increase,risk
Arformoterol,Bupivacaine,The metabolism of Arformoterol can be decreased when combined with Bupivacaine.,decrease,no risk
Arformoterol,Buprenorphine,The metabolism of Arformoterol can be decreased when combined with Buprenorphine.,decrease,no risk
Arformoterol,Bupropion,The metabolism of Arformoterol can be decreased when combined with Bupropion.,decrease,no risk
Arformoterol,Buserelin,The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Buserelin.,increase,risk
Arformoterol,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Arformoterol.,increase,risk
Arformoterol,Butabarbital,Butabarbital may decrease the excretion rate of Arformoterol which could result in a higher serum level.,decrease,no risk
Arformoterol,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Arformoterol.,increase,risk
Arformoterol,Butylscopolamine,The risk or severity of Tachycardia can be increased when Arformoterol is combined with Butylscopolamine.,increase,risk
Hydralazine,Bisoprolol,Bisoprolol may increase the hypotensive activities of Hydralazine.,increase,no risk
Hydralazine,Bisoxatin,Hydralazine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Hydralazine,Bleomycin,Bleomycin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Hydralazine,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Hydralazine.,increase,no risk
Hydralazine,Bosentan,Bosentan may increase the hypotensive activities of Hydralazine.,increase,no risk
Hydralazine,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Hydralazine.,increase,no risk
Hydralazine,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Hydralazine.,increase,no risk
Hydralazine,Bretylium,Bretylium may increase the hypotensive activities of Hydralazine.,increase,no risk
Hydralazine,Brexpiprazole,Brexpiprazole may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Hydralazine,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Hydralazine.,increase,no risk
Hydralazine,Brimonidine,Brimonidine may increase the antihypertensive activities of Hydralazine.,increase,no risk
Hydralazine,Brivaracetam,Hydralazine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Hydralazine,Bromazepam,Hydralazine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Hydralazine,Bromocriptine,Bromocriptine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Hydralazine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydralazine,Budesonide,Budesonide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Hydralazine,Bumadizone,Bumadizone may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Hydralazine,Bumetanide,Bumetanide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydralazine,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Hydralazine.,increase,risk
Hydralazine,Bupropion,Bupropion may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Hydralazine,Buspirone,Buspirone may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Hydralazine,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Hydralazine.,increase,no risk
Hydralazine,Butabarbital,Butabarbital may increase the hypotensive activities of Hydralazine.,increase,no risk
Hydralazine,Butalbital,Butalbital may increase the hypotensive activities of Hydralazine.,increase,no risk
Hydralazine,Butriptyline,Butriptyline may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Hydralazine,Gabapentin enacarbil,Hydralazine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Hydralazine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Hydralazine,Gadodiamide,Gadodiamide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Hydralazine,Gadofosveset trisodium,Hydralazine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Hydralazine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Exenatide,Gatifloxacin,The therapeutic efficacy of Exenatide can be increased when used in combination with Gatifloxacin.,increase,no risk
Exenatide,Gefapixant,The therapeutic efficacy of Exenatide can be increased when used in combination with Gefapixant.,increase,no risk
Exenatide,Gemifloxacin,The therapeutic efficacy of Exenatide can be increased when used in combination with Gemifloxacin.,increase,no risk
Exenatide,Gestrinone,Exenatide can cause a decrease in the absorption of Gestrinone resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Exenatide,Gliclazide,Exenatide may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Exenatide,Glimepiride,Exenatide may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Exenatide,Glipizide,Exenatide may increase the hypoglycemic activities of Glipizide.,increase,no risk
Exenatide,Gliquidone,Exenatide may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Exenatide,Glyburide,Exenatide may increase the hypoglycemic activities of Glyburide.,increase,no risk
Exenatide,Glymidine,The risk or severity of hypoglycemia can be increased when Exenatide is combined with Glymidine.,increase,risk
Exenatide,Goserelin,The therapeutic efficacy of Exenatide can be decreased when used in combination with Goserelin.,decrease,no risk
Exenatide,Grepafloxacin,The therapeutic efficacy of Exenatide can be increased when used in combination with Grepafloxacin.,increase,no risk
Exenatide,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Exenatide.,increase,risk
Exenatide,Haloperidol,The therapeutic efficacy of Exenatide can be decreased when used in combination with Haloperidol.,decrease,no risk
Exenatide,Histrelin,The therapeutic efficacy of Exenatide can be decreased when used in combination with Histrelin.,decrease,no risk
Exenatide,Hydrochlorothiazide,The therapeutic efficacy of Exenatide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Exenatide,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Exenatide.,increase,risk
Exenatide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Exenatide.,increase,risk
Exenatide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Exenatide.,increase,risk
Exenatide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Exenatide.,increase,risk
Exenatide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Exenatide.,increase,risk
Exenatide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Exenatide.,increase,risk
Exenatide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Exenatide.,increase,risk
Exenatide,Hydroflumethiazide,The therapeutic efficacy of Exenatide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Exenatide,Hydroxychloroquine,The therapeutic efficacy of Exenatide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Exenatide,Hydroxyprogesterone caproate,Exenatide can cause a decrease in the absorption of Hydroxyprogesterone caproate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Exenatide,Octreotide,The therapeutic efficacy of Exenatide can be decreased when used in combination with Octreotide.,decrease,no risk
Exenatide,Ofloxacin,The therapeutic efficacy of Exenatide can be increased when used in combination with Ofloxacin.,increase,no risk
Exenatide,Olanzapine,The therapeutic efficacy of Exenatide can be decreased when used in combination with Olanzapine.,decrease,no risk
Exenatide,Olsalazine,Olsalazine may increase the hypoglycemic activities of Exenatide.,increase,no risk
Exenatide,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Exenatide.,increase,no risk
Exenatide,Oxprenolol,The therapeutic efficacy of Exenatide can be increased when used in combination with Oxprenolol.,increase,no risk
Exenatide,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Exenatide.,increase,no risk
Exenatide,Quetiapine,The therapeutic efficacy of Exenatide can be decreased when used in combination with Quetiapine.,decrease,no risk
Exenatide,Quinethazone,The therapeutic efficacy of Exenatide can be decreased when used in combination with Quinethazone.,decrease,no risk
Exenatide,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Exenatide.,increase,risk
Exenatide,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Exenatide.,decrease,no risk
Exenatide,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Exenatide.,increase,risk
Exenatide,Udenafil,The therapeutic efficacy of Exenatide can be increased when used in combination with Udenafil.,increase,no risk
Exenatide,Ulipristal,Exenatide can cause a decrease in the absorption of Ulipristal resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Exenatide,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Exenatide.,increase,risk
Exenatide,Valdecoxib,The therapeutic efficacy of Exenatide can be increased when used in combination with Valdecoxib.,increase,no risk
Exenatide,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Exenatide.,increase,risk
Exenatide,Vemurafenib,The therapeutic efficacy of Exenatide can be increased when used in combination with Vemurafenib.,increase,no risk
Exenatide,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Exenatide.,increase,risk
Exenatide,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Exenatide.,increase,risk
Exenatide,Vildagliptin,The risk or severity of hypoglycemia can be increased when Exenatide is combined with Vildagliptin.,increase,risk
Exenatide,Vorinostat,The therapeutic efficacy of Exenatide can be decreased when used in combination with Vorinostat.,decrease,no risk
Exenatide,Warfarin,Exenatide can cause an increase in the absorption of Warfarin resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Exenatide,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Exenatide.,increase,risk
Exenatide,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Exenatide.,increase,risk
Exenatide,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Exenatide.,increase,risk
Exenatide,Ziprasidone,The therapeutic efficacy of Exenatide can be decreased when used in combination with Ziprasidone.,decrease,no risk
Exenatide,Zonisamide,The therapeutic efficacy of Exenatide can be increased when used in combination with Zonisamide.,increase,no risk
Mecasermin,Gatifloxacin,The therapeutic efficacy of Mecasermin can be increased when used in combination with Gatifloxacin.,increase,no risk
Mecasermin,Gefapixant,The therapeutic efficacy of Mecasermin can be increased when used in combination with Gefapixant.,increase,no risk
Mecasermin,Gemifloxacin,The therapeutic efficacy of Mecasermin can be increased when used in combination with Gemifloxacin.,increase,no risk
Mecasermin,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Mecasermin.,increase,risk
Mecasermin,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Mecasermin.,increase,risk
Mecasermin,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Mecasermin.,increase,risk
Mecasermin,Gliquidone,The risk or severity of hypoglycemia can be increased when Mecasermin is combined with Gliquidone.,increase,risk
Mecasermin,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Mecasermin.,increase,risk
Mecasermin,Glymidine,The risk or severity of hypoglycemia can be increased when Mecasermin is combined with Glymidine.,increase,risk
Mecasermin,Goserelin,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Goserelin.,decrease,no risk
Mecasermin,Grepafloxacin,The therapeutic efficacy of Mecasermin can be increased when used in combination with Grepafloxacin.,increase,no risk
Mecasermin,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Mecasermin.,increase,risk
Mecasermin,Haloperidol,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Haloperidol.,decrease,no risk
Mecasermin,Histrelin,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Histrelin.,decrease,no risk
Mecasermin,Hydrochlorothiazide,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Mecasermin,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Mecasermin.,increase,risk
Mecasermin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Mecasermin.,increase,risk
Mecasermin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Mecasermin.,increase,risk
Mecasermin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Mecasermin.,increase,risk
Mecasermin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Mecasermin.,increase,risk
Mecasermin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Mecasermin.,increase,risk
Mecasermin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Mecasermin.,increase,risk
Mecasermin,Hydroflumethiazide,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Mecasermin,Hydroxychloroquine,The therapeutic efficacy of Mecasermin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Mecasermin,Hydroxyprogesterone caproate,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Mecasermin,Octreotide,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Octreotide.,decrease,no risk
Mecasermin,Ofloxacin,The therapeutic efficacy of Mecasermin can be increased when used in combination with Ofloxacin.,increase,no risk
Mecasermin,Olanzapine,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Olanzapine.,decrease,no risk
Mecasermin,Olsalazine,Olsalazine may increase the hypoglycemic activities of Mecasermin.,increase,no risk
Mecasermin,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Mecasermin.,increase,no risk
Mecasermin,Oxprenolol,The therapeutic efficacy of Mecasermin can be increased when used in combination with Oxprenolol.,increase,no risk
Mecasermin,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Mecasermin.,increase,no risk
Mecasermin,Quetiapine,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Quetiapine.,decrease,no risk
Mecasermin,Quinethazone,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Quinethazone.,decrease,no risk
Mecasermin,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Mecasermin.,increase,risk
Mecasermin,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Mecasermin.,decrease,no risk
Mecasermin,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Mecasermin.,increase,risk
Mecasermin,Udenafil,The therapeutic efficacy of Mecasermin can be increased when used in combination with Udenafil.,increase,no risk
Mecasermin,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Mecasermin.,increase,risk
Mecasermin,Valdecoxib,The therapeutic efficacy of Mecasermin can be increased when used in combination with Valdecoxib.,increase,no risk
Mecasermin,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Mecasermin.,increase,risk
Mecasermin,Vemurafenib,The therapeutic efficacy of Mecasermin can be increased when used in combination with Vemurafenib.,increase,no risk
Mecasermin,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Mecasermin.,increase,risk
Mecasermin,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Mecasermin.,increase,risk
Mecasermin,Vildagliptin,The risk or severity of hypoglycemia can be increased when Mecasermin is combined with Vildagliptin.,increase,risk
Mecasermin,Vorinostat,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Vorinostat.,decrease,no risk
Mecasermin,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Mecasermin.,increase,risk
Mecasermin,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Mecasermin.,increase,risk
Mecasermin,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Mecasermin.,increase,risk
Mecasermin,Ziprasidone,The therapeutic efficacy of Mecasermin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Mecasermin,Zonisamide,The therapeutic efficacy of Mecasermin can be increased when used in combination with Zonisamide.,increase,no risk
Pramlintide,Gallamine triethiodide,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Gallamine triethiodide.,increase,risk
Pramlintide,Gatifloxacin,The therapeutic efficacy of Pramlintide can be increased when used in combination with Gatifloxacin.,increase,no risk
Pramlintide,Gefapixant,The therapeutic efficacy of Pramlintide can be increased when used in combination with Gefapixant.,increase,no risk
Pramlintide,Gemifloxacin,The therapeutic efficacy of Pramlintide can be increased when used in combination with Gemifloxacin.,increase,no risk
Pramlintide,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Pramlintide.,increase,risk
Pramlintide,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Pramlintide.,increase,risk
Pramlintide,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Pramlintide.,increase,risk
Pramlintide,Gliquidone,The risk or severity of hypoglycemia can be increased when Pramlintide is combined with Gliquidone.,increase,risk
Pramlintide,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Pramlintide.,increase,risk
Pramlintide,Glycopyrronium,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Glycopyrronium.,increase,risk
Pramlintide,Glymidine,The risk or severity of hypoglycemia can be increased when Pramlintide is combined with Glymidine.,increase,risk
Pramlintide,Goserelin,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Goserelin.,decrease,no risk
Pramlintide,Grepafloxacin,The therapeutic efficacy of Pramlintide can be increased when used in combination with Grepafloxacin.,increase,no risk
Pramlintide,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Pramlintide.,increase,risk
Pramlintide,Haloperidol,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Haloperidol.,decrease,no risk
Pramlintide,Hexocyclium,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Hexocyclium.,increase,risk
Pramlintide,Histrelin,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Histrelin.,decrease,no risk
Pramlintide,Homatropine methylbromide,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Homatropine methylbromide.,increase,risk
Pramlintide,Hydrochlorothiazide,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Pramlintide,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Pramlintide.,increase,risk
Pramlintide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Pramlintide.,increase,risk
Pramlintide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Pramlintide.,increase,risk
Pramlintide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Pramlintide.,increase,risk
Pramlintide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Pramlintide.,increase,risk
Pramlintide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Pramlintide.,increase,risk
Pramlintide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Pramlintide.,increase,risk
Pramlintide,Hydroflumethiazide,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Pramlintide,Hydroxychloroquine,The therapeutic efficacy of Pramlintide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Pramlintide,Hydroxyprogesterone caproate,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Pramlintide,Hyoscyamine,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Hyoscyamine.,increase,risk
Pramlintide,Octreotide,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Octreotide.,decrease,no risk
Pramlintide,Ofloxacin,The therapeutic efficacy of Pramlintide can be increased when used in combination with Ofloxacin.,increase,no risk
Pramlintide,Olanzapine,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Olanzapine.,increase,risk
Pramlintide,Olsalazine,Olsalazine may increase the hypoglycemic activities of Pramlintide.,increase,no risk
Pramlintide,Orphenadrine,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Orphenadrine.,increase,risk
Pramlintide,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Pramlintide.,increase,no risk
Pramlintide,Oxprenolol,The therapeutic efficacy of Pramlintide can be increased when used in combination with Oxprenolol.,increase,no risk
Pramlintide,Oxybutynin,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Oxybutynin.,increase,risk
Pramlintide,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Pramlintide.,increase,no risk
Pramlintide,Oxyphencyclimine,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Oxyphencyclimine.,increase,risk
Pramlintide,Oxyphenonium,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Oxyphenonium.,increase,risk
Pramlintide,Quetiapine,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Quetiapine.,increase,risk
Pramlintide,Quinethazone,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Quinethazone.,decrease,no risk
Pramlintide,Quinidine,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Quinidine.,increase,risk
Pramlintide,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Pramlintide.,increase,risk
Pramlintide,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Pramlintide.,decrease,no risk
Pramlintide,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Pramlintide.,increase,risk
Pramlintide,Udenafil,The therapeutic efficacy of Pramlintide can be increased when used in combination with Udenafil.,increase,no risk
Pramlintide,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Pramlintide.,increase,risk
Pramlintide,Umeclidinium,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Umeclidinium.,increase,risk
Pramlintide,Valdecoxib,The therapeutic efficacy of Pramlintide can be increased when used in combination with Valdecoxib.,increase,no risk
Pramlintide,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Pramlintide.,increase,risk
Pramlintide,Vemurafenib,The therapeutic efficacy of Pramlintide can be increased when used in combination with Vemurafenib.,increase,no risk
Pramlintide,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Pramlintide.,increase,risk
Pramlintide,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Pramlintide.,increase,risk
Pramlintide,Vildagliptin,The risk or severity of hypoglycemia can be increased when Pramlintide is combined with Vildagliptin.,increase,risk
Pramlintide,Vorinostat,The therapeutic efficacy of Pramlintide can be decreased when used in combination with Vorinostat.,decrease,no risk
Pramlintide,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Pramlintide.,increase,risk
Pramlintide,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Pramlintide.,increase,risk
Pramlintide,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Pramlintide.,increase,risk
Pramlintide,Ziprasidone,The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Ziprasidone.,increase,risk
Pramlintide,Zonisamide,The therapeutic efficacy of Pramlintide can be increased when used in combination with Zonisamide.,increase,no risk
Nelarabine,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Nelarabine.,increase,risk
Nelarabine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Nelarabine.,increase,risk
Nelarabine,Glatiramer,The risk or severity of adverse effects can be increased when Nelarabine is combined with Glatiramer.,increase,risk
Nelarabine,Golimumab,The risk or severity of adverse effects can be increased when Nelarabine is combined with Golimumab.,increase,risk
Nelarabine,Guselkumab,The risk or severity of adverse effects can be increased when Nelarabine is combined with Guselkumab.,increase,risk
Nelarabine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Nelarabine.,decrease,no risk
Nelarabine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Nelarabine.,increase,risk
Nelarabine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Nelarabine.,decrease,no risk
Nelarabine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Nelarabine.,decrease,no risk
Nelarabine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Nelarabine.,increase,risk
Nelarabine,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Nelarabine.,increase,risk
Nelarabine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Nelarabine is combined with Hydrocortisone acetate.,increase,risk
Nelarabine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Nelarabine is combined with Hydrocortisone butyrate.,increase,risk
Nelarabine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Nelarabine is combined with Hydrocortisone succinate.,increase,risk
Nelarabine,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Nelarabine.,increase,risk
Nelarabine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Nelarabine is combined with Hydroxychloroquine.,increase,risk
Nelarabine,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Nelarabine.,increase,risk
Nelarabine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Nelarabine.,decrease,no risk
Nelarabine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Nelarabine.,decrease,no risk
Nelarabine,Obinutuzumab,The risk or severity of adverse effects can be increased when Nelarabine is combined with Obinutuzumab.,increase,risk
Nelarabine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Nelarabine.,increase,no risk
Nelarabine,Ofatumumab,The risk or severity of adverse effects can be increased when Nelarabine is combined with Ofatumumab.,increase,risk
Nelarabine,Olaparib,The risk or severity of adverse effects can be increased when Nelarabine is combined with Olaparib.,increase,risk
Nelarabine,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Nelarabine.,increase,risk
Nelarabine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Nelarabine is combined with Oxetacaine.,increase,risk
Nelarabine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Nelarabine is combined with Oxybuprocaine.,increase,risk
Nelarabine,Ozanimod,The risk or severity of adverse effects can be increased when Nelarabine is combined with Ozanimod.,increase,risk
Nelarabine,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Nelarabine.,increase,risk
Nelarabine,Upadacitinib,The risk or severity of adverse effects can be increased when Nelarabine is combined with Upadacitinib.,increase,risk
Nelarabine,Uracil mustard,The risk or severity of adverse effects can be increased when Nelarabine is combined with Uracil mustard.,increase,risk
Nelarabine,Urethane,The risk or severity of adverse effects can be increased when Nelarabine is combined with Urethane.,increase,risk
Nelarabine,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Nelarabine.,increase,risk
Nelarabine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Nelarabine.,increase,risk
Nelarabine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Nelarabine.,decrease,no risk
Nelarabine,Vedolizumab,The risk or severity of adverse effects can be increased when Nelarabine is combined with Vedolizumab.,increase,risk
Nelarabine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Nelarabine.,decrease,no risk
Nelarabine,Vilanterol,The risk or severity of adverse effects can be increased when Nelarabine is combined with Vilanterol.,increase,risk
Nelarabine,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Nelarabine.,increase,risk
Nelarabine,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Nelarabine.,increase,risk
Nelarabine,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Nelarabine.,increase,risk
Nelarabine,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Nelarabine.,increase,risk
Nelarabine,Voclosporin,The risk or severity of adverse effects can be increased when Nelarabine is combined with Voclosporin.,increase,risk
Nelarabine,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Nelarabine.,increase,risk
Nelarabine,Vorinostat,The risk or severity of adverse effects can be increased when Nelarabine is combined with Vorinostat.,increase,risk
Nelarabine,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Nelarabine.,increase,risk
Nelarabine,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Nelarabine.,increase,risk
Nelarabine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Nelarabine.,increase,risk
Nelarabine,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Nelarabine.,increase,risk
Abatacept,Bosutinib,The metabolism of Bosutinib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Abatacept.,increase,no risk
Abatacept,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Abatacept.,increase,no risk
Abatacept,Brigatinib,The metabolism of Brigatinib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Abatacept.,increase,no risk
Abatacept,Brodalumab,The risk or severity of adverse effects can be increased when Abatacept is combined with Brodalumab.,increase,risk
Abatacept,Bromazepam,The metabolism of Bromazepam can be increased when combined with Abatacept.,increase,no risk
Abatacept,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Abatacept.,increase,no risk
Abatacept,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Abatacept.,increase,risk
Abatacept,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Bupropion,The metabolism of Bupropion can be increased when combined with Abatacept.,increase,no risk
Abatacept,Buspirone,The metabolism of Buspirone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Busulfan,The metabolism of Busulfan can be increased when combined with Abatacept.,increase,no risk
Abatacept,Galantamine,The metabolism of Galantamine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Gefitinib,The metabolism of Gefitinib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Abatacept.,increase,risk
Abatacept,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Abatacept.,increase,risk
Abatacept,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Glasdegib,The metabolism of Glasdegib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Glatiramer,The risk or severity of adverse effects can be increased when Abatacept is combined with Glatiramer.,increase,risk
Abatacept,Gliclazide,The metabolism of Gliclazide can be increased when combined with Abatacept.,increase,no risk
Abatacept,Glimepiride,The metabolism of Glimepiride can be increased when combined with Abatacept.,increase,no risk
Abatacept,Glipizide,The metabolism of Glipizide can be increased when combined with Abatacept.,increase,no risk
Abatacept,Gliquidone,The metabolism of Gliquidone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Glyburide,The metabolism of Glyburide can be increased when combined with Abatacept.,increase,no risk
Abatacept,Golimumab,The risk or severity of infection can be increased when Golimumab is combined with Abatacept.,increase,risk
Abatacept,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Abatacept.,increase,no risk
Abatacept,Guanabenz,The metabolism of Guanabenz can be increased when combined with Abatacept.,increase,no risk
Abatacept,Guselkumab,The risk or severity of adverse effects can be increased when Abatacept is combined with Guselkumab.,increase,risk
Abatacept,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Abatacept.,decrease,no risk
Abatacept,Halofantrine,The metabolism of Halofantrine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Haloperidol,The metabolism of Haloperidol can be increased when combined with Abatacept.,increase,no risk
Abatacept,Halothane,The metabolism of Halothane can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Abatacept.,decrease,no risk
Abatacept,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Abatacept.,decrease,no risk
Abatacept,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Abatacept.,increase,risk
Abatacept,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Abatacept is combined with Hydrocortisone succinate.,increase,risk
Abatacept,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Abatacept.,increase,no risk
Abatacept,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Abatacept.,increase,risk
Abatacept,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Abatacept.,decrease,no risk
Abatacept,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Abatacept.,decrease,no risk
Abatacept,Ketamine,The metabolism of Ketamine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Ketorolac,The metabolism of Ketorolac can be increased when combined with Abatacept.,increase,no risk
Abatacept,Obinutuzumab,The risk or severity of adverse effects can be increased when Abatacept is combined with Obinutuzumab.,increase,risk
Abatacept,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Abatacept.,increase,no risk
Abatacept,Ofatumumab,The risk or severity of adverse effects can be increased when Abatacept is combined with Ofatumumab.,increase,risk
Abatacept,Olanzapine,The metabolism of Olanzapine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Olaparib,The metabolism of Olaparib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Oliceridine,The metabolism of Oliceridine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Olodaterol,The metabolism of Olodaterol can be increased when combined with Abatacept.,increase,no risk
Abatacept,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Abatacept.,increase,no risk
Abatacept,Omeprazole,The metabolism of Omeprazole can be increased when combined with Abatacept.,increase,no risk
Abatacept,Ondansetron,The metabolism of Ondansetron can be increased when combined with Abatacept.,increase,no risk
Abatacept,Opium,The metabolism of Opium can be increased when combined with Abatacept.,increase,no risk
Abatacept,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Abatacept.,increase,no risk
Abatacept,Osimertinib,The metabolism of Osimertinib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Ospemifene,The metabolism of Ospemifene can be increased when combined with Abatacept.,increase,no risk
Abatacept,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Abatacept.,increase,risk
Abatacept,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Abatacept.,increase,no risk
Abatacept,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Abatacept.,increase,no risk
Abatacept,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Abatacept.,increase,no risk
Abatacept,Oxycodone,The metabolism of Oxycodone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Ozanimod,The risk or severity of adverse effects can be increased when Abatacept is combined with Ozanimod.,increase,risk
Abatacept,Quetiapine,The metabolism of Quetiapine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Quinidine,The metabolism of Quinidine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Quinine,The metabolism of Quinine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Quizartinib,The metabolism of Quizartinib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Abatacept.,increase,risk
Abatacept,Udenafil,The metabolism of Udenafil can be increased when combined with Abatacept.,increase,no risk
Abatacept,Umeclidinium,The metabolism of Umeclidinium can be increased when combined with Abatacept.,increase,no risk
Abatacept,Upadacitinib,The risk or severity of adverse effects can be increased when Abatacept is combined with Upadacitinib.,increase,risk
Abatacept,Valbenazine,The metabolism of Valbenazine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Valproic acid,The metabolism of Valproic acid can be increased when combined with Abatacept.,increase,no risk
Abatacept,Valsartan,The metabolism of Valsartan can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vandetanib,The metabolism of Vandetanib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vardenafil,The metabolism of Vardenafil can be increased when combined with Abatacept.,increase,no risk
Abatacept,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Abatacept.,increase,risk
Abatacept,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Abatacept.,decrease,no risk
Abatacept,Vedolizumab,The risk or severity of adverse effects can be increased when Abatacept is combined with Vedolizumab.,increase,risk
Abatacept,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Venetoclax,The metabolism of Venetoclax can be increased when combined with Abatacept.,increase,no risk
Abatacept,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Verapamil,The metabolism of Verapamil can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vernakalant,The metabolism of Vernakalant can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Abatacept.,decrease,no risk
Abatacept,Vilanterol,The risk or severity of adverse effects can be increased when Abatacept is combined with Vilanterol.,increase,risk
Abatacept,Vilazodone,The metabolism of Vilazodone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vinblastine,The metabolism of Vinblastine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vincristine,The metabolism of Vincristine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vindesine,The metabolism of Vindesine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vinflunine,The metabolism of Vinflunine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Voclosporin,The risk or severity of adverse effects can be increased when Abatacept is combined with Voclosporin.,increase,risk
Abatacept,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Abatacept.,increase,no risk
Abatacept,Voriconazole,The metabolism of Voriconazole can be increased when combined with Abatacept.,increase,no risk
Abatacept,Vorinostat,The risk or severity of adverse effects can be increased when Abatacept is combined with Vorinostat.,increase,risk
Abatacept,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Voxelotor,The metabolism of Voxelotor can be increased when combined with Abatacept.,increase,no risk
Abatacept,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Abatacept.,increase,no risk
Abatacept,Warfarin,The metabolism of Warfarin can be increased when combined with Abatacept.,increase,no risk
Abatacept,Ximelagatran,The metabolism of Ximelagatran can be increased when combined with Abatacept.,increase,no risk
Abatacept,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Abatacept.,increase,risk
Abatacept,Yohimbine,The metabolism of Yohimbine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zaleplon,The metabolism of Zaleplon can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zidovudine,The metabolism of Zidovudine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zileuton,The metabolism of Zileuton can be increased when combined with Abatacept.,increase,no risk
Abatacept,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zolpidem,The metabolism of Zolpidem can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zonisamide,The metabolism of Zonisamide can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zopiclone,The metabolism of Zopiclone can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zotepine,The metabolism of Zotepine can be increased when combined with Abatacept.,increase,no risk
Abatacept,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Abatacept.,increase,no risk
Carbetocin,Obinutuzumab,The risk or severity of adverse effects can be increased when Carbetocin is combined with Obinutuzumab.,increase,risk
Carbetocin,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Carbetocin.,increase,risk
Carbetocin,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Carbetocin.,increase,risk
Carbetocin,Opicapone,The risk or severity of adverse effects can be increased when Carbetocin is combined with Opicapone.,increase,risk
Carbetocin,Oxprenolol,The risk or severity of adverse effects can be increased when Carbetocin is combined with Oxprenolol.,increase,risk
Carbetocin,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Carbetocin.,increase,risk
Carbetocin,Quinapril,The risk or severity of adverse effects can be increased when Quinapril is combined with Carbetocin.,increase,risk
Carbetocin,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Carbetocin.,increase,risk
Carbetocin,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Carbetocin.,increase,risk
Carbetocin,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Carbetocin.,increase,risk
Carbetocin,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Carbetocin.,increase,risk
Carbetocin,Vericiguat,The risk or severity of adverse effects can be increased when Carbetocin is combined with Vericiguat.,increase,risk
Carbetocin,Zofenopril,Carbetocin may increase the hypotensive activities of Zofenopril.,increase,no risk
Lumiracoxib,Bendazac,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Bendazac.,increase,risk
Lumiracoxib,Bendroflumethiazide,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Benorilate,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Benorilate.,increase,risk
Lumiracoxib,Benoxaprofen,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Benoxaprofen.,increase,risk
Lumiracoxib,Benserazide,Lumiracoxib may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Benzatropine,Lumiracoxib may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Benznidazole,Lumiracoxib may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Benzphetamine,The risk or severity of hypertension can be increased when Benzphetamine is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Benzthiazide,The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Benzydamine,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Benzydamine.,increase,risk
Lumiracoxib,Bepotastine,Lumiracoxib may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Bepridil,The therapeutic efficacy of Bepridil can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Betamethasone,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Betamethasone phosphate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Betaxolol,Lumiracoxib may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Lumiracoxib,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Betulinic Acid,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Betulinic Acid.,increase,risk
Lumiracoxib,Bexarotene,The metabolism of Lumiracoxib can be decreased when combined with Bexarotene.,decrease,no risk
Lumiracoxib,Bicisate,Lumiracoxib may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Bimekizumab,The metabolism of Lumiracoxib can be increased when combined with Bimekizumab.,increase,no risk
Lumiracoxib,Bismuth subgallate,Lumiracoxib may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Bisoprolol,Lumiracoxib may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Lumiracoxib,Bisoxatin,Lumiracoxib may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Bivalirudin.,increase,risk
Lumiracoxib,Bleomycin,Lumiracoxib may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Bortezomib,The metabolism of Lumiracoxib can be decreased when combined with Bortezomib.,decrease,no risk
Lumiracoxib,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Brexpiprazole,The risk or severity of hypertension can be increased when Lumiracoxib is combined with Brexpiprazole.,increase,risk
Lumiracoxib,Brivaracetam,Lumiracoxib may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Bromazepam,Lumiracoxib may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Bufexamac,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Bufexamac.,increase,risk
Lumiracoxib,Bumadizone,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Bumadizone.,increase,risk
Lumiracoxib,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Lumiracoxib.,decrease,no risk
Lumiracoxib,Buprenorphine,The metabolism of Lumiracoxib can be decreased when combined with Buprenorphine.,decrease,no risk
Lumiracoxib,Bupropion,Lumiracoxib may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Butabarbital,Lumiracoxib may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Lumiracoxib.,increase,risk
Lumiracoxib,Gabapentin enacarbil,Lumiracoxib may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gadobenic acid,Lumiracoxib may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gadodiamide,Lumiracoxib may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gadofosveset trisodium,Lumiracoxib may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gadopentetic acid,Lumiracoxib may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gadoteric acid,Lumiracoxib may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gadoteridol,Lumiracoxib may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Ganciclovir,Lumiracoxib may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gatifloxacin,Lumiracoxib may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Lumiracoxib,Gemcitabine,Lumiracoxib may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gemfibrozil,The metabolism of Lumiracoxib can be decreased when combined with Gemfibrozil.,decrease,no risk
Lumiracoxib,Gemifloxacin,Lumiracoxib may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Lumiracoxib,Gentamicin,Lumiracoxib may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Gimeracil,Lumiracoxib may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Ginkgo biloba,The metabolism of Lumiracoxib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Lumiracoxib,Givosiran,The risk or severity of nephrotoxicity can be increased when Lumiracoxib is combined with Givosiran.,increase,risk
Lumiracoxib,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Lumiracoxib.,decrease,no risk
Lumiracoxib,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Lumiracoxib.,decrease,no risk
Lumiracoxib,Glipizide,The protein binding of Glipizide can be decreased when combined with Lumiracoxib.,decrease,no risk
Lumiracoxib,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Lumiracoxib.,decrease,no risk
Lumiracoxib,Glofitamab,The serum concentration of Lumiracoxib can be increased when it is combined with Glofitamab.,increase,no risk
Lumiracoxib,Glyburide,The protein binding of Glyburide can be decreased when combined with Lumiracoxib.,decrease,no risk
Lumiracoxib,Glycerol phenylbutyrate,Lumiracoxib may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Lumiracoxib,Glycol salicylate,The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Glycol salicylate.,increase,risk
Lumiracoxib,Golimumab,The metabolism of Lumiracoxib can be increased when combined with Golimumab.,increase,no risk
Lumiracoxib,Golodirsen,Lumiracoxib may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Tetracosactide,Brexanolone,The risk or severity of liver damage can be increased when Tetracosactide is combined with Brexanolone.,increase,risk
Tetracosactide,Brivaracetam,The risk or severity of liver damage can be increased when Tetracosactide is combined with Brivaracetam.,increase,risk
Tetracosactide,Butalbital,The risk or severity of liver damage can be increased when Tetracosactide is combined with Butalbital.,increase,risk
Tetracosactide,Gabapentin,The risk or severity of liver damage can be increased when Tetracosactide is combined with Gabapentin.,increase,risk
Tetracosactide,Ganaxolone,The risk or severity of liver damage can be increased when Tetracosactide is combined with Ganaxolone.,increase,risk
Tetracosactide,Oxcarbazepine,The risk or severity of liver damage can be increased when Tetracosactide is combined with Oxcarbazepine.,increase,risk
Tetracosactide,Valproic acid,Tetracosactide may increase the hepatotoxic activities of Valproic acid.,increase,no risk
Tetracosactide,Vigabatrin,The risk or severity of liver damage can be increased when Tetracosactide is combined with Vigabatrin.,increase,risk
Tetracosactide,Zaleplon,The risk or severity of liver damage can be increased when Tetracosactide is combined with Zaleplon.,increase,risk
Tetracosactide,Zonisamide,The risk or severity of liver damage can be increased when Tetracosactide is combined with Zonisamide.,increase,risk
Corticotropin,Bromocriptine,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Bromocriptine.,increase,risk
Corticotropin,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Corticotropin.,increase,risk
Corticotropin,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Bumadizone.,increase,risk
Corticotropin,Bumetanide,The risk or severity of hypokalemia can be increased when Corticotropin is combined with Bumetanide.,increase,risk
Corticotropin,Busulfan,The metabolism of Busulfan can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Gatifloxacin,The risk or severity of tendinopathy can be increased when Corticotropin is combined with Gatifloxacin.,increase,risk
Corticotropin,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Corticotropin.,increase,risk
Corticotropin,Gemifloxacin,The risk or severity of tendinopathy can be increased when Corticotropin is combined with Gemifloxacin.,increase,risk
Corticotropin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Corticotropin.,increase,risk
Corticotropin,Gestrinone,The serum concentration of Corticotropin can be increased when it is combined with Gestrinone.,increase,no risk
Corticotropin,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Glatiramer,The risk or severity of adverse effects can be increased when Corticotropin is combined with Glatiramer.,increase,risk
Corticotropin,Gliclazide,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Gliclazide.,increase,risk
Corticotropin,Glimepiride,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Glimepiride.,increase,risk
Corticotropin,Glipizide,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Glipizide.,increase,risk
Corticotropin,Gliquidone,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Gliquidone.,increase,risk
Corticotropin,Glofitamab,The serum concentration of Corticotropin can be increased when it is combined with Glofitamab.,increase,no risk
Corticotropin,Glyburide,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Glyburide.,increase,risk
Corticotropin,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Glycol salicylate.,increase,risk
Corticotropin,Glymidine,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Glymidine.,increase,risk
Corticotropin,Golimumab,The risk or severity of adverse effects can be increased when Corticotropin is combined with Golimumab.,increase,risk
Corticotropin,Grepafloxacin,The risk or severity of tendinopathy can be increased when Corticotropin is combined with Grepafloxacin.,increase,risk
Corticotropin,Guselkumab,The risk or severity of adverse effects can be increased when Corticotropin is combined with Guselkumab.,increase,risk
Corticotropin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Corticotropin.,increase,no risk
Corticotropin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Corticotropin is combined with Hydrochlorothiazide.,increase,risk
Corticotropin,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Corticotropin is combined with Hydrocortisone acetate.,increase,risk
Corticotropin,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Corticotropin is combined with Hydrocortisone butyrate.,increase,risk
Corticotropin,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Corticotropin is combined with Hydrocortisone succinate.,increase,risk
Corticotropin,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Corticotropin is combined with Hydroflumethiazide.,increase,risk
Corticotropin,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Corticotropin is combined with Hydroxychloroquine.,increase,risk
Corticotropin,Hydroxyprogesterone caproate,The serum concentration of Corticotropin can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Corticotropin,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Corticotropin.,increase,risk
Corticotropin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Ketoconazole,The metabolism of Corticotropin can be decreased when combined with Ketoconazole.,decrease,no risk
Corticotropin,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Ketoprofen.,increase,risk
Corticotropin,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Ketorolac.,increase,risk
Corticotropin,Obinutuzumab,The risk or severity of adverse effects can be increased when Corticotropin is combined with Obinutuzumab.,increase,risk
Corticotropin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Corticotropin.,increase,no risk
Corticotropin,Ofatumumab,The risk or severity of adverse effects can be increased when Corticotropin is combined with Ofatumumab.,increase,risk
Corticotropin,Ofloxacin,The risk or severity of tendinopathy can be increased when Corticotropin is combined with Ofloxacin.,increase,risk
Corticotropin,Olaparib,The metabolism of Olaparib can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Corticotropin.,decrease,no risk
Corticotropin,Olodaterol,The risk or severity of hypokalemia can be increased when Corticotropin is combined with Olodaterol.,increase,risk
Corticotropin,Olsalazine,The serum concentration of Olsalazine can be decreased when it is combined with Corticotropin.,decrease,no risk
Corticotropin,Omaveloxolone,The serum concentration of Corticotropin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Corticotropin,Orciprenaline,The risk or severity of hypokalemia can be increased when Corticotropin is combined with Orciprenaline.,increase,risk
Corticotropin,Osimertinib,The metabolism of Osimertinib can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Corticotropin.,increase,risk
Corticotropin,Oxandrolone,The risk or severity of fluid retention can be increased when Corticotropin is combined with Oxandrolone.,increase,risk
Corticotropin,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Oxaprozin.,increase,risk
Corticotropin,Oxymetholone,The risk or severity of fluid retention can be increased when Corticotropin is combined with Oxymetholone.,increase,risk
Corticotropin,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Oxyphenbutazone.,increase,risk
Corticotropin,Ozanimod,The risk or severity of adverse effects can be increased when Corticotropin is combined with Ozanimod.,increase,risk
Corticotropin,Quinestrol,The serum concentration of Corticotropin can be increased when it is combined with Quinestrol.,increase,no risk
Corticotropin,Quinethazone,Corticotropin may increase the hypokalemic activities of Quinethazone.,increase,no risk
Corticotropin,Quinidine,The metabolism of Quinidine can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Quinine,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Quinine.,increase,risk
Corticotropin,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Corticotropin.,increase,risk
Corticotropin,Ulipristal,The serum concentration of Corticotropin can be increased when it is combined with Ulipristal.,increase,no risk
Corticotropin,Upadacitinib,The risk or severity of adverse effects can be increased when Corticotropin is combined with Upadacitinib.,increase,risk
Corticotropin,Vadadustat,The serum concentration of Corticotropin can be increased when it is combined with Vadadustat.,increase,no risk
Corticotropin,Valdecoxib,The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Valdecoxib.,increase,risk
Corticotropin,Vandetanib,The metabolism of Vandetanib can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Vecuronium,The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Corticotropin.,increase,risk
Corticotropin,Vedolizumab,The risk or severity of adverse effects can be increased when Corticotropin is combined with Vedolizumab.,increase,risk
Corticotropin,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Venetoclax,The metabolism of Venetoclax can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Verapamil,The metabolism of Corticotropin can be decreased when combined with Verapamil.,decrease,no risk
Corticotropin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Vilanterol,The risk or severity of adverse effects can be increased when Corticotropin is combined with Vilanterol.,increase,risk
Corticotropin,Vildagliptin,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Vildagliptin.,increase,risk
Corticotropin,Viloxazine,The metabolism of Corticotropin can be decreased when combined with Viloxazine.,decrease,no risk
Corticotropin,Vinblastine,The metabolism of Vinblastine can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Vincristine,The metabolism of Vincristine can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Vindesine,The metabolism of Vindesine can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Vinflunine,The metabolism of Vinflunine can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Vitamin D,The therapeutic efficacy of Vitamin D can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Voclosporin,The risk or severity of adverse effects can be increased when Corticotropin is combined with Voclosporin.,increase,risk
Corticotropin,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Voriconazole,The serum concentration of Corticotropin can be increased when it is combined with Voriconazole.,increase,no risk
Corticotropin,Vorinostat,The risk or severity of adverse effects can be increased when Corticotropin is combined with Vorinostat.,increase,risk
Corticotropin,Warfarin,Corticotropin may increase the anticoagulant activities of Warfarin.,increase,no risk
Corticotropin,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Corticotropin.,decrease,no risk
Corticotropin,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Corticotropin.,increase,risk
Corticotropin,Zimelidine,The metabolism of Corticotropin can be decreased when combined with Zimelidine.,decrease,no risk
Corticotropin,Ziprasidone,The metabolism of Corticotropin can be decreased when combined with Ziprasidone.,decrease,no risk
Corticotropin,Zolpidem,The metabolism of Zolpidem can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Corticotropin.,increase,no risk
Corticotropin,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Corticotropin.,decrease,no risk
Fenoterol,Galantamine,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Galantamine.,decrease,no risk
Fenoterol,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Fenoterol.,increase,risk
Fenoterol,Ginkgo biloba,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Fenoterol,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Fenoterol.,decrease,no risk
Fenoterol,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Fenoterol.,decrease,no risk
Fenoterol,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Fenoterol.,increase,risk
Fenoterol,Guanabenz,Fenoterol may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Fenoterol,Guanadrel,Fenoterol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Fenoterol,Guanethidine,Fenoterol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Fenoterol,Guanfacine,Fenoterol may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Fenoterol,Guanoxan,Fenoterol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Fenoterol,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Fenoterol.,increase,risk
Fenoterol,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Fenoterol.,increase,risk
Fenoterol,Hexocyclium,The risk or severity of adverse effects can be increased when Fenoterol is combined with Hexocyclium.,increase,risk
Fenoterol,Homatropine,The risk or severity of adverse effects can be increased when Fenoterol is combined with Homatropine.,increase,risk
Fenoterol,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Fenoterol.,increase,risk
Fenoterol,Huperzine A,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Huperzine A.,decrease,no risk
Fenoterol,Hydralazine,Fenoterol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Fenoterol,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Fenoterol is combined with Hydrochlorothiazide.,increase,risk
Fenoterol,Hydrocodone,The risk or severity of adverse effects can be increased when Fenoterol is combined with Hydrocodone.,increase,risk
Fenoterol,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Fenoterol.,increase,risk
Fenoterol,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Fenoterol.,increase,risk
Fenoterol,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Fenoterol.,increase,risk
Fenoterol,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Fenoterol.,increase,risk
Fenoterol,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Fenoterol.,increase,risk
Fenoterol,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Fenoterol is combined with Hydroflumethiazide.,increase,risk
Fenoterol,Hydromorphone,The risk or severity of adverse effects can be increased when Fenoterol is combined with Hydromorphone.,increase,risk
Fenoterol,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Fenoterol.,increase,risk
Fenoterol,Ketamine,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Ketamine.,decrease,no risk
Fenoterol,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Fenoterol.,increase,risk
Fenoterol,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Fenoterol.,increase,risk
Fenoterol,Olanzapine,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Olanzapine.,decrease,no risk
Fenoterol,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Fenoterol is combined with Oliceridine.",increase,risk
Fenoterol,Olmesartan,Fenoterol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Fenoterol,Olodaterol,The risk or severity of adverse effects can be increased when Fenoterol is combined with Olodaterol.,increase,risk
Fenoterol,Opium,The risk or severity of adverse effects can be increased when Fenoterol is combined with Opium.,increase,risk
Fenoterol,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Fenoterol.,increase,risk
Fenoterol,Orphenadrine,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Fenoterol.,increase,risk
Fenoterol,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Fenoterol.,increase,risk
Fenoterol,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Fenoterol.,decrease,no risk
Fenoterol,Oxtriphylline,The risk or severity of adverse effects can be increased when Fenoterol is combined with Oxtriphylline.,increase,risk
Fenoterol,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Fenoterol.,increase,risk
Fenoterol,Oxycodone,The risk or severity of adverse effects can be increased when Fenoterol is combined with Oxycodone.,increase,risk
Fenoterol,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Fenoterol.,increase,risk
Fenoterol,Oxymorphone,The risk or severity of adverse effects can be increased when Fenoterol is combined with Oxymorphone.,increase,risk
Fenoterol,Oxyphenbutazone,The risk or severity of hypertension can be increased when Fenoterol is combined with Oxyphenbutazone.,increase,risk
Fenoterol,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Fenoterol.,increase,risk
Fenoterol,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Fenoterol.,decrease,no risk
Fenoterol,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Fenoterol.,increase,risk
Fenoterol,Quetiapine,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Quetiapine.,decrease,no risk
Fenoterol,Quinapril,Fenoterol may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Fenoterol,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Fenoterol.,increase,no risk
Fenoterol,Quinidine,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Quinidine.,decrease,no risk
Fenoterol,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Fenoterol.,increase,risk
Fenoterol,Umeclidinium,The risk or severity of adverse effects can be increased when Fenoterol is combined with Umeclidinium.,increase,risk
Fenoterol,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Fenoterol.,increase,risk
Fenoterol,Valsartan,Fenoterol may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Fenoterol,Vamorolone,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Fenoterol.,increase,risk
Fenoterol,Vecuronium,The risk or severity of adverse effects can be increased when Fenoterol is combined with Vecuronium.,increase,risk
Fenoterol,Venlafaxine,Venlafaxine may increase the tachycardic activities of Fenoterol.,increase,no risk
Fenoterol,Verapamil,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Verapamil.,decrease,no risk
Fenoterol,Vilanterol,The risk or severity of adverse effects can be increased when Fenoterol is combined with Vilanterol.,increase,risk
Fenoterol,Vilazodone,The risk or severity of hypertension can be increased when Fenoterol is combined with Vilazodone.,increase,risk
Fenoterol,Vortioxetine,The risk or severity of hypertension can be increased when Fenoterol is combined with Vortioxetine.,increase,risk
Fenoterol,Xamoterol,The risk or severity of hypertension can be increased when Fenoterol is combined with Xamoterol.,increase,risk
Fenoterol,Xylometazoline,The risk or severity of hypertension can be increased when Fenoterol is combined with Xylometazoline.,increase,risk
Fenoterol,Yohimbine,The risk or severity of hypertension can be increased when Fenoterol is combined with Yohimbine.,increase,risk
Fenoterol,Ziprasidone,The therapeutic efficacy of Fenoterol can be decreased when used in combination with Ziprasidone.,decrease,no risk
Fenoterol,Zofenopril,Fenoterol may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Fenoterol,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Fenoterol.,increase,risk
Glisoxepide,Gatifloxacin,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Gatifloxacin.,increase,no risk
Glisoxepide,Gefapixant,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Gefapixant.,increase,no risk
Glisoxepide,Gemfibrozil,The metabolism of Glisoxepide can be decreased when combined with Gemfibrozil.,decrease,no risk
Glisoxepide,Gemifloxacin,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Gemifloxacin.,increase,no risk
Glisoxepide,Gestrinone,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Gestrinone.,decrease,no risk
Glisoxepide,Ginkgo biloba,The metabolism of Glisoxepide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Glisoxepide,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Glisoxepide.,increase,risk
Glisoxepide,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Glisoxepide.,increase,risk
Glisoxepide,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Glisoxepide.,increase,risk
Glisoxepide,Gliquidone,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Glisoxepide.,increase,risk
Glisoxepide,Glofitamab,The serum concentration of Glisoxepide can be increased when it is combined with Glofitamab.,increase,no risk
Glisoxepide,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Glisoxepide.,increase,risk
Glisoxepide,Glycol salicylate,The protein binding of Glisoxepide can be decreased when combined with Glycol salicylate.,decrease,no risk
Glisoxepide,Glymidine,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Glymidine.,increase,no risk
Glisoxepide,Golimumab,The metabolism of Glisoxepide can be increased when combined with Golimumab.,increase,no risk
Glisoxepide,Goserelin,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Goserelin.,decrease,no risk
Glisoxepide,Grepafloxacin,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Grepafloxacin.,increase,no risk
Glisoxepide,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Glisoxepide.,increase,risk
Glisoxepide,Haloperidol,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Haloperidol.,decrease,no risk
Glisoxepide,Halothane,The metabolism of Glisoxepide can be decreased when combined with Halothane.,decrease,no risk
Glisoxepide,Histrelin,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Histrelin.,decrease,no risk
Glisoxepide,Hydrochlorothiazide,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Glisoxepide,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Glisoxepide.,increase,risk
Glisoxepide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Glisoxepide.,increase,risk
Glisoxepide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Glisoxepide.,increase,risk
Glisoxepide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Glisoxepide.,increase,risk
Glisoxepide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Glisoxepide.,increase,risk
Glisoxepide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Glisoxepide.,increase,risk
Glisoxepide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Glisoxepide.,increase,risk
Glisoxepide,Hydroflumethiazide,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Glisoxepide,Hydromorphone,The metabolism of Glisoxepide can be decreased when combined with Hydromorphone.,decrease,no risk
Glisoxepide,Hydroxychloroquine,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Glisoxepide,Hydroxyprogesterone caproate,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Glisoxepide,Ketamine,The metabolism of Glisoxepide can be decreased when combined with Ketamine.,decrease,no risk
Glisoxepide,Ketoprofen,The protein binding of Glisoxepide can be decreased when combined with Ketoprofen.,decrease,no risk
Glisoxepide,Ketorolac,The protein binding of Glisoxepide can be decreased when combined with Ketorolac.,decrease,no risk
Glisoxepide,Ketotifen,The risk or severity of thrombocytopenia can be increased when Glisoxepide is combined with Ketotifen.,increase,risk
Glisoxepide,Octreotide,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Octreotide.,decrease,no risk
Glisoxepide,Ofloxacin,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Ofloxacin.,increase,no risk
Glisoxepide,Olanzapine,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Olanzapine.,decrease,no risk
Glisoxepide,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Glisoxepide.,decrease,no risk
Glisoxepide,Olsalazine,Olsalazine may increase the hypoglycemic activities of Glisoxepide.,increase,no risk
Glisoxepide,Ondansetron,The metabolism of Glisoxepide can be decreased when combined with Ondansetron.,decrease,no risk
Glisoxepide,Oritavancin,The metabolism of Glisoxepide can be decreased when combined with Oritavancin.,decrease,no risk
Glisoxepide,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Glisoxepide.,decrease,no risk
Glisoxepide,Oxandrolone,The metabolism of Glisoxepide can be decreased when combined with Oxandrolone.,decrease,no risk
Glisoxepide,Oxaprozin,The protein binding of Glisoxepide can be decreased when combined with Oxaprozin.,decrease,no risk
Glisoxepide,Oxprenolol,The therapeutic efficacy of Glisoxepide can be increased when used in combination with Oxprenolol.,increase,no risk
Glisoxepide,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Glisoxepide.,increase,no risk
Glisoxepide,Oxyphenbutazone,The protein binding of Glisoxepide can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Pirbuterol,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Pirbuterol.,increase,risk
Pirbuterol,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Pirbuterol.,increase,risk
Pirbuterol,Guanabenz,Pirbuterol may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Pirbuterol,Guanadrel,Pirbuterol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Pirbuterol,Guanethidine,Pirbuterol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Pirbuterol,Guanfacine,Pirbuterol may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Pirbuterol,Guanoxan,Pirbuterol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Pirbuterol,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Pirbuterol.,increase,risk
Pirbuterol,Hexocyclium,The risk or severity of Tachycardia can be increased when Pirbuterol is combined with Hexocyclium.,increase,risk
Pirbuterol,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Pirbuterol.,increase,risk
Pirbuterol,Hydralazine,Pirbuterol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Pirbuterol,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Pirbuterol is combined with Hydrochlorothiazide.,increase,risk
Pirbuterol,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Pirbuterol.,increase,risk
Pirbuterol,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Pirbuterol.,increase,risk
Pirbuterol,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Pirbuterol.,increase,risk
Pirbuterol,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Pirbuterol.,increase,risk
Pirbuterol,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Pirbuterol.,increase,risk
Pirbuterol,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Pirbuterol is combined with Hydroflumethiazide.,increase,risk
Pirbuterol,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Pirbuterol.,increase,risk
Pirbuterol,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Pirbuterol.,increase,risk
Pirbuterol,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Pirbuterol.,increase,risk
Pirbuterol,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Pirbuterol.,increase,risk
Pirbuterol,Olanzapine,The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Olanzapine.,decrease,no risk
Pirbuterol,Olmesartan,Pirbuterol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Pirbuterol,Olodaterol,The risk or severity of adverse effects can be increased when Pirbuterol is combined with Olodaterol.,increase,risk
Pirbuterol,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Pirbuterol.,increase,risk
Pirbuterol,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Pirbuterol.,increase,risk
Pirbuterol,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Pirbuterol.,increase,risk
Pirbuterol,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Pirbuterol.,decrease,no risk
Pirbuterol,Oxtriphylline,The risk or severity of hypokalemia can be increased when Oxtriphylline is combined with Pirbuterol.,increase,risk
Pirbuterol,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Pirbuterol.,increase,risk
Pirbuterol,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Pirbuterol.,increase,risk
Pirbuterol,Oxyphenbutazone,The risk or severity of hypertension can be increased when Pirbuterol is combined with Oxyphenbutazone.,increase,risk
Pirbuterol,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Pirbuterol.,increase,risk
Pirbuterol,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Pirbuterol.,increase,risk
Pirbuterol,Quetiapine,The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Quetiapine.,decrease,no risk
Pirbuterol,Quinapril,Pirbuterol may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Pirbuterol,Quinethazone,Pirbuterol may increase the hypokalemic activities of Quinethazone.,increase,no risk
Pirbuterol,Quinidine,The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Quinidine.,decrease,no risk
Pirbuterol,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Pirbuterol.,increase,risk
Pirbuterol,Umeclidinium,The risk or severity of Tachycardia can be increased when Pirbuterol is combined with Umeclidinium.,increase,risk
Pirbuterol,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Pirbuterol.,increase,risk
Pirbuterol,Valsartan,Pirbuterol may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Pirbuterol,Vamorolone,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Pirbuterol.,increase,risk
Pirbuterol,Venlafaxine,Venlafaxine may increase the tachycardic activities of Pirbuterol.,increase,no risk
Pirbuterol,Verapamil,The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Verapamil.,decrease,no risk
Pirbuterol,Vilanterol,The risk or severity of adverse effects can be increased when Pirbuterol is combined with Vilanterol.,increase,risk
Pirbuterol,Vilazodone,The risk or severity of hypertension can be increased when Pirbuterol is combined with Vilazodone.,increase,risk
Pirbuterol,Vortioxetine,The risk or severity of hypertension can be increased when Pirbuterol is combined with Vortioxetine.,increase,risk
Pirbuterol,Xamoterol,The risk or severity of hypertension can be increased when Pirbuterol is combined with Xamoterol.,increase,risk
Pirbuterol,Xylometazoline,The risk or severity of hypertension can be increased when Pirbuterol is combined with Xylometazoline.,increase,risk
Pirbuterol,Yohimbine,The risk or severity of hypertension can be increased when Pirbuterol is combined with Yohimbine.,increase,risk
Pirbuterol,Ziprasidone,The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Ziprasidone.,decrease,no risk
Pirbuterol,Zofenopril,Pirbuterol may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Pirbuterol,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Pirbuterol.,increase,risk
Pirbuterol,Zuclopenthixol,The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Bismuth subsalicylate,Ginkgo biloba,The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Bismuth subsalicylate.,increase,risk
Bismuth subsalicylate,Gliclazide,Bismuth subsalicylate may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Bismuth subsalicylate,Glimepiride,Bismuth subsalicylate may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Bismuth subsalicylate,Glipizide,Bismuth subsalicylate may increase the hypoglycemic activities of Glipizide.,increase,no risk
Bismuth subsalicylate,Gliquidone,Bismuth subsalicylate may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Bismuth subsalicylate,Glyburide,Bismuth subsalicylate may increase the hypoglycemic activities of Glyburide.,increase,no risk
Bismuth subsalicylate,Glymidine,Bismuth subsalicylate may increase the hypoglycemic activities of Glymidine.,increase,no risk
Bismuth subsalicylate,Heparin,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Heparin.,increase,risk
Bismuth subsalicylate,Hydrocortisone,The serum concentration of Bismuth subsalicylate can be decreased when it is combined with Hydrocortisone.,decrease,no risk
Bismuth subsalicylate,Ketoprofen,The risk or severity of bleeding and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Ketoprofen.,increase,risk
Bismuth subsalicylate,Ketorolac,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Ketorolac.,decrease,no risk
Bismuth subsalicylate,Olsalazine,"The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Olsalazine is combined with Bismuth subsalicylate.",increase,risk
Bismuth subsalicylate,Omadacycline,The serum concentration of Omadacycline can be decreased when it is combined with Bismuth subsalicylate.,decrease,no risk
Bismuth subsalicylate,Ouabain,The serum concentration of Ouabain can be decreased when it is combined with Bismuth subsalicylate.,decrease,no risk
Bismuth subsalicylate,Oxaprozin,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Oxaprozin.,decrease,no risk
Bismuth subsalicylate,Oxytetracycline,The serum concentration of Oxytetracycline can be decreased when it is combined with Bismuth subsalicylate.,decrease,no risk
Bismuth subsalicylate,Quinapril,The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Quinapril.,increase,risk
Bismuth subsalicylate,Quinine,Bismuth subsalicylate may increase the hypoglycemic activities of Quinine.,increase,no risk
Bismuth subsalicylate,Urokinase,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Urokinase.,increase,risk
Bismuth subsalicylate,Valproate bismuth,Bismuth subsalicylate may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Bismuth subsalicylate,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Bismuth subsalicylate.,increase,no risk
Bismuth subsalicylate,Varicella zoster vaccine (live/attenuated),The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Varicella zoster vaccine (live/attenuated).,increase,risk
Bismuth subsalicylate,Verapamil,The risk or severity of bleeding can be increased when Verapamil is combined with Bismuth subsalicylate.,increase,risk
Bismuth subsalicylate,Vildagliptin,Bismuth subsalicylate may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Bismuth subsalicylate,Vorapaxar,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Vorapaxar.,increase,risk
Bismuth subsalicylate,Warfarin,Bismuth subsalicylate may increase the anticoagulant activities of Warfarin.,increase,no risk
Bismuth subsalicylate,Ximelagatran,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Ximelagatran.,increase,risk
Bismuth subsalicylate,Zofenopril,The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Zofenopril.,increase,risk
Bismuth subsalicylate,Zonisamide,The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Zonisamide.,increase,risk
Bevantolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Bevantolol is combined with Bromotheophylline.,increase,risk
Bevantolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Bevantolol.,increase,risk
Bevantolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Bumetanide,Bumetanide may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Bevantolol.,increase,no risk
Bevantolol,Buprenorphine,The metabolism of Bevantolol can be decreased when combined with Buprenorphine.,decrease,no risk
Bevantolol,Bupropion,The metabolism of Bevantolol can be decreased when combined with Bupropion.,decrease,no risk
Bevantolol,Buspirone,Buspirone may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Butabarbital,The serum concentration of Bevantolol can be decreased when it is combined with Butabarbital.,decrease,no risk
Bevantolol,Butalbital,The serum concentration of Bevantolol can be decreased when it is combined with Butalbital.,decrease,no risk
Bevantolol,Butaperazine,The serum concentration of Bevantolol can be increased when it is combined with Butaperazine.,increase,no risk
Bevantolol,Butriptyline,Butriptyline may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Galantamine,Galantamine may increase the bradycardic activities of Bevantolol.,increase,no risk
Bevantolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Bevantolol.,increase,no risk
Bevantolol,Gefitinib,The metabolism of Bevantolol can be decreased when combined with Gefitinib.,decrease,no risk
Bevantolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Bevantolol.,increase,no risk
Bevantolol,Givosiran,The serum concentration of Bevantolol can be increased when it is combined with Givosiran.,increase,no risk
Bevantolol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Bevantolol.,increase,no risk
Bevantolol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Bevantolol.,increase,no risk
Bevantolol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Bevantolol.,increase,no risk
Bevantolol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Bevantolol.,increase,no risk
Bevantolol,Glucagon,The therapeutic efficacy of Bevantolol can be decreased when used in combination with Glucagon.,decrease,no risk
Bevantolol,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Bevantolol.,increase,no risk
Bevantolol,Glycerol phenylbutyrate,The metabolism of Bevantolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Bevantolol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Bevantolol.,increase,no risk
Bevantolol,Golimumab,The metabolism of Bevantolol can be increased when combined with Golimumab.,increase,no risk
Bevantolol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Guanadrel,Guanadrel may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Guanethidine,Guanethidine may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Guanoxan,Bevantolol may increase the hypotensive activities of Guanoxan.,increase,no risk
Bevantolol,Halofantrine,The metabolism of Bevantolol can be decreased when combined with Halofantrine.,decrease,no risk
Bevantolol,Haloperidol,The serum concentration of Bevantolol can be increased when it is combined with Haloperidol.,increase,no risk
Bevantolol,Halothane,Halothane may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Bevantolol.,increase,risk
Bevantolol,Hexafluronium,Hexafluronium may increase the bradycardic activities of Bevantolol.,increase,no risk
Bevantolol,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Bevantolol.,increase,risk
Bevantolol,Huperzine A,Huperzine A may increase the bradycardic activities of Bevantolol.,increase,no risk
Bevantolol,Hydralazine,Hydralazine may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Hydrochlorothiazide,The therapeutic efficacy of Bevantolol can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Bevantolol,Hydroflumethiazide,The therapeutic efficacy of Bevantolol can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Bevantolol,Hydroxychloroquine,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Bevantolol.,decrease,risk
Bevantolol,Hydroxyzine,The metabolism of Bevantolol can be decreased when combined with Hydroxyzine.,decrease,no risk
Bevantolol,Ketamine,Ketamine may increase the bradycardic activities of Bevantolol.,increase,no risk
Bevantolol,Ketoconazole,The metabolism of Bevantolol can be decreased when combined with Ketoconazole.,decrease,no risk
Bevantolol,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Ketorolac,Ketorolac may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Bevantolol.,increase,risk
Bevantolol,Obinutuzumab,Bevantolol may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Bevantolol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Bevantolol.,increase,no risk
Bevantolol,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bevantolol.",increase,no risk
Bevantolol,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Bevantolol.,decrease,no risk
Bevantolol,Olmesartan,Olmesartan may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Ondansetron,The metabolism of Bevantolol can be decreased when combined with Ondansetron.,decrease,no risk
Bevantolol,Opicapone,Opicapone may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Opium,The metabolism of Opium can be decreased when combined with Bevantolol.,decrease,no risk
Bevantolol,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Oritavancin,The metabolism of Bevantolol can be decreased when combined with Oritavancin.,decrease,no risk
Bevantolol,Orphenadrine,The metabolism of Bevantolol can be decreased when combined with Orphenadrine.,decrease,no risk
Bevantolol,Osilodrostat,The metabolism of Bevantolol can be decreased when combined with Osilodrostat.,decrease,no risk
Bevantolol,Ospemifene,The metabolism of Bevantolol can be decreased when combined with Ospemifene.,decrease,no risk
Bevantolol,Ouabain,Bevantolol may increase the bradycardic activities of Ouabain.,increase,no risk
Bevantolol,Oxamniquine,The metabolism of Bevantolol can be decreased when combined with Oxamniquine.,decrease,no risk
Bevantolol,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Oxprenolol,Oxprenolol may increase the orthostatic hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Oxtriphylline,The risk or severity of adverse effects can be increased when Bevantolol is combined with Oxtriphylline.,increase,risk
Bevantolol,Oxybutynin,The metabolism of Bevantolol can be decreased when combined with Oxybutynin.,decrease,no risk
Bevantolol,Oxycodone,The metabolism of Bevantolol can be decreased when combined with Oxycodone.,decrease,no risk
Bevantolol,Oxymetazoline,The therapeutic efficacy of Bevantolol can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Bevantolol,Oxymorphone,The metabolism of Bevantolol can be decreased when combined with Oxymorphone.,decrease,no risk
Bevantolol,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Quetiapine,Quetiapine may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Quinapril,Quinapril may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Quinidine,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bevantolol.",increase,no risk
Bevantolol,Quinine,The metabolism of Bevantolol can be decreased when combined with Quinine.,decrease,no risk
Bevantolol,Quinupramine,Quinupramine may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Bevantolol.,increase,risk
Bevantolol,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Bevantolol.,decrease,no risk
Bevantolol,Unoprostone,Bevantolol may increase the hypotensive activities of Unoprostone.,increase,no risk
Bevantolol,Urochloa mutica pollen,The risk of a hypersensitivity reaction to Urochloa mutica pollen is increased when it is combined with Bevantolol.,increase,risk
Bevantolol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Bevantolol.,decrease,no risk
Bevantolol,Valdecoxib,Valdecoxib may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Valsartan,Valsartan may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Vardenafil,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Bevantolol.,increase,risk
Bevantolol,Varenicline,The risk or severity of adverse effects can be increased when Bevantolol is combined with Varenicline.,increase,risk
Bevantolol,Vemurafenib,The metabolism of Bevantolol can be decreased when combined with Vemurafenib.,decrease,no risk
Bevantolol,Venlafaxine,The metabolism of Bevantolol can be decreased when combined with Venlafaxine.,decrease,no risk
Bevantolol,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Bevantolol.,increase,risk
Bevantolol,Vericiguat,Vericiguat may increase the hypotensive activities of Bevantolol.,increase,no risk
Bevantolol,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Bevantolol.,decrease,no risk
Bevantolol,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Vilazodone,The metabolism of Bevantolol can be decreased when combined with Vilazodone.,decrease,no risk
Bevantolol,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Bevantolol.,increase,no risk
Bevantolol,Viloxazine,The metabolism of Bevantolol can be decreased when combined with Viloxazine.,decrease,no risk
Bevantolol,Vinblastine,The metabolism of Bevantolol can be decreased when combined with Vinblastine.,decrease,no risk
Bevantolol,Vinorelbine,The metabolism of Bevantolol can be decreased when combined with Vinorelbine.,decrease,no risk
Bevantolol,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Bevantolol.,decrease,no risk
Bevantolol,Xylometazoline,The risk or severity of bradycardia can be increased when Xylometazoline is combined with Bevantolol.,increase,risk
Bevantolol,Yohimbine,Yohimbine may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Ziconotide,The risk or severity of bradycardia can be increased when Ziconotide is combined with Bevantolol.,increase,risk
Bevantolol,Zimelidine,The serum concentration of Bevantolol can be increased when it is combined with Zimelidine.,increase,no risk
Bevantolol,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Bevantolol.,increase,no risk
Bevantolol,Zofenopril,Bevantolol may increase the hypotensive activities of Zofenopril.,increase,no risk
Bevantolol,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Bevantolol.,decrease,no risk
Bevantolol,Zolpidem,The metabolism of Bevantolol can be decreased when combined with Zolpidem.,decrease,no risk
Bevantolol,Zonisamide,The risk or severity of bradycardia can be increased when Zonisamide is combined with Bevantolol.,increase,risk
Bevantolol,Zuclopenthixol,"Bevantolol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Zuclopenthixol.",increase,no risk
Glucosamine,Vorapaxar,Glucosamine may increase the antiplatelet activities of Vorapaxar.,increase,no risk
Glucosamine,Warfarin,Glucosamine may increase the anticoagulant activities of Warfarin.,increase,no risk
Practolol,Brexpiprazole,Practolol may increase the orthostatic hypotensive activities of Brexpiprazole.,increase,no risk
Practolol,Brimonidine,Brimonidine may increase the antihypertensive activities of Practolol.,increase,no risk
Practolol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Practolol.,increase,no risk
Practolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Practolol is combined with Bromotheophylline.,increase,risk
Practolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Practolol.,increase,risk
Practolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Bumetanide,Bumetanide may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Practolol.,increase,no risk
Practolol,Buprenorphine,The metabolism of Practolol can be decreased when combined with Buprenorphine.,decrease,no risk
Practolol,Bupropion,The metabolism of Practolol can be decreased when combined with Bupropion.,decrease,no risk
Practolol,Buspirone,Buspirone may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Butabarbital,The serum concentration of Practolol can be decreased when it is combined with Butabarbital.,decrease,no risk
Practolol,Butalbital,The serum concentration of Practolol can be decreased when it is combined with Butalbital.,decrease,no risk
Practolol,Butaperazine,The serum concentration of Practolol can be increased when it is combined with Butaperazine.,increase,no risk
Practolol,Butriptyline,Butriptyline may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Galantamine,Galantamine may increase the bradycardic activities of Practolol.,increase,no risk
Practolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Practolol.,increase,no risk
Practolol,Gefitinib,The metabolism of Practolol can be decreased when combined with Gefitinib.,decrease,no risk
Practolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Practolol.,increase,no risk
Practolol,Givosiran,The serum concentration of Practolol can be increased when it is combined with Givosiran.,increase,no risk
Practolol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Practolol.,increase,no risk
Practolol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Practolol.,increase,no risk
Practolol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Practolol.,increase,no risk
Practolol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Practolol.,increase,no risk
Practolol,Glucagon,The therapeutic efficacy of Practolol can be decreased when used in combination with Glucagon.,decrease,no risk
Practolol,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Practolol.,increase,no risk
Practolol,Glycerol phenylbutyrate,The metabolism of Practolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Practolol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Practolol.,increase,no risk
Practolol,Golimumab,The metabolism of Practolol can be increased when combined with Golimumab.,increase,no risk
Practolol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Practolol.,decrease,no risk
Practolol,Guanadrel,Guanadrel may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Guanethidine,Guanethidine may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Practolol.,decrease,no risk
Practolol,Guanoxan,Practolol may increase the hypotensive activities of Guanoxan.,increase,no risk
Practolol,Halofantrine,The metabolism of Practolol can be decreased when combined with Halofantrine.,decrease,no risk
Practolol,Haloperidol,The serum concentration of Practolol can be increased when it is combined with Haloperidol.,increase,no risk
Practolol,Halothane,Halothane may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Practolol.,increase,risk
Practolol,Hexafluronium,Hexafluronium may increase the bradycardic activities of Practolol.,increase,no risk
Practolol,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Practolol.,increase,risk
Practolol,Huperzine A,Huperzine A may increase the bradycardic activities of Practolol.,increase,no risk
Practolol,Hydralazine,Hydralazine may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Hydrochlorothiazide,The therapeutic efficacy of Practolol can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Practolol,Hydroflumethiazide,The therapeutic efficacy of Practolol can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Practolol,Hydroxychloroquine,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Practolol.,decrease,risk
Practolol,Hydroxyzine,The metabolism of Practolol can be decreased when combined with Hydroxyzine.,decrease,no risk
Practolol,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Practolol.,increase,no risk
Practolol,Ketamine,Ketamine may increase the bradycardic activities of Practolol.,increase,no risk
Practolol,Ketoconazole,The metabolism of Practolol can be decreased when combined with Ketoconazole.,decrease,no risk
Practolol,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Ketorolac,Ketorolac may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Practolol.,increase,risk
Practolol,Obinutuzumab,Practolol may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Practolol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Practolol.,increase,no risk
Practolol,Olanzapine,Practolol may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Practolol,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Practolol.,decrease,no risk
Practolol,Olmesartan,Olmesartan may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Practolol.,decrease,no risk
Practolol,Ondansetron,The metabolism of Practolol can be decreased when combined with Ondansetron.,decrease,no risk
Practolol,Opicapone,Opicapone may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Opium,The metabolism of Opium can be decreased when combined with Practolol.,decrease,no risk
Practolol,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Practolol.,decrease,no risk
Practolol,Oritavancin,The metabolism of Practolol can be decreased when combined with Oritavancin.,decrease,no risk
Practolol,Orphenadrine,The metabolism of Practolol can be decreased when combined with Orphenadrine.,decrease,no risk
Practolol,Osilodrostat,The metabolism of Practolol can be decreased when combined with Osilodrostat.,decrease,no risk
Practolol,Ospemifene,The metabolism of Practolol can be decreased when combined with Ospemifene.,decrease,no risk
Practolol,Ouabain,Practolol may increase the bradycardic activities of Ouabain.,increase,no risk
Practolol,Oxamniquine,The metabolism of Practolol can be decreased when combined with Oxamniquine.,decrease,no risk
Practolol,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Oxprenolol,Practolol may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Practolol,Oxtriphylline,The risk or severity of adverse effects can be increased when Practolol is combined with Oxtriphylline.,increase,risk
Practolol,Oxybutynin,The metabolism of Practolol can be decreased when combined with Oxybutynin.,decrease,no risk
Practolol,Oxycodone,The metabolism of Practolol can be decreased when combined with Oxycodone.,decrease,no risk
Practolol,Oxymetazoline,The therapeutic efficacy of Practolol can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Practolol,Oxymorphone,The metabolism of Practolol can be decreased when combined with Oxymorphone.,decrease,no risk
Practolol,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Quetiapine,Quetiapine may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Quinapril,Quinapril may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Quinidine,Quinidine may increase the arrhythmogenic activities of Practolol.,increase,no risk
Practolol,Quinine,The metabolism of Practolol can be decreased when combined with Quinine.,decrease,no risk
Practolol,Quinupramine,Quinupramine may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Udenafil,Udenafil may increase the antihypertensive activities of Practolol.,increase,no risk
Practolol,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Practolol.,decrease,no risk
Practolol,Unoprostone,Practolol may increase the hypotensive activities of Unoprostone.,increase,no risk
Practolol,Urochloa mutica pollen,The risk of a hypersensitivity reaction to Urochloa mutica pollen is increased when it is combined with Practolol.,increase,risk
Practolol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Practolol.,decrease,no risk
Practolol,Valdecoxib,Valdecoxib may decrease the antihypertensive activities of Practolol.,decrease,no risk
Practolol,Valsartan,Valsartan may increase the hypotensive activities of Practolol.,increase,no risk
Practolol,Vardenafil,Vardenafil may increase the antihypertensive activities of Practolol.,increase,no risk
Practolol,Varenicline,The risk or severity of adverse effects can be increased when Practolol is combined with Varenicline.,increase,risk
